<body style="font: 10pt Times New Roman, Times, Serif"> <document>  <type>   10-K   <sequence>    1    <filename>     form10-k.htm     <text>      <title>      </title>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <!-- Field: Rule-Page -->      <div style="width: 100%">       <div style="font-size: 1pt; border-top: Black 4pt solid; border-bottom: Black 1.5pt solid">        <font style="font-family: Times New Roman, Times, Serif">        </font>       </div>      </div>      <!-- Field: /Rule-Page -->      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">       <font style="font-family: Times New Roman, Times, Serif; font-size: 18pt">        <b>         UNITEDSTATES        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">       <font style="font-family: Times New Roman, Times, Serif; font-size: 18pt">        <b>         SECURITIESAND EXCHANGE COMMISSION        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">       <font style="font-family: Times New Roman, Times, Serif; font-size: 12pt">        <b>         Washington,D.C. 20549        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">       <font style="font-family: Times New Roman, Times, Serif; font-size: 18pt">        <b>         FORM10-K        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">       <tbody>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           <b>            [X]           </b>          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           <b>            Annual    Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934           </b>          </font>         </td>        </tr>       </tbody>      </table>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         Forthe fiscal year ended December 31, 2020        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         OR        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">       <tbody>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           <b>            [           </b>           ]          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           <b>            Transition    Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934           </b>          </font>         </td>        </tr>       </tbody>      </table>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         Commissionfile number 1-16467        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">       <font style="font-family: Times New Roman, Times, Serif; font-size: 18pt">        <b>         RespireRxPharmaceuticals Inc.        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         (Exactname of registrant as specified in its charter)        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">       <tbody>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif; width: 49%; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           <b>            Delaware           </b>          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; width: 2%">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; width: 49%; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           <b>            33-0303583           </b>          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif">          <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            <b>             (State                                         or other jurisdiction of            </b>           </font>          </p>          <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            <b>             incorporation        or organization)            </b>           </font>          </p>         </td>         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif">          <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            <b>             (I.R.S.                                         Employer            </b>           </font>          </p>          <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            <b>             Identification        Number)            </b>           </font>          </p>         </td>        </tr>       </tbody>      </table>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         126Valley Road, Suite C        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         GlenRock, New Jersey 07452        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         (Addressof principal executive offices, including zip code)        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         (201)444-4947        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         (Registrant’stelephone number, including area code)        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         Securitiesregistered under Section 12(b) of the Act:        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">       <tbody>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 24%">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           Title    of each class          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; width: 2%">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 24%">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           Trading    Symbol(s)          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; width: 2%">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 48%">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           Name    of each exchange on which registered          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           N/A          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           N/A          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           N/A          </font>         </td>        </tr>       </tbody>      </table>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         Securitiesregistered under Section 12(g) of the Act:        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         CommonStock, $0.001 par value        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         (Titleof Class)        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Indicateby check mark whether the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. YES [  ]NO [X]       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Indicateby check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Exchange Act. YES[  ] NO [X]       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Indicateby check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities ExchangeAct during the preceding 12 months (or for such shorter period that the registrant was required to file such reports); and (2)has been subject to such filing requirements for the past 90 days. YES [X] NO [  ]       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Indicateby check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuantto Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submitsuch files). YES [X] NO [  ]       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Indicateby check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reportingcompany, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,”“smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">       <tbody>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif; width: 20%">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           Large    accelerated filer [  ]          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; width: 2%">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; width: 19%">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           Accelerated    filer [  ]          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; width: 1%">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; width: 18%">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           Non-accelerated    filer [X]          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; width: 2%">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; width: 18%">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           Smaller    reporting company [X]          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; width: 2%">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; width: 18%">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           Emerging    growth company [  ]          </font>         </td>        </tr>       </tbody>      </table>      <p style="text-indent: 20pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Ifan emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period forcomplying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. [  ]       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Indicateby check mark whether the registrant has filed a report on and attestation to its management’s assessment of the effectivenessof its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registeredpublic accounting firm that prepared or issued its audit report. [  ]       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Indicateby check mark whether the registrant is a shell company (as defined in Exchange Act Rule 12b-2). YES [  ] NO [X]       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Theaggregate market value of the voting stock held by non-affiliates as of June 30, 2020 was approximately $1,300,112(based on the closing sale price of the common stock as reported by the OTC QB) on June 30, 2020.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Asof April 13, 2021, there were 89,496,596 shares of the registrant’s common stock outstanding.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         DOCUMENTSINCORPORATED BY REFERENCE:        </b>        NONE       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <!-- Field: Rule-Page -->      <div style="margin-top: 0; margin-bottom: 0; width: 100%">       <div style="font-size: 1pt; border-top: Black 1.5pt solid; border-bottom: Black 4pt solid">        <font style="font-family: Times New Roman, Times, Serif">        </font>       </div>      </div>      <!-- Field: /Rule-Page -->      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">      </p>      <!-- Field: Page; Sequence: 1 -->      <div style="margin-bottom: 6pt; border-bottom: Black 1.5pt solid">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="width: 100%">          </td>         </tr>        </tbody>       </table>      </div>      <div style="break-before: page; margin-top: 6pt">       <p style="margin: 0pt">       </p>      </div>      <!-- Field: /Page -->      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         TABLEOF CONTENTS        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">       <tbody>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; width: 0.65in">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: center; font: 10pt Times New Roman, Times, Serif; width: 0.5in">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           <b>            Page           </b>          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           <b>            <a href="#a_001">             PART    I            </a>           </b>          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="text-align: center; font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="text-align: center; font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           Item    1.          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           <a href="#a_002">            Business           </a>          </font>         </td>         <td style="text-align: center; font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           4          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="text-align: center; font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           Item    1A.          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           <a href="#a_003">            Risk    Factors           </a>          </font>         </td>         <td style="text-align: center; font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           20          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="text-align: center; font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           Item    1B.          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           <a href="#a_004">            Unresolved    Staff Comments           </a>          </font>         </td>         <td style="text-align: center; font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           30          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="text-align: center; font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           Item    2.          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           <a href="#a_005">            Properties           </a>          </font>         </td>         <td style="text-align: center; font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           30          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="text-align: center; font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           Item    3.          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           <a href="#a_006">            Legal    Proceedings           </a>          </font>         </td>         <td style="text-align: center; font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           30          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="text-align: center; font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           Item    4.          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           <a href="#a_007">            Mine    Safety Disclosures           </a>          </font>         </td>         <td style="text-align: center; font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           30          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="text-align: center; font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           <b>            <a href="#a_008">             PART    II            </a>           </b>          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="text-align: center; font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="text-align: center; font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           Item    5.          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           <a href="#a_009">            Market    for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities           </a>          </font>         </td>         <td style="text-align: center; font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           31          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="text-align: center; font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           Item    6.          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           <a href="#a_010">            Selected    Financial Data           </a>          </font>         </td>         <td style="text-align: center; font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           31          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="text-align: center; font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           Item    7.          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           <a href="#a_011">            Management’s    Discussion and Analysis of Financial Condition and Results of Operations           </a>          </font>         </td>         <td style="text-align: center; font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           31          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="text-align: center; font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           Item    7A.          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           <a href="#a_012">            Quantitative    and Qualitative Disclosures About Market Risk           </a>          </font>         </td>         <td style="text-align: center; font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           44          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="text-align: center; font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           Item    8.          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           <a href="#a_015">            Financial    Statements and Supplementary Data           </a>          </font>         </td>         <td style="text-align: center; font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           44          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="text-align: center; font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           Item    9.          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           <a href="#a_014">            Changes    in and Disagreements with Accountants on Accounting and Financial Disclosure           </a>          </font>         </td>         <td style="text-align: center; font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           44          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="text-align: center; font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           Item    9A.          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           <a href="#a_015">            Controls    and Procedures           </a>          </font>         </td>         <td style="text-align: center; font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           44          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="text-align: center; font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           Item    9B.          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           <a href="#a_016">            Other    Information           </a>          </font>         </td>         <td style="text-align: center; font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           46          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="text-align: center; font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           <b>            <a href="#a_017">             PART    III            </a>           </b>          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="text-align: center; font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="text-align: center; font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           Item    10.          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           <a href="#a_018">            Directors,    Executive Officers and Corporate Governance           </a>          </font>         </td>         <td style="text-align: center; font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           46          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="text-align: center; font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           Item    11.          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           <a href="#a_019">            Executive    Compensation           </a>          </font>         </td>         <td style="text-align: center; font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           50          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="text-align: center; font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           Item    12.          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           <a href="#b_001">            Security    Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters           </a>          </font>         </td>         <td style="text-align: center; font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           54          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="text-align: center; font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           Item    13.          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           <a href="#b_002">            Certain    Relationships and Related Transactions, and Director Independence           </a>          </font>         </td>         <td style="text-align: center; font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           57          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="text-align: center; font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           Item    14.          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           <a href="#b_003">            Principal    Accountant Fees and Services           </a>          </font>         </td>         <td style="text-align: center; font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           58          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="text-align: center; font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           <b>            <a href="#b_004">             PART    IV            </a>           </b>          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="text-align: center; font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="text-align: center; font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           Item    15.          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           <a href="#b_005">            Exhibits    and Financial Statement Schedules           </a>          </font>         </td>         <td style="text-align: center; font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           58          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="text-align: center; font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           Item    16.          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           <a href="#b_006">            Form    10-K Summary           </a>          </font>         </td>         <td style="text-align: center; font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           58          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="text-align: center; font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">         <td colspan="2" style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           <b>            <a href="#b_007">             Signatures            </a>           </b>          </font>         </td>         <td style="text-align: center; font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           67          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="text-align: center; font: 10pt Times New Roman, Times, Serif">         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">         <td colspan="2" style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           <b>            <a href="#b_008">             Consolidated    Financial Statements            </a>           </b>          </font>         </td>         <td style="text-align: center; font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           F-1          </font>         </td>        </tr>       </tbody>      </table>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->      <div style="margin-bottom: 6pt; border-bottom: Black 1.5pt solid">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="text-align: center; width: 100%">           <!-- Field: Sequence; Type: Arabic; Name: PageNo -->           2           <!-- Field: /Sequence -->          </td>         </tr>        </tbody>       </table>      </div>      <div style="break-before: page; margin-top: 6pt">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="width: 100%">          </td>         </tr>        </tbody>       </table>      </div>      <!-- Field: /Page -->      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Inthis Annual Report on Form 10-K, the terms “RespireRx,” the “Company,” “we,” “us”and “our” refer to RespireRx Pharmaceuticals Inc. a Delaware corporation, and, unless the context indicates otherwise,its consolidated subsidiaries.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         INTRODUCTORYNOTE REGARDING FORWARD-LOOKING STATEMENTS        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        ThisAnnual Report on Form 10-K of RespireRx Pharmaceuticals Inc. (“RespireRx” and together with RespireRx’s whollyowned subsidiary, Pier Pharmaceuticals, Inc. (“Pier”), the “Company, “we,” or “our,”unless the context indicates otherwise) contains certain forward-looking statements within the meaning of Section 27A of the SecuritiesAct of 1933, as amended (the “Securities Act”) and Section 21E of the Securities Exchange Act of 1934, as amended(the “Exchange Act”), and the Company intends that such forward-looking statements be subject to the safe harbor createdthereby. These might include statements regarding the Company’s future plans, targets, estimates, assumptions, financialposition, business strategy and other plans and objectives for future operations, and assumptions and predictions about researchand development efforts, including, but not limited to, preclinical and clinical research design, execution, timing, costs andresults, future product demand, supply, manufacturing, costs, marketing and pricing factors.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Insome cases, forward-looking statements may be identified by words including “assumes,” “could,” “ongoing,”“potential,” “predicts,” “projects,” “should,” “will,” “would,”“anticipates,” “believes,” “intends,” “estimates,” “expects,” “plans,”“contemplates,” “targets,” “continues,” “budgets,” “may,” or the negativeof these terms or other comparable terminology, although not all forward-looking statements contain these words, and such statementsmay include, but are not limited to, statements regarding (i) future research plans, expenditures and results, (ii) potentialcollaborative arrangements, (iii) the potential utility of the Company’s products candidates, (iv) reorganization plans,and (v) the need for, and availability of, additional financing. Forward-looking statements are based on information availableat the time the statements are made and involve known and unknown risks, uncertainties and other factors that may cause our results,levels of activity, performance or achievements to be materially different from the information expressed or implied by the forward-lookingstatements in this report.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Youshould read these risk factors and the other cautionary statements made in the Company’s filings as being applicable toall related forward-looking statements wherever they appear in this report. We cannot assure you that the forward-looking statementsin this report will prove to be accurate and therefore prospective investors are encouraged not to place undue reliance on forward-lookingstatements. You should read this report completely. Other than as required by law, we undertake no obligation to update or revisethese forward-looking statements, even though our situation may change in the future.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Wecaution investors not to place undue reliance on any forward-looking statement that speaks only as of the date made and to recognizethat forward-looking statements are predictions of future results, which may not occur as anticipated. Actual results could differmaterially from those anticipated in the forward-looking statements and from historical results, due to the risks and uncertaintiesdescribed in this report, as well as others that we may consider immaterial or do not anticipate at this time. These forward-lookingstatements are based on assumptions regarding the Company’s business and technology, which involve judgments with respectto, among other things, future scientific, economic, regulatory and competitive conditions, collaborations with third parties,and future business decisions, all of which are difficult or impossible to predict accurately and many of which are beyond theCompany’s control. Although we believe that the expectations reflected in our forward-looking statements are reasonable,we do not know whether our expectations will prove correct. Our expectations reflected in our forward-looking statements can beaffected by inaccurate assumptions that we might make or by known or unknown risks and uncertainties, including those describedin this report. These risks and uncertainties are not exclusive and further information concerning us and our business, includingfactors that potentially could materially affect our financial results or condition, may emerge from time to time.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Formore information about the risks and uncertainties the Company faces, see “Item 1A. Risk Factors.” Forward-lookingstatements speak only as of the date they are made. The Company does not undertake and specifically declines any obligation toupdate any forward-looking statements or to publicly announce the results of any revisions to any statements to reflect new informationor future events or developments. We advise investors to consult any further disclosures we may make on related subjects in ourannual reports on Form 10-K, quarterly reports on Form 10-Q and current reports on Form 8-K that we file with or furnish to theSEC.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <!-- Field: Page; Sequence: 3; Value: 2 -->      <div style="margin-bottom: 6pt; border-bottom: Black 1.5pt solid">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="text-align: center; width: 100%">           <!-- Field: Sequence; Type: Arabic; Name: PageNo -->           3           <!-- Field: /Sequence -->          </td>         </tr>        </tbody>       </table>      </div>      <div style="break-before: page; margin-top: 6pt">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="width: 100%">          </td>         </tr>        </tbody>       </table>      </div>      <!-- Field: /Page -->      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         <a name="a_001">         </a>         PARTI        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         <a name="a_002">         </a>         Item1. Business        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif">        TheCompany was incorporated in Delaware in 1987 as Cortex Pharmaceuticals, Inc. and change its name to RespireRx PharmaceuticalsInc. in 2015.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Themission of the Company is to develop innovative and revolutionary treatments to combat disorders caused by disruption of neuronalsignaling. We are developing treatment options that address obstructive sleep apnea (“OSA”), attention deficithyperactivity disorder (“ADHD”) epilepsy, chronic pain, including inflammatory and neuropathic pain, and recoveryfrom spinal cord injury (“SCI”), which are conditions that affect millions of people but for which there are limitedor poor treatment options. We are also developing treatment options for other conditions based on results of animal studiesto date.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        RespireRxis developing a pipeline of new drug products supported by our broad patent portfolios across two distinct drug platforms:       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">       <tbody>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           (i)          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           our    pharmaceutical cannabinoids platform (which we refer to as ResolutionRx), which includes dronabinol (a synthetic form    of ∆9-tetrahydrocannabinol (“Δ9-THC”)), which acts upon the nervous system’s endogenous cannabinoid    receptors, and          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           (ii)          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           our    neuromodulators platform (which we refer to as EndeavourRx) comprising two programs: (a) our AMPAkines program, including    proprietary compounds that are positive allosteric modulators (“PAMs”) of AMPA-type glutamate receptors to promote    neuronal function and (b) our GABAkines program, including proprietary compounds that are PAMs of GABA           <sub>            A           </sub>           receptors,    which program was recently established pursuant to our entry with the University of Wisconsin-Milwaukee Research Foundation,    Inc., an affiliate of the University of Wisconsin-Milwaukee (“UWMRF”), into a patent license agreement (the UWMRF    Patent License Agreement”).          </font>         </td>        </tr>       </tbody>      </table>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Inorder to facilitate our business activities and product development, we have organized our drug platforms into two separatebusiness units. The business unit focused on pharmaceutical cannabinoids is referred to as ResolutionRx and the businessunit focused on neuromodulators is referred to as EndeavourRx. It is anticipated that the Company will use, at least initially,its management personnel to provide management, operational and oversight services to these two business units.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Managementintends to organize our ResolutionRx and EndeavourRx business units into two subsidiaries: (i) a ResolutionRx subsidiary, intowhich we would contribute our pharmaceutical cannabinoid platform and its related tangible and intangible assets and certainof its liabilities and (ii) an EndeavourRx subsidiary, into which we would contribute our neuromodulator platform, includingboth the AMPAkine and GABAkine programs and their related tangible and intangible assets and certain of their liabilities.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Managementbelieves that there are advantages to separating these platforms formally into newly formed subsidiaries, including but not limitedto optimizing their asset values through separate financing channels and making them more attractive for capital raisingas well as for strategic transactions.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        TheCompany is also engaged in a number of business development efforts (licensing/sub-licensing, joint venture and other commercialstructures) with a view to securing strategic partnerships that represent strategic and operational infrastructure additions,as well as cash and in-kind funding opportunities. These efforts have focused on, but have not been limited to, transacting withbrand and generic pharmaceutical and biopharmaceutical companies as well as companies with potentially useful formulation or manufacturingcapabilities, significant subject matter expertise and financial resources. No assurance can be given that any transaction willcome to fruition and that if it does, that the terms will be favorable to the Company.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <!-- Field: Page; Sequence: 4; Value: 2 -->      <div style="margin-bottom: 6pt; border-bottom: Black 1.5pt solid">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="text-align: center; width: 100%">           <!-- Field: Sequence; Type: Arabic; Name: PageNo -->           4           <!-- Field: /Sequence -->          </td>         </tr>        </tbody>       </table>      </div>      <div style="break-before: page; margin-top: 6pt">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="width: 100%">          </td>         </tr>        </tbody>       </table>      </div>      <!-- Field: /Page -->      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         <i>          Neurotransmission         </i>        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        RespireRxis developing drugs to modify neurotransmission and create advanced treatments for disorders with high unmet needs. Neurotransmissionis the basic process in the brain by which specialized nerve cells called neurons communicate information with each other.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">       <tbody>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif; width: 49%">          <font style="font-family: Times New Roman, Times, Serif">           <img alt="" src="image_01.jpg"/>          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; width: 1%">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; width: 50%; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           As    illustrated in this figure, during neurotransmission, neurons release chemicals called neurotransmitters which attach to receptors,    very specific protein structures residing on adjacent neurons. This enables neurons to communicate with one another by either    increasing or decreasing the excitability of the neuron receiving the communication. For example, glutamate is the primary    excitatory neurotransmitter in the brain, while gamma-amino-butyric acid (“GABA”) is the primary inhibitory neurotransmitter.    Neurons also contain receptors for the brain’s own natural cannabinoid (endocannabinoid) substances.          </font>         </td>        </tr>       </tbody>      </table>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         <i>          ResolutionRx– Pharmaceutical Cannabinoids         </i>        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <i>         Background        </i>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Cannabinoidsare pharmacologically active substances found within the marijuana plant. Due to the liberalization of state laws regulating theuse and sales of marijuana over the last 5 years, a major industry has grown around the commercialization of marijuana for bothmedical and recreational use. However, while personal marijuana use has been legalized in certain states, it still is not legalunder federal statutes and regulations. The medical use of any pharmacological agent must be approved by the U.S Food and DrugAdministration (“FDA”) and, to date, the FDA has not recognized or approved the marijuana plant as medicine nor isit federally legal to sell products that contain cannabinoids as drugs or dietary supplements without its approval.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Worldwideclinical research efforts have established the cannabinoid class of compounds as        <i>         bona fide        </i>        pharmaceutical products, or“pharmaceutical cannabinoids,” which are being developed and commercialized according to FDA regulatory and industryguidelines. Scientific research and commercial development to date has focused primarily on two major cannabinoids, Δ9-THCand cannabidiol (“CBD”). This research and development began in 1985 when dronabinol, a synthetic form of Δ9-THC,was approved as Marinol        <sup>         ®        </sup>        by the FDA for the treatment of AIDS-related anorexia and later for the treatment of chemotherapy-inducednausea and vomiting. Dronabinol, in its Marinol® formulation as well as numerous generic formulations, is available in 2.5mg, 5 mg, and 10 mg capsules, with a maximum labelled dosage of 20 mg/day for the AIDS indication, or 15 mg/m        <sup>         2        </sup>        perdose for chemotherapy-induced nausea and vomiting.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif">        One       </font>       <font style="font-family: Times New Roman, Times, Serif">        breakthrough subsequently led to the 2018 FDA approval ofEpidiolex        <sup>         ®        </sup>        , a proprietary oral solution of highly purified, plant-derived CBD sold by GW Pharmaceuticals plc (“GWPharma”) for the treatment of certain rare, treatment-resistant forms of epilepsy. Nabiximol        <sup>         ®        </sup>        , an oromucosalspray containing Δ9-THC and CBD, was approved under the tradename Sativex        <sup>         ®        </sup>        by applicable regulatory authoritiesin 29 countries outside the United States and is marketed and distributed by GW Pharmaceuticals plc (“GW”) (onFebruary 3, 2021, GW and Jazz Pharmaceuticals plc (“Jazz”) announced a definitive agreement pursuant to which Jazzwould acquire GW) in those countries for the treatment of multiple sclerosis.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <!-- Field: Page; Sequence: 5; Value: 2 -->      <div style="margin-bottom: 6pt; border-bottom: Black 1.5pt solid">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="text-align: center; width: 100%">           <!-- Field: Sequence; Type: Arabic; Name: PageNo -->           5           <!-- Field: /Sequence -->          </td>         </tr>        </tbody>       </table>      </div>      <div style="break-before: page; margin-top: 6pt">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="width: 100%">          </td>         </tr>        </tbody>       </table>      </div>      <!-- Field: /Page -->      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Thecommercialization of these pharmaceutical cannabinoids has opened the door to an expanding market sector. As part of our effortto capitalize upon this opportunity, the Company has implemented an internal restructuring plan by forming ResolutionRxas a business unit focused on the pharmaceutical cannabinoid market. ResolutionRx’s initial primary focushas been and will continue to be the re-purposing of dronabinol using new proprietary formulations and therapeutic indications.Because dronabinol already is an approved drug, we intend to use publicly available information, particularly safety data, insupport of a 505(b)(2) New Drug Application (“NDA”), a potentially more rapid route to FDA approval than a standard505(b)(1) NDA.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <i>         ObstructiveSleep Apnea (OSA)        </i>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        TheCompany is developing dronabinol for the treatment of OSA, a sleep-related breathing disorder that afflicts an estimated 29 millionpeople in the United States according to the American Academy of Sleep Medicine (“AASM”), and an additional 26 millionin Germany and 8 million in the United Kingdom, as presented at the European Respiratory Society’s annual Congress in Paris,France in September 2018. OSA involves a decrease or complete halt in airflow despite an ongoing effort to breathe during sleep.When the muscles relax during sleep, soft tissue in the back of the throat collapses and obstructs the upper airway. OSA remainssignificantly under-recognized, as only 20% of cases in the United States according to the AASM and 20% of cases globally havebeen properly diagnosed. About 24 percent of adult men and 9 percent of adult women are believed to have the breathing symptomsof OSA with or without daytime sleepiness. OSA significantly impacts the lives of sufferers who do not get enough sleep; theirquality of sleep is deteriorated such that daily function is compromised and limited. OSA is associated with decreased qualityof life, significant functional impairment, and increased risk of road traffic accidents, especially in professions like roadand rail transportation and shipping.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Researchhas established links between OSA and several important co-morbidities, including hypertension, type II diabetes, obesity, stroke,congestive heart failure, coronary artery disease, cardiac arrhythmias, and even early mortality. The consequences of undiagnosedand untreated OSA are medically serious and economically costly. According to the AASM, the estimated economic burden of OSA inthe United States is approximately $162 billion annually. All current treatment options have serious drawbacks. We believe thata new drug therapy that is effective in reducing the medical and economic burden of OSA would have major benefits for the treatmentof this costly disease indication.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        ContinuousPositive Airway Pressure (“CPAP”) is the most common treatment for OSA. CPAP devices work by blowing pressurized airinto the nose (or mouth and nose), which keeps the pharyngeal airway open. Patients must use the device whenever they sleep. Reductionof the apnea-hypopnea index (“AHI”) is the standard objective measure of therapeutic response in OSA. Apnea is thecessation of breathing for 10 seconds or more and hypopnea is a reduction in breathing. AHI is the sum of apnea and hypopnea eventsper hour. In the sleep laboratory, CPAP is highly effective at reducing AHI. However, the device is cumbersome and difficult formany patients to tolerate. Most studies describe that 25-50% of patients refuse to initiate or completely discontinue CPAP usewithin the first several months and that most patients who continue to use the device do so only intermittently.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Oraldevices may be an option for patients who cannot tolerate CPAP. Several dental devices are available. The cost of these devicestends to be high and side effects associated with them include night-time pain, dry lips, tooth discomfort, and excessive salivation.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Patientswith clinically significant OSA who cannot be treated adequately with CPAP or oral devices may elect to undergo surgery, the mostcommon form of which involves the removal of excess tissue in the throat to make the airway wider. Patients who undergo surgeryfor the treatment of OSA risk complications. Surgery is often unsuccessful, and at present, no method exists to reliably predicttherapeutic outcome from surgery.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        In2014 another surgical option became available based on upper airway stimulation. It is a combination of an implantablenerve stimulator and an external remote controlled by the patient. The implanted device stimulates the hypoglossal nerve, whichcontrols the tongue, with every attempted breath, regardless of whether such stimulation is needed for that breath. The deviceis turned on at night and off in the morning by the patient with the remote.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <i>        </i>       </font>      </p>      <!-- Field: Page; Sequence: 6; Value: 2 -->      <div style="margin-bottom: 6pt; border-bottom: Black 1.5pt solid">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="text-align: center; width: 100%">           <!-- Field: Sequence; Type: Arabic; Name: PageNo -->           6           <!-- Field: /Sequence -->          </td>         </tr>        </tbody>       </table>      </div>      <div style="break-before: page; margin-top: 6pt">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="width: 100%">          </td>         </tr>        </tbody>       </table>      </div>      <!-- Field: /Page -->      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <i>         TheCompany’s Research Efforts Regarding the Treatment of OSA with Cannabinoids        </i>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <i>        </i>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        TheCompany conducted a 21-day, randomized, double-blind, placebo-controlled, dose escalation Phase 2A clinical study in 22 patientswith OSA, in which FDA approved and commercially available dronabinol produced a statistically significant reduction in AHI, theprimary therapeutic end-point, and was observed to be safe and well tolerated, with the frequency of side effects no differentfrom placebo. This clinical trial provided data supporting the submission of patent applications claiming unique dosage strengths,blood levels and controlled release formulations optimized for use in the treatment of OSA. If approved, these pending patentswould extend market exclusivity until January 2042.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Withapproximately $5 million in funding from the National Heart, Lung and Blood Institute of the National Institutes of Health (“NIH”),Dr. David Carley of the University of Illinois at Chicago (“UIC”), along with his colleagues at UIC and NorthwesternUniversity, completed a Phase 2B multi-center, double-blind, placebo-controlled clinical trial of FDA approved and commerciallyavailable dronabinol in patients with OSA. This study, named “Pharmacotherapy of Apnea with Cannabimimetic Enhancement”(“PACE”) replicated our earlier Phase 2A study. The authors published in January 2018 in the journal SLEEP and reportedthat, in a dose-dependent fashion, treatment with 2.5 mg and 10 mg of dronabinol once per day at night, significantly reduced,compared to placebo, AHI during sleep in 56 evaluable patients with moderate to severe OSA who completed the study. Additionally,treatment with 10 mg of dronabinol significantly improved daytime sleepiness as measured by the Epworth Sleepiness Scale and achievedthe greatest overall patient satisfaction. As in our previous Phase 2A study, dronabinol was observed to be safe and well tolerated,with the frequency of side effects no different from placebo. The Company did not manage this clinical trial, which was fundedentirely by the National Heart, Lung and Blood Institute of NIH.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <i>         TheOpportunity to Improve Dronabinol Formulations        </i>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Dronabinolis currently marketed as a soft gelatin capsule that suffers from several major deficiencies.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        First,dronabinol exhibits poor and erratic absorption. Δ9-THC is not water soluble. The market-dominant commercial gel cap formulationof dronabinol is currently formulated as a sesame oil-based liquid within a soft gelatin capsule. The absorption of dronabinolafter oral administration is poor and highly variable with some patients achieving very high levels and others achieving verylow levels. This erratic absorption may be responsible for the variable therapeutic responses observed in dronabinol clinicaltrials. Syndros        <sup>         ®        </sup>        , on the other hand, is formulated as a solution in dehydrated alcohol, polyethylene glycol andother materials and exhibits its own challenges and deficiencies, including but not limited to it being classified as a ScheduleII drug by the U.S. Drug Enforcement Administration (the “DEA”) as compared to the capsule formulation that is classifiedas a Schedule III drug.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Second,dronabinol is rapidly and extensively (approximately 80%) metabolized upon first pass through the liver, resulting in low bloodlevels. Additionally, dronabinol has a relatively short half-life (approximately 3 – 4 hours) and, in its present formulation,is not optimally suited for therapeutic indications requiring blood levels to be sustained for 6 hours or longer.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Third,in order to achieve sustained, therapeutic blood levels, we have found it necessary to use higher doses of dronabinol in our OSAclinical trials. For example, over an 8-hour period, the 2.5 mg and 10 mg doses produced therapeutically equivalent effects duringthe first 4 hours, but only the 10 mg dose produced therapeutic effects during the second 4 hours. Unfortunately, the 10 mg doseproduces a higher occurrence of side effects than the 2.5 mg dose (as described in the Marinol        <sup>         ®        </sup>        package insert).We are currently focusing on new formulations that would achieve the blood levels produced by the lower doses for a sustainedtime period, resulting in the desired therapeutic effect(s) while minimizing undesirable side effects.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <i>         TheCompany’s Cannabinoid Intellectual Property Rights        </i>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Inorder to expand RespireRx’s respiratory disorders program and develop cannabinoids for the treatment of OSA, RespireRx acquired100% of the issued and outstanding equity securities of Pier Pharmaceuticals, Inc. (“Pier”) effective August 10, 2012pursuant to an Agreement and Plan of Merger. Pier was a clinical stage pharmaceutical company developing a pharmacologic treatmentfor OSA and had been engaged in research and clinical development activities.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Throughthe merger, RespireRx gained access to an Exclusive License Agreement (as amended, the “2007 License Agreement”) thatPier had entered into with UIC on October 10, 2007. The 2007 License Agreement covered certain patents and patent applicationsin the United States and other countries claiming the use of certain compounds referred to as cannabinoids, of which dronabinolis a specific example, for the treatment of sleep-related breathing disorders, including sleep apnea.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <!-- Field: Page; Sequence: 7; Value: 2 -->      <div style="margin-bottom: 6pt; border-bottom: Black 1.5pt solid">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="text-align: center; width: 100%">           <!-- Field: Sequence; Type: Arabic; Name: PageNo -->           7           <!-- Field: /Sequence -->          </td>         </tr>        </tbody>       </table>      </div>      <div style="break-before: page; margin-top: 6pt">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="width: 100%">          </td>         </tr>        </tbody>       </table>      </div>      <!-- Field: /Page -->      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        The2007 License Agreement was terminated effective March 21, 2013 and the Company entered into a new license agreement (the “2014License Agreement”) with UIC on June 27, 2014, the material terms of which were substantially similar to the 2007 LicenseAgreement. The 2014 License Agreement grants the Company, among other provisions, exclusive rights: (i) to practice certain patentsin the United States, Germany and the United Kingdom, as defined in the 2014 License Agreement, that are held by UIC; (ii) toidentify, develop, make, have made, import, export, lease, sell, have sold or offer for sale any related licensed products; and(iii) to grant sub-licenses of the rights granted in the 2014 License Agreement, subject to the provisions of the 2014 LicenseAgreement.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        The2014 License Agreement obligates the Company to pay UIC a license fee, royalties, patent costs and certain milestones. Royaltypayments include a royalty on net sales of 4%, payment on sub-licensee revenues of 12.5%, and a minimum annual royalty beginningin 2015 of $100,000, which is due and payable on December 31 of each year beginning on December 31, 2015. The due date of theminimum annual royalty obligation of $100,000 originally due on December 31, 2020, was extended to April 19, 2021 and was paid on April 1, 2021. One-time milestone payments may become due based uponthe achievement of certain development milestones. $350,000 will be due within five days after the dosing of the first patientin a Phase III human clinical trial anywhere in the world. $500,000 will be due within five days after the first NDA filing withthe FDA, as defined below, or a foreign equivalent. $1,000,000 will be due within twelve months of the first commercial sale.One-time and annual royalty payments may also become due and payable. In the year after the first application for market approvalis submitted to the FDA or a foreign equivalent and until approval is obtained, the minimum annual royalty will increase to $150,000.In the year after the first market approval is obtained from the FDA or a foreign equivalent and until the first sale of a product,the minimum annual royalty will increase to $200,000. In the year after the first commercial sale of a product, the minimum annualroyalty will increase to $250,000. For each of the fiscal years ended December 31, 2020 and 2019, the Company recorded a chargeto operations of $100,000 as its minimum annual royalty obligation, which is included in research and development expenses inthe Company’s consolidated statements of operations for the fiscal years ended December 31, 2020 and 2019, respectively.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        RespireRxhas exclusive rights to issued and pending patents claiming cannabinoid compositions and methods for treating cannabinoid-sensitivedisorders, including sleep apnea, pain, glaucoma, muscular spasticity, anorexia and other conditions. In October 2019, we fileda continuation-in-part for our pending patent that describes and claims novel doses, controlled release compositions and methodsof use for cannabinoids, and in January 2021, a provisional patent application further disclosing novel dosage and controlledrelease compositions and methods of use for cannabinoids, alone or in combination, including with cannabinoid and non-cannabinoidmolecules. Specific claims describe low dosage strengths and controlled release formulations for attaining a therapeutic windowof cannabinoid blood levels that produce the desired therapeutic effect(s) for a controlled period of time, while minimizing undesirableside effects. Certain original patents were filed by RespireRx and are now included in the 2014 License Agreement. See Note 9.Commitments and Contingencies—        <i>         University of Illinois 2014 Exclusive License Agreement        </i>        in the notes to our consolidatedfinancial statements as of December 31, 2020 for more information on the 2014 License Agreement. While no assurance can be providedthat the claims in this continuation-in-part or the U.S. provisional patent application will be allowed in whole or in part, orthat the patents will ultimately issue, we believe that these new filings, if allowed, will provide market protections throughJanuary 2042.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Webelieve our intellectual property initiatives may afford expanding strategic options and market exclusivity in the burgeoningpharmaceutical cannabinoid business sector. New cannabinoid formulation technology, including nano- and micro-emulsions and thinfilms, have been shown to bypass the normal route of absorption and liver metabolism of cannabinoids, thus dramatically increasingblood levels and allowing for the use of low doses. Similarly, technologies may be used to achieve a controlled release of dronabinol,and we believe that our pending patent priority relating back to 2010 predates the efforts of others seeking to develop low-doseor controlled or extended release formulations of cannabinoids.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <!-- Field: Page; Sequence: 8; Value: 2 -->      <div style="margin-bottom: 6pt; border-bottom: Black 1.5pt solid">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="text-align: center; width: 100%">           <!-- Field: Sequence; Type: Arabic; Name: PageNo -->           8           <!-- Field: /Sequence -->          </td>         </tr>        </tbody>       </table>      </div>      <div style="break-before: page; margin-top: 6pt">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="width: 100%">          </td>         </tr>        </tbody>       </table>      </div>      <!-- Field: /Page -->      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 40.5pt">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Datafrom our Phase 2 clinical trials has allowed us to design new proprietary formulations of dronabinol, disclosed in our patentfilings and optimized for the treatment of not only OSA, but also other indications. In support of this formulation program, DavidDickason joined the Company as Senior Vice-President Preclinical Product Development on September 15, 2020. Mr. Dickasonhas an extensive background in product formulation development. In laboratory studies, he has generated data confirming the potentialfor the creation of a proprietary dronabinol formulation with optimized dose and duration of action for treating OSA. If successfulin our development efforts, we believe that the development of a proprietary formulation of dronabinol for RespireRx basedon our pending patents for low-dose and extended release dronabinol could lead to the development of a marketable proprietaryformulation of dronabinol. We also believe that the development of a novel, proprietary formulation of dronabinol would only extendtime to market entry by approximately 12 months compared to the market entry with a currently available generic soft gel capsulebut would increase market value and extend market exclusivity given the anticipated new patents and our belief that certainstrategic partners would be more interested in a proprietary formulation than an existing one; however, no assurance can beprovided that any of the formulation technologies that we are currently analyzing will result in viable products.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <i>         ProposedRegulatory Approach for Dronabinol        </i>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Inconjunction with its management and consultants, the Company intends to file a new NDA under Section 505(b)(2) of the FederalFood, Drug and Cosmetic Act (as amended, the “FDCA” and such NDA a “505(b)(2) NDA”), claiming the efficacyand safety of our proposed proprietary dronabinol formulation in the treatment of OSA. We believe the use of dronabinol for thetreatment of OSA is a novel indication for an already approved drug, making it eligible for a 505(b)(2) NDA, as opposed to thesubmission and approval of a full 505(b)(1) NDA.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        The505(b)(2) NDA was created by the Hatch-Waxman Act, as amended (the “Hatch-Waxman Act”), which amended the FDCA tohelp avoid unnecessary duplication of studies already performed on a previously approved drug. As amended, the FDCA gives theFDA express permission to rely on data not developed by the NDA applicant. Accordingly, a 505(b)(2) NDA contains full safety andeffectiveness reports but allows at least some of the information required for NDA approval, such as safety and efficacy informationabout the active ingredient, to come from studies not conducted by or for the applicant. This can result in a less expensiveand faster route to approval, compared with a traditional development path, such as 505(b)(1), while still allowing for the creationof new, differentiated products. The 505(b)(2) NDA regulatory path offers the applicant market protections, such as market exclusivity,under the Hatch-Waxman Act and the rules promulgated thereunder. Other, international regulatory routes are available to pursueproprietary formulations of dronabinol and would provide further market protections. For example, in Europe, a regulatory approvalroute similar to the 505(b)(2) pathway is the hybrid procedure based on Article 10 of Directive 2001/83/EC.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Wehave worked with regulatory consultants who will assist with FDA filings and regulatory strategy. If we can secure sufficientfinancing, of which no assurance can be provided, we anticipate requesting a pre-IND (pre-Investigational New Drug application)meeting with the FDA. This meeting also could create the type of dialogue with the FDA that is normally communicated at an end-of-Phase2 meeting. The FDA responses to this meeting will be incorporated into an IND.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Ifwe can secure sufficient financing and successfully create a proprietary formulation of Δ9-THC, of which no assurance canbe provided, we plan to propose conducting the appropriate clinical studies with our proprietary controlled release formulationin OSA patients to determine safety, pharmacokinetics (“PK”) and efficacy, as well as a standard Phase 1 clinicalstudy to determine potential abuse liability. When a Phase 3 study is required for a 505(b)(2), usually only one study with fewerpatients is necessary versus the two, large scale, confirmatory studies generally required for the standard 505(b)(1) NDA. Whileno assurance can be provided, with an extensive safety database tracking chronic, long-term use of Marinol® and generics,we believe that the FDA should not have major safety concerns with dronabinol in the treatment of OSA.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        TheCompany has worked with the investigators who conducted the Phase 2B clinical trial and our Clinical Advisory Panel to designa draft Phase 3 protocol that, based on the experience and results from the Phase 2A and Phase 2B trials, we believe will providesufficient data for FDA approval of a RespireRx dronabinol controlled release formulation for OSA. The current version of theprotocol is designed as a 90-day randomized, blinded, placebo-controlled study of dronabinol in the treatment of OSA. Dependingon feedback from the FDA, the Company estimates that the Phase 3 trial would require between 120 and 300 patients at 15 to 20sites, and take 18 to 24 months to complete, at a cost of between $10 million and $14 million.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <!-- Field: Page; Sequence: 9; Value: 2 -->      <div style="margin-bottom: 6pt; border-bottom: Black 1.5pt solid">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="text-align: center; width: 100%">           <!-- Field: Sequence; Type: Arabic; Name: PageNo -->           9           <!-- Field: /Sequence -->          </td>         </tr>        </tbody>       </table>      </div>      <div style="break-before: page; margin-top: 6pt">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="width: 100%">          </td>         </tr>        </tbody>       </table>      </div>      <!-- Field: /Page -->      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Webelieve our rights under the Purisys Agreement would help facilitate regulatory approval. See “Information with Respectto our Company—Description of Business—        <i>         Manufacturing        </i>        ” for information on the Purisys Agreement. Underthe Purisys Agreement, Purisys has agreed to (i) provide all of the API estimated to be needed for the clinical development processfor first- and second-generation products, three validation batches for NDA filings and adequate supply for the initial inventorystocking for the wholesale and retail channels, subject to certain limitations, (ii) maintain or file valid DMFs with the FDAor any other regulatory authority and provide the Company with access or a right of reference letter entitling the Company tomake continuing reference to the DMFs during the term of the agreement in connection with any regulatory filings made with theFDA by the Company, (iii) participate on a development committee, and (iv) make available its regulatory consultants, collaboratewith any regulatory consulting firms engaged by the Company and participate in all FDA or DEA meetings as appropriate and as relatedto the API.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Inconsideration for these supplies and services, the Company has agreed to (i) purchase exclusively from Purisys, during the commercializationphase, all API for these products at a pre-determined price subject to certain producer price adjustments and (ii) allow Purisys’sparticipation in the economic success of the commercialized products up to the earlier of the achievement of a maximum dollaramount or the expiration of a period of time.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <i>         LargeCommercial Opportunity        </i>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Asa serious public health issue, the important need for diagnosing and ultimately treating OSA has recently been highlighted bythe FDA clearance of several sleep apnea home test kits that are now third party reimbursed. Further highlighting this need, CVSHealth Corporation (NYSE: CVS) announced the implementation of a program to diagnose and treat OSA initially within itsown in-store, walk-in MinuteClinics. If implemented throughout its HealthHUB store network, we expect the numberof people diagnosed with sleep apnea and eligible for treatment to increase dramatically. Fitbit, Inc., (NYSE: FIT), ahealth oriented smart watch company is seeking clearance from the FDA to diagnose sleep apnea. We believe that the combinationof more efficient and patient friendly diagnostic procedures and, ultimately, pharmaceutical treatments such as those we are developingwill encourage more patients to seek diagnosis and treatment. As noted above, there are approximately 29 million OSA patientsin the United States and an additional 26 million in Germany and 8 million in the United Kingdom. There are currently no drugsapproved for the treatment of OSA.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: -0.25in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         <i>          EndeavourRx– Neuromodulators         </i>        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <i>         Background        </i>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Asdescribed above, during the neurotransmission process, neurons release neurotransmitters that attach to specific receptors residingon adjacent neurons, enabling them to communicate with one another and produce excitatory or inhibitory effects. For example,glutamate is the primary excitatory neurotransmitter in the brain and GABA is the primary inhibitory neurotransmitter. While theneurotransmitter attachment site on each of these receptors does not change, the receptor protein subunit structures can varyso that the receptors can produce a variety of effects. With the AMPA glutamate receptor, the binding of glutamate or an artificialagonist to its attachment site causes a change in the structure of the AMPA receptor resulting in an influx of cations and anincreased excitability. Likewise, in the case of the GABA        <sub>         A        </sub>        receptor, the binding of GABA or an artificial agonist toits attachment site causes a change in the structure of the GABA        <sub>         A        </sub>        receptor ion channel and increases the flow of chlorideions (negatively charged anion) into the cell, resulting in a decreased excitability.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Neurotransmitterreceptor proteins also may contain auxiliary “allosteric” binding sites, which are located adjacent to the agonistbinding sites at which neurotransmitters act. Unlike neurotransmitters, neuromodulators are drugs that act at these allostericbinding sites rather than directly at the agonist binding site. They can act either as PAMs, which enhance, or as negative allostericmodulators (“NAMs”), which reduce, the actions of neurotransmitters at their primary receptor sites. Neuromodulatorshave no intrinsic activity of their own. We have coined the terms “AMPAkines” and “GABAkines” to referto drugs that act as PAMs at the AMPA and GABA        <sub>         A        </sub>        receptors, respectively. By enhancing the effects of neurotransmitterswithout altering the normal pattern of neuronal activity, neuromodulators offer the possibility of developing “kinder andgentler” neuropharmacological drugs effective in certain neurological and neuropsychiatric disorders, with greater pharmacologicalspecificity and reduced side effects.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <!-- Field: Page; Sequence: 10; Value: 2 -->      <div style="margin-bottom: 6pt; border-bottom: Black 1.5pt solid">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="text-align: center; width: 100%">           <!-- Field: Sequence; Type: Arabic; Name: PageNo -->           10           <!-- Field: /Sequence -->          </td>         </tr>        </tbody>       </table>      </div>      <div style="break-before: page; margin-top: 6pt">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="width: 100%">          </td>         </tr>        </tbody>       </table>      </div>      <!-- Field: /Page -->      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif">        <i>         ProposedRegulatory Approach for AMPAkines and GABAkines        </i>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif">        Inconjunction with its management and consultants, the Company intends to initially perform appropriate and required preclinicalstudies with its GABAkines and file investigational new drug applications (“INDs”) to commence clinical trials withone or more of those drug candidates and either amend INDs or file new INDs for its AMPAkines in order to conduct additional clinicaltrials with those drug candidates. If such studies shows statistically significant improvement in appropriate clinical endpointswould likely result in the filing of one or more NDAs for the AMPAkine and GABAkine drug product candidates, under Section505(b)(1) of the Federal Food, Drug and Cosmetic Act as amended, The 505(b)(1) NDA is the traditional regulatory path for newchemical entities (NCEs).       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Aspart of our effort to       </font>       <font style="font: 10pt Times New Roman, Times, Serif">        capitalize upon a possible market opportunitywith respect to neuromodulators, the Company has implemented an internal restructuring plan, by which EndeavourRxbecame a stand-alone business unit focused on the neuromodulator market. EndeavourRx comprises our AMPAkineprogram and our GABAkine program.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <i>         AMPAkines        </i>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        TheCompany is developing a class of proprietary compounds known as AMPAkines, which are PAMs of the AMPA glutamate receptor. AMPAkinesare small molecule compounds that enhance the excitatory actions of glutamate at the AMPA receptor complex, which mediates mostexcitatory transmission in the central nervous system (“CNS”). Through an extensive translational research effortfrom the cellular level through Phase 2 clinical trials, we have developed a family of AMPAkines, including CX717, CX1739 andCX1942 that may have clinical application in the treatment of CNS-driven neurobehavioral and cognitive disorders, SCI, neurologicaldiseases, and certain orphan indications. CX717 and CX1739, our lead clinical compounds, have successfully completed multiplePhase 1 safety trials with no drug-associated serious adverse events. Both compounds have also completed Phase 2 efficacy trialsdemonstrating target engagement, by antagonizing the process of opioid-induced respiratory depression (“OIRD”). CX717has successfully completed a Phase 2 trial demonstrating the ability to significantly reduce the symptoms of adult ADHD. In anearly Phase 2 study, CX1739 improved breathing in patients with central sleep apnea. Preclinical studies have highlighted thepotential ability of these AMPAkines to improve motor function in animals with SCI. Subject to raising sufficient financing (ofwhich no assurance can be provided), we believe that we will be able to initiate a human Phase 2 study with CX1739 or CX717 inpatients with SCI and a human Phase 2 study in patients with ADHD using either CX1739 or CX717.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <i>         AMPAkinesas Treatment for ADHD        </i>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        ADHDis a relatively common neurobehavioral disorder. Currently available treatments for ADHD include amphetamine-type stimulants andnon-stimulant agents targeting monoaminergic neurotransmitter systems in the brain. However, these neurotransmitter systems arenot restricted to the brain and are widely found throughout the body. Thus, while these agents can be effective in amelioratingADHD symptoms, they also can produce adverse cardiovascular effects, such as increased heart rate and blood pressure. Existingtreatments also affect eating habits and can reduce weight gain and growth in children and have been associated with suicidalideation in adolescents and adults. In addition, approved stimulant treatments are DEA classified as controlled substances andpresent logistical issues for distribution and protection from diversion. Approved non-stimulant treatments, such as atomoxetine(Strattera® and its generic equivalents), can take four to eight weeks to become effective and undesirable side effects alsohave been observed.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Variousinvestigators have generated data supporting the concept that alterations in AMPA receptor function might underlie the productionof some of the symptoms of ADHD. In rodent and primate models of cognition, AMPAkines have been demonstrated to reduce inattentionand impulsivity, two of the cardinal symptoms of ADHD. Furthermore, AMPAkines do not stimulate spontaneous locomotor activityin either mice or rats, unlike the stimulants presently used for the treatment of ADHD, nor do they increase the stimulation producedby amphetamine or cocaine. These preclinical considerations prompted us to conduct a randomized, double-blind, placebo controlled,two period crossover study to assess the efficacy and safety of CX717 in adults with ADHD.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Ina repeated measures analysis, a statistically significant treatment effect on ADHD Rating Scale (ADHD-RS), the primary outcomemeasure, was observed after a three-week administration of CX717, 800 mg BID. Differences between this dose of CX717 and placebowere observed as early as week one of treatment and continued throughout the remainder of the study. The low dose of CX717, 200mg BID, did not differ from placebo. In general, results from both the ADHD-RS hyperactivity and inattentiveness subscales, whichwere secondary efficacy variables, paralleled the results of the total score. CX717 was considered safe and well tolerated.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <!-- Field: Page; Sequence: 11; Value: 2 -->      <div style="margin-bottom: 6pt; border-bottom: Black 1.5pt solid">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="text-align: center; width: 100%">           <!-- Field: Sequence; Type: Arabic; Name: PageNo -->           11           <!-- Field: /Sequence -->          </td>         </tr>        </tbody>       </table>      </div>      <div style="break-before: page; margin-top: 6pt">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="width: 100%">          </td>         </tr>        </tbody>       </table>      </div>      <!-- Field: /Page -->      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Basedon these clinical results, we believe that AMPAkines such as CX717 or CX1739 might represent a breakthrough opportunityto develop a non-stimulating therapeutic for ADHD with the rapidity of onset normally seen with stimulants. Subject to raisingsufficient financing (of which no assurance can be provided), we are planning to continue this program with a Phase 2 clinicaltrial in patients with adult ADHD using one of our two lead ampakine compounds.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <i>         AMPAkinesas Treatment for SCI        </i>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        AMPAkinesalso may have potential utility in the treatment and management of SCI to enhance motor functions and improve the quality of lifefor SCI patients. An estimated 17,000 new cases of SCI occur each year in the United States, most a result of automobile accidents.Currently, there are roughly 282,000 people living with spinal cord injuries, which often produce impaired motor function.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        SCIcan profoundly impair neural plasticity leading to significant morbidity and mortality in human accident victims. Plasticity isa fundamental property of the nervous system that enables continuous alteration of neural pathways and synapses in response toexperience or injury. A large body of literature exists regarding the ability of AMPAkines to stimulate neural plasticity, possiblydue to an enhanced synthesis and secretion of various growth factors.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        TheCompany has been working with Dr. David Fuller at the University of Florida which has funding from NIH, to evaluate theuse of AMPAkines for the treatment of compromised motor function in SCI. Using mice that have received spinal hemi-sections, CX717was observed to increase motor nerve activity bilaterally. The effect on the hemisected side was greater than that measured onthe intact side, with the recovery approximating that seen on the intact side prior to administration of ampakine. The doses ofAMPAkines active in SCI were comparable to those demonstrating antagonism of OIRD, indicating target engagement of the AMPA receptors.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Recently,studies in patients with SCI have demonstrated that neural plasticity can be induced to improve motor function. This is basedon the ability of spinal circuitry to learn how to adjust spinal and brainstem synaptic strength following repeated hypoxic bouts.Animal studies have demonstrated the ability of AMPAkines to dramatically enhance the effects of AIH on motor neuron activityafter SCI. Because AMPAkines are known to enhance synaptic plasticity, the potential exists to harness repetitive AIH in combinationwith AMPAkines as a means of inducing functional recovery of motor function following SCI.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Theseanimal models of motor nerve function following SCI support proof of concept for a new treatment paradigm using AMPAkines to improvemotor functions in patients with SCI. With additional funding granted by NIH to Dr. Fuller, the Company is continuing its collaborativepreclinical research with him, while it is planning a clinical trial program focused on developing AMPAkines for the restorationof certain motor functions in patients with SCI. The Company is working with researchers at highly regarded clinical sites tofinalize a Phase 2 clinical trial protocol. We believe that a clinical study could be initiated within several months of raisingsufficient financing (of which no assurance can be provided).       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <i>         GABAkines        </i>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        TheGABAkine program was established pursuant to the UWMRF Patent License Agreement. At present, the program is focused on developingnovel GABAkines with certain GABA        <sub>         A        </sub>        receptor subtype selectivity. We believe that there is a considerable degree ofreceptor subtype heterogeneity, making subtype selectivity of our compounds a desirable attribute.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Benzodiazepines(“BDZs”), such as Valium        <sup>         ®        </sup>        (diazepam), Librium        <sup>         ®        </sup>        (chlordiazepoxide) and Xanax        <sup>         ®        </sup>        (alprazolam) were the first major class of drugs reported to act as GABA        <sub>         A        </sub>        PAMs, by binding at a site distinctfrom the binding site for GABA. These drugs produced a wide range of pharmacological properties, including anxiety reduction,sedation, hypnosis, anti-convulsant, muscle relaxation, respiratory depression, cognitive impairment, as well as tolerance, abuseand withdrawal. For this reason, it was not surprising that BDZs were observed to act as GABA        <sub>         A        </sub>        PAMs indiscriminatelyacross all GABA        <sub>         A        </sub>        receptor subtypes. Following the identification of BDZ binding sites on GABA        <sub>         A        </sub>        receptors,Dr. Lippa described CL218,872, the first non-BDZ to demonstrate that these receptors were heterogeneous by binding selectivelyto a subtype of GABA        <sub>         A        </sub>        receptor. This demonstration of receptor heterogeneity led to the hypothesis that the variouspharmacological actions of the BDZs might be separable depending on the receptor subtype involved. In animal testing, CL218,872provided the proof of principle that such a separation could be achieved by displaying anti-anxiety and anti-convulsant propertiesin the absence of sedation, amnesia and muscular incoordination. These findings gave impetus to the search for novel therapeuticdrugs for neurological and psychiatric illnesses that display improvements in efficacy and reductions in side effects.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <!-- Field: Page; Sequence: 12; Value: 2 -->      <div style="margin-bottom: 6pt; border-bottom: Black 1.5pt solid">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="text-align: center; width: 100%">           <!-- Field: Sequence; Type: Arabic; Name: PageNo -->           12           <!-- Field: /Sequence -->          </td>         </tr>        </tbody>       </table>      </div>      <div style="break-before: page; margin-top: 6pt">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="width: 100%">          </td>         </tr>        </tbody>       </table>      </div>      <!-- Field: /Page -->      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Overthe last several years, a group of scientists led by Dr. James Cook of the University of Wisconsin and Dr. Jeffrey Witkin affiliatedwith the Indiana University School of Medicine, have synthesized and tested a broad series of novel drugs that display GABA        <sub>         A        </sub>        receptor subtype selectivity and pharmacological specificity.       </font>       <font style="font-family: Times New Roman, Times, Serif">        Certainof these chemical compounds are the subject of the UWMRF Patent License Agreement and Drs Cook and Witkin have been engagedas consulting Research Fellows, while still maintaining their academic affiliations.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Ofthese compounds, we have identified KRM-II-81 as a clinical lead. KRM-II-81 is the most advanced and druggable of a series ofcompounds that display certain receptor subtype selectivity and pharmacological specificity. In studies using cell cultures, braintissues and whole animals, KRM-II-81 acts as a GABA        <sub>         A        </sub>        PAM at selective GABA        <sub>         A        </sub>        receptor subtypes that we feelare intimately involved in neuronal processes underlying epilepsy, pain, anxiety and certain other indications. KRM-II-81 hasdemonstrated highly desirable properties in animal models of these and other potential therapeutic indications, in the absenceof or with greatly reduced liability to produce sedation, motor incoordination, cognitive impairments, respiratory depression,tolerance, abuse and withdrawal seizures, all side effects associated with BDZs. We currently are focused on the potential treatmentof epilepsy and pain.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <i>         Epilepsyand Existing Treatments        </i>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Epilepsyis a chronic and highly prevalent neurological disorder that affects millions of people world-wide and has serious consequencesfor the life of the affected individual. A first-line approach to the control of epilepsy is through the administration of anticonvulsantdrugs. Repeated, uncontrolled seizures due to drug resistance and the side effects arising from seizure medications have a negativeeffect on the developing brain and can lead to brain cell loss and severe impairment of neurocognitive function. The continuedoccurrence of seizure activity also increases the probability of subsequent epileptic events through sensitization mechanismscalled seizure kindling. Seizures that are unresponsive to anti-epileptic treatments are life-disrupting and life-threateningwith broad health, life, and economic consequences.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Likemany diseases, epilepsy is still remarkably underserved by currently available medicines. Pharmaco-resistance to anticonvulsanttherapy continues to be one of the key obstacles to the treatment of epilepsy. Although many anticonvulsant drugs are approvedto decrease seizure probability, seizures frequently are not fully controlled and patients are generally maintained daily on multipleantiepileptic drugs with the hope of enhancing the probability of seizure control. Despite this polypharmacy approach, as manyas 60% to 70% of patients continue to have seizures. As a result of the lack of seizure control, pharmaco-resistant epilepsy patients,including young children, sometimes require and elect to have invasive therapeutic procedures such as surgical resection oftargeted brain tissue.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Despitethe availability of a host of marketed drugs of different mechanistic classes, the lack of seizure control in patients is theprimary factor driving the need for improved antiepileptic drugs, as emphasized by researchers and patient advocacy communities.Increasing inhibitory tone in the CNS through enhancement of GABAergic inhibition is a proven mechanism for seizure control. However,GABAergic medications also exhibit liabilities that limit their antiepileptic potential. Tolerance develops to GABAergic drugssuch as BDZs, limiting their use in a chronic setting. These drugs can produce cognitive impairment, somnolence, sedation, toleranceand withdrawal seizures that create dosing limitations such that they are generally used only for acute convulsive episodes.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <i>         GABAkinesas Treatments for Epilepsy        </i>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        KRM-II-81has demonstrated efficacy in multiple rodent models and measures of antiepileptic drug efficacy        <i>         in vivo        </i>        . This includesnine acute seizure provocation models in mice and rats, four seizure sensitization models in rats and mice, two models of chronicepilepsy, and three models specifically testing pharmaco-resistant antiepileptic drug efficacy. Because it appears to have a substantiallyreduced side effect liability, it might be possible to use higher, more effective doses than standard of care medications.Predictions of superior efficacy of KRM-II-81 over standard of care anti-epileptics comes from the efficacy of this compound acrossa broad range of animal models of epilepsy. Importantly, KRM-II-81 has been shown to be effective in models assessing pharmaco-resistantepilepsy. Under these conditions, KRM-II-81 is efficacious in cases where standard of care medicines do not work.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <!-- Field: Page; Sequence: 13; Value: 2 -->      <div style="margin-bottom: 6pt; border-bottom: Black 1.5pt solid">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="text-align: center; width: 100%">           <!-- Field: Sequence; Type: Arabic; Name: PageNo -->           13           <!-- Field: /Sequence -->          </td>         </tr>        </tbody>       </table>      </div>      <div style="break-before: page; margin-top: 6pt">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="width: 100%">          </td>         </tr>        </tbody>       </table>      </div>      <!-- Field: /Page -->      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Inthe absence of seizure control by anti-epileptics, surgical resection of affected brain tissue is one potential alternative tohelp with the control of seizures. In the process of this surgery, epileptic brain tissue can become available for research intoepileptic mechanisms and the identification of novel antiepileptic drugs. The anticonvulsant action of KRM-II-81 has been confirmedby microelectrode recordings from slices obtained from freshly excised cortex from epileptic patients where KRM-II-81 suppressedepileptiform electrical activity. While preliminary, these translational data lend support to the further development of KRM-II-81for the treatment of epilepsy.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <i>         GABAkinesas Treatments for Pain        </i>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Itis impossible not to be aware of the crisis that the opioid epidemic has created in the treatment of chronic pain. While thereis no question as to their efficacy, the clinical use of opioids is severely limited due to the rapid development of toleranceand the production of OIRD, the major cause of opioid-induced lethality. Research programs are underway nationwide to discoverand develop new non-opioid drugs that are effective analgesics without the tolerance and abuse liability ascribed to opioids.Chronic pain is especially difficult to treat due to its complex nature with a variety of different etiologies. For example, chronicpain may be produced by injury, surgery, neuropathy, the inflammation produced by arthritis or by certain drugs such as cancerchemotherapeutics. For these reasons, better management and control of chronic pain continues to be a serious need in medicalpractice.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Datafrom both preclinical and clinical studies are consistent with the idea that GABAergic neurotransmission is an important regulatorymechanism for the control of pain. Gabapentin (Neurontin        <sup>         ®        </sup>        ) and pregabalin (Lyrica        <sup>         ®        </sup>        ), two commonlyused drugs for the treatment of chronic pain, are believed to produce their analgesic effects by enhancing GABAergic neurotransmission.However, although they have received FDA approval, the clinical results have not been overwhelming. In a published review of 37clinical trials with a total of 5,914 patients experiencing neuropathic pain there was no difference in the percentage of patientsexperiencing pain reduction of greater than 50% when comparing gabapentin to placebo. The most common side effects produced bygabapentin were sedation, dizziness and problems walking. It is uncertain whether greater efficacy was not observed because ofpoor intrinsic pharmacological efficacy or insufficient dosages due to dose limiting side effects.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Analternate approach to enhancing GABAergic neurotransmission is the use of GABA        <sub>         A        </sub>        PAMs. This approach has been under-utilizedbecause of the general lack of efficacy of the BDZ PAMs. However, a strong case for the potential value of subtype selective GABA        <sub>         A        </sub>        PAMs for the treatment of pain can be made. First, GABA        <sub>         A        </sub>        receptor regulated pathways are integral to pain processingwith α2/3 containing GABA        <sub>         A        </sub>        receptor subtypes present on nerve pathways modulating pain sensation and perception.Second, we believe that the analgesic properties of BDZs may be masked by concurrent activation of other GABA        <sub>         A        </sub>        receptorsubtypes that mediate the side effects. Diazepam has been reported to produce maximal analgesia if the side effects are attenuatedby GABA        <sub>         A        </sub>        subtype genetic manipulation. Third, predecessor GABAkines, made by Dr. Cook, that selectively amplify GABA        <sub>         A        </sub>        receptor subtype signaling are effective in pain models in rodents at doses lower than those producing motor side effects.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Ina number of laboratory procedures and animal studies, KRM-II-81 has been shown to selectively bind to GABA        <sub>         A        </sub>        receptorsubtypes and enhance GABAergic neurotransmission. Sub-chronic dosing for 22 days with KRM-II-81 and the structural analogue, MP-III-80,demonstrated enduring analgesic efficacy without tolerance development. In contrast, tolerance developed to the analgesic effectsof gabapentin. At a dose that produces maximal analgesic effect in an inflammatory chronic pain model, KRM-II-81 does not substitutefor the BDZ midazolam in a drug discrimination assay, suggesting a reduced abuse liability. Furthermore, KRM-II-81 did not producethe respiratory depression observed with alprazolam, a major problem with BDZs leading to emergency room visits and overdose.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Webelieve that the ability to attenuate both acute and chronic pain combined with a greatly reduced side effect profile, a lackof tolerance and a reduced abuse potential makes KRM-II-81 a promising clinical lead and a potential advance in pain therapeutics.Results from preliminary chemistry, metabolism and pharmacokinetic studies support its further development.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <!-- Field: Page; Sequence: 14; Value: 2 -->      <div style="margin-bottom: 6pt; border-bottom: Black 1.5pt solid">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="text-align: center; width: 100%">           <!-- Field: Sequence; Type: Arabic; Name: PageNo -->           14           <!-- Field: /Sequence -->          </td>         </tr>        </tbody>       </table>      </div>      <div style="break-before: page; margin-top: 6pt">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="width: 100%">          </td>         </tr>        </tbody>       </table>      </div>      <!-- Field: /Page -->      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         <i>          Corporateand Product Development Plans         </i>        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif">        Asdiscussed above, in order to facilitate our business activities and product development, we have organized our drug platformsinto two separate business units which currently operate as divisions, but which are anticipated to be re-organized as separatelegal entity subsidiaries in the future. ResolutionRx is focused on pharmaceutical cannabinoids and EndeavourRx is focusedon neuromodulators. Below is a description of the Company’s product development plans within these business units.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <i>         ResolutionRx– Dronabinol program        </i>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Forthe dronabinol program within our ResolutionRx cannabinoid platform, the Company plans to manufacture, on a pilot scale, one ormore new proprietary formulations of dronabinol with the enhanced properties described in our patent applications, for which weanticipate needing to raise and spend approximately $150,000 to bench test        <i>         in vitro        </i>        several versions of dronabinolformulations, in order to determine those with the most optimum physico-chemical properties.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Assumingsufficient additional financing in available, of which no assurance can be provided, the Company intends to spend approximately$450,000 to $600,000 of these funds on the continued development of a proprietary formulation of dronabinol. This developmentwould include (i) improvements to the Company’s intellectual property position, (ii) improvements to our dronabinol formulation’sPK profile, (iii) improvements to regulatory compliance, and (iv) expenditures for the initial stocking of clinical supply, packagingand distribution in anticipation of a Phase 2 PK/PD (pharmacokinetic/pharmacodynamic) clinical trial and a pivotal Phase3 clinical study. The performance of the Phase 2 PK/PD clinical trial and Phase 3 clinical study, however, would need yet additionalfunds either from separate financings or a collaboration with a strategic partner.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif">        ThePurisys Agreement and the 2014 License Agreement will need to be transferred or otherwise made available to ResolutionRx. See“—        <i>         Noramco Inc./Purisys, LLC - Dronabinol Development and Supply Agreement        </i>        ” and “—        <i>         Universityof Illinois 2014 Exclusive License Agreement        </i>        ” in Note 9. Commitments and Contingencies in the notes to consolidatedfinancial statements as of December 31, 2020 for more information on these agreements. Initially, ResolutionRx’sprimary focus will be on re-purposing dronabinol for the treatment of OSA, we believe that our broad enabling patents and our2019 and 2021 patent applications for proprietary formulation technology may provide a framework for expanding into the largerburgeoning pharmaceutical cannabinoid industry. We believe that by converting this division to a subsidiary, it may bepossible, through separate finance channels and potential strategic transactions, to optimize the asset value not only of thecannabinoid platform, but separately, our neuromodulation platform as well.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <i>         EndeavourRx– AMPAkines program        </i>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Forthe AMPAkines program within our EndeavourRx neuromodulators platform, the Company plans to initiate clinical testing of our AMPAkinesin the treatment of SCI. To this end, we anticipate needing to raise and spend approximately $145,000 to assess the purityof our existing drug supplies and finalize a clinical trial protocol for a Phase 2A clinical trial to determine the safety, pharmacokinetic(PK) and pharmacodynamic (PD) properties of one of our lead AMPAkines in patients who have had SCI. These tasks are critical forapplying to the FDA for permission to amend our existing IND or initiate a new IND enabling the commencement of clinical trials.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Assumingsufficient additional financing in available, of which no assurance can be provided, the Company would continue to focus on SCI,as we believe it would be the most efficient expenditure of our resources and yield an actionable result in the shortest periodof time. Expenditures would include: (i) an estimated spend of $200,000 for chemistry, manufacturing and controls (“CMC”)efforts, depending on the assessment of our drug supplies, (ii) an estimated spend of $400,000 on an initial Phase 2A single ascendingdose safety and PK and PD study in human SCI patients, (iii) an estimated spend of $600,000 on a Phase 2A multiple ascending dosesafety and PK and PD study in SCI patients, and (iv) an estimated spend of $650,000 on a Phase 2B efficacy study in SCI patients.Our initial, anticipated spend for ADHD would be approximately $100,000 for regulatory costs, with the larger spends occurringlater dependent upon availability of financing.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <!-- Field: Page; Sequence: 15; Value: 2 -->      <div style="margin-bottom: 6pt; border-bottom: Black 1.5pt solid">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="text-align: center; width: 100%">           <!-- Field: Sequence; Type: Arabic; Name: PageNo -->           15           <!-- Field: /Sequence -->          </td>         </tr>        </tbody>       </table>      </div>      <div style="break-before: page; margin-top: 6pt">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="width: 100%">          </td>         </tr>        </tbody>       </table>      </div>      <!-- Field: /Page -->      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <i>         EndeavourRx– GABAkines program        </i>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Assumingsufficient additional financing in available, of which no assurance can be provided, the Company plans to finance efforts withrespect to the GABAkines program within our EndeavourRx neuromodulators platform. These efforts would be in preparation of anIND to be submitted to the FDA to commence human studies of KRM-II-81, our lead GABAkine drug candidate, for treatment-resistantepilepsy and chronic pain, and expenditures would include (i) an estimated spend of $530,000 for CMC efforts, (ii) an estimatedspend of $450,000 for pre-clinical pharmacology, safety and absorption, distribution, metabolism, excretion (“ADME”)studies, (iii) an estimated spend of $225,000 for animal safety studies and (iv) an estimated spend of $65,000 for regulatoryconsultants.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Inconnection with the organization and development of the ResolutionRx and EndeavourRx business units, we are planning certain corporateand development actions as summarized below. All of the below are subject to raising additional financing and/or entering intostrategic relationships, of which no assurance can be given.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         <i>          ProposedCreation of Subsidiaries         </i>        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Pendingapproval by the Board of Directors, management intends to organize our ResolutionRx and EndeavourRx business units into two subsidiaries:(i) a ResolutionRx subsidiary, into which we intend to contribute our pharmaceutical cannabinoid platform and its related tangibleand intangible assets and certain of its liabilities and (ii) an EndeavourRx subsidiary, into which we plan to contribute ourneuromodulator platform, including both the AMPAkine and GABAkine programs and their related tangible and intangible assets andcertain of their liabilities.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Managementbelieves that there are several advantages to separating these platforms formally into newly formed subsidiaries, including butnot limited to optimizing their asset values through separate finance channels and making them more attractive for capital raisingas well as for strategic deal making.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         <i>          Employee/ConsultantInfrastructure Build-out         </i>        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Itis anticipated that the Company will continue to use, at least initially, its management personnel to provide management,operational and oversight services to these two business units. In order to broaden our operational expertise, we are planningto hire a number of highly qualified individuals, either as employees or consultants and, in tandem, increase our administrativesupport function. To date, we have hired David Dickason as Senior Vice-president of Pre-Clinical Product Development, and engagedDrs. James Cook and Jeffrey Witkin as consulting Research Fellows and engaged Dr. Rok Cerne as Senior ResearchScientist.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         <u>          Competition         </u>        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Thepharmaceutical industry is characterized by intensive research efforts, rapidly advancing technologies, intense competition anda strong emphasis on proprietary therapeutics. Our competitors include many companies, research institutes and universities thatare working in a number of pharmaceutical or biotechnology disciplines to develop therapeutic products similar to those we arecurrently investigating. Most of these competitors have substantially greater financial, technical, manufacturing, marketing,distribution and/or other resources than we do. In addition, many of our competitors have experience in performing human clinicaltrials of new or improved therapeutic products and obtaining approvals from the FDA and other regulatory agencies. We have noexperience in conducting and managing later-stage clinical testing or in preparing applications necessary to obtain regulatoryapprovals. We expect that competition in this field will continue to intensify.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         <u>          RegulatoryRequirements for Drug Market Approval         </u>        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        TheFDA and other similar agencies in foreign countries have substantial requirements for therapeutic products. Such requirementsoften involve lengthy and detailed laboratory, clinical and post-clinical testing procedures and are expensive to complete. Itoften takes companies many years to satisfy these requirements, depending on the complexity and novelty of the product. The reviewprocess is also extensive, which may delay the approval process further. Failure to comply with applicable FDA or other requirementsmay subject a company to a variety of administrative or judicial sanctions, such as the FDA’s refusal to approve pendingapplications, a clinical hold, warning letters, recall or seizure of products, partial or total suspension of production, withdrawalof the product from the market, injunctions, fines, civil penalties or criminal prosecution.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <!-- Field: Page; Sequence: 16; Value: 2 -->      <div style="margin-bottom: 6pt; border-bottom: Black 1.5pt solid">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="text-align: center; width: 100%">           <!-- Field: Sequence; Type: Arabic; Name: PageNo -->           16           <!-- Field: /Sequence -->          </td>         </tr>        </tbody>       </table>      </div>      <div style="break-before: page; margin-top: 6pt">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="width: 100%">          </td>         </tr>        </tbody>       </table>      </div>      <!-- Field: /Page -->      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        FDAapproval is required before any new drug or dosage form, including the new use of a previously approved drug, can be marketedin the United States. Other similar agencies in foreign countries also impose substantial requirements.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Theprocess of developing drug candidates normally begins with a discovery process of potential candidates that are then initiallytested in        <i>         in vitro        </i>        and        <i>         in vivo        </i>        non-human animal (preclinical) studies which include but are not limited to toxicityand other safety related studies, pharmacokinetics, pharmacodynamics and ADME (absorption, distribution, metabolism, excretion).Once sufficient preclinical data are obtained, a company must submit an IND and receive authorization from the FDA in order tobegin clinical trials in the United States. Successful drug candidates then move into human studies that are characterized generallyas Phase 1, Phase 2 and Phase 3. Phase 1 studies seeking safety and other data normally utilize healthy volunteers. Phase 2 studiesutilize one or more prospective patient populations and are designed to establish safety and preliminary measures of efficacy.Sometimes studies may be referred to as Phase 2A and 2B depending on the size of the patient population. Phase 3 studies are largetrials in the targeted patient population, performed in multiple centers, often for longer periods of time and are designed toestablish statistically significant efficacy as well as safety in the larger population. Most often the FDA and similar regulatoryagencies in other countries require two confirmatory Phase 3 or pivotal studies. Upon completion of both the preclinical and clinicalphases, an NDA (New Drug Application) is filed with the FDA or a similar filing is made to the regulatory authority in other countries.NDA filings are extensive and include the data from all prior studies. These filings are reviewed by the FDA and, only if approved,may the company or its partners commence marketing of the new drug in the United States.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Therealso are variations of these procedures. For example, companies seeking approval for new indications for an already approved drugmay choose to pursue an abbreviated approval process such as the filing for an NDA under Section 505(b)(2). Another example wouldbe a Supplementary NDA (“SNDA”). A third example would be an Abbreviated NDA (“ANDA”) claiming bioequivalenceto an already approved drug and claiming the same indications such as in the case of generic drugs. Other opportunities allowfor accelerated review and approval based upon several factors, including potential fast-track status for serious medical conditionsand unmet medical needs, potential breakthrough therapy designation of the drug for serious conditions where preliminary evidenceshows that the drug may show substantial improvement over available therapy or orphan designation (generally, an orphan indicationin the United States is one with a patient population of less than 200,000).       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <!-- Field: Page; Sequence: 17; Value: 2 -->      <div style="margin-bottom: 6pt; border-bottom: Black 1.5pt solid">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="text-align: center; width: 100%">           <!-- Field: Sequence; Type: Arabic; Name: PageNo -->           17           <!-- Field: /Sequence -->          </td>         </tr>        </tbody>       </table>      </div>      <div style="break-before: page; margin-top: 6pt">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="width: 100%">          </td>         </tr>        </tbody>       </table>      </div>      <!-- Field: /Page -->      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Asof yet, we have not obtained any approvals to market our products. Further, we cannot assure you that the FDA or other regulatoryagency will grant us approval for any of our products on a timely basis, if at all. Even if regulatory clearances are obtained,a marketed product is subject to continual review, and later discovery of previously unknown problems may result in restrictionson marketing or withdrawal of the product from the market.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Therecent COVID-19 pandemic has made it very difficult to recruit subjects and patients and to conduct clinical trials in generaland it is unclear how long these challenges will last. Given the public health emergency during the winter and spring of2020 which continues into 2021, the FDA issued guidance to be implemented without the normal prior public comment period as theFDA had concluded that public participation would not be feasible or appropriate. Guidance is not legally enforceable, but theFDA recommends the following of its guidance. Challenges are expected to arise from quarantines, site closures, travel limitations,interruptions to the supply chain for investigational products, or other considerations if site personnel or trial subjects becomeinfected with COVID-19. These challenges may lead to difficulties in meeting protocol-specified procedures. The FDA emphasizedthat safety of trial participants is critically important. Decisions to continue or discontinue individual patients or the trialare expected to be made by trial sponsors in consultation with clinical investors and Institutional Review Boards. COVID-19 screeningprocedures may need to be implemented. As challenging as the clinical trial process is during normal times, the risks, strategicand operational challenges and the costs of conducting such trials has increased substantially during the pandemic.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        See“Risk Factors—        <i>         Risks related to our business—        </i>        We are at an early stage of development and we may not beable to successfully develop and commercialize our products and technologies.”       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         <u>          Manufacturing         </u>        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Wehave no experience or capability to either manufacture bulk quantities of the new compounds that we develop, or to produce finisheddosage forms of the compounds, such as tablets or capsules. We rely, and presently intend to continue to rely, on the manufacturingand quality control expertise of contract manufacturing organizations (see below with respect to dronabinol) or current and prospectivecorporate partners. There is no assurance that we will be able to enter into manufacturing arrangements to produce bulk quantitiesof our compounds on favorable financial terms. There is generally, absent any disruptions that may be caused by the current pandemic,substantial availability of both bulk chemical manufacturing and dosage form manufacturing capability throughout the world thatwe believe we can readily access.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        OnSeptember 4, 2018, RespireRx entered into a dronabinol Development and Supply Agreement with Noramco Inc., one of the world’smajor dronabinol manufacturers, which Noramco subsequently assigned to its subsidiary, Purisys LLC. Under the terms of the PurisysAgreement, Noramco agreed to (i) provide all of the active pharmaceutical ingredient (“API”) estimated to be neededfor the clinical development process for both the first- and second-generation products (each a “Product” and collectively,the “Products”), three validation batches for New Drug Application (“NDA”) filing(s) and adequate supplyfor the initial inventory stocking for the wholesale and retail channels, subject to certain limitations, (ii) maintain or filevalid drug master files (“DMFs”) with the FDA or any other regulatory authority and provide the Company with accessor a right of reference letter entitling the Company to make continuing reference to the DMFs during the term of the agreementin connection with any regulatory filings made with the FDA by the Company, (iii) participate on a development committee, and(iv) make available its regulatory consultants, collaborate with any regulatory consulting firms engaged by the Company and participatein all FDA or Drug Enforcement Agency (“DEA”) meetings as appropriate and as related to the API. We now refer to thesecond-generation product as our proprietary formulation or proprietary product and have de-emphasized the first-generation product.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Inconsideration for these supplies and services, the Company has agreed to purchase exclusively from Noramco during the commercializationphase all API for its Products (as defined in the Development and Supply Agreement) at a pre-determined price subject to certainproducer price adjustments and agreed to Noramco’s participation in the economic success of the commercialized Product orProducts up to the earlier of the achievement of a maximum dollar amount or the expiration of a period of time.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <!-- Field: Page; Sequence: 18; Value: 2 -->      <div style="margin-bottom: 6pt; border-bottom: Black 1.5pt solid">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="text-align: center; width: 100%">           <!-- Field: Sequence; Type: Arabic; Name: PageNo -->           18           <!-- Field: /Sequence -->          </td>         </tr>        </tbody>       </table>      </div>      <div style="break-before: page; margin-top: 6pt">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="width: 100%">          </td>         </tr>        </tbody>       </table>      </div>      <!-- Field: /Page -->      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        See“Risk Factors—        <i>         Risks related to our business—        </i>        We are at an early stage of development and we may not beable to successfully develop and commercialize our products and technologies” for a discussion of certain risks relatedto the development and commercialization of our products.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         <u>          Marketing         </u>        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Wehave no experience in the marketing of pharmaceutical products and do not anticipate having the resources to distribute and broadlymarket any products that we may develop. We will therefore continue to seek commercial development arrangements with other pharmaceuticalcompanies for our proposed products for those indications that require significant sales forces to effectively market. In enteringinto such arrangements, we may seek to retain the right to promote or co-promote products for certain of the orphan drug indicationsin North America. We believe that there is a significant expertise base for such marketing and sales functions within the pharmaceuticalindustry and expect that we could recruit such expertise if we choose to directly market a drug.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        See“Risk Factors—        <i>         Risks related to our business—        </i>        We are at an early stage of development and we may not beable to successfully develop and commercialize our products and technologies” for a discussion of certain risks relatedto the marketing of our products.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         <u>          Employees         </u>        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Asof December 31, 2020 and as of the date of filing of this Annual Report on Form 10-K, the Company employed five people (all officers),three of whom were full time. The Company also engages certain contractors who provide substantial services to the Company.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         <u>          TechnologyRights         </u>        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <i>         Universityof Illinois License Agreement        </i>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        SeeNote 9. Commitments and Contingencies – Significant Agreements and Contracts –        <i>         University of Illinois 2014Exclusive License Agreement        </i>        to our consolidated financial statements at December 31, 2020.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <i>         UWMRFPatent License Agreement        </i>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif">        SeeNote 9. Commitments and Contingencies – Significant Agreements and Contracts -       </font>       <font style="font-family: Times New Roman, Times, Serif">        to our consolidated financial statements at December 31, 2020.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <!-- Field: Page; Sequence: 19; Value: 2 -->      <div style="margin-bottom: 6pt; border-bottom: Black 1.5pt solid">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="text-align: center; width: 100%">           <!-- Field: Sequence; Type: Arabic; Name: PageNo -->           19           <!-- Field: /Sequence -->          </td>         </tr>        </tbody>       </table>      </div>      <div style="break-before: page; margin-top: 6pt">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="width: 100%">          </td>         </tr>        </tbody>       </table>      </div>      <!-- Field: /Page -->      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         <a name="a_003">         </a>         Item1A. Risk Factors        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Inaddition to the other matters set forth in this Annual Report on Form 10-K, our continuing operations and the price of our commonstock are subject to the following risks:       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         Risksrelated to our business        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         <i>          Ourindependent registered public accounting firm has expressed substantial doubt about our ability to continue as a going concern.         </i>        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Inits audit opinion issued in connection with our consolidated financial statements as of December 31, 2020 and 2019, our independentregistered public accounting firm has expressed substantial doubt about our ability to continue as a going concern given our limitedworking capital, recurring net losses and negative cash flows from operations. The accompanying consolidated financial statementshave been prepared on a going concern basis, which contemplates the realization of assets and the satisfaction of liabilitiesand commitments in the normal course of business. The consolidated financial statements do not include any adjustments relatingto the recoverability and classification of recorded asset amounts or amounts of liabilities that might be necessary should webe unable to continue in existence. While we have relied principally in the past on external financing to provide liquidity andcapital resources for our operations, we can provide no assurance that cash generated from our operations together with cash receivedin the future from external financing, if any, will be sufficient to enable us to continue as a going concern.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         <i>          Ourindependent registered public accounting firm has identified material weaknesses in our financial reporting process.         </i>        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         <i>         </i>        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        AtDecember 31, 2020, management and our independent registered public accounting firm identified material weaknesses in ourinternal control over financial reporting. There can be no assurance that we will be able to successfully implement our plansto remediate the material weaknesses in our financial reporting process. Our failure to successfully implement our plans to remediatethese material weaknesses could cause us to fail to meet our reporting obligations, to produce timely and reliable financial information,and to effectively prevent fraud. Additionally, such failure, or other weaknesses that we may experience in our financial reportingprocess or other internal controls, could cause investors to lose confidence in our reported financial information, which couldhave a negative impact on our financial condition and stock price.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         <i>          Wehave a history of net losses; we expect to continue to incur net losses and we may never achieve or maintain profitability.         </i>        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Sinceour formation on February 10, 1987 through the end of our most recent fiscal year ended December 31, 2020, we have generated onlyminimal operating revenues. For the fiscal year ended December 31, 2020, our net loss was $4,301,211 and as of December 31, 2020,we had an accumulated deficit of $170,810,296. We have not generated any revenue from product sales to date, and it is possiblethat we will never generate revenues from product sales in the future. Even if we do achieve significant revenues from productsales, we expect to continue to incur significant net losses over the next several years. As with other biotechnology companies,it is possible that we will never achieve profitable operations.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <!-- Field: Page; Sequence: 20; Value: 2 -->      <div style="margin-bottom: 6pt; border-bottom: Black 1.5pt solid">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="text-align: center; width: 100%">           <!-- Field: Sequence; Type: Arabic; Name: PageNo -->           20           <!-- Field: /Sequence -->          </td>         </tr>        </tbody>       </table>      </div>      <div style="break-before: page; margin-top: 6pt">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="width: 100%">          </td>         </tr>        </tbody>       </table>      </div>      <!-- Field: /Page -->      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         <i>          Wewill need additional capital in the near term and the future and, if such capital is not available on terms acceptable to us oravailable to us at all, we may need to scale back our research and development efforts and may be unable to continue our businessoperations.         </i>        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Werequire additional cash resources for basic operations and will require substantial additional funds to advance our research anddevelopment programs and to continue our operations, particularly if we decide to independently conduct later-stage clinical testingand apply for regulatory approval of any of our proposed products, and if we decide to independently undertake the marketing andpromotion of our products. Additionally, we may require additional funds in the event that we decide to pursue strategic acquisitionsof or licenses for other products or businesses. Based on our operating plan as of December 31, 2020, we estimated that our existingcash resources will not be sufficient to meet our requirements for 2021. We also need additional capital in the near term to fundon-going operations including basic operations. Additional funds may come from the sale of common equity, preferred equity, convertiblepreferred equity or equity-linked securities, debt, including debt convertible into equity, or may result from agreements withlarger pharmaceutical companies that include the license or rights to the technologies and products that we are currently developing,although there is no assurance that we will secure any such funding or other transaction in a timely manner, or at all.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Ourcash requirements in the future may differ significantly from our current estimates, depending on a number of factors, including:       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">       <tbody>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="width: 0.25in">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           ●          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           Our    ability to raise equity or debt capital, or our ability to obtain in-kind services which may be more difficult during the    current pandemic health crisis;          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           ●          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           the    results of our clinical trials;          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           ●          </font>         </td>         <td style="text-align: justify; font: 10pt Times New Roman, Times, Serif">          <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            the                                         time and costs involved in obtaining regulatory approvals;           </font>          </p>          <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">          </p>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif">           ●          </font>         </td>         <td style="text-align: justify; font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif">           the    costs associated with the implementation of a corporate restructure          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           ●          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           the    costs of setting up and operating our own marketing and sales organization;          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           ●          </font>         </td>         <td style="text-align: justify; font: 10pt Times New Roman, Times, Serif">          <p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            the                                         ability to obtain funding under contractual and licensing agreements;           </font>          </p>          <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            the        ongoing obligations to make contractual licensed patent maintenance fees, milestone payments and royalty payments           </font>          </p>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           ●          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           the    costs involved in filing, prosecuting, maintaining and enforcing patents or any litigation by third parties regarding intellectual    property;          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           ●          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           the    costs involved in meeting our contractual obligations including employment agreements; and          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           ●          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           our    success in entering into collaborative relationships with other parties.          </font>         </td>        </tr>       </tbody>      </table>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         <i>          CommonStock reserve requirements may restrict our ability to raise capital and continue to operate our business         </i>        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        CommonStock reserve requirements may restrict our ability to raise capital and continue to operate our business. As of December 31,2020, the Company was required to reserve 126,855,971 shares of its authorized and unissued Common Stock with respect to convertiblenotes, convertible Series B Preferred Stock, warrants, options granted not yet exercised and shares available for issuance itsequity plans, inclusive of incremental contractual reserves in excess of the calculated number of conversion shares and warrantshares. There are 1,801,872,935 authorized, unissued and unreserved shares of Common Stock available after reserving forthe incremental contractual reserves of 68,777,142. If we breach the contractual reserve requirements we will be in default ofsuch contractual obligations which may have material adverse consequences which may make it more difficult to raise additionalnecessary capital.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         <i>          Ourproduct opportunities rely on licenses from research institutions and if we lose access to these technologies or applications,our business could be substantially impaired.         </i>        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Throughour acquisition of Pier, we gained access to a pre-existing relationship between Pier and the UIC. Effective in September 2014,the Company entered into the UIC License Agreement with the UIC, which gave the Company certain exclusive rights with respectto certain patents and patent applications in the United States and other countries claiming the use of dronabinol and other cannabinoidsfor the treatment of sleep-related breathing disorders, including sleep apnea. The UIC License Agreement obligates the Companyto comply with various commercialization and reporting requirements and to make various royalty payments, including potentialone-time and annual royalty payments, as well as payments upon the achievement of certain development milestones.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <!-- Field: Page; Sequence: 21; Value: 2 -->      <div style="margin-bottom: 6pt; border-bottom: Black 1.5pt solid">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="text-align: center; width: 100%">           <!-- Field: Sequence; Type: Arabic; Name: PageNo -->           21           <!-- Field: /Sequence -->          </td>         </tr>        </tbody>       </table>      </div>      <div style="break-before: page; margin-top: 6pt">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="width: 100%">          </td>         </tr>        </tbody>       </table>      </div>      <!-- Field: /Page -->      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        TheCompany and UWMRF executed the UWMRF Patent License Agreement effective August 1, 2020 pursuant to which RespireRx licensed theintellectual property identified therein, including with respect to GABAkines. In consideration for the licenses granted, theCompany will pay to UWMRF patent filing and prosecution costs, annual license maintenance fees, one-time milestone payments, andannual royalties.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Ifwe are unable to comply with the terms of these licenses, such as required payments thereunder, these licenses might be terminated.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         <i>          Wemay not be able to successfully develop and commercialize our product candidates and technologies.         </i>        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Thedevelopment of our product candidates is subject to risks commonly experienced in the development of products based upon innovativetechnologies and the expense and difficulty of obtaining approvals from regulatory agencies. Drug discovery and development istime consuming, expensive and unpredictable. On average, only one out of many thousands of chemical compounds discovered by researchersproves to be both medically effective and safe enough to become an approved medicine.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif">        Allof our product candidates are in development spectrum that runs from preclinical to Phase 2 clinical trials, butwe not have any currently active trials. Assuming these trials are initiated, which will require additional financing, weare planning for additional preclinical studies and Phase 1, Phase 2A, Phase 2B and Phase 3 clinical trials, we do nothave any currently active trials. Accordingly, we will require significant additional funding for research, development and clinicaltesting of our product candidates, which may not be available on favorable terms or at all.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Additionally,our success, at least in part, is dependent upon the strength of our intellectual property, including, but not limited to licensedand owned patents, patent applications, continuations-in-part, provisional patent applications, know-how, trade secrets and otherforms of intellectual property. The issuance of patents with relevant claims is subject to varying degrees of uncertainty. Ourability to defend our intellectual property or challenge third party intellectual property infringement claims is expensive, timeconsuming and uncertain. If our patent applications do not issue with relevant claims or if we cannot defend our patents, or,as appropriate, challenge interfering patents or actions of third parties, or otherwise maintain our intellectual property, ourbusiness and operations will be adversely affected.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Theprocess from discovery to development to regulatory approval can take several years and drug candidates can fail at any stageof the process. Late-stage clinical trials often fail to replicate results achieved in earlier studies. We cannot be certain thatwe will be able to successfully complete any of our research and development activities. One of our product candidates is based,at least in part, on the development of one or more new formulations and the repurposing of an approved drug, the developmentof which is inherently risky while others of our product candidates have never been approved for marketing by any regulatory bodiesand are subject to substantial research and development risks. Concerns about the safety and efficacy of our product candidatescould limit our future success.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <!-- Field: Page; Sequence: 22; Value: 2 -->      <div style="margin-bottom: 6pt; border-bottom: Black 1.5pt solid">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="text-align: center; width: 100%">           <!-- Field: Sequence; Type: Arabic; Name: PageNo -->           22           <!-- Field: /Sequence -->          </td>         </tr>        </tbody>       </table>      </div>      <div style="break-before: page; margin-top: 6pt">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="width: 100%">          </td>         </tr>        </tbody>       </table>      </div>      <!-- Field: /Page -->      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Evenif we do complete our research and development activities, we may not be able to successfully market any of the product candidatesor be able to obtain the necessary regulatory approvals or assure that healthcare providers and payors will accept our productcandidates. We also face the risk that any or all of our product candidates will not work as intended or that they will be unsafe,or that, even if they do work and are safe, that our product candidates will be uneconomical to manufacture and market on a largescale. Due to the extended testing and regulatory review process required before we can obtain marketing clearance, we do notexpect to be able to commercialize any therapeutic drug for several years, either directly or through our corporate partners orlicensees.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         <i>          Wehave announced a restructuring plan to facilitate the financing of our business initiatives. We may not achieve some or all ofthe expected benefits of our restructuring plan and the restructuring may adversely affect our business.         </i>        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif">        Weplan to incorporate as newly formed subsidiaries, what are currently identified divisions of the Company, namely, ResolutionRxand EndeavourRx with the goals, among others, of improving our ability to finance those platforms and attract potential strategicpartners. There can be no assurance that these goals or any of our intended goals will be achieved.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         <i>          Wehave not voluntarily implemented various corporate governance measures, in the absence of which stockholders may have more limitedprotections against interested director transactions, conflicts of interests and similar matters.         </i>        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Wehave not adopted any corporate governance measures since our securities are not yet listed on a national securities exchange andwe are not required to do so. We have not adopted corporate governance measures such as separate audit or other independent committeesof our Board as we presently have only one independent director. If we expand our board membership in future periods to includeadditional independent directors, we may seek to establish an audit and other committees of our Board. It is possible that ifour Board included additional independent directors and if we were to adopt some or all of these corporate governance measures,stockholders would benefit from somewhat greater assurances that internal corporate decisions were being made by disinteresteddirectors and that policies had been implemented to define responsible conduct. For example, in the absence of audit, nominatingand compensation committees comprised of at least a majority of independent directors, decisions concerning matters such as compensationpackages to our senior officers and recommendations for director nominees may be made by a majority of directors who have an interestin the outcome of the matters being decided. You should bear in mind our current lack of corporate governance measures in formulatinginvestment decisions.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         <i>          Thenovel coronavirus (COVID-19) pandemic may negatively impact our ability to successfully develop and commercialize our productcandidates and technologies and may ultimately affect our business, financial condition and results of operations.         </i>        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        InMarch 2020, the World Health Organization declared COVID-19 a global pandemic, and governmental authorities around the world haveimplemented measures to reduce the spread of COVID-19. These measures have adversely affected workforces, customers, supply chains,consumer sentiment, economies, and financial markets, and, along with decreased consumer spending, have led to an economic downturnacross many global economies. The COVID-19 pandemic rapidly escalated in the United States and continues to evolve, creating significantuncertainty and economic disruption, and leading to record levels of unemployment nationally. Numerous state and local jurisdictionshad imposed, and those and others in the future may impose, shelter-in-place orders, quarantines, shut-downs of non-essentialbusinesses, and similar government orders and restrictions on their residents to control the spread of COVID-19.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        TheCOVID-19 pandemic and government responses thereto have made it very difficult to recruit clinical trial subjects and patientsand to conduct clinical trials in general. We expect the life sciences industry and clinical trial activity to continue to facechallenges arising from quarantines, site closures, travel limitations, interruptions to the supply chain for investigationalproducts and other considerations if site personnel or trial subjects become infected with or are significantly at risk of contractingCOVID-19. These challenges may lead to difficulties in meeting protocol-specified procedures. Further, in response to the publichealth emergency, the FDA issued guidance in March and July 2020 emphasizing that safety of trial participants is critically important.Decisions to continue or discontinue individual patients or the trial are expected to be made by trial sponsors in consultationwith clinical investors and Institutional Review Boards, which may lead to the implementation of additional protocols such asCOVID-19 screening procedures, resulting in potential delays and additional costs. The risks, strategic and operational challengesand costs of conducting such trials as a result of the global pandemic have exacerbated an already challenging clinical trialprocess, which may negatively impact our ability to plan or conduct trials if we secure sufficient financing to enable us to pursuesuch activity.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <!-- Field: Page; Sequence: 23; Value: 2 -->      <div style="margin-bottom: 6pt; border-bottom: Black 1.5pt solid">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="text-align: center; width: 100%">           <!-- Field: Sequence; Type: Arabic; Name: PageNo -->           23           <!-- Field: /Sequence -->          </td>         </tr>        </tbody>       </table>      </div>      <div style="break-before: page; margin-top: 6pt">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="width: 100%">          </td>         </tr>        </tbody>       </table>      </div>      <!-- Field: /Page -->      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Inaddition, we may be impacted by the downturn in the U.S. economy, which could have an adverse impact on our ability to raise capitaland our business operations.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Theextent to which COVID-19 ultimately impacts our business, financial condition and results of operations will depend on futuredevelopments, which are highly uncertain and unpredictable, including new information which may emerge concerning the severityand duration of the COVID-19 pandemic and the effectiveness of actions taken to contain the COVID-19 pandemic or treat its impact,among others. Additionally, the extent to which COVID-19 ultimately impacts our operations will depend on a number of factors,many of which will be outside of our control. The COVID-19 pandemic is evolving and new information emerges regularly, includingfor example, the FDA’s and other governmental regulatory bodies’ approval of various COVID-19 vaccinationsproducts which are being widely distributed and administered in the United States and around the world; accordingly, theultimate consequences of the COVID-19 pandemic cannot be predicted with certainty. In addition to the disruptions adversely impactingour business and financial results, they may also have the effect of heightening many of the other risks described in these riskfactors, including risks relating to our ability to begin to generate revenue, to generate positive cash flow, our relationshipswith third parties, and many other factors. We will attempt to minimize these impacts, but there can be no assurance that we willbe successful in doing so.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         <i>          Wemay not be able to enter into the strategic alliances necessary to fully develop and commercialize our products and technologies,and we will be dependent on our strategic partners if we do.         </i>        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Weare seeking pharmaceutical companies and other strategic partners to participate with us in the development of major indicationsfor the cannabinoids and neuromodulator compounds. These agreements would potentially provide us with additional funds or in-kindservices in exchange for exclusive or non-exclusive license or other rights to the technologies and products that we are currentlydeveloping. Competition between biopharmaceutical companies for these types of arrangements is intense. We cannot give any assurancethat our discussions with candidate companies will result in an agreement or agreements in a timely manner, or at all. Additionally,we cannot assure you that any resulting agreement will generate sufficient revenues to offset our operating expenses and longer-termfunding requirements.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         <i>          Ifour third-party manufacturers’ facilities do not follow established current good manufacturing guidelines and practices,our product development and commercialization efforts may be harmed.         </i>        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Thereare a limited number of manufacturers that operate under the FDA’s and European Union’s good manufacturing practicesregulations and are capable of manufacturing products like those we are developing. Third-party manufacturers may encounter difficultiesin achieving quality control and quality assurance and may experience shortages of qualified personnel. A failure of third-partymanufacturers to follow current good manufacturing practices or other regulatory requirements and to document their adherenceto such practices may lead to significant delays in the availability of products for commercial use or clinical study, the terminationof, or hold on, a clinical study, or may delay or prevent filing or approval of marketing applications for our products. In addition,we could be subject to sanctions, including fines, injunctions and civil penalties. Changing manufacturers may require additionalclinical trials and the revalidation of the manufacturing process and procedures in accordance with FDA mandated current goodmanufacturing practices and would require FDA approval. This revalidation may be costly and time consuming. If we are unable toarrange for third-party manufacturing of our products, or to do so on commercially reasonable terms, we may not be able to completedevelopment or marketing of our products.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         <i>          Ourability to use our net operating loss carry forwards will be subject to limitations upon a change in ownership, which could reduceour ability to use those loss carry forwards following any change in Company ownership.         </i>        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Generally,a change of more than 50% in the ownership of a Company’s stock, by value, over a three-year period constitutes an ownershipchange for U.S. federal income tax purposes. An ownership change may limit our ability to use our net operating loss carry forwardsattributable to the period prior to such change. We have sold or otherwise issued shares of our common stock in various transactionssufficient to constitute an ownership change. As a result, if we earn net taxable income in the future, our ability to use ourpre-change net operating loss carry forwards to offset U.S. federal taxable income will be subject to limitations, which wouldrestrict our ability to reduce future tax liability. Future shifts in our ownership, including transactions in which we may engage,may cause additional ownership changes, which could have the effect of imposing additional limitations on our ability to use ourpre-change net operating loss carry forwards.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         <i>         </i>        </b>       </font>      </p>      <!-- Field: Page; Sequence: 24; Value: 2 -->      <div style="margin-bottom: 6pt; border-bottom: Black 1.5pt solid">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="text-align: center; width: 100%">           <!-- Field: Sequence; Type: Arabic; Name: PageNo -->           24           <!-- Field: /Sequence -->          </td>         </tr>        </tbody>       </table>      </div>      <div style="break-before: page; margin-top: 6pt">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="width: 100%">          </td>         </tr>        </tbody>       </table>      </div>      <!-- Field: /Page -->      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         <i>         </i>        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         Risksrelated to our industry        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         <i>          Ifwe fail to secure adequate intellectual property protection, it could significantly harm our financial results and ability tocompete.         </i>        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Oursuccess will depend, in part, on our ability to obtain and maintain patent protection for our products and processes in the UnitedStates and elsewhere. We have filed and intend to continue to file patent applications as we need them. However, additional patentsthat may issue from any of these applications may not be sufficiently broad to protect our technology. Also, any patents issuedto us or licensed by us may be designed around or challenged by others, and if such design or challenge is effective, it may diminishour rights and negatively affect our financial results.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Ifwe are unable to obtain and maintain sufficient protection of our proprietary rights in our products or processes prior to orafter obtaining regulatory clearances, our competitors may be able to obtain regulatory clearance and market similar or competingproducts by demonstrating at a minimum the equivalency of their products to our products. If they are successful at demonstratingat least the equivalency between the products, our competitors would not have to conduct the same lengthy clinical tests thatwe have or will have conducted.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Wealso rely on trade secrets and confidential information that we protect by entering into confidentiality agreements with otherparties. Those confidentiality agreements could be breached, and our remedies may be insufficient to protect the confidentialinformation. Further, our competitors may independently learn our trade secrets or develop similar or superior technologies. Tothe extent that our consultants, key employees or others apply technological information independently developed by them or byothers to our projects, disputes may arise regarding the proprietary rights to such information or developments. We cannot assureyou that such disputes will be resolved in our favor.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         <i>          Wemay be subject to potential product liability claims. One or more successful claims brought against us could materially adverselyaffect our business and financial condition.         </i>        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Theclinical testing, manufacturing and marketing of our products may expose us to product liability claims. We have never been subjectto a product liability claim, and we require each patient in our clinical trials to sign an informed consent agreement that describesthe risks related to the trials, but we cannot assure you that the coverage limits of our insurance policies will be adequateor that one or more successful claims brought against us would not have a material adverse effect on our business, financial conditionand result of operations. Further, if one of our cannabinoid or AMPAkine compounds is approved by the FDA for marketing, we cannotassure you that adequate product liability insurance will be available, or if available, that it will be available at a reasonablecost. Any adverse outcome resulting from a product liability claim could have a material adverse effect on our business, financialcondition and results of operations.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         <i>          Weface intense competition, and our competitors may develop products that are superior to those we are developing.         </i>        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Thepharmaceutical industry is characterized by intensive research efforts, rapidly advancing technologies, intense competition anda strong emphasis on proprietary therapeutics. Our competitors include many companies, research institutes and universities thatare working in a number of pharmaceutical or biotechnology disciplines to develop therapeutic products similar to those we arecurrently investigating. Most of these competitors have substantially greater financial, technical, manufacturing, marketing,distribution or other resources than we do. In addition, many of our competitors have experience in performing human clinicaltrials of new or improved therapeutic products and obtaining approvals from the FDA and other regulatory agencies. We have noexperience in conducting and managing later-stage clinical testing or in preparing applications necessary to obtain regulatoryapprovals. We expect that competition in this field will continue to intensify.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <!-- Field: Page; Sequence: 25; Value: 2 -->      <div style="margin-bottom: 6pt; border-bottom: Black 1.5pt solid">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="text-align: center; width: 100%">           <!-- Field: Sequence; Type: Arabic; Name: PageNo -->           25           <!-- Field: /Sequence -->          </td>         </tr>        </tbody>       </table>      </div>      <div style="break-before: page; margin-top: 6pt">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="width: 100%">          </td>         </tr>        </tbody>       </table>      </div>      <!-- Field: /Page -->      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Ourpatents and patent applications do not cover the entire world, thus limiting the potential exclusive commercialization of ourproducts to those countries in which we have intellectual property protection. We are aware of at least one company that may bedeveloping a product or product similar to one of our prospective products for our proposed indication in countries where we donot have intellectual property protection. Such company or companies may choose to compete with us in countries where we do haveintellectual property protection and cause us to expend resources defending our intellectual property. A liberal regulatory environmentor unenforced or poorly enforced regulations may encourage competition from non-drug products such as medical marijuana or dietarysupplements and similar products containing cannabis-derived molecules making claims that would be competitive with our proposedregulatory-approved claims. Since our target markets are very large, there is a great deal of economic incentive for others toenter and compete in those markets. We must compete with other companies with respect to their research and development effortsand for capital and other forms of funding. An inability to compete would have a material adverse impact on our business operations.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         <i>          Wemay be unable to recruit and retain our senior management and other key technical personnel on whom we are dependent.         </i>        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Weare highly dependent upon senior management and key technical personnel and currently do not carry any insurance policies on suchpersons. In particular, we are highly dependent on Timothy L. Jones, our CEO and President, Arnold S. Lippa, Ph.D., our ChiefScientific Officer and Executive Chairman, Jeff E. Margolis, our Senior Vice President, Chief Financial Officer, Treasurer andSecretary, and David Dickason, our Senior Vice President of Preclinical Product Development. Competition for qualified employeesamong pharmaceutical and biotechnology companies is intense. The loss of any of our senior management or other key employees,or our inability to attract, retain and motivate the additional or replacement highly skilled employees and consultants that ourbusiness requires, could substantially hurt our business prospects.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         <i>          Theregulatory approval process is expensive, time consuming, uncertain and may prevent us from obtaining required approvals for thecommercialization of some of our products.         </i>        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        TheFDA and other similar agencies in foreign countries have substantial requirements for therapeutic products. Such requirementsoften involve lengthy and detailed laboratory, clinical and post-clinical testing procedures and are expensive to complete. Itoften takes companies many years to satisfy these requirements, depending on the complexity and novelty of the product. The reviewprocess is also extensive, which may delay the approval process even more.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Asof yet, we have not obtained any approvals to market our products. Further, we cannot assure you that the FDA or other regulatoryagency will grant us approval for any of our products on a timely basis, if at all. Even if regulatory clearances are obtained,a marketed product is subject to continual review, and later discovery of previously unknown problems may result in restrictionson marketing or withdrawal of the product from the market.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         Risksrelated to capital structure        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         <i>          Ourstock price is volatile and our common stock could decline in value.         </i>        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        OurCommon Stock is currently quoted for public trading on the OTCQB Venture Market. The trading price of our Common Stock has beensubject to wide fluctuations and may fluctuate in response to a number of factors, many of which will be beyond our control.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Themarket price of securities of life sciences companies in general has been very unpredictable. Broad market and industry factorsmay adversely affect the market price of our Common Stock, regardless of our operating performance. In the past, following periodsof volatility in the market price of a company’s securities, securities class-action litigation has often been instituted.Such litigation, if instituted, could result in substantial costs for us and a diversion of management’s attention and resources.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Therange of sales prices of our common stock, as adjusted for the reverse stock-split effected on January 5, 2021, for the fiscalyears ended December 31, 2020 and 2019, as quoted on the OTC Markets, was $1.499 and $0.0200 and $8.5000 to $0.9800, respectively.The following factors, in addition to factors that affect that market generally, could significantly affect our business, andthe market price of our common stock could decline:       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">       <tbody>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           ●          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           competitors    announcing technological innovations or new commercial products;          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           ●          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           competitors’    publicity regarding actual or potential products under development;          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           ●          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           regulatory    developments in the United States and foreign countries;          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           ●          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           legal    developments regarding cannabinoids and cannabis products in the United States and foreign countries          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           ●          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           developments    concerning proprietary rights, including patent litigation;          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           ●          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           public    concern over the safety of therapeutic products; and          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           ●          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           changes    in healthcare reimbursement policies, healthcare regulations and standard of care requirements.          </font>         </td>        </tr>       </tbody>      </table>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <!-- Field: Page; Sequence: 26; Value: 2 -->      <div style="margin-bottom: 6pt; border-bottom: Black 1.5pt solid">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="text-align: center; width: 100%">           <!-- Field: Sequence; Type: Arabic; Name: PageNo -->           26           <!-- Field: /Sequence -->          </td>         </tr>        </tbody>       </table>      </div>      <div style="break-before: page; margin-top: 6pt">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="width: 100%">          </td>         </tr>        </tbody>       </table>      </div>      <!-- Field: /Page -->      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         <i>          Ourcommon stock is thinly traded and you may be unable to sell some or all of your shares at the price you would like, or at all,and sales of large blocks of shares may depress the price of our common stock.         </i>        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Ourcommon stock has historically been sporadically or “thinly-traded,” meaning that the number of persons interestedin purchasing shares of our common stock at prevailing prices at any given time may be relatively small or nonexistent. As a consequence,there may be periods of several days or more when trading activity in shares of our common stock is minimal or non-existent, ascompared to a seasoned issuer that has a large and steady volume of trading activity that will generally support continuous saleswithout an adverse effect on share price. This could lead to wide fluctuations in our share price. You may be unable to sell yourcommon stock at or above your purchase price, which may result in substantial losses to you. Also, as a consequence of this lackof liquidity, the trading of relatively small quantities of shares by our stockholders may disproportionately influence the priceof shares of our common stock in either direction. The price of shares of our common stock could, for example, decline precipitouslyin the event a large number of shares of our common shares are sold on the market without commensurate demand, as compared toa seasoned issuer which could better absorb those sales without adverse impact on its share price.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         <i>          Thereis a large number of shares of the Company’s common stock that may be issued or sold, and if such shares are issued or sold,the market price of our common stock may decline.         </i>        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Asof December 31, 2020, we had 71,271,095 shares of our common stock outstanding on a post-reverse stock split basis which occurredon January 5, 2021.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Ifall warrants and options outstanding as of December 31, 2020 were exercised prior to their respective expiration dates, up to35,974,567 additional shares of our common stock could become freely tradable. The issuance of such shares would dilutethe interests of the current stockholders and sales of substantial amounts of common stock in the public market could adverselyaffect the prevailing market price of our common stock and could also make it more difficult for us to raise funds through futureofferings of common stock.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Asof December 31, 2020, there were remaining outstanding convertible notes totaling $414,860 inclusive of accrued interest. Of thatamount, $372,659 was convertible into 13,333,036 shares of common stock and $42,201 was convertible into an indeterminate numberof shares of common stock as such notes may convert, at the option of each note holder, acting separately and independently ofthe other note holders, into the next exempt private securities offering of equity securities.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Ifwe issue additional equity or equity-based securities, the number of shares of our common stock outstanding could increase substantially,which could adversely affect the prevailing market price of our common stock and could also make it more difficult for us to raisefunds through future offerings of common stock.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         <i>          Ourcharter document and other governing documents may prevent or delay an attempt by our stockholders to replace or remove management.         </i>        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Certainprovisions of our restated certificate of incorporation, as amended, could make it more difficult for a third party to acquirecontrol of our business, even if such change in control would be beneficial to our stockholders. Our restated certificate of incorporation,as amended, allows the Board of Directors of the Company to issue, as of December 31, 2020, up to 5,000,000 shares of preferredstock, with characteristics to be determined by the board, without stockholder approval. The ability of our Board of Directorsto issue additional preferred stock may have the effect of delaying or preventing an attempt by our stockholders to replace orremove existing directors and management.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Historically,warrants to purchase common stock have been issued as compensation for professional services, typically related to fund raisingor have been issued in connection with the issuance of certain notes.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <!-- Field: Page; Sequence: 27; Value: 2 -->      <div style="margin-bottom: 6pt; border-bottom: Black 1.5pt solid">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="text-align: center; width: 100%">           <!-- Field: Sequence; Type: Arabic; Name: PageNo -->           27           <!-- Field: /Sequence -->          </td>         </tr>        </tbody>       </table>      </div>      <div style="break-before: page; margin-top: 6pt">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="width: 100%">          </td>         </tr>        </tbody>       </table>      </div>      <!-- Field: /Page -->      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Inaddition, on several occasions, certain executive officers, members of the Board of Directors and certain vendors have offeredto forgive accrued compensation and other amounts due to them, and the Board of Directors accepted such offers in exchange foreither shares of common stock or options to purchase common stock. In particular, if executive officers offered and if the Boardof Directors accepts such offer(s) in the future, a significant number of shares of common stock or one or more options to purchasea significant number of shares of common stock could be issued or granted. The ability of our Board of Directors to issue additionalshares of common stock or options to purchase shares of common stock, or warrants to purchase shares of common stock, may havethe effect of delaying or preventing an attempt by our stockholders to replace or remove existing directors and management.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         <i>          Ifour common stock is determined to be a “penny stock,” a broker-dealer may find it more difficult to trade our commonstock and an investor may find it more difficult to acquire or dispose of our common stock in the secondary market.         </i>        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Inaddition, our common stock may be subject to the so-called “penny stock” rules. The United States Securities and ExchangeCommission (“SEC”) has adopted regulations that define a “penny stock” to be any equity security thathas a market price per share of less than $5.00, subject to certain exceptions, such as any securities listed on a national securitiesexchange. For any transaction involving a “penny stock,” unless exempt, the rules impose additional sales practicerequirements on broker-dealers, subject to certain exceptions. If our common stock is determined to be a “penny stock,”a broker-dealer may find it more difficult to trade our common stock and an investor may find it more difficult to acquire ordispose of our common stock on the secondary market.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         <i>          Wemay issue additional shares of our Common Stock, and investment in our company is likely to be subject to substantial dilution.         </i>        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Stockholders’interests in the Company will be diluted and stockholders may suffer dilution in their net book value per share when we issueadditional shares. Dilution is the difference between what investors pay for their stock and the net tangible book value per shareimmediately after the additional shares are purchased. We are authorized to issue up to 2,000,000,000 (2 billion) shares of CommonStock. Our financing activities in the past focused on convertible note financing that requires us to issue shares of Common Stockto satisfy principal, interest and any applicable penalties related to these convertible notes. When required under the termsand conditions of the convertible notes, we issue additional shares of Common Stock that have a dilutive effect on our stockholders.We anticipate that all or at least a substantial portion of our future funding, if any, will be in the form of equity financingfrom the sale of our Common Stock and so any investment in the Company will likely be diluted, with a resulting decline in thevalue of our Common Stock.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Additionalfinancing may not be available on terms acceptable to us, and our ability to raise capital through equity financing may be limitedby the number of authorized shares of our Common Stock. In order to raise significant additional amounts from equity financing,we will need to seek, and have sought, stockholder approval to amend our Certificate of Incorporation to increase the number ofauthorized shares of our Common Stock, and any such amendment would require the approval of the holders of a majority of the outstandingshares of our Common Stock. If we are unable to obtain needed financing on acceptable terms, we may not be able to implement ourbusiness plan, which could have a material adverse effect on our business, financial condition, results of operations and prospects.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         <i>          OurCommon Stock was subject to removal from the OTC Markets OTCQB quotation service due to our stock not have a closing bid priceof at least $0.01 per share for a period of 10 consecutive trading days on or before December 10, 2020         </i>        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Adowngrade of our Common Stock to the lower OTC Pink market occurred on December 10, 2020.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Tobring the Company’s stock price back into compliance, the Company gained stockholder approval for a ten-to-one (10:1) reversestock split as described in Note 10. Subsequent Events—Special Meeting of the Stockholders. The reverse stock split occurredon January 5, 2021 and Common Stock began trading on a post-reverse stock split basis on the OTC Markets OTC Pink Market fromJanuary 6, 2021 through February 5, 2021 while measuring for thirty calendar days, compliance with the uplisting requirementsfor listing on the OTC Markets OTCQB Venture Market.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <!-- Field: Page; Sequence: 28; Value: 2 -->      <div style="margin-bottom: 6pt; border-bottom: Black 1.5pt solid">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="text-align: center; width: 100%">           <!-- Field: Sequence; Type: Arabic; Name: PageNo -->           28           <!-- Field: /Sequence -->          </td>         </tr>        </tbody>       </table>      </div>      <div style="break-before: page; margin-top: 6pt">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="width: 100%">          </td>         </tr>        </tbody>       </table>      </div>      <!-- Field: /Page -->      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Ourcommon stock was subject to an uplisting back to the OTC Markets OTCQB quotation service on February 8, 2021       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         <i>          Delawarelaw, our Certificate of Incorporation and our Bylaws provides for the indemnification of our officers and directors at our expense,and correspondingly limits their liability, which may result in a major cost to us and hurt the interests of our shareholdersbecause corporate resources may be expended for the benefit of officers and/or directors.         </i>        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        OurCertificate of Incorporation and By-Laws of the Company, as amended (the “Bylaws”) include provisions that eliminatethe personal liability of our directors for monetary damages for breach of fiduciary duty as a director, except for liability(i) for any breach of the director’s duty of loyalty to the Company or its stockholders, (ii) for acts or omissions notin good faith or which involve intentional misconduct or a knowing violation of law, (iii) under Section 174 of the Delaware GeneralCorporation Law, or (iv) for any transaction from which the director derived an improper personal benefit. These provisions eliminatethe personal liability of our directors and our shareholders for monetary damages arising out of any violation of a director ofhis fiduciary duty of due care, but do not affect a director’s liabilities under the federal securities laws or the recoveryof damages by third parties.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         <i>          Wedo not intend to pay cash dividends on any investment in the shares of stock of our Company and any gain on an investment in ourCompany will need to come through an increase in our stock’s price, which may never happen.         </i>        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Wehave never paid any cash dividends and currently do not intend to pay any cash dividends for the foreseeable future. To the extentthat we require additional funding currently not provided for, our funding sources may prohibit the payment of a dividend. Becausewe do not currently intend to declare dividends, any gain on an investment in our Company will need to come through an increasein our Common Stock’s price. This may never happen, and investors may lose all of their investment in our Company.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         <i>          FINRAsales practice requirements may also limit a stockholder’s ability to buy and sell our stock.         </i>        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Inaddition to the “penny stock” rules described above, FINRA has adopted rules that require that in recommending aninvestment to a customer, a broker-dealer must have reasonable grounds for believing that the investment is suitable for thatcustomer. Prior to recommending speculative low-priced securities to their non-institutional customers, broker-dealers must makereasonable efforts to obtain information about the customer’s financial status, tax status, investment objectives and otherinformation. Under interpretations of these rules, FINRA believes that there is a high probability that speculative low-pricedsecurities will not be suitable for at least some customers. FINRA requirements make it more difficult for broker-dealers to recommendthat their customers buy our Common Stock, which may limit your ability to buy and sell our stock and have an adverse effect onthe market for our shares.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         <i>          Costsand expenses of being a reporting company under the Exchange Act are substantial and prevent us from achieving profitability.         </i>        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Weare subject to the reporting requirements of the Exchange Act and aspects of the Sarbanes-Oxley Act. We expect that the requirementsof these rules and regulations will continue to comprise a substantial portion of our legal, accounting and financial compliancecosts, and to make some activities more difficult, time-consuming and costly, placing significant strain on our personnel, systemsand resources.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         <i>          Ifwe fail to remain current on our reporting requirements, we could be periodically removed from the OTCQB, which would limit theability of broker-dealers to sell our Common Stock and the ability of stockholders to sell their Common Stock in the secondarymarket.         </i>        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">        Companiestrading on the OTCQB must be reporting issuers under Section 12 of the Exchange Act, and must be current in their filings underthe Exchange Act to maintain price quotation privileges on the OTCQB. If we fail to remain current on our reporting requirements,we could be removed from the OTCQB and be forced to be traded on the OTC Pink Sheets, which requires a more challenging stockpurchase process. As a result, the liquidity for our Common Stock could be adversely affected by limiting the ability of broker-dealersto sell our common stock and the ability of stockholders to sell their Common Stock in the secondary market. The OTCQB is recognizedby the SEC as an established public market. The OTC Pink Sheets is the lowest and most speculative tier of the three marketplacesfor the trading of over-the-counter stocks.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">        OTCPink Sheets shares generally trade thinly and infrequently making it hard to buy or sell when the investor wants to complete atransaction. Accordingly, the market for our Common Stock would be significantly diminished if we were forced to trade on theOTC Pink Sheets market.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">       </font>      </p>      <!-- Field: Page; Sequence: 29; Value: 2 -->      <div style="margin-bottom: 6pt; border-bottom: Black 1.5pt solid">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="text-align: center; width: 100%">           <!-- Field: Sequence; Type: Arabic; Name: PageNo -->           29           <!-- Field: /Sequence -->          </td>         </tr>        </tbody>       </table>      </div>      <div style="break-before: page; margin-top: 6pt">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="width: 100%">          </td>         </tr>        </tbody>       </table>      </div>      <!-- Field: /Page -->      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         <a name="a_004">         </a>         Item1B. Unresolved Staff Comments        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        None.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         <a name="a_005">         </a>         Item2. Properties        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Asof December 31, 2020, the Company did not own any real property or maintain any leases with respect to real property. The Companyperiodically contracts for services provided at the facilities owned by third parties and may, from time-to-time, have employeeswho work in these facilities.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         <a name="a_006">         </a>         Item3. Legal Proceedings        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>        </b>       </font>      </p>      <p style="margin: 0pt 0; font: 10pt Times New Roman, Times, Serif; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Weare periodically subject to various pending and threatened legal actions and claims. See Note 9. Commitments and Contingencies–        <i>         Pending or Threatened Legal Actions and Claims        </i>        in the notes to our consolidated financial statements for the yearended December 31, 2020 for additional information regarding these matters.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Thelegal proceedings discussed in this report could result in adverse judgments, settlements, fines, injunctions, restitutions orother relief that could require significant expenditures or have other effects on our business. Management believes, based oncurrent knowledge and after consultation with counsel, that the outcome of such actions will not have a material adverse effecton our consolidated financial condition. The outcome of litigation and other legal proceedings is inherently uncertain, and itis possible that one or more of the matters currently pending or threatened could have an adverse effect on our liquidity, financialcondition or results of operations for any particular period.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         <a name="a_007">         </a>         Item4. Mine Safety Disclosures        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Notapplicable.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <!-- Field: Page; Sequence: 30; Value: 2 -->      <div style="margin-bottom: 6pt; border-bottom: Black 1.5pt solid">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="text-align: center; width: 100%">           <!-- Field: Sequence; Type: Arabic; Name: PageNo -->           30           <!-- Field: /Sequence -->          </td>         </tr>        </tbody>       </table>      </div>      <div style="break-before: page; margin-top: 6pt">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="width: 100%">          </td>         </tr>        </tbody>       </table>      </div>      <!-- Field: /Page -->      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         <a name="a_008">         </a>         PARTII        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         <a name="a_009">         </a>         Item5. Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Ourcommon stock was quoted on the OTC Pink Market on December 31, 2020 and is quoted as of February 8, 2021 on the OTCQB VentureMarket, under the symbol “RSPI”. The current quotations on the OTCQB Venture Market and prior quotations on the OTBPink Market reflect inter-dealer prices, without retail mark-up, mark-down or commission and may not necessarily represent actualtransactions.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Asof April 9, 2021, there were 95 stockholders of record of our common stock, and approximately 4,000 beneficialowners. The high and low sales prices for our common stock on December 31, 2020, as quoted on the OTC Pink Market market, were$0.0350 and $0.0285, respectively, the last date of the fiscal year on which the common stock traded (81,220 shares of commonstock). The high and low prices and the volume of shares traded were based on post-reverse split shares. On January 5,2021, we effected a 10:1 reverse stock split, exchanging one new share for each ten old shares.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Wehave never paid cash dividends on our common stock and do not anticipate paying such dividends in the foreseeable future. Thepayment of dividends, if any, will be determined by the Board in light of conditions then existing, including our financial conditionand requirements, future prospects, restrictions in financing agreements, business conditions and other factors deemed relevantby the Board.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Duringthe fiscal year ended December 31, 2020, we did not repurchase any of our securities.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         <a name="a_010">         </a>         Item6. Selected Financial Data        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Notapplicable to smaller reporting companies.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         <a name="a_011">         </a>         Item7. Management’s Discussion and Analysis of Financial Condition and Results of Operations        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <i>         Thefollowing discussion and analysis should be read in conjunction with the audited financial statements and notes related theretoappearing elsewhere in this document.        </i>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         Overview        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Themission of the Company is to develop innovative and revolutionary treatments to combat disorders caused by disruption of neuronalsignaling. We are developing treatment options that address conditions that affect millions of people, but for which there arelimited or poor treatment options, including OSA, attention deficit hyperactivity disorder (“ADHD”) epilepsy, chronicpain, including inflammatory and neuropathic pain, recovery from spinal cord injury (“SCI”), as well as other areasof interest based on results of animal studies to date.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        RespireRxis developing a pipeline of new drug products based on our broad patent portfolios across two distinct drug platforms:       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">       <tbody>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           (i)          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           our    pharmaceutical cannabinoids platform (which we refer to as ResolutionRx), including dronabinol (a synthetic form of ∆9-tetrahydrocannabinol    (“Δ9-THC”)), which acts upon the nervous system’s endogenous cannabinoid receptors, and          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           (ii)          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           our    neuromodulators platform (which we refer to as EndeavourRx) is made up of two programs: (a) our AMPAkines program, including    proprietary compounds that are positive allosteric modulators (“PAMs”) of AMPA-type glutamate receptors to promote    neuronal function and (b) our GABAkines program, including proprietary compounds that are PAMs of GABA           <sub>            A           </sub>           receptors,    which was established pursuant to our entry with the University of Wisconsin-Milwaukee Research Foundation, Inc., an affiliate    of the University of Wisconsin-Milwaukee (“UWMRF”), into a patent license agreement (the UWMRF Patent License    Agreement”).          </font>         </td>        </tr>       </tbody>      </table>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <!-- Field: Page; Sequence: 31; Value: 2 -->      <div style="margin-bottom: 6pt; border-bottom: Black 1.5pt solid">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="text-align: center; width: 100%">           <!-- Field: Sequence; Type: Arabic; Name: PageNo -->           31           <!-- Field: /Sequence -->          </td>         </tr>        </tbody>       </table>      </div>      <div style="break-before: page; margin-top: 6pt">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="width: 100%">          </td>         </tr>        </tbody>       </table>      </div>      <!-- Field: /Page -->      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         <i>          Financingour Platforms         </i>        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">       We anticipate filing aForm 1-A with the SEC, which if qualified would enable the Company to engage in a Regulation A offering (Reg A Offering). We provideno assurance that we will file a Form 1-A, or if filed that the Reg A Offering would be qualified, or if qualified, would resultin a financing on terms as to price per share or other securities offered, amount of funds raised or other terms acceptable tothe Company or at all. Our major challenge has been to raise substantial equity or equity-linked financing to support researchand development plans for our cannabinoid and neuromodulator platforms, while minimizing the dilutive effect to pre-existing stockholders.At present, we believe that we are hindered primarily by our public corporate structure, our OTCQB listing, and low market capitalizationas a result of our low stock price. For this reason, the Company has effected an internal restructuring plan throughwhich our two drug platforms have been reorganized into separate businesses units, and may, in the future, be spunout into subsidiaries.      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 38.4pt">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Webelieve that by creating one or more subsidiaries to further the aims of Project ResolutionRx and Project EndeavourRx, it maybe possible, through separate finance channels, to optimize the asset values of each.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 38.4pt">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 38.4pt">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Fora more detailed discussion of our Cannabinoid and Neuromodulator programs, see subsections I and II under Item 1 – Businessabove.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         RecentDevelopments        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 38.4pt">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         <i>          UICExtension         </i>        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        UIChas granted the Company an extension of the due date for the payment of the minimum annual royal obligation of $100,000 that wasoriginally due on December 31, 2020 until April 19, 2021. The amount due to UIC was paid in full on April 1, 2021.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 38.4pt">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         <i>          UWMResearch Foundation Option Agreement         </i>        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        OnAugust 1, 2020, RespireRx exercised its option pursuant to its option agreement dated March 2, 2020, between RespireRx and UWMResearch Foundation, an affiliate of the University of Wisconsin-Milwaukee (“UWMRF”). Upon exercise RespireRx andUWMRF executed the UWMRF Patent License Agreement effective August 1, 2020 pursuant to which RespireRx licensed the identifiedintellectual property.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Underthe UWMRF Patent License Agreement, the Company has an exclusive license to commercialize GABAkine products based on UWMRF’srights in certain patents and patent applications, and a non-exclusive license to commercialize products based on UWMRF’srights in certain technology that is not the subject of the patents or patent applications. UWMRF maintains the right to use,and, upon the approval of the Company, to license, these patent and technology rights for any non-commercial purpose, includingresearch and education. The UWMRF Patent License Agreement expires upon the later of the expiration of the Company’s paymentobligations to UWMRF or the expiration of the last remaining licensed patent granted thereunder, subject to early terminationupon the occurrence of certain events. The License Agreement also contains a standard indemnification provision in favor of UWMRFand confidentiality provisions obligating both parties.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <!-- Field: Page; Sequence: 32; Value: 2 -->      <div style="margin-bottom: 6pt; border-bottom: Black 1.5pt solid">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="text-align: center; width: 100%">           <!-- Field: Sequence; Type: Arabic; Name: PageNo -->           32           <!-- Field: /Sequence -->          </td>         </tr>        </tbody>       </table>      </div>      <div style="break-before: page; margin-top: 6pt">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="width: 100%">          </td>         </tr>        </tbody>       </table>      </div>      <!-- Field: /Page -->      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif">        <b>         <i>          Conversionsof Convertible Notes         </i>        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        SeeNote 4. Notes Payable – Convertible Notes Payable in the Notes to Consolidated Financial Statements for the years endedDecember 31, 2020 and 2019, included with this report for a detailed description of the terms of, and accounting for, the above-referencedconvertible notes.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         <i>          Forgivenessof Accrued Compensation and Related Costs         </i>        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         <i>         </i>        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        OnMarch 22, 2020, two executive officers forgave an aggregate of $306,000 ($153,000 each) of accrued compensation and related costsand received 900,000 (450,000 each) shares of common stock.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        OnJuly 13, 2020, two executive officers forgave an aggregate of $1,100,000 of accrued unpaid compensation in exchange for 1,100shares of Series H 2% Voting, Non-Participating Convertible Preferred Stock (“Series H Preferred Stock”). On September30, 2020, three executive officers forgave $278,218 of accrued unpaid compensation for 278.218 shares of Series H Preferred Stock.On September 30, 2020, a portion of accounts payable due to two vendors totaling $241,109 for 241.10948 shares of Series H PreferredStock. On September 30, 2020, all holders of Series H Preferred Stock converted 100% of the Series H Preferred Stock inclusiveof accrued unpaid dividends, converted all of their Series H Preferred Stock into 25,377,426 shares of Common Stock and 25,377,426common stock purchase warrants, both reflected on a post-reverse stock split basis, which reverse stock split occurred on January5, 2021. As of December 31, 2020, there is no Series H preferred Stock outstanding.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         <i>          Complaintand Summons         </i>        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         <i>          SharpSettlement Agreement and related Complaint         </i>        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        SeeItem 3. Legal Proceedings for detailed information about the status of the Sharp Settlement Agreement and the related complaint.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         <i>          Salamandra         </i>        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        SeeItem 3. Legal Proceedings for detailed information about the status of the Salamandra settlement agreement.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         RecentAccounting Pronouncements        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Fora description of recent accounting pronouncements, see Note 3-Summary of Significant Accounting Policies-        <i>         Recent AccountingPronouncements        </i>        to the consolidated financial statements for the fiscal years ended December 31, 2020 and 2019, included withthis report.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         Concentrationof Risk        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Financialinstruments that potentially subject the Company to concentrations of credit risk consist primarily of cash and cash equivalents.The Company limits its exposure to credit risk by investing its cash with high credit quality financial institutions.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        TheCompany’s research and development efforts and potential products rely on licenses from research institutions and if theCompany loses access to these technologies or applications, its business could be substantially impaired.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <!-- Field: Page; Sequence: 33; Value: 2 -->      <div style="margin-bottom: 6pt; border-bottom: Black 1.5pt solid">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="text-align: center; width: 100%">           <!-- Field: Sequence; Type: Arabic; Name: PageNo -->           33           <!-- Field: /Sequence -->          </td>         </tr>        </tbody>       </table>      </div>      <div style="break-before: page; margin-top: 6pt">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="width: 100%">          </td>         </tr>        </tbody>       </table>      </div>      <!-- Field: /Page -->      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Throughthe merger with Pier, the Company gained access to the 2007 License Agreement that Pier had entered into with the University ofIllinois on October 10, 2007. The 2007 License Agreement covered certain patents and patent applications in the United Statesand other countries claiming the use of certain compounds referred to as cannabinoids for the treatment of sleep related breathingdisorders (including sleep apnea), of which dronabinol is a specific example of one type of cannabinoid. The 2007 License Agreementwas terminated effective March 21, 2013 and on June 27, 2014, the Company entered into the 2014 License Agreement with the Universityof Illinois, the material terms of which were similar to the 2007 License Agreement that had been terminated and also includedthe assignment of rights to the University of Illinois, to certain patent applications filed by RespireRx.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        TheCompany received an extension of time to make a $100,000 payment that would have been due on December 31, 2020. The payment datehas been extended to April 19, 2021 and was paid in full by the Company on April 1, 2021 (See Note 9 – Commitmentsand Contingencies – Significant Agreements and Contracts – University of Illinois 2014 Exclusive License Agreementin notes to the consolidated financial statements as of December 31, 2020 and 2019, included with this report).       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         CriticalAccounting Policies and Estimates        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="margin: 0pt 0; font: 10pt Times New Roman, Times, Serif; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        SECguidance defines Critical Accounting Estimates as those estimates made in accordance with GAAP that involve a significant levelof estimation uncertainty and have had or are reasonably likely to have a material impact on the financial condition or resultsof operation of the registrant. These items require the application of management’s most difficult, subjective or complexjudgments, often because of the need to make estimates about the effect of matters that are inherently uncertain and that maychange in subsequent periods. In preparing our consolidated financial statements in accordance with GAAP, management has madeestimates, assumptions and judgments that affect the reported amounts of assets and liabilities at the date of the financial statementsand the reported amounts of revenues and expenses during the reporting periods.       </font>      </p>      <p style="margin: 0pt 0; font: 10pt Times New Roman, Times, Serif; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Inpreparing these financial statements, management has utilized available information, including our past history, industry standardsand the current and projected economic environment, among other factors, in forming its estimates, assumptions and judgments,giving due consideration to materiality. Because the use of estimates is inherent in GAAP, actual results could differ from thoseestimates. In addition, other companies may utilize different estimates, which may impact comparability of our results of operationsto those of companies in similar businesses. A summary of the accounting estimates that management believes are critical to thepreparation of our consolidated financial statements is set forth below. See Note 3 in the notes to consolidated financial statementsas of December 31, 2020 for additional disclosures regarding our significant accounting policies.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         <i>          Stock-BasedCompensation and Awards         </i>        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        TheCompany periodically issues common stock and stock options to officers, directors and consultants for services rendered. Suchissuances vest and expire according to terms established at the issuance date of each grant.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 38.4pt">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        TheCompany accounts for stock-based payments to officers, directors, outside consultants and vendors by measuring the cost of servicesreceived in exchange for equity awards based on the grant date fair value of the awards, with the cost recognized as compensationexpense on the straight-line basis in the Company’s consolidated financial statements over the vesting period of the awards.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 38.4pt">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Thefair value of stock options granted as stock-based payments is determined utilizing the Black-Scholes option-pricing model, andis affected by several variables, the most significant of which are the life of the equity award, the exercise price of the stockoption as compared to the fair market value of the common stock on the grant date, and the estimated volatility of the commonstock over the term of the equity award. Estimated volatility is based on the historical volatility of the Company’s commonstock. The risk- free interest rate is based on the U.S. Treasury yield curve in effect at the time of grant. The fair marketvalue of common stock is determined by reference to the quoted market price of the Company’s common stock.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 38.4pt">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <!-- Field: Page; Sequence: 34; Value: 2 -->      <div style="margin-bottom: 6pt; border-bottom: Black 1.5pt solid">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="text-align: center; width: 100%">           <!-- Field: Sequence; Type: Arabic; Name: PageNo -->           34           <!-- Field: /Sequence -->          </td>         </tr>        </tbody>       </table>      </div>      <div style="break-before: page; margin-top: 6pt">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="width: 100%">          </td>         </tr>        </tbody>       </table>      </div>      <!-- Field: /Page -->      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 38.4pt">      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Stockgrants, which are sometimes subject to time-based vesting, are measured at the grant date fair value and charged to operationsratably over the vesting period.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Stockoptions and warrants issued to non-employees as compensation for services to be provided to the Company or in settlement of debtare accounted for based upon the fair value of the services provided or the estimated fair value of the stock option or warrant,whichever can be more clearly determined. Management uses the Black-Scholes option-pricing model to determine the fair value ofthe stock options and warrants issued by the Company. The Company recognizes this expense over the period in which the servicesare provided.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         <i>          Researchand Development Costs         </i>        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Researchand development costs consist primarily of fees paid to consultants and outside service providers and organizations (includingresearch institutes at universities) and other expenses relating to the acquisition, design, development and testing of the Company’streatments and product candidates. Research and development costs include salaries of our officers who also perform administrativeduties for the Company. Management makes an allocation of those salaries to research and development based on estimates of timespent on those activities.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Researchand development costs incurred by the Company under research grants are expensed as incurred over the life of the underlying contracts,unless the terms of the contract indicate that a different expensing schedule is more appropriate.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        TheCompany reviews the status of its research and development contracts on a quarterly basis.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         <i>          LicenseAgreements         </i>        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Obligationsincurred with respect to mandatory payments provided for in license agreements are recognized ratably over the appropriate period,as specified in the underlying license agreement, and are recorded as liabilities in the Company’s consolidated balancesheet, with a corresponding charge to research and development costs in the Company’s consolidated statement of operations.Obligations incurred with respect to milestone payments provided for in license agreements are recognized when it is probablethat such milestone will be reached and are recorded as liabilities in the Company’s consolidated balance sheet, with acorresponding charge to research and development costs in the Company’s consolidated statement of operations. Payments ofsuch liabilities are made in the ordinary course of business.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         <i>          PatentCosts         </i>        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Dueto the significant uncertainty associated with the successful development of one or more commercially viable products based onthe Company’s research efforts and any related patent applications, all patent costs, including patent-related legal andfiling fees, are expensed as incurred and, in accordance with generally accepted accounting principles, are charged to generaland administrative expenses.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <!-- Field: Page; Sequence: 35; Value: 2 -->      <div style="margin-bottom: 6pt; border-bottom: Black 1.5pt solid">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="text-align: center; width: 100%">           <!-- Field: Sequence; Type: Arabic; Name: PageNo -->           35           <!-- Field: /Sequence -->          </td>         </tr>        </tbody>       </table>      </div>      <div style="break-before: page; margin-top: 6pt">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="width: 100%">          </td>         </tr>        </tbody>       </table>      </div>      <!-- Field: /Page -->      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         Resultsof Operations        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        TheCompany’s consolidated statements of operations as discussed herein are presented below.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">      </p>      <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">       <tbody>        <tr style="vertical-align: bottom">         <td style="padding-bottom: 1.5pt; font-weight: bold">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="padding-bottom: 1.5pt; font-weight: bold">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td colspan="6" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">          <font style="font-family: Times New Roman, Times, Serif">           Years    Ended December 31,          </font>         </td>         <td style="padding-bottom: 1.5pt; font-weight: bold">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>        </tr>        <tr style="vertical-align: bottom">         <td style="padding-bottom: 1.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="padding-bottom: 1.5pt; font-weight: bold">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">          <font style="font-family: Times New Roman, Times, Serif">           2020          </font>         </td>         <td style="padding-bottom: 1.5pt; font-weight: bold">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="padding-bottom: 1.5pt; font-weight: bold">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">          <font style="font-family: Times New Roman, Times, Serif">           2019          </font>         </td>         <td style="padding-bottom: 1.5pt; font-weight: bold">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>        </tr>        <tr style="vertical-align: bottom">         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td colspan="2">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td colspan="2">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>        </tr>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           Operating expenses:          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>        </tr>        <tr style="vertical-align: bottom; background-color: White">         <td style="padding-left: 10pt; width: 60%; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           General    and administrative, including $1,230,370 and $485,332 to related parties for the years ended December 31, 2020 and    2019, respectively          </font>         </td>         <td style="width: 2%">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="width: 1%; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           $          </font>         </td>         <td style="width: 16%; text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           2,676,860          </font>         </td>         <td style="width: 1%; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="width: 2%">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="width: 1%; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           $          </font>         </td>         <td style="width: 16%; text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           1,137,175          </font>         </td>         <td style="width: 1%; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>        </tr>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td style="padding-bottom: 1.5pt; padding-left: 10pt; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           Research    and development, including $490,850 and $490,908 to related parties for the years ended December 31, 2020 and 2019,    respectively          </font>         </td>         <td style="padding-bottom: 1.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           638,275          </font>         </td>         <td style="padding-bottom: 1.5pt; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="padding-bottom: 1.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           599,329          </font>         </td>         <td style="padding-bottom: 1.5pt; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>        </tr>        <tr style="vertical-align: bottom; background-color: White">         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>        </tr>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td style="padding-bottom: 1.5pt; padding-left: 20pt; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           Total    operating costs and expenses          </font>         </td>         <td style="padding-bottom: 1.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           3,315,135          </font>         </td>         <td style="padding-bottom: 1.5pt; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="padding-bottom: 1.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           1,736,504          </font>         </td>         <td style="padding-bottom: 1.5pt; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>        </tr>        <tr style="vertical-align: bottom; background-color: White">         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>        </tr>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           Loss from operations          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           (3,315,135          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           )          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           (1,736,504          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           )          </font>         </td>        </tr>        <tr style="vertical-align: bottom; background-color: White">         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>        </tr>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           Loss on extinguishment of debt and other    liabilities in exchange for equity          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           (389,902          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           )          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           -          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>        </tr>        <tr style="vertical-align: bottom; background-color: White">         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           Interest expense, including $11,329    and $60,135 to related parties for the years ended December 31, 2020 and 2019, respectively          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           (545,675          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           )          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           (404,661          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           )          </font>         </td>        </tr>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td style="padding-bottom: 1.5pt; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           Foreign currency    transaction (loss) gain          </font>         </td>         <td style="padding-bottom: 1.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           (50,499          </font>         </td>         <td style="padding-bottom: 1.5pt; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           )          </font>         </td>         <td style="padding-bottom: 1.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           26,132          </font>         </td>         <td style="padding-bottom: 1.5pt; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>        </tr>        <tr style="vertical-align: bottom; background-color: White">         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>        </tr>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           Net loss          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           $          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           (4,301,211          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           )          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           $          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           (2,115,033          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           )          </font>         </td>        </tr>        <tr style="vertical-align: bottom; background-color: White">         <td style="padding-bottom: 1.5pt">          <p style="margin: 0; font: 10pt Times New Roman, Times, Serif">           <font style="font-family: Times New Roman, Times, Serif">            Deemed        dividends from warrant anti-dilution provisions           </font>          </p>         </td>         <td style="padding-bottom: 1.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: left">          <p style="margin: 0; font: 10pt Times New Roman, Times, Serif">           <font style="font-family: Times New Roman, Times, Serif">            $           </font>          </p>         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           (1,440,214          </font>         </td>         <td style="padding-bottom: 1.5pt; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           )          </font>         </td>         <td style="padding-bottom: 1.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: left">          <p style="margin: 0; font: 10pt Times New Roman, Times, Serif">           <font style="font-family: Times New Roman, Times, Serif">            $           </font>          </p>         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           -          </font>         </td>         <td style="padding-bottom: 1.5pt; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>        </tr>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td style="padding-bottom: 2.5pt; width: 60%">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           Net    loss attributable to common shareholders          </font>         </td>         <td style="padding-bottom: 2.5pt; width: 2%">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="border-bottom: Black 2.5pt double; width: 1%">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           $          </font>         </td>         <td style="border-bottom: Black 2.5pt double; text-align: right; width: 16%">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           (5,714,425          </font>         </td>         <td style="padding-bottom: 2.5pt; width: 1%">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           )          </font>         </td>         <td style="padding-bottom: 2.5pt; width: 2%">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="border-bottom: Black 2.5pt double; width: 1%">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           $          </font>         </td>         <td style="border-bottom: Black 2.5pt double; text-align: right; width: 16%">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           (2,115,033          </font>         </td>         <td style="padding-bottom: 2.5pt; width: 1%">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>        </tr>        <tr style="vertical-align: bottom; background-color: White">         <td>          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>        </tr>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td style="padding-bottom: 2.5pt">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           Net loss per common share - basic and diluted    respectively (reflected on a post 10 for 1 reverse stock split basis which occurred on January 5, 2021)          </font>         </td>         <td style="padding-bottom: 2.5pt">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="border-bottom: Black 2.5pt double">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           $          </font>         </td>         <td style="border-bottom: Black 2.5pt double; text-align: right">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           (0.22)          </font>         </td>         <td style="padding-bottom: 2.5pt">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="padding-bottom: 2.5pt">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="border-bottom: Black 2.5pt double">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           $          </font>         </td>         <td style="border-bottom: Black 2.5pt double; text-align: right">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           (5.41          </font>         </td>         <td style="padding-bottom: 2.5pt">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>        </tr>        <tr style="vertical-align: bottom; background-color: White">         <td style="width: 60%">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="width: 2%">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left; width: 1%">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right; width: 16%">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left; width: 1%">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="width: 2%">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left; width: 1%">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right; width: 16%">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left; width: 1%">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>        </tr>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td style="padding-bottom: 2.5pt; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           Weighted average    common shares outstanding - basic and diluted – post-reverse split basis          </font>         </td>         <td style="padding-bottom: 2.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="border-bottom: Black 2.5pt double; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="border-bottom: Black 2.5pt double; text-align: right">          <p style="margin: 0; font: 10pt Times New Roman, Times, Serif">           <font style="font-family: Times New Roman, Times, Serif">            25,855,664           </font>          </p>         </td>         <td style="padding-bottom: 2.5pt; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="padding-bottom: 2.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="border-bottom: Black 2.5pt double; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="border-bottom: Black 2.5pt double; text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           390,848          </font>         </td>         <td style="padding-bottom: 2.5pt; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>        </tr>       </tbody>      </table>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         YearsEnded December 31, 2020 and 2019        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <u>         Revenues        </u>        .During the year ended December 31, 2020 and 2019, the Company had no revenues.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <u>         Generaland Administrative        </u>        . For the year ended December 31, 2020, general and administrative expenses were $2,676,860, an increaseof $1,539,685, as compared to $1,137,175 for the year ended December 31, 2019.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Stock-basedcompensation costs and fees included in general and administrative expenses were $345,500 for the year ended December 31,2020, as compared to $0 for the year ended December 31, 2019, reflecting an increase of $345,500. The increase is the result stockoption grants to general and administrative employees and consultants and service providers of the Company during the year endedDecember 31, 2020. Salaries included in general and administrative expenses were $693,676 for the year ended December 31, 2020as compared to $300,000 for the year ended December 31, 2019, an increase of $393,676. The increase is primarily due to engagementof Timothy Jones as CEO and President commencing on May 6, 2020 and the accrual of salary and a scheduled bonus. Legal fees forgeneral corporate purposes were $859,258 for the year ended December 31, 2020 as compared to $213,289 for the year ended December31, 2019, an increase of $645,969 related to periodic filings with the SEC in the ordinary course of business, advise and researchwith respect to our planned securities offering pursuant to Regulation A, settlement negotiations with certain vendors, fees associatedwith our entering into first the option agreement and then the license agreement with UWMRF (as herein defined) and other generalcorporate matters. Legal fees associated with our filing of a Form S-1 registration statement and its becoming effective resultingin financings associated with our equity line have been charged against Additional paid-in capital as a cost of the financingto the extent such completed financings occurred in 2020 and have been recorded as a deferred financing cost, a current asset,on our consolidated balance sheet as of December 31, 2020. Legal fees for patents and other patent expenses included in generaland administrative expenses were $213,916 for the year ended December 31, 2020, an increase of $66,194 as compared to $147,722for the year ended December 31, 2019. The increase in legal fees associated with patents and other patent costs is a result ofan increase in patent related activities with respect to the UWMRF licensed assets as well as foreign fees, patent maintenancefees and other patent related activities.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <!-- Field: Page; Sequence: 36; Value: 2 -->      <div style="margin-bottom: 6pt; border-bottom: Black 1.5pt solid">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="text-align: center; width: 100%">           <!-- Field: Sequence; Type: Arabic; Name: PageNo -->           36           <!-- Field: /Sequence -->          </td>         </tr>        </tbody>       </table>      </div>      <div style="break-before: page; margin-top: 6pt">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="width: 100%">          </td>         </tr>        </tbody>       </table>      </div>      <!-- Field: /Page -->      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <u>         Researchand Development        </u>        . For the year ended December 31, 2020, research and development expenses were $638,275, an increase of $38,946as compared to $599,329 for the year ended December 31, 2019, primarily due to the addition of several consultants offset by thedecrease in the utilization of one consultant.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <u>         Losson Extinguishment of Debt and other Liabilities in Exchange for Equity        </u>        . The loss on extinguishment of debt or other liabilitiesfor the year ended December 31, 2020 was $389,902 as compared to $0 for the year ended December 31, 2019. The loss is attributableto the exchange of certain notes for Common Stock and the payment of certain liabilities to vendors with Common Stock in 2020as compared to no such transactions occurring in 2019.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <u>         InterestExpense.        </u>        During the year ended December 31, 2020, interest expense was $545,675 (including $11,3429 to related parties),an increase of $141,014, as compared to $404,661 (including $60,135 to related parties) for the year ended December 31, 2019.The increase in interest expense resulted primarily from interest on five new convertible notes issued from April, June and July2020 totaling $348,500 of principal amount in 2020, plus partial year interest on convertible notes from 2019 until paid in fulland additional interest with respect to the Salamandra legal settlement. Also included in interest expense is the amortizationof note discounts.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <u>         ForeignCurrency Transaction Loss or Gain.        </u>        The foreign currency transaction loss was $50,499 for the year ended December 31, 2020,as compared to a foreign currency transaction gain of $26,132 for the year ended December 31, 2019. The foreign currency transactionloss or gain relates to the $399,774 loan from SY Corporation Co., Ltd., formerly known as Samyang Optics Co. Ltd. (“SYCorporation”), made in June 2012, which is denominated in the South Korean Won.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <u>         NetLoss        </u>        . For the year ended December 31, 2020, the Company incurred a net loss of $4,301,211, as compared to a net loss of $2,115,033for the year ended December 31, 2019.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         Liquidityand Capital Resources        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <u>         WorkingCapital and Cash        </u>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        TheCompany’s consolidated financial statements have been presented on the basis that it is a going concern, which contemplatesthe realization of assets and satisfaction of liabilities in the normal course of business. The Company has incurred net lossesof $4,301,210 for the fiscal year ended December 31, 2020 and $2,115,033 for the fiscal year ended December 31, 2019, and negativeoperating cash flows of $513,001 and $487,745 for the fiscal years ended December 31, 2020 and 2019 respectively. The Companyhad a stockholders’ deficiency of $8,063,320 as of December 31, 2020 and expects to continue to incur net losses and negativeoperating cash flows for at least the next few years. As a result, management has concluded that there is substantial doubt aboutthe Company’s ability to continue as a going concern. In addition, the Company’s independent registered public accountingfirm, in its report on the Company’s consolidated financial statements for the year ended December 31, 2020, has expressedsubstantial doubt about the Company’s ability to continue as a going concern (see “Going Concern” below).       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        AtDecember 31, 2020, the Company had a working capital deficit of $8,063,320, as compared to a working capital deficit of $7,444,819at December 31, 2019, reflecting an increase in the working capital deficit of $618,501 for the fiscal year ended December 31,2020. This increase is comprised of an increase in total current liabilities of $658,260, offset by an increase in current assetsof $39,759. The increase in total current liabilities consists of a net increase in accounts payable and accrued expenses of $1,211,417,decrease in accrued compensation and related expenses of $543,032, a decrease in convertible notes payable of $107,090, an increasein the note payable to SY Corporation of $98,315 and an increase in notes payable to officers and former officers of $28,317.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        AtDecember 31, 2020, the Company had cash aggregating $825 as compared to $16,690 at December 31, 2019, reflecting a decrease incash of $15,865 during the fiscal year ended December 31, 2019.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <u>         OperatingActivities        </u>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Forthe fiscal year ended December 31, 2020, operating activities utilized cash of $513,001 as compared to utilizing cash of$487,745 for the fiscal year ended December 31, 2019, to support the Company’s ongoing operations and research and developmentactivities.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <!-- Field: Page; Sequence: 37; Value: 2 -->      <div style="margin-bottom: 6pt; border-bottom: Black 1.5pt solid">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="text-align: center; width: 100%">           <!-- Field: Sequence; Type: Arabic; Name: PageNo -->           37           <!-- Field: /Sequence -->          </td>         </tr>        </tbody>       </table>      </div>      <div style="break-before: page; margin-top: 6pt">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="width: 100%">          </td>         </tr>        </tbody>       </table>      </div>      <!-- Field: /Page -->      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <u>         FinancingActivities        </u>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Forthe fiscal year ended December 31, 2020, financing activities consisted of five convertible note financings and an equity line.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        TheCompany and PowerUp Lending Group Ltd. (“PowerUp”) entered into Securities Purchase Agreements, dated as of April15, 2020 and June 7, 2020 (each, a “PowerUp Agreement”), by which PowerUp loaned $53,000 and $43,000, respectively,to the Company in return for two convertible promissory notes (the “April 2020 Note” and the “June 2020 Note”respectively). The proceeds of the loans, which equal $90,000 after payment of $5,000 in legal fees and $1,000 in due diligencefees, were used for general corporate purposes.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        TheApril 2020 Note and the June 2020 Note were repaid in full inclusive of principal or interest at 12% per year by conversion ofthe Notes into Common Stock on October 22, 2020, October 23, 2020, October 26, 2020, December 14, 2020 and December 15, 2020.The conversions resulted in the issuance by the Company of 5,586,895 shares of Common Stock (post-reverse stock split basis).       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        OnJuly 2, 2020, the Company and FirstFire Global Opportunities Fund LLC (“FirstFire”) entered into a Securities PurchaseAgreement (the “FirstFire SPA”) pursuant to which FirstFire provided a sum of $125,000 (the “FirstFire Consideration”)to the Company, in return for a convertible promissory note (the “FirstFire Note”) with a face amount of $137,500(which difference in value as compared to the FirstFire Consideration is due to an original issue discount of $12,500), a commonstock purchase warrant for 687,500 shares of Common Stock (post-reverse stock split basis (the “FirstFire Warrant”),and a confession of judgment, among other agreements and obligations. The net proceeds of the First Fire Consideration, whichwere received by the Company on July 6, 2020, equal $121,000 after payment of $4,000 in FirstFire’s legal fees.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        TheFirstFire Note was paid in full inclusive of principal and interest at 10% per annum by conversion into the Company’s CommonStock on January 19, 2021, February 4, 2021, February 16, 2021 and March 3, 2021. The conversions resulted in the issuance bythe Company of 7,218,750 shares of Common Stock (post-reverse stock split basis). See Note 10 – Subsequent Events in thenotes to our consolidated financial statements as of December 31, 2020.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        OnJuly 28, 2020, the Company issued a convertible note, as amended (“Commitment Note”) to White Lion Capital, LLC (“WhiteLion”) pursuant to, and to induce White Lion to enter into an equity purchase agreement dated July 28, 2020 (“WhiteLion EPA”). See Note 9 - Commitments and Contingencies -        <i>         Entry into Equity Purchase Agreement        </i>        to our consolidatedfinancial statements as of December 31, 2020 for a description of the White Lion EPA and the other agreements entered into pursuantto the White Lion EPA. The Commitment Note had an initial face amount of $25,000 which was subsequently amended effective July28, 2020 to $40,000 in consideration for an amendment to the White Lion EPA extending the date by which the Company wasto file a registration statement on Form S-1 listing White Lion as the selling stockholder on Form S-1. The Commitment Note wasaccounted for as equity issuance costs in Additional paid-in capital.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <!-- Field: Page; Sequence: 38; Value: 2 -->      <div style="margin-bottom: 6pt; border-bottom: Black 1.5pt solid">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="text-align: center; width: 100%">           <!-- Field: Sequence; Type: Arabic; Name: PageNo -->           38           <!-- Field: /Sequence -->          </td>         </tr>        </tbody>       </table>      </div>      <div style="break-before: page; margin-top: 6pt">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="width: 100%">          </td>         </tr>        </tbody>       </table>      </div>      <!-- Field: /Page -->      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        TheCommitment Note obligates the Company to pay by July 28, 2021 a principal amount of $40,000, together with a guaranteed interestpayment of $3,200 representing an 8% per annum interest rate applied regardless of any payments or prepayments other than paymentsmade by conversion of the Commitment Note. Unless an event of default has occurred, White Lion may convert at a per share conversionprice equal to $0.02.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif">        $25,000of the principal amount of the       </font>       <font style="font-family: Times New Roman, Times, Serif">        Commitment Note was paid inpart, by conversion into the Company’s Common Stock on March 15, 2021. The conversion resulted in the issuance by the Companyof 1,250,000 shares of Common Stock (post-reverse stock split basis). See Note 10 – Subsequent Events in the notes to ourconsolidated financial statements as of December 31, 2020. As of December 31, 2020, there remains $15,000 of principal amountplus accrued interest outstanding.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        OnJuly 28, 2020, the Company and White Lion entered into the White Lion EPA and a registration rights agreement (the “WhiteLion Registration Rights Agreement”). Pursuant to the White Lion EPA, White Lion agreed to invest up to $2,000,000 to purchaseCommon Stock at a purchase price of 85% of the lowest daily volume weighted average price of Common Stock for the five tradingdays prior to a given closing date.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Additionally,the Commitment Note described above was issued pursuant to the White Lion EPA and to induce White Lion to execute the White LionEPA. See Note 4. Notes Payable—        <i>         Convertible Notes Payable        </i>        —Q3 2020 Convertible Notes—        <i>         ConvertibleNote and Equity Purchase Agreement with White Lion Capital, LLC        </i>        .       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Pursuantto the Registration Rights Agreement, RespireRx is obligated to register for resale under the Securities Act the shares of CommonStock to be issued and sold to White Lion pursuant to the White Lion EPA. On October 14, 2020, Respire Rx filed a registrationstatement on Form S-1 with respect to the resale of up to 11,500,000 of the shares of Common Stock (post-reverse stock split basis)to be issued and sold to White Lion pursuant to the White Lion EPA, and on October 29, 2020, the registration statement becameeffective. The registration statement does not necessarily represent all shares that may be sold to White Lion in order to fulfillits purchase commitment of $2,000,000 under the White Lion EPA.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <!-- Field: Page; Sequence: 39; Value: 2 -->      <div style="margin-bottom: 6pt; border-bottom: Black 1.5pt solid">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="text-align: center; width: 100%">           <!-- Field: Sequence; Type: Arabic; Name: PageNo -->           39           <!-- Field: /Sequence -->          </td>         </tr>        </tbody>       </table>      </div>      <div style="break-before: page; margin-top: 6pt">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="width: 100%">          </td>         </tr>        </tbody>       </table>      </div>      <!-- Field: /Page -->      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        OnOctober 28, 2020, November 13, 2020, December 1, 2020 and February 19, 2021, the Company sent purchases notices to White Lion.The three purchase notices pursuant to which White Lion was required to purchase shares of Common Stock, in the fourth quarterof 2020, were for an aggregate 7,900,000 shares and resulted in net proceeds after closing costs of 8,235, of an aggregate of$162,886. The one purchase notice on February 19, 2021 was for 3,600,000 shares of Common Stock resulting in net proceeds afterclosing costs of $2,070 aggregating $115,229. The total of all shares sold pursuant to purchase notices is 11,500,000 which isall of the shares registered and offered for sale is the registration statement on Form S-1 that became effective on October 29,2020. There are no shares available for sale under that registration statement. In order for the Company to issue additional purchasenotices to White Lion, the Company would either have to file a new registration statement or amend the current registration statementcovering shares representing any remaining amounts available under the White Lion EPA, or up to $1,711,581. See Note 10. SubsequentEvents -        <i>         Issuances of Common Stock        </i>        –        <i>         White Lion Capital LLC        </i>        .       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        TheWhite Lion EPA terminates on the earlier of (i) June 30, 2021, (ii) the date on which White Lion has purchased $2,000,000 of CommonStock, (iii) the date on which the White Lion Registration Rights Agreement is no longer in effect, (iv) upon White Lion’smaterial breach of the White Lion EPA, (v) in the event a voluntary or involuntary bankruptcy petition is filed with respect tothe Company, or (vi) if a custodian is appointed for the Company for all or substantially all of its property or the Company makesa general assignment for the benefit of its creditors.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        OnJuly 30, 2020, the Company and EMA Financial, LLC (“EMA”) entered into a Securities Purchase Agreement (the “EMASPA”) by which EMA provided a sum of $68,250 (the “EMA Consideration”) to RespireRx, in return for a fixed rateconvertible note (the “EMA Note”) with a face amount of $75,000, and a common stock purchase warrant (the “EMAWarrant”) for 375,000 shares of Common Stock (post-reverse stock split basis). The net proceeds received by RespireRx onAugust 4, 2020 were $63,750 after payment of $3,500 in EMA’s legal fees and the withholding by EMA of $1,000 in diligencefees.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        TheEMA Note obligates RespireRx to pay by October 30, 2021 (the “EMA Maturity Date”) a principal amount of $75,000 togetherwith interest at a rate equal to 10% per annum, which principal exceeds the EMA Consideration by the amount of an original issuediscount of $6,750.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        TheEMA Warrant is a common stock purchase warrant to purchase 375,000 shares of Common Stock, for value received in connection withthe issuance of the EMA Note, from the date of issuance of the EMA Warrant until September 30, 2023, at an exercise price of $0.07(post-reverse stock split basis and subject to adjustment as provided therein)  per share of Common Stock.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        TheEMA Note was paid in full inclusive of principal and interest at 10% per annum by conversion into the Company’s Common Stockon February 4, 2021, February 10, 2021, February 12, 2021 and March 3, 2021. The conversions resulted in the issuance by the Companyof 4,156,807 shares of Common Stock (post-reverse stock split basis). See Note 10. Subsequent Events in the notes to our consolidatedfinancial statements as of December 31, 2020.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif">        TheCompany has engaged in additional convertible note financings in 2021 and may continue to do so. The Company is planning an equitysecurities offering pursuant to Regulation A in 2021 as well and will continue to consider additional forms of debt, equity andstrategic partner financing throughout 2021.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">      </p>      <!-- Field: Page; Sequence: 40; Value: 2 -->      <div style="margin-bottom: 6pt; border-bottom: Black 1.5pt solid">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="text-align: center; width: 100%">           <!-- Field: Sequence; Type: Arabic; Name: PageNo -->           40           <!-- Field: /Sequence -->          </td>         </tr>        </tbody>       </table>      </div>      <div style="break-before: page; margin-top: 6pt">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="width: 100%">          </td>         </tr>        </tbody>       </table>      </div>      <!-- Field: /Page -->      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <u>         GoingConcern        </u>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        TheCompany’s consolidated financial statements have been presented on the basis that it is a going concern, which contemplatesthe realization of assets and satisfaction of liabilities in the normal course of business. The Company has incurred net lossesof $4,301,210 for the fiscal year ended December 31, 2020 and $2,115,033 for the fiscal year ended December 31, 2019, and negativeoperating cash flows of $513,001 and $487,745 for the fiscal years ended December 31, 2020 and 2019, respectively. TheCompany had a stockholders’ deficiency of $8,063,320 at December 31, 2020 and expects to continue to incur net losses andnegative operating cash flows for at least the next few years. As a result, management has concluded that there is substantialdoubt about the Company’s ability to continue as a going concern, and the Company’s independent registered publicaccounting firm, in its report on the Company’s consolidated financial statements for the year ended December 31, 2020,expressed substantial doubt about the Company’s ability to continue as a going concern.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        TheCompany is currently, and has for some time, been in significant financial distress. It has limited cash resources and currentassets and has no ongoing source of sustainable revenue. Management is continuing to address various aspects of the Company’soperations and obligations, including, without limitation, debt obligations, financing requirements, intellectual property, licensingagreements, legal and patent matters and regulatory compliance, and has continued to raise new debt and equity capital to fundthe Company’s business activities from both related and unrelated parties.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        TheCompany is continuing its efforts to raise additional capital in order to be able to pay its liabilities and fund its businessactivities on a going forward basis, including the pursuit of the Company’s planned research and development activities.We anticipate filing a Form 1-A with the SEC, which if qualified would enable the Company to engage in a Regulation A Offering.We provide no assurance that we will file a Form 1-A, or if filed that the Reg A Offering would be qualified, or if qualified,would result in a financing on terms as to price per share or other securities offered, amount of funds raised or other termsacceptable to the Company or at all. The Company regularly evaluates various other measures to satisfy the Company’s liquidityneeds, including development and other agreements with collaborative partners and, when necessary, seeking to exchange or restructurethe Company’s outstanding securities. The Company is evaluating certain changes to its operations and structure to facilitatingraising capital from sources that may be interested in financing only discrete aspects of the Company’s development programs.Such changes could include a significant reorganization, which may include the formation of one or more subsidiaries into whichone or more programs may be contributed. As a result of the Company’s current financial situation, the Company has limitedaccess to external sources of debt and equity financing. Accordingly, there can be no assurances that the Company will be ableto secure additional financing in the amounts necessary to fully fund its operating and debt service requirements. If the Companyis unable to access sufficient cash resources, the Company may be forced to discontinue its operations entirely and liquidate.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <!-- Field: Page; Sequence: 41; Value: 2 -->      <div style="margin-bottom: 6pt; border-bottom: Black 1.5pt solid">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="text-align: center; width: 100%">           <!-- Field: Sequence; Type: Arabic; Name: PageNo -->           41           <!-- Field: /Sequence -->          </td>         </tr>        </tbody>       </table>      </div>      <div style="break-before: page; margin-top: 6pt">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="width: 100%">          </td>         </tr>        </tbody>       </table>      </div>      <!-- Field: /Page -->      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         PrincipalCommitments        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         <i>          EmploymentAgreements         </i>        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         <i>         </i>        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Effectiveon May 6, 2020, Timothy Jones was appointed as RespireRx’s President and Chief Executive Officer and entered into an employmentagreement as of that date. See Note 9 – Commitments and Contingencies – Significant Agreements and Contracts– Employment Agreements to the consolidated financial statements as of December 31, 2020.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif">        EffectiveMay 6, 2020, with the appointment of Timothy Jones as RespireRx’s President and Chief Executive Officer, Dr. Lippa resignedthe interim officer positions of Interim Chief Executive Officer and Interim President, positions that Dr. Lippa had assumed onOctober 12, 2018 after the resignation of Dr. James Manuso on September 30, 2018. Dr. Lippa continues to serve as RespireRx’sExecutive Chairman and as a member of the Board of Directors as well as the Company’s Chief Scientific Officer. See Note9 – Commitments and Contingencies – Significant Agreements and Contracts – Employment Agreementsto the consolidated financial statements as of December 31, 2020.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        JeffE. Margolis currently serves as the Company’s Senior Vice President, Chief Financial Officer, Treasurer and Secretary. SeeNote Note 9 – Commitments and Contingencies – Significant Agreements and Contracts – Employment Agreementsto the consolidated financial statements as of December 31, 2020.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         <i>          ConsultingAgreements         </i>        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         <i>         </i>        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <i>         DavidDickason        </i>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <i>        </i>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        TheCompany entered into a consulting contract with David Dickason effective September 15, 2020 pursuant to which Mr. Dickason wasappointed to and serves as the Company’s Senior Vice President of Pre-Clinical Product Development on an at-will basis atthe rate of $250 per hour. See Note 9. Commitments and Contingencies – Significant Agreements and Contracts – ConsultingAgreements to the consolidated financial statements as of December 31, 2020.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <i>        </i>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <i>         DNAHealthlink, Inc. and Richard Purcell        </i>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        RichardPurcell, the Company’s Senior Vice President of Research and Development since October 15, 2014, provides his services tothe Company on a month-to-month basis through his consulting firm, DNA Healthlink, Inc., through which the Company has contractedfor his services, for a monthly cash fee of $12,500. See Note 9. Commitments and Contingencies – Significant Agreementsand Contracts – Consulting Agreements to the consolidated financial statements as of December 31, 2020.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         <i>          Universityof Illinois 2014 Exclusive License Agreement         </i>        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        OnJune 27, 2014, the Company entered into an Exclusive License Agreement (the “2014 License Agreement”) with the Universityof Illinois, the material terms of which were similar to a License Agreement between the parties that had been previously terminatedon March 21, 2013. The 2014 License Agreement became effective on September 18, 2014. See Note 9. Commitments and Contingencies– Significant Agreements and Contracts – University of Illinois 2014 Exclusive License Agreement to the consolidatedfinancial statements as of December 31, 2020.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         <i>          NoramcoInc. - Dronabinol Development and Supply Agreement         </i>        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        OnSeptember 4, 2018, RespireRx entered into a dronabinol Development and Supply Agreement with Noramco Inc., one of the world’smajor dronabinol manufacturers, which was subsequently assigned by Noramco to its subsidiary, Purisys LLC. See Note 9. Commitmentsand Contingencies – Significant Agreements and Contracts – Normaco Inc. – Dronabinol Development and SupplyAgreement to the consolidated financial statements as of December 31, 2020.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         <i>          UWMResearch Foundation         </i>        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        OnAugust 1, 2020, RespireRx exercised its option pursuant to its option agreement dated March 2, 2020, between RespireRx and UWMResearch Foundation, an affiliate of the University of Wisconsin-Milwaukee (“UWMRF”). Upon exercise RespireRx andUWMRF executed the UWMRF Patent License Agreement effective August 1, 2020 pursuant to which RespireRx licensed the identifiedintellectual property. Note 9. Commitments and Contingencies – Significant Agreements and Contracts – UWMRF PatentLicense Agreement to the consolidated financial statements as of December 31, 2020.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <!-- Field: Page; Sequence: 42; Value: 2 -->      <div style="margin-bottom: 6pt; border-bottom: Black 1.5pt solid">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="text-align: center; width: 100%">           <!-- Field: Sequence; Type: Arabic; Name: PageNo -->           42           <!-- Field: /Sequence -->          </td>         </tr>        </tbody>       </table>      </div>      <div style="break-before: page; margin-top: 6pt">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="width: 100%">          </td>         </tr>        </tbody>       </table>      </div>      <!-- Field: /Page -->      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         <i>          Transactionswith Biovail Laboratories International SRL         </i>        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Beginningin March 2010, the Company entered into a series of asset purchase and license agreements with Biovail Laboratories InternationalSRL later merged with Valeant Pharmaceuticals International, Inc. which was later renamed Bausch Health Companies Inc. (“Biovail”).       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        InMarch 2011, the Company entered into a new agreement with Biovail to reacquire the ampakine compounds, patents and rights thatBiovail had acquired from the Company in March 2010.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        SeeNote 9. Commitments and Contingencies – Significant Agreements and Contracts – Transactions with BioVail LaboratoriesInternational SRL to the consolidated financial statements as of December 31, 2020.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         <i>          Summaryof Principal Cash Obligations and Commitments         </i>        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Thefollowing table sets forth the Company’s principal cash obligations and commitments for the next five fiscal years as ofDecember 31, 2020, aggregating $2,885,270. Employment agreement amounts included in the 2021 column represent amounts contractuallydue from January 1, 2021 through September 30, 2021 or in one case, September 30, 2023 when such contracts expire unless extendedpursuant to the terms of the contracts.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">       <tbody>        <tr style="vertical-align: bottom">         <td style="text-align: center">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="padding-bottom: 1.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td colspan="2" style="text-align: center">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="padding-bottom: 1.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="padding-bottom: 1.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td colspan="18" style="text-align: center; border-bottom: Black 1.5pt solid">          <font style="font-family: Times New Roman, Times, Serif">           Payments    Due By Year          </font>         </td>         <td style="padding-bottom: 1.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>        </tr>        <tr style="vertical-align: bottom">         <td style="text-align: center">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="padding-bottom: 1.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid">          <font style="font-family: Times New Roman, Times, Serif">           Total          </font>         </td>         <td style="padding-bottom: 1.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="padding-bottom: 1.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid">          <font style="font-family: Times New Roman, Times, Serif">           2021          </font>         </td>         <td style="padding-bottom: 1.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="padding-bottom: 1.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid">          <font style="font-family: Times New Roman, Times, Serif">           2022          </font>         </td>         <td style="padding-bottom: 1.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="padding-bottom: 1.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid">          <font style="font-family: Times New Roman, Times, Serif">           2023          </font>         </td>         <td style="padding-bottom: 1.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="padding-bottom: 1.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid">          <font style="font-family: Times New Roman, Times, Serif">           2024          </font>         </td>         <td style="padding-bottom: 1.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="padding-bottom: 1.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid">          <font style="font-family: Times New Roman, Times, Serif">           2025          </font>         </td>         <td style="padding-bottom: 1.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>        </tr>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td style="width: 40%; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           License agreements          </font>         </td>         <td style="width: 2%">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="width: 1%; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           $          </font>         </td>         <td style="width: 6%; text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           560,370          </font>         </td>         <td style="width: 1%; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="width: 2%">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="width: 1%; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           $          </font>         </td>         <td style="width: 6%; text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           100,000          </font>         </td>         <td style="width: 1%; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="width: 2%">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="width: 1%; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           $          </font>         </td>         <td style="width: 6%; text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           115,092          </font>         </td>         <td style="width: 1%; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="width: 2%">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="width: 1%; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           $          </font>         </td>         <td style="width: 6%; text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           115,093          </font>         </td>         <td style="width: 1%; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="width: 2%">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="width: 1%; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           $          </font>         </td>         <td style="width: 6%; text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           130,185          </font>         </td>         <td style="width: 1%; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="width: 2%">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="width: 1%; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           $          </font>         </td>         <td style="width: 6%; text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           100,000          </font>         </td>         <td style="width: 1%; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>        </tr>        <tr style="vertical-align: bottom; background-color: White">         <td style="text-align: left; padding-bottom: 1.5pt">          <font style="font-family: Times New Roman, Times, Serif">           Employment agreements    (1)          </font>         </td>         <td style="padding-bottom: 1.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           2,294,900          </font>         </td>         <td style="padding-bottom: 1.5pt; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="padding-bottom: 1.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           1,100,600          </font>         </td>         <td style="padding-bottom: 1.5pt; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="padding-bottom: 1.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           639,600          </font>         </td>         <td style="padding-bottom: 1.5pt; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="padding-bottom: 1.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           554,700          </font>         </td>         <td style="padding-bottom: 1.5pt; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="padding-bottom: 1.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           -          </font>         </td>         <td style="padding-bottom: 1.5pt; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="padding-bottom: 1.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           -          </font>         </td>         <td style="padding-bottom: 1.5pt; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>        </tr>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td style="padding-bottom: 2.5pt">          <font style="font-family: Times New Roman, Times, Serif">           Total          </font>         </td>         <td style="padding-bottom: 2.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="border-bottom: Black 2.5pt double; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           $          </font>         </td>         <td style="border-bottom: Black 2.5pt double; text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           2,855,270          </font>         </td>         <td style="padding-bottom: 2.5pt; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="padding-bottom: 2.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="border-bottom: Black 2.5pt double; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           $          </font>         </td>         <td style="border-bottom: Black 2.5pt double; text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           1,200,600          </font>         </td>         <td style="padding-bottom: 2.5pt; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="padding-bottom: 2.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="border-bottom: Black 2.5pt double; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           $          </font>         </td>         <td style="border-bottom: Black 2.5pt double; text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           754,692          </font>         </td>         <td style="padding-bottom: 2.5pt; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="padding-bottom: 2.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="border-bottom: Black 2.5pt double; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           $          </font>         </td>         <td style="border-bottom: Black 2.5pt double; text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           669,793          </font>         </td>         <td style="padding-bottom: 2.5pt; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="padding-bottom: 2.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="border-bottom: Black 2.5pt double; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           $          </font>         </td>         <td style="border-bottom: Black 2.5pt double; text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           130,185          </font>         </td>         <td style="padding-bottom: 2.5pt; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="padding-bottom: 2.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="border-bottom: Black 2.5pt double; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           $          </font>         </td>         <td style="border-bottom: Black 2.5pt double; text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           100,000          </font>         </td>         <td style="padding-bottom: 2.5pt; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>        </tr>       </tbody>      </table>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        (1)The payment of certain of such amounts has been deferred indefinitely, as described above in “Employment Agreements”.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <!-- Field: Page; Sequence: 43; Value: 2 -->      <div style="margin-bottom: 6pt; border-bottom: Black 1.5pt solid">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="text-align: center; width: 100%">           <!-- Field: Sequence; Type: Arabic; Name: PageNo -->           43           <!-- Field: /Sequence -->          </td>         </tr>        </tbody>       </table>      </div>      <div style="break-before: page; margin-top: 6pt">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="width: 100%">          </td>         </tr>        </tbody>       </table>      </div>      <!-- Field: /Page -->      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         Off-BalanceSheet Arrangements        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        AtDecember 31, 2020, the Company did not have any transactions, obligations or relationships that could be considered off-balancesheet arrangements.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         <a name="a_012">         </a>         Item7A. Quantitative and Qualitative Disclosures About Market Risk        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Notapplicable for smaller reporting companies.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         <a name="a_013">         </a>         Item8. Financial Statements and Supplementary Data        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Ourfinancial statements and other information required by this item are set forth herein in a separate section beginning with theIndex to Consolidated Financial Statements on page F-1.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         <a name="a_014">         </a>         Item9. Changes in and Disagreements with Accountants on Accounting and Financial Disclosure        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Notapplicable.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         <a name="a_015">         </a>         Item9A. Controls and Procedures        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <u>         DisclosureControls and Procedures        </u>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        TheCompany maintains disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Securities ExchangeAct of 1934, as amended (the “Exchange Act”) that are designed to ensure that information required to be disclosedin the reports that the Company files with the Securities and Exchange Commission (the “SEC”) under the Exchange Actis recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms and thatsuch information is accumulated and communicated to the Company’s management, including its Chief Executive Officer andChief Financial Officer, to allow for timely decisions regarding required disclosures.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        TheCompany carried out an evaluation, under the supervision and with the participation of its management, consisting of its principalexecutive officer and principal financial officer, of the effectiveness of the Company’s disclosure controls and procedures(as defined in Rules 13a-15(e) and 15d-15(e) of the Exchange Act). Based upon that evaluation, the Company’s principal executiveofficer and principal financial officer concluded that, as of the end of the period covered in this Annual Report on Form 10-K,the Company’s disclosure controls and procedures were not effective to ensure that information required to be disclosedin reports filed under the Exchange Act is recorded, processed, summarized and reported within the required time periods and isaccumulated and communicated to the Company’s management, consisting of the Company’s principal executive officerand principal financial officer, to allow timely decisions regarding required disclosure.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Managementhas been focusing on developing replacement controls and procedures that are adequate to ensure that information required to bedisclosed in reports filed under the Exchange Act is recorded, processed, summarized and reported within the required time periodsand is accumulated and communicated to the Company’s management to allow timely decisions regarding required disclosure.The Company is current in its SEC periodic reporting obligations, but as of the date of the filing of this Annual Report on Form10-K, the Company had not yet established adequate internal controls over financial reporting.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <!-- Field: Page; Sequence: 44; Value: 2 -->      <div style="margin-bottom: 6pt; border-bottom: Black 1.5pt solid">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="text-align: center; width: 100%">           <!-- Field: Sequence; Type: Arabic; Name: PageNo -->           44           <!-- Field: /Sequence -->          </td>         </tr>        </tbody>       </table>      </div>      <div style="break-before: page; margin-top: 6pt">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="width: 100%">          </td>         </tr>        </tbody>       </table>      </div>      <!-- Field: /Page -->      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        TheCompany’s management, consisting of its principal executive officer and principal financial officer, does not expect thatits disclosure controls and procedures or its internal controls will prevent all error or fraud. A control system, no matter howwell conceived and operated, can provide only reasonable, not absolute, assurance that the objectives of the control system aremet. Furthermore, the design of a control system must reflect the fact that there are resource constraints and the benefits ofcontrols must be considered relative to their costs. Due to the inherent limitations in all control systems, no evaluation ofcontrols can provide absolute assurance that all control issues and instances of fraud, if any, have been detected. In addition,as conditions change over time, so too may the effectiveness of internal controls. However, management believes that the financialstatements included in this Annual Report on Form 10-K fairly present, in all material respects, the Company’s financialcondition, results of operations and cash flows for the periods presented.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <u>         Management’sAnnual Report on Internal Control over Financial Reporting        </u>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Ourmanagement is responsible for establishing and maintaining adequate internal control over financial reporting as defined in Rules13a-15(f) and 15d-15(f) under the Exchange Act. Our internal control over financial reporting is designed to ensure that materialinformation regarding our operations is made available to management and the board of directors to provide them reasonable assurancethat the published financial statements are fairly presented. There are limitations inherent in any internal control, such asthe possibility of human error and the circumvention or overriding of controls. As a result, even effective internal controlscan provide only reasonable assurance with respect to financial statement preparation. As conditions change over time so too maythe effectiveness of internal controls.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Ourmanagement, consisting of our Chief Executive Officer, our Chief Scientific Officer and our Chief Financial Officer, has evaluatedour internal control over financial reporting as of December 31, 2020 based on the 2013 Internal Control – Integrated Frameworkissued by the Committee of Sponsoring Organizations (“COSO”) of the Treadway Commission. Based on this assessment,and taking into account the operating structure of the Company, our management has concluded that material weaknesses in the Company’sinternal control over financial reporting existed as of December 31, 2020, as a result of which our internal control over financialreporting was not effective at December 31, 2020.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Withinthe constraints of the Company’s limited financial resources and as of the date of the filing of this Annual Report on Form10-K, the Company has not yet completed this process of reestablishing adequate internal controls over financial reporting.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        ThisAnnual Report on Form 10-K does not include an attestation report of the Company’s independent registered public accountingfirm regarding internal control over financial reporting. Management’s report was not subject to attestation by the Company’sindependent registered public accounting firm pursuant to rules of the SEC that permit the Company to provide only management’sreport in this Annual Report on Form 10-K.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <!-- Field: Page; Sequence: 45; Value: 2 -->      <div style="margin-bottom: 6pt; border-bottom: Black 1.5pt solid">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="text-align: center; width: 100%">           <!-- Field: Sequence; Type: Arabic; Name: PageNo -->           45           <!-- Field: /Sequence -->          </td>         </tr>        </tbody>       </table>      </div>      <div style="break-before: page; margin-top: 6pt">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="width: 100%">          </td>         </tr>        </tbody>       </table>      </div>      <!-- Field: /Page -->      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <u>         Changesin Internal Control over Financial Reporting        </u>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        TheCompany’s management, consisting of its principal executive officer and principal financial officer, has determined thatno change in the Company’s internal control over financial reporting (as that term is defined in Rules 13(a)-15(f) and 15(d)-15(f)of the Securities Exchange Act of 1934) occurred during or subsequent to the fourth quarter of the year ended December 31, 2020that has materially affected, or is reasonably likely to materially affect, the Company’s internal control over financialreporting.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         <a name="a_016">         </a>         Item9B. Other Information        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Notapplicable.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         <a name="a_017">         </a>         PARTIII        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         <a name="a_018">         </a>         Item10. Directors, Executive Officers and Corporate Governance        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         Directors        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Asof the date of the filing of this Annual Report on Form 10-K, the names of each of the directors and certain biographical informationabout them are set forth below. Each of our directors serves until his or resignation or until a successor is appointed.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">       <tbody>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">         <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 24%">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           <b>            Name           </b>          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; width: 2%">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 8%; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           <b>            Age           </b>          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; width: 2%">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           <b>            Director    Since           </b>          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; width: 2%">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 52%; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           <b>            Principal    Occupation           </b>          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td colspan="2" style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td colspan="2" style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td colspan="2" style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           Arnold    S Lippa, Ph.D.          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           74          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           2013          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           Chief    Scientific Officer and Chairman of the Board of the of           <br/>           Directors          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td colspan="2" style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td colspan="2" style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td colspan="2" style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           Jeff    E. Margolis          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           65          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           2013          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           Senior    Vice President, Chief Financial Officer, Treasurer and Secretary and a Director of the Company and President of Aurora Capital    LLC, an investment banking and securities brokerage firm          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td colspan="2" style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td colspan="2" style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td colspan="2" style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           Kathryn    MacFarlane, PharmD          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           55          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           2014          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           Director    of the Company and Owner and Managing Partner of SmartPharma LLC, a consulting firm          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           Timothy    Jones          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           47          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           2020          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           President    and Chief Executive Officer and a Director of the Company.          </font>         </td>        </tr>       </tbody>      </table>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <i>         ArnoldS. Lippa, Ph.D.        </i>        : Dr. Lippa is a Senior Managing Director and founder of T Morgen Capital LLC through which he administershis family’s assets. T Morgen Capital LLC is a significant equity owner and managing member of Aurora Capital LLC (“Aurora”),a boutique investment bank and securities firm of which Mr. Margolis is the president and founder, which has served as a placementagent with respect to certain of the Company’s prior financings. Dr. Lippa and Mr. Margolis jointly manage, since 2004,Atypical BioCapital Management LLC and Atypical BioVentures Fund LLC, a life sciences fund management company and venture fund,respectively. Since 2006, Dr. Lippa has also been the Executive Chairman of the board of Xintria Pharmaceutical Corporation, aDelaware corporation, as well as a member of its board of directors. Dr. Lippa is a member of the Board of Directors of HepionPharmaceuticals, Inc. since December 2015 where he is a member of the audit committee, the compensation committee and the CorporateGovernance/Nominating Committee. Dr. Lippa was co-founder of DOV Pharmaceutical, Inc., where he served as Chairman of the Boardand Chief Executive Officer from its inception in 1995 through 2005. Dr. Lippa stepped down as a director of DOV Pharmaceuticals,Inc. in 2006.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <!-- Field: Page; Sequence: 46; Value: 2 -->      <div style="margin-bottom: 6pt; border-bottom: Black 1.5pt solid">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="text-align: center; width: 100%">           <!-- Field: Sequence; Type: Arabic; Name: PageNo -->           46           <!-- Field: /Sequence -->          </td>         </tr>        </tbody>       </table>      </div>      <div style="break-before: page; margin-top: 6pt">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="width: 100%">          </td>         </tr>        </tbody>       </table>      </div>      <!-- Field: /Page -->      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt">      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Webelieve that Dr. Lippa’s qualifications to serve on our Board include his current positionsof Chief Scientific Officer,his former positions and Interim Chief Executive Officer and Interim President and Chief Executive Officer and President, andhis experience working in management roles in other pharmaceutical companies as described above. We also believe that Dr. Lippa’squalifications also include his experiences as a financier of both biopharmaceutical and other companies. Dr. Lippa provides theBoard with both technical and scientific expertise in drug discovery and drug development, research management, governmental regulationsand strategic planning expertise that is important to the advancement of our research platforms as well as to the overall successof the Company. Dr. Lippa was appointed to our board of directors in March 2013.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <i>         JeffE. Margolis        </i>        : Mr. Margolis is the president and founder of Aurora and has been since its inception in 1994. Aurora CapitalCorp., a corporation wholly owned by Mr. Margolis, is a significant equity owner and managing member of Aurora. Dr. Lippa andMr. Margolis jointly manage, since 2004, Atypical BioCapital Management LLC and Atypical BioVentures Fund LLC, a life sciencesfund management company and venture fund, respectively. Since 2006, Mr. Margolis has also been the Chief Financial Officer ofXintria Pharmaceutical Corporation, a Delaware corporation, as well as a member of its board of directors.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Webelieve that Mr. Margolis’s qualifications to serve on our Board include his significant experience in financial, operationaland management roles within pharmaceutical companies and within the financial industry as described above. He also has extensiveprior experience working in business development and provides the Company with extremely useful expertise in financing and capitalmarkets, knowledge gained though his position as President of Aurora. Mr. Margolis also provides broad financial expertise. Mr.Margolis was appointed to our board of directors in March 2013.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <i>         KathrynMacFarlane, PharmD:        </i>        Ms. MacFarlane is the co-founder and Managing Partner of SmartPharma, LLC (“SmartPharma”),where she has contracted to serve as the Chief Commercial Officer of Agile Therapeutics and the Sr. Vice President of CommercialDevelopment for Napo Pharmaceuticals. SmartPharma performs market assessments and develops forecasts and commercial plans forpharmaceutical products. Ms. MacFarlane has provided advice to over 75 companies and investors on financing, licensing, and acquisitionof drug products and technologies. She is an experienced pharmaceutical executive with over 25 years in the industry, includingsenior level roles in drug development, marketing, and sales management at Parke-Davis, Pfizer, and Warner Chilcott, where shewas the Vice President of Sales, Marketing, and New Product Planning. Ms. MacFarlane played a key role in the launch of severalleading brands, most notably Lipitor®, Celexa®, and Loestrin® 24. Ms. MacFarlane earned a B.S. and PharmD from PurdueUniversity and completed a Postdoctoral Fellowship with Rutgers University and Hoffmann-LaRoche. She was named a DistinguishedAlumna and was awarded the Eaton Entrepreneur of the Year by the Purdue University School of Pharmacy, where she currently isan Affiliate Faculty member. Ms. MacFarlane is Chairwoman on the Finance Committee for the Board of Directors of INMED Partnershipsfor Children, and a member of the Executive Committee of the Woodley Park Community Association.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Webelieve Ms. MacFarlane’s qualifications to serve on our Board include both her biopharmaceutical consulting background andher familiarity with the biopharmaceutical regulatory and commercialization environment, as well as the breadth of her technicaland therapeutic knowledge, as discussed above. Ms. Macfarlane has also served in numerous senior executive positions at variousbiopharmaceutical companies. Ms. MacFarlane was appointed to our board of directors in September 2014.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <i>         TimothyJones:        </i>        Until April 10, 2020 Mr. Jones was the Vice President Global Pharmaceutical and Medical OTC at Purisys, an affiliateof Noramco formed in September 2019. Mr. Jones’ experience includes 15 years of API (active pharmaceutical ingredient) sales,business development, and sourcing in the niche, controlled substances space. He is recognized in the industry for his expertisein the strategic development and growth of active pharmaceutical ingredient categories, through partnerships with a broad crosssection of brand and generic companies worldwide. His extensive knowledge base and expertise across multiple pharmaceutical disciplineshave contributed to his successful track record of financial growth. He previously held leadership roles with QuVa Pharma, ParSterile Products, and Johnson Matthey.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Webelieve Mr. Jones’ qualifications to serve on our Board include his extensive background in biopharmaceutical business developmentand supply chain as well as his familiarity with business involving controlled substances, particularly cannabinoid controlledsubstances, as well as the breadth of his industry network. Mr. Jones has also served in numerous leadership positions at variousbiopharmaceutical companies. Mr. Jones was appointed to our board of directors in January 2020.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <!-- Field: Page; Sequence: 47; Value: 2 -->      <div style="margin-bottom: 6pt; border-bottom: Black 1.5pt solid">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="text-align: center; width: 100%">           <!-- Field: Sequence; Type: Arabic; Name: PageNo -->           47           <!-- Field: /Sequence -->          </td>         </tr>        </tbody>       </table>      </div>      <div style="break-before: page; margin-top: 6pt">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="width: 100%">          </td>         </tr>        </tbody>       </table>      </div>      <!-- Field: /Page -->      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         ExecutiveOfficers        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24.5pt">       Each executive officerof the Company serves at the discretion of the Board of Directors. The names of the Company’s executive officers are setforth below. At December 31, 2020, each of our executive officers except David Dickason and Richard Purcell was also a memberof our board of directors, and the biographical information of those officers appears above in the immediately prior section.See “Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations – PrincipalCommitments –       <i>        Employment Agreements       </i>       ” for information on the term of service for each of Mr. Jones, Dr. Lippaand Mr. Margolis. Mr. Dickason provides his services to the Company on a month-to-month basis pursuant to a consulting agreementwith the Company. Mr. Purcell provides his services to the Company on a month-to-month basis through his consulting firm, DNAHealthlink, Inc. for a monthly fee. The contract terms are currently being renegotiated. Additional information with respect toshares of common stock or stock options that have been issued to Mr. Dickason and Mr. Purcell is provided at Note 9 –Commitments and Contingencies – Significant Agreements and Contracts – Consulting Agreements in the Notes to ConsolidatedFinancial Statements for the fiscal years ended December 31, 2020 and 2019, included with this report.      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">       <tbody>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">         <td style="font: 10pt Times New Roman, Times, Serif; width: 36%; border-bottom: black 1.5pt solid">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           <b>            Name           </b>          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; width: 2%">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; width: 62%; border-bottom: black 1.5pt solid">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           <b>            Position    with Company           </b>          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           Timothy    L. Jones          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           Chief    Executive Officer and President          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           Arnold    S. Lippa, Ph.D.          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           Chief    Scientific Officer and Chairman of the Board          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           Jeff    E. Margolis          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           Senior    Vice President, Chief Financial Officer, Treasurer and Secretary          </font>         </td>        </tr>       </tbody>      </table>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         BOARDCOMMITTEES        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Theboard of directors does not maintain any separate standing board committees. Instead, the functions of each of the Audit Committee,the Compensation Committee and the Governance and Nomination Committee have been and are currently being addressed by the fullboard of directors. This arrangement was initially implemented in 2013 when current management was put in place. At that timethere were no independent directors. Since that time, the Company has added two independent directors, both in 2014, however,because of the small size of the Board generally and because the Board includes only two independent directors, the Company hasnot appointed standing committees.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         <i>          AuditCommittee         </i>         .        </b>        The board of directors meets with the Company’s independent registered public accountants and managementto prepare for and to review the results of the annual audit and to discuss the annual and quarterly financial statements, earningsreleases and related matters. The board of directors, among other things, (i) selects and retains the independent registered publicaccountants, (ii) reviews with the independent registered public accountants the scope and anticipated cost of their audit, andtheir independence and performance, (iii) reviews accounting practices, financial structure and financial reporting, (iv) receivesand considers the independent registered public accountants’ comments as to controls, adequacy of staff and management performanceand procedures in connection with audit and financial controls, (v) reviews and pre-approves all audit and non-audit servicesprovided to the Company by the independent registered public accountants, and (vi) reviews and pre-approves all related-partytransactions. The board of directors does not itself prepare financial statements or perform audits, and its members are not auditorsor certifiers of the Company’s financial statements.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <!-- Field: Page; Sequence: 48; Value: 2 -->      <div style="margin-bottom: 6pt; border-bottom: Black 1.5pt solid">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="text-align: center; width: 100%">           <!-- Field: Sequence; Type: Arabic; Name: PageNo -->           48           <!-- Field: /Sequence -->          </td>         </tr>        </tbody>       </table>      </div>      <div style="break-before: page; margin-top: 6pt">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="width: 100%">          </td>         </tr>        </tbody>       </table>      </div>      <!-- Field: /Page -->      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Sincethe change in composition of our board of directors in March 2013, the composition of an Audit Committee has not been determined,nor has the current board of directors adopted an amended written charter. When an Audit Committee is reestablished along witha written charter, such charter will be made available on the Company’s website at www.respirerx.com.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         <i>          CompensationCommittee.         </i>        </b>        The traditional functions of the Compensation Committee include, without limitation, administering the Company’sincentive ownership programs and approving the compensation to be paid to the Company’s directors and executive officers.The board of directors acting in the capacity of a Compensation Committee typically meets no less frequently than annually ascircumstances dictate to discuss and determine executive officer and director compensation. Historically, the Company’sChief Executive Officer annually reviews the performance of each executive officer (other than the Chief Executive Officer, whoseperformance is reviewed by the board of directors). The conclusions reached and recommendations based on these reviews, includingwith respect to salary adjustments and annual award amounts, are presented to the board of directors, which can exercise its discretionin modifying any recommended adjustments or awards to executive officers. The board of directors is entitled to, but generallydoes not, retain the services of any compensation consultants. Neither the board of directors nor management has engaged a compensationconsultant in the past fiscal year.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Sincethe change in composition of our board of directors in March 2013, the members of the board of directors have performed the functionsof a Compensation Committee and the composition of a Compensation Committee has not been determined nor has the current boardof directors adopted a written committee charter. When a Compensation Committee is reestablished along with a written charter,such charter will be made available on the Company’s website at www.respirerx.com.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         <i>          Governanceand Nominations Committee.         </i>        </b>        The traditional functions of the Governance and Nominations Committee include, without limitation,(i) identifying individuals qualified to become members of the board of directors, (ii) recommending director nominees for thenext annual meeting of stockholders and to fill vacancies that may be created by the expansion of the number of directors servingon the board of directors and by resignation, retirement or other termination of services of incumbent directors, (iii) developingand recommending to the board of directors corporate governance guidelines and changes thereto, (iv) ensuring that the board ofdirectors and the Company’s Certificate of Incorporation and Bylaws are structured in a way that best serves the Company’spractices and objectives, (v) leading the board of directors in its annual review of the board of directors’ performance;and (vi) recommending to the board of directors nominees for each committee. Accordingly, the board of directors, acting in thecapacity of a Governance and Nominations Committee, annually reviews the composition of the board of directors as a whole andmakes recommendations, if deemed necessary, to enhance the composition of the board of directors. The board of directors firstconsiders a candidate’s management experience and then considers issues of judgment, background, conflicts of interest,integrity, ethics and commitment to the goal of maximizing stockholder value when considering director candidates. The board ofdirectors also focuses on issues of diversity, such as diversity of gender, race and national origin, education, professionalexperience and differences in viewpoints and skills. The board of directors does not have a formal policy with respect to diversity;however, the board of directors believes that it is essential that the members of the board of directors represent diverse viewpoints.In considering candidates for the board of directors, the board considers the entirety of each candidate’s credentials inthe context of these standards. With respect to the nomination of continuing directors for re-election, the individual’scontributions to the board of directors are also considered.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Sincethe change in composition of our board of directors in March 2013, the members of the board of directors have performed the functionsof a Governance and Nominations Committee and the composition of a Governance and Nominations Committee has not been determinednor has the current board of directors adopted a written charter. When a Governance and Nominations Committee is reestablishedalong with a written committee charter, such charter will be made available on the Company’s website at www.respirerx.com.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <!-- Field: Page; Sequence: 49; Value: 2 -->      <div style="margin-bottom: 6pt; border-bottom: Black 1.5pt solid">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="text-align: center; width: 100%">           <!-- Field: Sequence; Type: Arabic; Name: PageNo -->           49           <!-- Field: /Sequence -->          </td>         </tr>        </tbody>       </table>      </div>      <div style="break-before: page; margin-top: 6pt">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="width: 100%">          </td>         </tr>        </tbody>       </table>      </div>      <!-- Field: /Page -->      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         Section16(a) Beneficial Ownership Reporting Compliance        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Section16(a) of the Exchange Act requires the Company’s executive officers and directors and persons who beneficially own morethan 10% of the Company’s outstanding common stock, whom the Company refers to collectively as the “reporting persons,”to file reports of ownership and changes in ownership with the SEC, and to furnish the Company with copies of these reports.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Basedsolely on the Company’s review of the copies of these reports received by it and written representations received fromcertain of the reporting persons with respect to the filing of reports on Forms 3, 4 and 5, the Company believes that allsuch filings required to be made by the reporting persons for the fiscal year ended December 31, 2020 were made on atimely basis, except for any Form 3 or Form 4 that may be required for any of the beneficial holders, other than officers anddirectors, listed in Item 12 in this report and except for a Form 3 with respect to Timothy L. Jones that was not timelyfiled when he became an insider after his appointment on January 28, 2020 as a director of the Company, which Form 3 was filedlate by Mr. Jones on August 4, 2020.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         Codeof Ethics        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        TheCompany had previously adopted a Code of Business Conduct and Ethics, which had covered all of our directors and employees, includingour principal executive and financial officers. That Code of Business Conduct and Ethics has never been adopted by the currentBoard of Directors that was appointed after the change in management that occurred in March 2013 described above. When practicable,the Board of Directors intends to adopt a Code of Business Conduct and Ethics with elements listed under Item 406(b) of RegulationS-K, and that document will be posted on our website at www.respirerx.com and in a report filed with the SEC on a Current Reporton Form 8-K.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         <a name="a_019">         </a>         Item11. Executive Compensation        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         SummaryCompensation Table for 2020        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Thetable below summarizes the total compensation paid or earned by each of the named executive officers for the fiscal years endedDecember 31, 2020 and 2019. The information contained under the heading “Stock Awards” for all named executive officersincludes the estimated value of equity awards using the Black-Scholes option-pricing model and does not reflect actual cash paymentsor actual dollars awarded.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">       <tbody>        <tr style="vertical-align: bottom">         <td style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">          <font style="font-family: Times New Roman, Times, Serif">           Name    and Principal Position          </font>         </td>         <td style="font-weight: bold; padding-bottom: 1.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">          <font style="font-family: Times New Roman, Times, Serif">           Year          </font>         </td>         <td style="padding-bottom: 1.5pt; font-weight: bold">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="font-weight: bold; padding-bottom: 1.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">          <font style="font-family: Times New Roman, Times, Serif">           Salary    ($)(1)          </font>         </td>         <td style="padding-bottom: 1.5pt; font-weight: bold">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="font-weight: bold; padding-bottom: 1.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">          <font style="font-family: Times New Roman, Times, Serif">           Bonus           <br/>           ($)          </font>         </td>         <td style="padding-bottom: 1.5pt; font-weight: bold">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="font-weight: bold; padding-bottom: 1.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">          <font style="font-family: Times New Roman, Times, Serif">           Stock    Awards           <br/>           ($)(1)          </font>         </td>         <td style="padding-bottom: 1.5pt; font-weight: bold">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="font-weight: bold; padding-bottom: 1.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">          <font style="font-family: Times New Roman, Times, Serif">           All    Other Compensation ($)(2)          </font>         </td>         <td style="padding-bottom: 1.5pt; font-weight: bold">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="font-weight: bold; padding-bottom: 1.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">          <font style="font-family: Times New Roman, Times, Serif">           Total           <br/>           ($)          </font>         </td>         <td style="padding-bottom: 1.5pt; font-weight: bold">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>        </tr>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td style="width: 40%; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           Arnold S. Lippa, Ph.D. Executive    Chairman          </font>         </td>         <td style="width: 2%">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="width: 1%; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="width: 6%; text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           2020          </font>         </td>         <td style="width: 1%; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="width: 2%">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="width: 1%; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="width: 6%; text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           339,600          </font>         </td>         <td style="width: 1%; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="width: 2%">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="width: 1%; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="width: 6%; text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           -          </font>         </td>         <td style="width: 1%; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="width: 2%">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="width: 1%; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="width: 6%; text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           -          </font>         </td>         <td style="width: 1%; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="width: 2%">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="width: 1%; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="width: 6%; text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           -          </font>         </td>         <td style="width: 1%; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="width: 2%">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="width: 1%; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="width: 6%; text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           339,600          </font>         </td>         <td style="width: 1%; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>        </tr>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           and Chief Scientific Officer          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           2019          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           339,600          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           -          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           -          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           -          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           339,600          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>        </tr>        <tr style="vertical-align: bottom; background-color: White">         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>        </tr>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           Timothy L. Jones, Chief Executive          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           2020          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           304,225          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           200,000          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           91,000          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           10,484          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           605,709          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>        </tr>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           Officer and President          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           2019          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           -          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           -          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           -          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           8,000          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           -          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>        </tr>        <tr style="vertical-align: bottom; background-color: White">         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>        </tr>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           Jeff E. Margolis Senior Vice President,          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           2020          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           321,600          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           -          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           -          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           -          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           321,600          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>        </tr>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           Chief Financial Officer, Treasurer and    Secretary          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           2019          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           321,600          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           -          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           -          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           -          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           321,600          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>        </tr>       </tbody>      </table>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">       <tbody>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           (1)          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           The    2020 and 2019 salary amounts in the table above reflect contractual salary amounts plus employee benefits. There were no bonuses,    stock or stock option awards or other compensation during the years ended December 31, 2020 and 2019.          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           (2)          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           In    accordance with Securities and Exchange Commission rules, “Other Annual Compensation” in the form of perquisites    and other personal benefits has been omitted where the aggregate amount of such perquisites and other personal benefits was    less than $10,000. The amount reflected for Mr. Jones is the amount of Board of Directors fees for the period of time prior    to Mr. Jones becoming an executive officer at which time he was no longer eligible to received fees for serving on the Company’s    Board of Directors.          </font>         </td>        </tr>       </tbody>      </table>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <!-- Field: Page; Sequence: 50; Value: 2 -->      <div style="margin-bottom: 6pt; border-bottom: Black 1.5pt solid">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="text-align: center; width: 100%">           <!-- Field: Sequence; Type: Arabic; Name: PageNo -->           50           <!-- Field: /Sequence -->          </td>         </tr>        </tbody>       </table>      </div>      <div style="break-before: page; margin-top: 6pt">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="width: 100%">          </td>         </tr>        </tbody>       </table>      </div>      <!-- Field: /Page -->      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         Narrativeto Summary Compensation Table        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        In2020, the Company accrued a cash bonus of $200,000 for Mr. Jones in accordance with the terms of his employment contract. In 2020,options were awarded to Mr. Jones. In 2019, no cash bonuses (performance or otherwise), stock awards or option awards wereawarded. See Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations-Principal Commitments-        <i>         EmploymentAgreements        </i>        for more information about the compensation terms under the employment agreements of Mr. Jones, Dr. Lippa and Mr.Margolis.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Takinginto account the Company’s current operating structure and business plans, management is currently reevaluating the compensationpolicies of the Company and, as a result of that reassessment and in light of the Company’s current financial circumstances,has made departures from the Company’s historic compensation policies and will likely make substantial adjustments to suchpolicies, including the termination of such policies, in the future.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         OutstandingEquity Awards at Fiscal Year End        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Thefollowing table shows information concerning outstanding equity awards at December 31, 2020, made by The Company to its namedexecutive officers.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">       <tbody>        <tr style="vertical-align: bottom">         <td style="text-align: center">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="font-weight: bold; padding-bottom: 1.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td colspan="14" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">          <font style="font-family: Times New Roman, Times, Serif">           Option    Awards          </font>         </td>         <td style="padding-bottom: 1.5pt; font-weight: bold">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="font-weight: bold; padding-bottom: 1.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="font-weight: bold">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>        </tr>        <tr style="vertical-align: bottom">         <td style="font-weight: bold; text-align: justify; border-bottom: Black 1.5pt solid">          <font style="font-family: Times New Roman, Times, Serif">           Name          </font>         </td>         <td style="padding-bottom: 1.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid">          <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            <b>             Number                                         of            </b>           </font>          </p>          <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            <b>             Securities            </b>           </font>          </p>          <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            <b>             Underlying            </b>           </font>          </p>          <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            <b>             Unexercised            </b>           </font>          </p>          <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            <b>             Options            </b>           </font>          </p>          <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            <b>             Exercisable            </b>           </font>          </p>          <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            <b>             (#)            </b>           </font>          </p>         </td>         <td style="padding-bottom: 1.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="padding-bottom: 1.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid">          <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            <b>             Number                                         of            </b>           </font>          </p>          <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            <b>             Securities            </b>           </font>          </p>          <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            <b>             Underlying            </b>           </font>          </p>          <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            <b>             Unexercised            </b>           </font>          </p>          <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            <b>             Options            </b>           </font>          </p>          <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            <b>             Unexercisable            </b>           </font>          </p>          <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            <b>             (#)            </b>           </font>          </p>         </td>         <td style="padding-bottom: 1.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="padding-bottom: 1.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid">          <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            <b>             Equity            </b>           </font>          </p>          <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            <b>             Incentive            </b>           </font>          </p>          <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            <b>             Plan            </b>           </font>          </p>          <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            <b>             Awards:            </b>           </font>          </p>          <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            <b>             Number                                         of            </b>           </font>          </p>          <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            <b>             Securities            </b>           </font>          </p>          <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            <b>             Underlying            </b>           </font>          </p>          <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            <b>             Unexercised            </b>           </font>          </p>          <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            <b>             Unearned            </b>           </font>          </p>          <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            <b>             Options                                         (#)            </b>           </font>          </p>         </td>         <td style="padding-bottom: 1.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="padding-bottom: 1.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid">          <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            <b>             Option            </b>           </font>          </p>          <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            <b>             Exercise            </b>           </font>          </p>          <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            <b>             Price            </b>           </font>          </p>          <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            <b>             ($)            </b>           </font>          </p>         </td>         <td style="padding-bottom: 1.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="padding-bottom: 1.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: center; border-bottom: Black 1.5pt solid">          <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            <b>             Option            </b>           </font>          </p>          <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            <b>             Expiration            </b>           </font>          </p>          <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            <b>             Date            </b>           </font>          </p>         </td>        </tr>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td style="width: 27%; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           Timothy L. Jones          </font>         </td>         <td style="width: 1%">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="width: 1%; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="width: 12%; text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           1,700,000          </font>         </td>         <td style="width: 1%; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="width: 1%">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="width: 1%; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="width: 12%; text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           400,000          </font>         </td>         <td style="width: 1%; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="width: 1%">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="width: 1%; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="width: 12%; text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           0          </font>         </td>         <td style="width: 1%; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="width: 1%">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="width: 1%; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="width: 12%; text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           0.072          </font>         </td>         <td style="width: 1%; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="width: 1%">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="width: 12%; text-align: center">          <font style="font-family: Times New Roman, Times, Serif">           7/31/25          </font>         </td>        </tr>        <tr style="vertical-align: bottom; background-color: White">         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           Arnold S. Lippa          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           4,615          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           0          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           0          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           81.250          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: center">          <font style="font-family: Times New Roman, Times, Serif">           6/30/22          </font>         </td>        </tr>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           3,076          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           0          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           0          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           63.960          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: center">          <font style="font-family: Times New Roman, Times, Serif">           8/18/22          </font>         </td>        </tr>        <tr style="vertical-align: bottom; background-color: White">         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           7,384          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           0          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           0          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           73.775          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: center">          <font style="font-family: Times New Roman, Times, Serif">           3/31/21          </font>         </td>        </tr>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           5,000          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           0          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           0          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           39.000          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: center">          <font style="font-family: Times New Roman, Times, Serif">           1/17/22          </font>         </td>        </tr>        <tr style="vertical-align: bottom; background-color: White">         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           5,000          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           0          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           0          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           20.000          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: center">          <font style="font-family: Times New Roman, Times, Serif">           6/30/22          </font>         </td>        </tr>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           55,959          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           0          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           0          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           14.500          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: center">          <font style="font-family: Times New Roman, Times, Serif">           12/9/27          </font>         </td>        </tr>        <tr style="vertical-align: bottom; background-color: White">         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           Jeff E. Margolis          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           4,615          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           0          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           0          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           81.250          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: center">          <font style="font-family: Times New Roman, Times, Serif">           6/30/22          </font>         </td>        </tr>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           3,076          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           0          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           0          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           63.960          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: center">          <font style="font-family: Times New Roman, Times, Serif">           8/18/22          </font>         </td>        </tr>        <tr style="vertical-align: bottom; background-color: White">         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           7,384          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           0          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           0          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           73.775          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: center">          <font style="font-family: Times New Roman, Times, Serif">           3/31/21          </font>         </td>        </tr>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           5,000          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           0          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           0          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           39.000          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: center">          <font style="font-family: Times New Roman, Times, Serif">           1/17/22          </font>         </td>        </tr>        <tr style="vertical-align: bottom; background-color: White">         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           5,000          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           0          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           0          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           20.000          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: center">          <font style="font-family: Times New Roman, Times, Serif">           6/30/22          </font>         </td>        </tr>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           2,500          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           0          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           0          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           20.000          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: center">          <font style="font-family: Times New Roman, Times, Serif">           7/26/22          </font>         </td>        </tr>        <tr style="vertical-align: bottom; background-color: White">         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           38,868          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           0          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           0          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           14.500          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: center">          <font style="font-family: Times New Roman, Times, Serif">           12/9/27          </font>         </td>        </tr>       </tbody>      </table>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24.45pt; text-align: justify; text-indent: -24.5pt">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        AtDecember 31, 2020, there were 1,847,477 options outstanding to named executive officers 1,447,477 of which had vestedand 400,000 of which are unvested.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <!-- Field: Page; Sequence: 51; Value: 2 -->      <div style="margin-bottom: 6pt; border-bottom: Black 1.5pt solid">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="text-align: center; width: 100%">           <!-- Field: Sequence; Type: Arabic; Name: PageNo -->           51           <!-- Field: /Sequence -->          </td>         </tr>        </tbody>       </table>      </div>      <div style="break-before: page; margin-top: 6pt">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="width: 100%">          </td>         </tr>        </tbody>       </table>      </div>      <!-- Field: /Page -->      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         OPTIONEXERCISES AND STOCK VESTED FOR 2020        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Noneof the Company’s named executive officers exercised any options to purchase shares of the Company’s common stock duringthe year ended December 31, 2020. There were unvested option awards as of December 31, 2020 exercisable into 675,000 shares ofCommon Stock and none for 2019. At December 31, 2020, there were 3,248,168 options outstanding to named executive officers 2,573,168of which had vested and 675,000 of which are unvested, the vested options having exercise prices ranging from $0.054 to $81.250per share.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         EmploymentAgreements – Termination or Change in Control        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Threeof the Company’s named executive officers, Timothy L. Jones, Arnold S. Lippa, Ph.D. and Jeff E. Margolis (each an “Executive”),entered into employment agreements with the Company on May 06, 2020 and August 18, 2015 Upon entering into such agreements, theCompany disclosed these agreements and filed them as exhibits on a Current Report on Form 8-K filed May 6, 2020 and August 19,2015. The employment agreements that would have terminated on September 30, 2018 for Dr. Lippa and Mr. Margolis, were automaticallyextended for periods of one year pursuant to the terms of such agreements on September 30, 2019 and 2020. Following is a summaryof the arrangements that provide for payment to a named executive officer at, following or in connection with any termination,including resignation, retirement or other termination, or in connection with a change of control or a change in the named executiveofficer’s responsibilities following a change in control.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Eachof the Executive employment agreements provide that if the Executive is terminated by the Company for cause, or by the Executivewithout good reason, or as a result of death or disability, Executive (or his estate) would be entitled to receive (i) any basesalary earned but not paid through the date of such termination, paid on the next regularly scheduled payroll date following suchtermination and (ii) all other benefits, if any, due Executive, as determined in accordance with the plans, policies and practicesof the Company. There are currently no plans policies or practices of the Company under clause (ii) of the prior sentence thatwould provide any additional benefits.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Eachof the Executive employment agreements provide that if the Executive is terminated by the Company without cause, or by the Executivefor good reason, the Executive Officer would be entitled to (i) a lump sum payment equal to twelve months of the Executive’sthen current base salary and (ii) full acceleration of the vesting of any then unvested stock options or other equity compensationawards held by the Executive (with any unvested performance-based awards accelerated at 100% of target performance levels).       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Ifthe Executive were to breach any of section of the employment agreement related to confidentiality, inventions or restrictivecovenants, or the Company determines that Executive engaged in an act or omission that, if discovered during Executive’semployment, would have entitled the Company to terminate Executive’s employment hereunder for Cause, the Executive wouldforfeit the right to any unpaid severance and any unexercised options.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Asused in the employment agreements, “cause” means (i) any act of personal dishonesty taken by the Executive in connectionwith his employment hereunder, (ii) the Executive’s conviction or plea of        <i>         nolo contendere        </i>        to a felony, (iii) anyact by the Executive that constitutes material misconduct and is injurious to the Company, (iv) continued violations by the Executiveof the Executive’s obligations to the Company, (v) material breach of the employment agreement, (vi) commission of any actof serious moral turpitude, or (vii) material failure to comply with the lawful direction of the Board. As used in the employmentagreements, “for good reason” means without Executive’s express written consent (i) a material diminution ofExecutive’s duties, position or responsibilities relative to Executive’s duties, position or responsibilities in effectimmediately prior to such reduction; (ii) a material diminution by the Company of Executive’s base salary as in effect immediatelyprior to such reduction, other than a general reduction in base salary that affects all of the Company’s executive officers;(iii) any material breach by the Company of the employment agreement; or (iv) the relocation of Executive to a facility or a locationmore than fifty (50) miles from the current location of the Executive’s principal office, which the Company and Executiveagree would constitute a material change in the geographic location at which Executive must perform services to the Company.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <!-- Field: Page; Sequence: 52; Value: 2 -->      <div style="margin-bottom: 6pt; border-bottom: Black 1.5pt solid">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="text-align: center; width: 100%">           <!-- Field: Sequence; Type: Arabic; Name: PageNo -->           52           <!-- Field: /Sequence -->          </td>         </tr>        </tbody>       </table>      </div>      <div style="break-before: page; margin-top: 6pt">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="width: 100%">          </td>         </tr>        </tbody>       </table>      </div>      <!-- Field: /Page -->      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Inthe event of a change in control of the company prior to the vesting of any of the options granted to the Executive in connectionwith entering into the employment agreement, all such unvested options would vest and become exercisable and would be exercisedby cashless or net exercise, subject to any limitations set forth in the applicable option plans, option agreements and applicablelaw. As used in the employment agreements, “Change in Control” means the occurrence of any of the following events:(i) any “person” (as such term is used in Sections 13(d) and 14(d) of the Exchange Act) becomes the “beneficialowner” (as defined in Rule 13d-3 of the Exchange Act), directly or indirectly, of securities of the Company representingmore than fifty percent (50%) of the total voting power represented by the Company’s then outstanding voting securities;(ii) the consummation of the sale or disposition by the Company of all or substantially all of the Company’s assets; or(iii) the consummation of a merger or consolidation of the Company with any other corporation, other than a merger consolidationwhich would result in the voting securities of the Company outstanding immediately prior thereto continuing to represent (eitherby remaining outstanding or by being converted into voting securities of the surviving entity or its parent) more than fifty percent(50%) of the total voting power represented by the voting securities of the Company or such surviving entity or its parent outstandingimmediately after such merger or consolidation; provided, however, that notwithstanding the foregoing, the following shall notconstitute a Change in Control: (A) any acquisition directly from the Company, (B) any acquisition by the Company, (C) any acquisitionby any employee benefit plan (or related trust) sponsored or maintained by the Company or one of its affiliates, (D) any jointventure, (E) any royalty agreement, or (F) any license agreement.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        TheCompany entered into an agreement with DNA Healthlink, Inc. effective on October 15, 2014 pursuant to which, Richard Purcell,the fourth named executive officer, was to serve as the Company’s Senior Vice President of Research and Development on amonth-to-month basis at the rate of $12,500 per month. Mr. Purcell did not provide such services during the fourth quarter of2020 and is expected to resume providing such services in 2021.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        TheCompany entered into an agreement with David Dickason effective September 15, 2020 pursuant to which, Mr. Dickason, the fifthnamed executive officer, was to serve as the Company’s Senior Vice President of Preclinical Product Development, at will,at an hourly rate of $250 per hour. In addition, the agreement called for a restricted common stock grant of 200,000 shares ofCommon Stock, with a vesting schedule of 25% on December 15, 2020 and 25% on each of March 15, June 15 and September 15, 2021.200,000 stock options were granted in lieu of restricted common stock.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         DirectorCompensation        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Whenthe Compensation Committee was standing, it had used a combination of cash and stock-based incentive compensation to attract andretain qualified candidates to serve on the Board of Directors. In setting director compensation, the Compensation Committee consideredthe significant amount of time that directors expend in fulfilling their duties to the Company, as well as the skill-level requiredby the Company of members of the Board of Directors. The Board of Directors, sitting as a compensation committee has continuedthese policies in carrying out the duties of the previous Compensation Committee.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Therewere no option grants to either James Sapirstein (resigned as a member of the Board of Directors in December 2019) or KathrynMacFarlane during 2019 and 2018. During 2019, Ms. MacFarlane earned $60,000 in cash compensation and Mr. Sapirstein earned $58,207in 2019 through the date of his resignation from the Board of Directors of the Company. Such amounts have not yet been paid.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         DirectorSummary Compensation Table        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Thefollowing table shows the compensation received by the non-employee members of our board of directors for the year ended December31, 2020. Directors who are also employees/officers of the Company did not receive any additional compensation for services asa director.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">      </p>      <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">       <tbody>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">         <td style="font: bold 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           Name          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: center">          <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            <b>             Fees                                         Earned or            </b>           </font>          </p>          <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            <b>             Paid        in Cash ($)(2)            </b>           </font>          </p>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: center">          <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            <b>             Stock            </b>           </font>          </p>          <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            <b>             Awards        ($)            </b>           </font>          </p>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: center">          <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            <b>             Option            </b>           </font>          </p>          <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            <b>             Awards        ($)(1)            </b>           </font>          </p>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           Total    ($)          </font>         </td>         <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">         <td style="font: 10pt Times New Roman, Times, Serif; width: 32%; text-align: left">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           Kathryn    MacFarlane          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; width: 2%">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           60,000          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; width: 2%">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; width: 2%">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           77,500          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; width: 2%">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           137,500          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>        </tr>       </tbody>      </table>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">       <tbody>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           (1)          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           Options    exercisable into 1,250,000 shares were granted in 2020, all vesting upon grant. Options exercisable into 750,000 shares of    Common Stock expire on July 31, 2025 and are exercisable at $.072 per share and options exercisable into 500,000 shares of    Common Stock expire on September 30, 2025 and are exercisable $0.054 per share. No options were granted in 2019.          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           (2)          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           $15,000    per quarter was earned by our non-employee member of the board of directors.          </font>         </td>        </tr>       </tbody>      </table>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <!-- Field: Page; Sequence: 53; Value: 2 -->      <div style="margin-bottom: 6pt; border-bottom: Black 1.5pt solid">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="text-align: center; width: 100%">           <!-- Field: Sequence; Type: Arabic; Name: PageNo -->           53           <!-- Field: /Sequence -->          </td>         </tr>        </tbody>       </table>      </div>      <div style="break-before: page; margin-top: 6pt">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="width: 100%">          </td>         </tr>        </tbody>       </table>      </div>      <!-- Field: /Page -->      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         <a name="b_001">         </a>         Item12. Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         BeneficialOwnership of Common Stock        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24.5pt">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Thefollowing table sets forth certain information regarding the beneficial ownership of the Company’s common stock as of April13, 2021, by (i) each person known by the Company to be the beneficial owner of more than 5% of the outstanding common stock,(ii) each of the Company’s directors, (iii) each of the Company’s named executive officers, and (iv) all of the Company’sexecutive officers and directors as a group. Except as indicated in the footnotes to this table, the Company believes that thepersons named in this table have sole voting and investment power with respect to the shares of common stock indicated. In computingthe number and percentage ownership of shares beneficially owned by a person, shares of common stock that a person has a rightto acquire within sixty (60) days of April 13, 2021 pursuant to options, warrants or other rights are considered as outstanding,while these shares are not considered as outstanding for computing the percentage ownership of any other person or group.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24.5pt">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">       <tbody>        <tr style="vertical-align: bottom">         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="padding-bottom: 1.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td colspan="6" style="text-align: center; border-bottom: Black 1.5pt solid">          <font style="font-family: Times New Roman, Times, Serif">           <b>            Shares    Beneficially Owned           </b>          </font>         </td>         <td style="padding-bottom: 1.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>        </tr>        <tr style="vertical-align: bottom">         <td style="border-bottom: Black 1.5pt solid">          <font style="font-family: Times New Roman, Times, Serif">           <b>            Directors, Officers    and 5% Stockholders            <sup>             (a)            </sup>           </b>          </font>         </td>         <td style="padding-bottom: 1.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid">          <font style="font-family: Times New Roman, Times, Serif">           <b>            Amount    and Nature of Beneficial Ownership           </b>          </font>         </td>         <td style="padding-bottom: 1.5pt">          <font style="font-family: Times New Roman, Times, Serif">           <sup>           </sup>          </font>         </td>         <td style="padding-bottom: 1.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid">          <font style="font-family: Times New Roman, Times, Serif">           <b>            Percent    of Class           </b>          </font>         </td>         <td style="padding-bottom: 1.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>        </tr>        <tr style="vertical-align: bottom">         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td colspan="2" style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">           <sup>           </sup>          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td colspan="2" style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>        </tr>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td style="width: 60%; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           Arnold Lippa Family Trust    of 2007          </font>         </td>         <td style="width: 2%">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="width: 1%; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="width: 16%; text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           22,522,195          </font>         </td>         <td style="width: 1%; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           <sup>            (b)           </sup>          </font>         </td>         <td style="width: 2%">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="width: 1%; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="width: 16%; text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           22.40          </font>         </td>         <td style="width: 1%; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           %          </font>         </td>        </tr>        <tr style="vertical-align: bottom; background-color: White">         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           <sup>           </sup>          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>        </tr>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           Jeff Margolis Trusts          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           20,903,459          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           <sup>            (c)           </sup>          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           20.95          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           %          </font>         </td>        </tr>        <tr style="vertical-align: bottom; background-color: White">         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           <sup>           </sup>          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>        </tr>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           Directors and Officers:          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           <sup>           </sup>          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>        </tr>        <tr style="vertical-align: bottom; background-color: White">         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           <sup>           </sup>          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>        </tr>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           Jeff E. Margolis          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           20,902,659          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           <sup>            (c)           </sup>          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           20.95          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           %          </font>         </td>        </tr>        <tr style="vertical-align: bottom; background-color: White">         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           <sup>           </sup>          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>        </tr>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           Arnold S. Lippa, Ph.D.          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           140          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           <sup>            (d)           </sup>          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           0.00          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           %          </font>         </td>        </tr>        <tr style="vertical-align: bottom; background-color: White">         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           <sup>           </sup>          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>        </tr>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           Timothy Jones          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           2,581,812          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           <sup>            (e)           </sup>          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           2.82          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           %          </font>         </td>        </tr>        <tr style="vertical-align: bottom; background-color: White">         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           <sup>           </sup>          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>        </tr>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           Kathryn MacFarlane          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           1,264,040          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           <sup>            (f)           </sup>          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           1.39          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           %          </font>         </td>        </tr>        <tr style="vertical-align: bottom; background-color: White">         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           <sup>           </sup>          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>        </tr>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           Richard Purcell          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           526,306          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           <sup>            (g)           </sup>          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           0.58          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           %          </font>         </td>        </tr>        <tr style="vertical-align: bottom; background-color: White">         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           <sup>           </sup>          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>        </tr>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           David Dickason          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           200,000          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           <sup>            (h)           </sup>          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           0.22          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           %          </font>         </td>        </tr>        <tr style="vertical-align: bottom; background-color: White">         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           <sup>           </sup>          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>        </tr>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           All directors and current executive    officers as a group (6 persons)          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           25,475,757          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           <sup>           </sup>          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           24,52          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           %          </font>         </td>        </tr>       </tbody>      </table>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">       <tbody>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           (a)          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           Except    as otherwise indicated,          </font>          <font style="font-family: Times New Roman, Times, Serif">           each individual or entity has, or    is entitled to have within 60 days of April 13, 2021, sole voting or dispositive power with respect to the shares reported    as beneficially owned.          </font>         </td>        </tr>       </tbody>      </table>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">       <tbody>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           (b)          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif">           Dr.    Lippa is neither the trustee nor the beneficiary of the Arnold Lippa Family Trust of 2007 (the “Lippa Trust”).    Linda Lippa, Dr. Lippa’s wife is a beneficiary of the Lippa Trust. These holdings include 11,461,716    shares of Common Stock options to purchase 81,034 shares of Common Stock warrants to purchase 10,978,645 shares of Common    Stock and 800 shares directly owned by Aurora Capital LLC which entity is indirectly owned in part by the Lippa Trust and    through which the Lippa Trust has voting and dispositive power over the shares with Jeff E. Margolis.           <font style="font-size: 10pt">            The    address of the Lippa Trust is c/o RespireRx Pharmaceuticals Inc., 126 Valley Road, Suite C, Glen Rock, New Jersey 07452.           </font>          </font>         </td>        </tr>       </tbody>      </table>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <!-- Field: Page; Sequence: 54; Value: 2 -->      <div style="margin-bottom: 6pt; border-bottom: Black 1.5pt solid">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="text-align: center; width: 100%">           <!-- Field: Sequence; Type: Arabic; Name: PageNo -->           54           <!-- Field: /Sequence -->          </td>         </tr>        </tbody>       </table>      </div>      <div style="break-before: page; margin-top: 6pt">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="width: 100%">          </td>         </tr>        </tbody>       </table>      </div>      <!-- Field: /Page -->      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">       <tbody>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           (c)          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           Mr.    Margolis’ holdings directly held by six trusts, three of which Mr. Margolis is the trustee and the    balance of which Mr. Margolis’ spouse is the trustee (the “Margolis Trusts”). These holdings include    10,645,194 shares of Common Stock, options to purchase 66,443 shares of Common Stock, warrants to purchase 10,191,022    shares of Common Stock and 800 shares of Common Stock directly owned Aurora Capital LLC which entity is indirectly    owned in part by Mr. Margolis and through which he shares voting and dispositive power over the shares with the LIppa Trust.    The address of the Margolis Trusts is c/o RespireRx Pharmaceuticals Inc., 126 Valley Road, Suite C, Glen Rock, New Jersey    07452.          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           (d)          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif">           Dr.    Lippa’s holdings include          </font>          <font style="font-family: Times New Roman, Times, Serif">           <font style="font-size: 10pt">            59    shares of Common Stock and warrants to purchase 81 shares of Common Stock.           </font>          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           (e)          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif">           Mr.    Jones’ holdings include          </font>          <font style="font-family: Times New Roman, Times, Serif">           440,906 shares of Common    Stock, warrants to purchase 440,906 shares of Common Stock and options exercisable into 1,700,000 shares of    Common Stock.          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           (f)          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           Dr.    MacFarlane’s holdings include: (i) 615 shares of Common Stock, and (ii) options to purchase 1,263,425 shares of Common    Stock.          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           (g)          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           Mr.    Purcell’s holdings include: (i) 615 shares of Common Stock, and (ii) options to purchase 525,691 shares of Common Stock.          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           (h)          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           Mr.    Dickason’s holdings include options to purchase 200,000 shares of Common Stock.          </font>         </td>        </tr>       </tbody>      </table>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24.5pt">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        TheCompany is not aware of any arrangements that may at a subsequent date result in a change of control of the Company.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24.5pt">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <!-- Field: Page; Sequence: 55; Value: 2 -->      <div style="margin-bottom: 6pt; border-bottom: Black 1.5pt solid">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="text-align: center; width: 100%">           <!-- Field: Sequence; Type: Arabic; Name: PageNo -->           55           <!-- Field: /Sequence -->          </td>         </tr>        </tbody>       </table>      </div>      <div style="break-before: page; margin-top: 6pt">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="width: 100%">          </td>         </tr>        </tbody>       </table>      </div>      <!-- Field: /Page -->      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         EQUITYCOMPENSATION PLAN INFORMATION        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        OnMarch 18, 2014, RespireRx adopted its 2014 Equity, Equity-Linked and Equity Derivative Incentive Plan (the “2014 Plan”).The Plan permits the grant of options and restricted stock with respect to up to 325,025 shares of common stock, in addition tostock appreciation rights and phantom stock, to directors, officers, employees, consultants and other service providers of theCompany.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        OnJune 30, 2015, the Board of Directors adopted the 2015 Stock and Stock Option Plan (as amended, the “2015 Plan”).As of March 31, 2020, there were 8,985,260 shares that may be issued under the 2015 Plan. On May 5, 2020 the Board of Directorsincreased the number of shares that may be issued under the 2015 Plan to 58,985,260. On July 31, 2020 the Board of Directors increasedthe number of shares that may be issued under the 2015 Plan to 158,985,260. The Company has not and does not intend to presentthe 2015 Plan to stockholders for approval.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Otherthan the change in the number of shares available under the 2015 Plan, no other changes were made to the 2015 Plan by these amendmentsnoted above.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Therewere no stock grants and there were stock option grants for 6,750,000 shares of RespireRx’s Common Stock during the twelvemonths ended December 31, 2020 and there were no stock grants or stock option grants in the twelve months ended December 31, 2019.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Informationwith respect to the Black-Scholes variables used in connection with the evaluation of the fair value of stock-based compensationcosts and fees is provided at Note 3 Summary of Significant Accounting Policies.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">       <tbody>        <tr style="vertical-align: bottom">         <td style="border-bottom: Black 1.5pt solid">          <font style="font-family: Times New Roman, Times, Serif">           <b>            Plan Category           </b>          </font>         </td>         <td style="padding-bottom: 1.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid">          <font style="font-family: Times New Roman, Times, Serif">           <b>            Number    of securities            <br/>            to be issued upon            <br/>            exercise            <br/>            of outstanding options,            <br/>            warrants and rights            <br/>            (a)           </b>          </font>         </td>         <td style="padding-bottom: 1.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="padding-bottom: 1.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid">          <font style="font-family: Times New Roman, Times, Serif">           <b>            Weighted            <br/>            average            <br/>            exercise price of            <br/>            outstanding options,            <br/>            warrants and rights            <br/>            (b)           </b>          </font>         </td>         <td style="padding-bottom: 1.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="padding-bottom: 1.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid">          <font style="font-family: Times New Roman, Times, Serif">           <b>            Number    of securities            <br/>            remaining available for            <br/>            issuance under equity            <br/>            compensation plans            <br/>            (excluding securities            <br/>            reflected    in column (a))            <br/>            (c)           </b>          </font>         </td>         <td style="padding-bottom: 1.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>        </tr>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td style="width: 46%; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           Equity compensation plans    approved by security holders          </font>         </td>         <td style="width: 2%">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="width: 1%; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="width: 14%; text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           1,564          </font>         </td>         <td style="width: 1%; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="width: 2%">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="width: 1%; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           $          </font>         </td>         <td style="width: 14%; text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           64.025          </font>         </td>         <td style="width: 1%; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="width: 2%">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="width: 1%; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="width: 14%; text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           6,325          </font>         </td>         <td style="width: 1%; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>        </tr>        <tr style="vertical-align: bottom; background-color: White">         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>        </tr>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           Equity compensation plans not approved    by security holders (including non-plan options)          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           7,163,651          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           $          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           1.948          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           8,704,251          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>        </tr>        <tr style="vertical-align: bottom; background-color: White">         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>        </tr>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td>          <font style="font-family: Times New Roman, Times, Serif">           <b>            Total           </b>          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           7,165,215          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           $          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           1.961          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           8,710,576          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>        </tr>       </tbody>      </table>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <!-- Field: Page; Sequence: 56; Value: 2 -->      <div style="margin-bottom: 6pt; border-bottom: Black 1.5pt solid">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="text-align: center; width: 100%">           <!-- Field: Sequence; Type: Arabic; Name: PageNo -->           56           <!-- Field: /Sequence -->          </td>         </tr>        </tbody>       </table>      </div>      <div style="break-before: page; margin-top: 6pt">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="width: 100%">          </td>         </tr>        </tbody>       </table>      </div>      <!-- Field: /Page -->      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         <a name="b_002">         </a>         Item13. Certain Relationships and Related Transactions, and Director Independence        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         DirectorIndependence        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Asof December 31, 2020, Kathryn MacFarlane, PharmD. was an “independent director”, as that term is defined under Section803 of the NYSE Amex Company Guide. As noted above, as of December 31, 2020, all of the functions of the Audit, Compensation andGovernance and Nominations Committees were being performed by the full board of directors. Dr. Lippa, Mr. Jones and Mr. Margolisare not “independent directors” as defined above.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24.5pt">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         Transactionswith Related Persons        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Dr.Arnold S. Lippa and Jeff E. Margolis, officers and directors of RespireRx since March 22, 2013, have indirect ownership and managingmembership interests in Aurora Capital LLC (“Aurora”) through interests held in its members, and Jeff. E. Margolisis also an officer of Aurora. Aurora is a boutique investment banking firm specializing in the life sciences sector.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Duringthe fiscal year ended December 31, 2020, Arnold S. Lippa, the Company’s Chief Scientific Officer and Executive Chairmanextended credit to the Company in the aggregate amount of $81,037, of which $16,037 has been repaid. The aggregate of the netadvances of $65,000 during fiscal year ended December 31, 2020 and the $25,000 advanced by Dr. Lippa in 2019, results in an outstandingbalance due to Dr. Lippa of $90,000 as of December 31, 2020 and as of April 14, 2021, which amount has been accounted forby the Company as an advance by Dr. Lippa payable on demand. The proceeds of these advances were to make payments to the Company’sauditors, patent counsel and payments due with respect to an insurance premium that had been financed. See also Note 4.Notes Payable.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        OnMarch 21, 2020, July 13, 2020 and September 30, 2020, Dr. Lippa and Jeff E. Margolis, forgave an aggregate of $1,656,000 of accruedcompensation and benefits and received Series H Preferred Stock. On September 30, 2020, Timothy Jones forgave $28,218 or accruedcompensation and benefits and received Series H Preferred Stock. See Note 8. Commitments and Contingencies – SignificantAgreements and Contracts-Employment Agreements for a more detailed description of these transactions.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <!-- Field: Page; Sequence: 57; Value: 2 -->      <div style="margin-bottom: 6pt; border-bottom: Black 1.5pt solid">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="text-align: center; width: 100%">           <!-- Field: Sequence; Type: Arabic; Name: PageNo -->           57           <!-- Field: /Sequence -->          </td>         </tr>        </tbody>       </table>      </div>      <div style="break-before: page; margin-top: 6pt">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="width: 100%">          </td>         </tr>        </tbody>       </table>      </div>      <!-- Field: /Page -->      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         <a name="b_003">         </a>         Item14. Principal Accountant Fees and Services        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Haskell&amp; White LLP, acted as our independent registered public accounting firm for the fiscal years ended December 31, 2020 and 2019and for the interim periods in such fiscal years. The following table shows the approximate fees that were incurred by us foraudit and other services provided by Haskell &amp; White LLP in fiscal 2020 and 2019.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">       <tbody>        <tr style="vertical-align: bottom">         <td style="text-align: center">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="padding-bottom: 1.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid">          <font style="font-family: Times New Roman, Times, Serif">           <b>            2020           </b>          </font>         </td>         <td style="padding-bottom: 1.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="padding-bottom: 1.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid">          <font style="font-family: Times New Roman, Times, Serif">           <b>            2019           </b>          </font>         </td>         <td style="padding-bottom: 1.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>        </tr>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td style="width: 64%">          <font style="font-family: Times New Roman, Times, Serif">           Audit Fees           <sup>            (1)           </sup>          </font>         </td>         <td style="width: 2%">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="width: 1%; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           $          </font>         </td>         <td style="width: 14%; text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           95,352          </font>         </td>         <td style="width: 1%; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="width: 2%">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="width: 1%; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           $          </font>         </td>         <td style="width: 14%; text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           98,700          </font>         </td>         <td style="width: 1%; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>        </tr>        <tr style="vertical-align: bottom; background-color: White">         <td>          <font style="font-family: Times New Roman, Times, Serif">           Audit-Related Fees           <sup>            (2)           </sup>          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           -          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           -          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>        </tr>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td>          <font style="font-family: Times New Roman, Times, Serif">           Tax Fees           <sup>            (3)           </sup>          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           -          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           -          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>        </tr>        <tr style="vertical-align: bottom; background-color: White">         <td style="text-align: left; padding-bottom: 1.5pt">          <font style="font-family: Times New Roman, Times, Serif">           All Other Fees           <sup>            (4)           </sup>          </font>         </td>         <td style="padding-bottom: 1.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           16,500          </font>         </td>         <td style="padding-bottom: 1.5pt; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="padding-bottom: 1.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           -          </font>         </td>         <td style="padding-bottom: 1.5pt; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>        </tr>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td style="padding-bottom: 2.5pt">          <font style="font-family: Times New Roman, Times, Serif">           Total          </font>         </td>         <td style="padding-bottom: 2.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="border-bottom: Black 2.5pt double; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           $          </font>         </td>         <td style="border-bottom: Black 2.5pt double; text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           111,852          </font>         </td>         <td style="padding-bottom: 2.5pt; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="padding-bottom: 2.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="border-bottom: Black 2.5pt double; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           $          </font>         </td>         <td style="border-bottom: Black 2.5pt double; text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           98,700          </font>         </td>         <td style="padding-bottom: 2.5pt; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>        </tr>       </tbody>      </table>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">       <tbody>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           (1)          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           Audit    fees represent fees for professional services provided in connection with the audit of our annual financial statements and    the review of our financial statements included in our Quarterly Reports on Form 10-Q and services that are normally provided    in connection with statutory or regulatory filings.          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           (2)          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           Audit-related    fees, if any, represent fees for assurance and related services that are reasonably related to the performance of the audit    or review of our financial statements and not reported above under “Audit Fees.”          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           (3)          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           Tax    fees, if any, represent fees for professional services related to tax compliance, tax advice and tax planning.          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           (4)          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           All    other fees, if any, represent fees for products and services rendered by our independent registered accounting firm other    than those listed above, including fees for consents and work related to our registration statement filing on Form S-1.          </font>         </td>        </tr>       </tbody>      </table>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Allaudit related services and other services rendered by Haskell &amp; White LLP were pre-approved by our Board of Directors. TheBoard of Directors has adopted a pre-approval policy that provides for the pre-approval of all services performed for us by ourindependent registered public accounting firm. Tax services are not provided by Haskell &amp; White LLP.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         <a name="b_004">         </a>         PARTIV        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         <a name="b_005">         </a>         Item15. Exhibits and Financial Statement Schedules        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">       <tbody>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif; width: 24px; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           (a)          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           List    of documents filed as part of this report:          </font>         </td>        </tr>       </tbody>      </table>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">       <tbody>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           (1)          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           Financial    Statements          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           Reference    is made to the Index to Financial Statements on page F-1, where these documents are listed.          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           (2)          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           Financial    Statement Schedules          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           The    financial statement schedules have been omitted because the required information is not applicable, or not present in amounts    sufficient to require submission of the schedules, or because the information is included in the financial statements or notes    thereto.          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           (3)          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           Exhibits          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           A    list of exhibits required to be filed as a part of this Annual Report on Form 10-K is set forth in the Exhibit Index, which    is presented elsewhere in this document and incorporated herein by reference.          </font>         </td>        </tr>       </tbody>      </table>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         <a name="b_006">         </a>         Item16. Form 10-K Summary        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Notapplicable       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <!-- Field: Page; Sequence: 58; Value: 2 -->      <div style="margin-bottom: 6pt; border-bottom: Black 1.5pt solid">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="text-align: center; width: 100%">           <!-- Field: Sequence; Type: Arabic; Name: PageNo -->           58           <!-- Field: /Sequence -->          </td>         </tr>        </tbody>       </table>      </div>      <div style="break-before: page; margin-top: 6pt">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="width: 100%">          </td>         </tr>        </tbody>       </table>      </div>      <!-- Field: /Page -->      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         RESPIRERXPHARMACEUTICALS INC.        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         ANDSUBSIDIARY        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         <a name="b_008">         </a>         INDEXTO CONSOLIDATED FINANCIAL STATEMENTS        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         (INCLUDINGREPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM)        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         YearsEnded December 31, 2020 and 2019        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">       <tbody>        <tr style="font: 10pt Times New Roman, Times, Serif; background-color: #CCEEFF">         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           <a href="#f_001">            Report    of Independent Registered Public Accounting Firm           </a>          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           F-2          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; background-color: white">         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; background-color: #CCEEFF">         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           <a href="#f_002">            Consolidated    Balance Sheets - December 31, 2020 and 2019           </a>          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           F-5          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; background-color: white">         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; background-color: #CCEEFF">         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           <a href="#f_003">            Consolidated    Statements of Operations - Years Ended December 31, 2020 and 2019           </a>          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           F-6          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; background-color: white">         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; background-color: #CCEEFF">         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           <a href="#f_004">            Consolidated    Statements of Stockholders’ Deficiency - Years Ended December 31, 2020 and 2019           </a>          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           F-7          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; background-color: white">         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; background-color: #CCEEFF">         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           <a href="#f_005">            Consolidated    Statements of Cash Flows - Years Ended December 31, 2020 and 2019           </a>          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           F-8          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; background-color: white">         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; background-color: #CCEEFF">         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           <a href="#f_006">            Notes    to Consolidated Financial Statements - Years Ended December 31, 2020 and 2019           </a>          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           F-10          </font>         </td>        </tr>       </tbody>      </table>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <!-- Field: Page; Sequence: 59; Options: NewSection; Value: 1 -->      <div style="margin-bottom: 6pt; border-bottom: Black 1.5pt solid">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="text-align: center; width: 100%">           F-           <!-- Field: Sequence; Type: Arabic; Name: PageNo -->           1           <!-- Field: /Sequence -->          </td>         </tr>        </tbody>       </table>      </div>      <div style="break-before: page; margin-top: 6pt">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="width: 100%">          </td>         </tr>        </tbody>       </table>      </div>      <!-- Field: /Page -->      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         <a name="f_001">         </a>         REPORTOF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right; text-indent: 0.5in">      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="text-align: justify; font: 11pt Times New Roman, Times, Serif; margin: 0">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Tothe Stockholders and Board of Directors       </font>      </p>      <p style="text-align: justify; font: 11pt Times New Roman, Times, Serif; margin: 0">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        RespireRxPharmaceuticals Inc. and Subsidiary       </font>      </p>      <p style="text-align: justify; font: 11pt Times New Roman, Times, Serif; margin: 0">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>        </b>       </font>      </p>      <p style="text-align: justify; font: 11pt Times New Roman, Times, Serif; margin: 0">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         Opinionon the Consolidated Financial Statements        </b>       </font>      </p>      <p style="text-align: justify; font: 11pt Times New Roman, Times, Serif; margin: 0">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>        </b>       </font>      </p>      <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Wehave audited the accompanying consolidated balance sheets of RespireRx Pharmaceuticals Inc. and Subsidiary (the “Company”)as of December 31, 2020 and 2019, the related consolidated statements of operations, stockholders’ deficiency, and cashflows for each of the years then ended, and the related notes (collectively, the “consolidated financial statements”).In our opinion, the consolidated financial statements present fairly, in all material respects, the consolidated financial positionof the Company as of December 31, 2020 and 2019, and the consolidated results of its operations and its cash flows for each ofthe years then ended, in conformity with generally accepted accounting principles generally accepted in the United States of America.       </font>      </p>      <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         GoingConcern        </b>       </font>      </p>      <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Theaccompanying consolidated financial statements have been prepared assuming that the Company will continue as a going concern.As discussed in Note 2 to the consolidated financial statements, the Company has experienced recurring losses, negative cash flowsfrom operations, has limited capital resources, and a net stockholders’ deficiency. These matters raise substantial doubtabout the Company’s ability to continue as a going concern. Management’s plans in regard to these matters are alsodescribed in Note 2. The consolidated financial statements do not include any adjustments that might result from the outcome ofthis uncertainty.       </font>      </p>      <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>        </b>       </font>      </p>      <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         Basisfor Opinion        </b>       </font>      </p>      <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Theseconsolidated financial statements are the responsibility of the Company’s management. Our responsibility is to express anopinion on the Company’s consolidated financial statements based on our audits. We are a public accounting firm registeredwith the Public Company Accounting Oversight Board (United States) (“PCAOB”) and are required to be independent withrespect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securitiesand Exchange Commission and the PCAOB.       </font>      </p>      <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Weconducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the auditto obtain reasonable assurance about whether the consolidated financial statements are free of material misstatement, whetherdue to error or fraud. The Company is not required to have, nor were we engaged to perform, an audit of its internal control overfinancial reporting. As part of our audits, we are required to obtain an understanding of internal control over financial reportingbut not for the purpose of expressing an opinion on the effectiveness of the Company’s internal control over financial reporting.Accordingly, we express no such opinion.       </font>      </p>      <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="text-align: justify; margin: 0; font: 11pt Times New Roman, Times, Serif">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Ouraudits included performing procedures to assess the risks of material misstatement of the consolidated financial statements, whetherdue to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis,evidence regarding the amounts and disclosures in the consolidated financial statements. Our audits also included evaluating theaccounting principles used and significant estimates made by management, as well as evaluating the overall presentation of theconsolidated financial statements. We believe that our audits provide a reasonable basis for our opinion.       </font>      </p>      <p style="font: 11pt Times New Roman, Times, Serif; margin: 0">       <font style="font-family: Times New Roman, Times, Serif">       </font>      </p>      <p style="font: 11pt Times New Roman, Times, Serif; margin: 0">      </p>      <!-- Field: Page; Sequence: 60; Value: 1 -->      <div style="margin-bottom: 6pt; border-bottom: Black 1.5pt solid">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="text-align: center; width: 100%">           F-           <!-- Field: Sequence; Type: Arabic; Name: PageNo -->           2           <!-- Field: /Sequence -->          </td>         </tr>        </tbody>       </table>      </div>      <div style="break-before: page; margin-top: 6pt">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="width: 100%">          </td>         </tr>        </tbody>       </table>      </div>      <!-- Field: /Page -->      <p style="font: 11pt Times New Roman, Times, Serif; margin: 0">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="text-align: justify; font: 11pt Times New Roman, Times, Serif; margin: 0">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         CriticalAudit Matters        </b>       </font>      </p>      <p style="text-align: justify; font: 11pt Times New Roman, Times, Serif; margin: 0">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         <i>         </i>        </b>       </font>      </p>      <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Thecritical audit matters communicated below are matters arising from the current period audit of the consolidated financial statementsthat were communicated or required to be communicated to the audit committee and that: (1) relate to accounts or disclosures thatare material to the consolidated financial statements and (2) involved our especially challenging, subjective, or complex judgments.The communication of the critical audit matters does not alter in any way our opinion on the consolidated financial statements,taken as a whole, and we are not, by communicating the critical audit matters below, providing separate opinions on the criticalaudit matters or on the accounts or disclosures to which they relate.       </font>      </p>      <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <u>         ShareBased Compensation        </u>       </font>      </p>      <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <i>         CriticalAudit Matter Description        </i>       </font>      </p>      <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        TheCompany issues stock options to employees and vendors. Management uses the Black-Scholes option-pricing model to estimate thefair value of its stock options. The Black-Scholes option-pricing model involves the use of significant estimates, including thefollowing:       </font>      </p>      <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <table cellpadding="0" cellspacing="0" style="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0" width="100%">       <tbody>        <tr style="vertical-align: top">         <td style="text-align: justify; width: 0.25in">         </td>         <td style="text-align: justify; width: 0.25in">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           ■          </font>         </td>         <td style="text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           Risk-free                                         interest rate;          </font>         </td>        </tr>       </tbody>      </table>      <table cellpadding="0" cellspacing="0" style="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0" width="100%">       <tbody>        <tr style="vertical-align: top">         <td style="text-align: justify; width: 0.25in">         </td>         <td style="text-align: justify; width: 0.25in">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           ■          </font>         </td>         <td style="text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           Expected                                         share price volatility;          </font>         </td>        </tr>       </tbody>      </table>      <table cellpadding="0" cellspacing="0" style="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0" width="100%">       <tbody>        <tr style="vertical-align: top">         <td style="text-align: justify; width: 0.25in">         </td>         <td style="text-align: justify; width: 0.25in">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           ■          </font>         </td>         <td style="text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           Expected                                         dividend yield; and          </font>         </td>        </tr>       </tbody>      </table>      <table cellpadding="0" cellspacing="0" style="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0" width="100%">       <tbody>        <tr style="vertical-align: top">         <td style="text-align: justify; width: 0.25in">         </td>         <td style="text-align: justify; width: 0.25in">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           ■          </font>         </td>         <td style="text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           Expected                                         life of the award.          </font>         </td>        </tr>       </tbody>      </table>      <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Giventhe significant estimates involved in determining the fair value of stock options, the related audit effort in evaluating management’sestimates for the inputs to the Black-Scholes pricing model was extensive and required a high degree of auditor judgment.       </font>      </p>      <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <i>         Howthe Critical Audit Matter was Addressed in the Audit        </i>       </font>      </p>      <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Weobtained an understanding of the management’s process to estimate the fair value of stock options, including how managementdevelops each of the estimates required as inputs to the Black-Scholes option-pricing model. We applied the following audit proceduresrelated to testing management’s estimates utilized in the Black-Scholes option-pricing model:       </font>      </p>      <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <table cellpadding="0" cellspacing="0" style="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0" width="100%">       <tbody>        <tr style="vertical-align: top">         <td style="text-align: justify; width: 21pt">         </td>         <td style="text-align: justify; width: 18pt">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           ■          </font>         </td>         <td style="text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           We                                         compared the Company’s risk-free interest rate used to the comparable United States                                         Treasury yield for a term comparable to option’s estimated life.          </font>         </td>        </tr>       </tbody>      </table>      <table cellpadding="0" cellspacing="0" style="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0" width="100%">       <tbody>        <tr style="vertical-align: top">         <td style="text-align: justify; width: 21pt">         </td>         <td style="text-align: justify; width: 18pt">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           ■          </font>         </td>         <td style="text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           We                                         recalculated the Company’s historical share price volatility for a term of 12 months                                         prior to the grant date because management considered the volatility for this period                                         to be a better reflection of future value than the historical share price volatility                                         of the term of the options.          </font>         </td>        </tr>       </tbody>      </table>      <table cellpadding="0" cellspacing="0" style="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0" width="100%">       <tbody>        <tr style="vertical-align: top">         <td style="text-align: justify; width: 21pt">         </td>         <td style="text-align: justify; width: 18pt">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           ■          </font>         </td>         <td style="text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           We                                         performed a look-back of the Company’s previously issued dividends, noting there                                         were none. We inquired with management of the Company who informed us that no future                                         dividends were currently anticipated.          </font>         </td>        </tr>       </tbody>      </table>      <table cellpadding="0" cellspacing="0" style="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0" width="100%">       <tbody>        <tr style="vertical-align: top">         <td style="text-align: justify; width: 21pt">         </td>         <td style="text-align: justify; width: 18pt">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           ■          </font>         </td>         <td style="text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           We                                         agreed the inputs used for the life of the award to management’s estimate of the                                         expected life, which is the contractual life as no options have been exercised recently.          </font>         </td>        </tr>       </tbody>      </table>      <p style="margin-top: 0; margin-bottom: 0">       <font style="font-family: Times New Roman, Times, Serif">       </font>      </p>      <p style="margin-top: 0; margin-bottom: 0">      </p>      <!-- Field: Page; Sequence: 61; Value: 1 -->      <div style="margin-bottom: 6pt; border-bottom: Black 1.5pt solid">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="text-align: center; width: 100%">           F-           <!-- Field: Sequence; Type: Arabic; Name: PageNo -->           3           <!-- Field: /Sequence -->          </td>         </tr>        </tbody>       </table>      </div>      <div style="break-before: page; margin-top: 6pt">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="width: 100%">          </td>         </tr>        </tbody>       </table>      </div>      <!-- Field: /Page -->      <p style="text-align: justify; margin-top: 0; margin-bottom: 0">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <u>         Accountingfor Complex Debt Transactions        </u>       </font>      </p>      <p style="text-align: justify; font: 12pt Times New Roman, Times, Serif; margin: 0">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <i>         CriticalAudit Matter Description        </i>       </font>      </p>      <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Duringthe year ended December 31, 2020, the Company entered into several convertible notes payable that included original issue discounts,beneficial conversion features, and warrants. The proceeds of the convertible notes payable are allocated to the components ofthe convertible debt instrument in accordance with        <i>         ASC 470-20, Debt with Conversion and Other Options.        </i>        Management usedthe Black-Scholes option-pricing model to estimate the fair value of the warrants issued with the convertible notes, and allocatedthe proceeds to the warrants and the debt host based on a relative fair value basis. The Black-Scholes option-pricing model involvesthe use of significant estimates, including the following:       </font>      </p>      <p style="text-align: justify; font: 12pt Times New Roman, Times, Serif; margin: 0">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <table cellpadding="0" cellspacing="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0" width="100%">       <tbody>        <tr style="vertical-align: top">         <td style="text-align: justify; width: 0.5in">         </td>         <td style="text-align: justify; width: 0.25in">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           ●          </font>         </td>         <td style="text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           Risk-free                                         interest rate;          </font>         </td>        </tr>       </tbody>      </table>      <table cellpadding="0" cellspacing="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0" width="100%">       <tbody>        <tr style="vertical-align: top">         <td style="text-align: justify; width: 0.5in">         </td>         <td style="text-align: justify; width: 0.25in">          <font style="font-family: Times New Roman, Times, Serif">           ●          </font>         </td>         <td style="text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           Expected                                         share price volatility;          </font>         </td>        </tr>       </tbody>      </table>      <table cellpadding="0" cellspacing="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0" width="100%">       <tbody>        <tr style="vertical-align: top">         <td style="text-align: justify; width: 0.5in">         </td>         <td style="text-align: justify; width: 0.25in">          <font style="font-family: Times New Roman, Times, Serif">           ●          </font>         </td>         <td style="text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           Expected                                         dividend yield; and          </font>         </td>        </tr>       </tbody>      </table>      <table cellpadding="0" cellspacing="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0" width="100%">       <tbody>        <tr style="vertical-align: top">         <td style="text-align: justify; width: 0.5in">         </td>         <td style="text-align: justify; width: 0.25in">          <font style="font-family: Times New Roman, Times, Serif">           ●          </font>         </td>         <td style="text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           Contractual                                         life of the award.          </font>         </td>        </tr>       </tbody>      </table>      <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Giventhe significant estimates involved in determining the individual components of the debt instrument and the related debt discountsresulting from the relative fair value calculation for the warrants and intrinsic value of the beneficial conversion features,the related audit effort in evaluating management’s estimates in determining those items was extensive and required a highdegree of auditor judgment.       </font>      </p>      <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <i>         Howthe Critical Audit Matter was Addressed in the Audit        </i>       </font>      </p>      <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Weobtained an understanding over management’s process to determine the individual components of the debt instrument and themethodology to calculate the relative fair value of the warrants and beneficial conversion features, in accordance with the applicableaccounting standards. This also included assessing how management develops each of the estimates for the inputs to the Black-Scholesoption-pricing model. We applied the following audit procedures related to testing the management’s estimates utilized inthe Black-Scholes option-pricing model for valuing the warrants:       </font>      </p>      <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <table cellpadding="0" cellspacing="0" style="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0" width="100%">       <tbody>        <tr style="vertical-align: top">         <td style="text-align: justify; width: 21pt">         </td>         <td style="text-align: justify; width: 18pt">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           ■          </font>         </td>         <td style="text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           We                                         compared the Company’s risk-free interest rate used to the comparable United States                                         Treasury yield for a term comparable to the warrants’ remaining contractual term.          </font>         </td>        </tr>       </tbody>      </table>      <table cellpadding="0" cellspacing="0" style="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0" width="100%">       <tbody>        <tr style="vertical-align: top">         <td style="text-align: justify; width: 21pt">         </td>         <td style="text-align: justify; width: 18pt">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           ■          </font>         </td>         <td style="text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           We                                         recalculated the Company’s historical share price volatility for a term of 12 months                                         prior to the grant date because management considered the volatility for this period                                         to be a better reflection of future value than the historical share price volatility                                         of the term of the options.          </font>         </td>        </tr>       </tbody>      </table>      <table cellpadding="0" cellspacing="0" style="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0" width="100%">       <tbody>        <tr style="vertical-align: top">         <td style="text-align: justify; width: 21pt">         </td>         <td style="text-align: justify; width: 18pt">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           ■          </font>         </td>         <td style="text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           We                                         performed a look-back of the Company’s previously issued dividends, noting there                                         were none. We inquired with management of the Company who informed us that no future                                         dividends were currently anticipated.          </font>         </td>        </tr>       </tbody>      </table>      <table cellpadding="0" cellspacing="0" style="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0" width="100%">       <tbody>        <tr style="vertical-align: top">         <td style="text-align: justify; width: 21pt">         </td>         <td style="text-align: justify; width: 18pt">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           ■          </font>         </td>         <td style="text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           We                                         agreed the inputs used for the term of the warrants to the contractual term of the warrant.          </font>         </td>        </tr>       </tbody>      </table>      <p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 39pt; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Wealso reviewed management’s relative fair value calculation used to determine the components of the debt instrument and thevalues assigned to each as follows:       </font>      </p>      <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <table cellpadding="0" cellspacing="0" style="font: 11pt/107% Calibri, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0" width="100%">       <tbody>        <tr style="vertical-align: top">         <td style="text-align: justify; width: 0.25in">         </td>         <td style="text-align: justify; width: 0.25in">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           ■          </font>         </td>         <td style="text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           We                                         obtained a copy of the convertible debt agreement to understand its terms, noting management                                         properly identified the components of the debt instrument.          </font>         </td>        </tr>       </tbody>      </table>      <table cellpadding="0" cellspacing="0" style="font: 11pt/107% Calibri, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0" width="100%">       <tbody>        <tr style="vertical-align: top">         <td style="text-align: justify; width: 0.25in">         </td>         <td style="text-align: justify; width: 0.25in">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           ■          </font>         </td>         <td style="text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           We                                         agreed the proceeds of the notes to confirmation letters with the note holder or to deposits                                         in the banking records.          </font>         </td>        </tr>       </tbody>      </table>      <table cellpadding="0" cellspacing="0" style="font: 11pt/107% Calibri, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0" width="100%">       <tbody>        <tr style="vertical-align: top">         <td style="text-align: justify; width: 0.25in">         </td>         <td style="text-align: justify; width: 0.25in">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           ■          </font>         </td>         <td style="text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           We                                         evaluated the accounting methodology to assign values to the individual debt components                                         determining it was consistent with the applicable accounting standards.          </font>         </td>        </tr>       </tbody>      </table>      <table cellpadding="0" cellspacing="0" style="font: 11pt/107% Calibri, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0" width="100%">       <tbody>        <tr style="vertical-align: top">         <td style="text-align: justify; width: 0.25in">         </td>         <td style="text-align: justify; width: 0.25in">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           ■          </font>         </td>         <td style="text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           We                                         agreed the fair value assigned to the warrants to the fair value calculated using the                                         Black-Scholes option-pricing model.          </font>         </td>        </tr>       </tbody>      </table>      <table cellpadding="0" cellspacing="0" style="font: 11pt/107% Calibri, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 8pt" width="100%">       <tbody>        <tr style="vertical-align: top">         <td style="text-align: justify; width: 0.25in">         </td>         <td style="text-align: justify; width: 0.25in">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           ■          </font>         </td>         <td style="text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           We                                         recalculated the relative fair value assigned to the warrants and host debt instrument.          </font>         </td>        </tr>        <tr style="vertical-align: top">         <td style="text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           ■          </font>         </td>         <td style="text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           We                                         agreed the conversion price to the convertible note agreement and recalculated the intrinsic                                         value of the beneficial conversion features, noting it was properly recorded as a debt                                         discount.          </font>         </td>        </tr>       </tbody>      </table>      <p style="font: 12pt Times New Roman, Times, Serif; text-align: justify; margin: 0">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <table border="0" cellpadding="0" cellspacing="0" style="width: 100%">       <tbody>        <tr style="vertical-align: top">         <td style="text-align: right; width: 50%">         </td>         <td style="text-align: left; width: 50%">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           HASKELL    &amp; WHITE LLP          </font>         </td>        </tr>       </tbody>      </table>      <p style="font: 12pt Times New Roman, Times, Serif; margin: 0">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Wehave served as the Company’s auditor since 2004.       </font>      </p>      <p style="font: 11pt Times New Roman, Times, Serif; margin: 0">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 11pt Times New Roman, Times, Serif; margin: 0">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Irvine,California       </font>      </p>      <p style="font: 11pt Times New Roman, Times, Serif; margin: 0">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        April15, 2021       </font>      </p>      <p style="font: 11pt Times New Roman, Times, Serif; margin: 0">       <font style="font-family: Times New Roman, Times, Serif">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">      </p>      <!-- Field: Page; Sequence: 62; Value: 1 -->      <div style="margin-bottom: 6pt; border-bottom: Black 1.5pt solid">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="text-align: center; width: 100%">           F-           <!-- Field: Sequence; Type: Arabic; Name: PageNo -->           4           <!-- Field: /Sequence -->          </td>         </tr>        </tbody>       </table>      </div>      <div style="break-before: page; margin-top: 6pt">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="width: 100%">          </td>         </tr>        </tbody>       </table>      </div>      <!-- Field: /Page -->      <!-- Field: Split-Segment; Name: sp1 -->      <p style="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         RESPIRERXPHARMACEUTICALS INC.        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         ANDSUBSIDIARY        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         <a name="f_002">         </a>         CONSOLIDATEDBALANCE SHEETS        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">       <tbody>        <tr style="vertical-align: bottom">         <td style="text-align: center">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="font-weight: bold; padding-bottom: 1.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">          <font style="font-family: Times New Roman, Times, Serif">           December    31,          </font>         </td>         <td style="padding-bottom: 1.5pt; font-weight: bold">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>        </tr>        <tr style="vertical-align: bottom">         <td style="text-align: center">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="font-weight: bold; padding-bottom: 1.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">          <font style="font-family: Times New Roman, Times, Serif">           2020          </font>         </td>         <td style="padding-bottom: 1.5pt; font-weight: bold">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="font-weight: bold; padding-bottom: 1.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">          <font style="font-family: Times New Roman, Times, Serif">           2019          </font>         </td>         <td style="padding-bottom: 1.5pt; font-weight: bold">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>        </tr>        <tr style="vertical-align: bottom">         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td colspan="2" style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td colspan="2" style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>        </tr>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td>          <font style="font-family: Times New Roman, Times, Serif">           <b>            ASSETS           </b>          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>        </tr>        <tr style="vertical-align: bottom; background-color: White">         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           Current assets:          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>        </tr>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td style="padding-left: 10pt; width: 64%; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           Cash    and cash equivalents          </font>         </td>         <td style="width: 2%">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="width: 1%; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           $          </font>         </td>         <td style="width: 14%; text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           825          </font>         </td>         <td style="width: 1%; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="width: 2%">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="width: 1%; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           $          </font>         </td>         <td style="width: 14%; text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           16,690          </font>         </td>         <td style="width: 1%; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>        </tr>        <tr style="vertical-align: bottom; background-color: White">         <td style="padding-left: 10pt; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           Deferred financing    costs          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           52,609          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           -          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>        </tr>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td style="padding-left: 10pt; text-align: left; padding-bottom: 1.5pt">          <font style="font-family: Times New Roman, Times, Serif">           Prepaid    expenses, including current portion of long-term prepaid insurance of $0 at December 31, 2020 and $10,586 at December 31,    2019          </font>         </td>         <td style="padding-bottom: 1.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           31,653          </font>         </td>         <td style="padding-bottom: 1.5pt; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="padding-bottom: 1.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           28,638          </font>         </td>         <td style="padding-bottom: 1.5pt; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>        </tr>        <tr style="vertical-align: bottom; background-color: White">         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>        </tr>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td style="padding-bottom: 1.5pt; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           Total current    assets          </font>         </td>         <td style="padding-bottom: 1.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           85,087          </font>         </td>         <td style="padding-bottom: 1.5pt; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="padding-bottom: 1.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           45,328          </font>         </td>         <td style="padding-bottom: 1.5pt; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>        </tr>        <tr style="vertical-align: bottom; background-color: White">         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>        </tr>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td style="text-align: left; padding-bottom: 2.5pt">          <font style="font-family: Times New Roman, Times, Serif">           Total assets          </font>         </td>         <td style="padding-bottom: 2.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="border-bottom: Black 2.5pt double; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           $          </font>         </td>         <td style="border-bottom: Black 2.5pt double; text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           85,087          </font>         </td>         <td style="padding-bottom: 2.5pt; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="padding-bottom: 2.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="border-bottom: Black 2.5pt double; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           $          </font>         </td>         <td style="border-bottom: Black 2.5pt double; text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           45,328          </font>         </td>         <td style="padding-bottom: 2.5pt; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>        </tr>        <tr style="vertical-align: bottom; background-color: White">         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>        </tr>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           <b>            LIABILITIES AND STOCKHOLDERS’    DEFICIENCY           </b>          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>        </tr>        <tr style="vertical-align: bottom; background-color: White">         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           Current liabilities:          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>        </tr>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td style="padding-left: 10pt; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           Accounts payable    and accrued expenses, including $635,146 and $476,671 payable to related parties at December 31, 2020 and 2019, respectively          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           $          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           4,923,947          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           $          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           3,772,030          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>        </tr>        <tr style="vertical-align: bottom; background-color: White">         <td style="padding-left: 10pt; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           Accrued compensation    and related expenses          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           1,540,809          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           2,083,841          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>        </tr>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td style="padding-left: 10pt; text-align: left">          <p style="margin: 0; font: 10pt Times New Roman, Times, Serif">           <font style="font-family: Times New Roman, Times, Serif">            Convertible                                         notes payable, currently due and payable on demand, including accrued interest of $85,693                                         and $113,304 at December 31, 2020 and 2019, respectively, (of which $48,700,                                         including accrued interest of $23,700, was deemed to be in default at December                                         31, 2020) (Note 4)           </font>          </p>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           414,860          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           551,591          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>        </tr>        <tr style="vertical-align: bottom; background-color: White">         <td style="padding-left: 10pt; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           Note payable to    SY Corporation, including accrued interest of $411,385 and $363,280 at December 31, 2020 and 2019, respectively (payment    obligation currently in default – Note 4)          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           864,551          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           766,236          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>        </tr>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td style="padding-left: 10pt; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           Notes and advances    payable to officers, including accrued interest of $46,717 and $35,388 at December 31, 2020 and 2019, respectively    (Note 4)          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           213,067          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           142,238          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>        </tr>        <tr style="vertical-align: bottom; background-color: White">         <td style="padding-left: 10pt; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           Notes payable to    former officer, including accrued interest of $58,965 and $41,977 as of December 31, 2020 and December 31, 2019, respectively    (Note 4)          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           186,565          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           169,577          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>        </tr>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td style="padding-left: 10pt; text-align: left; padding-bottom: 1.5pt">          <font style="font-family: Times New Roman, Times, Serif">           Other    short-term notes payable          </font>         </td>         <td style="padding-bottom: 1.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           4,608          </font>         </td>         <td style="padding-bottom: 1.5pt; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="padding-bottom: 1.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           4,634          </font>         </td>         <td style="padding-bottom: 1.5pt; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>        </tr>        <tr style="vertical-align: bottom; background-color: White">         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>        </tr>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td style="text-align: left; padding-bottom: 1.5pt">          <font style="font-family: Times New Roman, Times, Serif">           Total current    liabilities          </font>         </td>         <td style="padding-bottom: 1.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           8,148,407          </font>         </td>         <td style="padding-bottom: 1.5pt; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="padding-bottom: 1.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           7,490,147          </font>         </td>         <td style="padding-bottom: 1.5pt; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>        </tr>        <tr style="vertical-align: bottom; background-color: White">         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>        </tr>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           Commitments and contingencies (Note    9)          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>        </tr>        <tr style="vertical-align: bottom; background-color: White">         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>        </tr>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           Stockholders’ deficiency: (Note    6)          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>        </tr>        <tr style="vertical-align: bottom; background-color: White">         <td style="padding-left: 10pt; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           Series B convertible    preferred stock, $0.001 par value; $0.6667 per share liquidation preference; aggregate liquidation preference $25,001; shares    authorized: 37,500; shares issued and outstanding: 37,500; common shares issuable upon conversion at 0.000030 common shares    per Series B share: 1          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           21,703          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           21,703          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>        </tr>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td style="padding-left: 10pt; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           Common stock, $0.001    par value; shares authorized: 2,000,000,000; shares issued and outstanding: 71,271,095 and 417,507 at December 31, 2020 and    2019, respectively (reflected on a post 10 for 1 reverse stock split basis which occurred on January 5, 2021)          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           71,271          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           418          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>        </tr>        <tr style="vertical-align: bottom; background-color: White">         <td style="padding-left: 10pt; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           Additional paid-in    capital          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           162,654,002          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           159,042,145          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>        </tr>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td style="padding-left: 10pt; text-align: left; padding-bottom: 1.5pt">          <font style="font-family: Times New Roman, Times, Serif">           Accumulated    deficit          </font>         </td>         <td style="padding-bottom: 1.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           (170,810,296          </font>         </td>         <td style="padding-bottom: 1.5pt; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           )          </font>         </td>         <td style="padding-bottom: 1.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           (166,509,085          </font>         </td>         <td style="padding-bottom: 1.5pt; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           )          </font>         </td>        </tr>        <tr style="vertical-align: bottom; background-color: White">         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>        </tr>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td style="text-align: left; padding-bottom: 1.5pt">          <font style="font-family: Times New Roman, Times, Serif">           Total stockholders’    deficiency          </font>         </td>         <td style="padding-bottom: 1.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           (8,063,320          </font>         </td>         <td style="padding-bottom: 1.5pt; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           )          </font>         </td>         <td style="padding-bottom: 1.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           (7,444,819          </font>         </td>         <td style="padding-bottom: 1.5pt; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           )          </font>         </td>        </tr>        <tr style="vertical-align: bottom; background-color: White">         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>        </tr>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td style="text-align: left; padding-bottom: 2.5pt">          <font style="font-family: Times New Roman, Times, Serif">           Total liabilities    and stockholders’ deficiency          </font>         </td>         <td style="padding-bottom: 2.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="border-bottom: Black 2.5pt double; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           $          </font>         </td>         <td style="border-bottom: Black 2.5pt double; text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           85,087          </font>         </td>         <td style="padding-bottom: 2.5pt; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="padding-bottom: 2.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="border-bottom: Black 2.5pt double; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           $          </font>         </td>         <td style="border-bottom: Black 2.5pt double; text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           45,328          </font>         </td>         <td style="padding-bottom: 2.5pt; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>        </tr>       </tbody>      </table>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Seeaccompanying notes to consolidated financial statements and       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        reportof independent registered public accounting firm.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <!-- Field: Page; Sequence: 63; Value: 1 -->      <div style="margin-bottom: 6pt; border-bottom: Black 1.5pt solid">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="text-align: center; width: 100%">           F-           <!-- Field: Sequence; Type: Arabic; Name: PageNo -->           5           <!-- Field: /Sequence -->          </td>         </tr>        </tbody>       </table>      </div>      <div style="break-before: page; margin-top: 6pt">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="width: 100%">          </td>         </tr>        </tbody>       </table>      </div>      <!-- Field: /Page -->      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         RESPIRERXPHARMACEUTICALS INC.        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         ANDSUBSIDIARY        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         <a name="f_003">         </a>         CONSOLIDATEDSTATEMENTS OF OPERATIONS        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">      </p>      <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">       <tbody>        <tr style="vertical-align: bottom">         <td style="font-size: 11pt; text-align: center">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="font-weight: bold; padding-bottom: 1.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">          <font style="font-family: Times New Roman, Times, Serif">           Years    Ended December 31,          </font>         </td>         <td style="padding-bottom: 1.5pt; font-weight: bold">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>        </tr>        <tr style="vertical-align: bottom">         <td style="font-size: 11pt; text-align: center">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="font-weight: bold; padding-bottom: 1.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">          <font style="font-family: Times New Roman, Times, Serif">           2020          </font>         </td>         <td style="padding-bottom: 1.5pt; font-weight: bold">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="font-weight: bold; padding-bottom: 1.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">          <font style="font-family: Times New Roman, Times, Serif">           2019          </font>         </td>         <td style="padding-bottom: 1.5pt; font-weight: bold">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>        </tr>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           Operating expenses:          </font>         </td>         <td style="font-size: 11pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="font-size: 11pt; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="font-size: 11pt; text-align: right">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="font-size: 11pt; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="font-size: 11pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="font-size: 11pt; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="font-size: 11pt; text-align: right">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="font-size: 11pt; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>        </tr>        <tr style="vertical-align: bottom; background-color: White">         <td style="padding-left: 10pt; width: 64%; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           General    and administrative, including $1,230,370 and $485,332 to related parties for the years ended December 31, 2020 and    2019, respectively          </font>         </td>         <td style="width: 2%">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="width: 1%; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           $          </font>         </td>         <td style="width: 14%; text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           2,676,860          </font>         </td>         <td style="width: 1%; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="width: 2%">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="width: 1%; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           $          </font>         </td>         <td style="width: 14%; text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           1,137,175          </font>         </td>         <td style="width: 1%; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>        </tr>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td style="padding-left: 10pt; text-align: left; padding-bottom: 1.5pt">          <font style="font-family: Times New Roman, Times, Serif">           Research    and development, including $490,850 and $490,908 to related parties for the years ended December 31, 2020 and 2019,    respectively          </font>         </td>         <td style="padding-bottom: 1.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           638,275          </font>         </td>         <td style="padding-bottom: 1.5pt; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="padding-bottom: 1.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           599,329          </font>         </td>         <td style="padding-bottom: 1.5pt; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>        </tr>        <tr style="vertical-align: bottom; background-color: White">         <td style="font-size: 11pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="font-size: 11pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="font-size: 11pt; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="font-size: 11pt; text-align: right">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="font-size: 11pt; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="font-size: 11pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="font-size: 11pt; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="font-size: 11pt; text-align: right">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="font-size: 11pt; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>        </tr>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td style="padding-left: 20pt; text-align: left; padding-bottom: 1.5pt">          <font style="font-family: Times New Roman, Times, Serif">           Total    operating costs and expenses          </font>         </td>         <td style="padding-bottom: 1.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           3,315,135          </font>         </td>         <td style="padding-bottom: 1.5pt; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="padding-bottom: 1.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           1,736,504          </font>         </td>         <td style="padding-bottom: 1.5pt; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>        </tr>        <tr style="vertical-align: bottom; background-color: White">         <td style="font-size: 11pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="font-size: 11pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="font-size: 11pt; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="font-size: 11pt; text-align: right">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="font-size: 11pt; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="font-size: 11pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="font-size: 11pt; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="font-size: 11pt; text-align: right">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="font-size: 11pt; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>        </tr>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           Loss from operations          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           (3,315,135          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           )          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           (1,736,504          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           )          </font>         </td>        </tr>        <tr style="vertical-align: bottom; background-color: White">         <td style="font-size: 11pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="font-size: 11pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="font-size: 11pt; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="font-size: 11pt; text-align: right">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="font-size: 11pt; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="font-size: 11pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="font-size: 11pt; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="font-size: 11pt; text-align: right">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="font-size: 11pt; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>        </tr>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           Loss on extinguishment of debt and other    liabilities in exchange for equity          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           (389,902          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           )          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <p style="margin-top: 0; margin-bottom: 0">          </p>          <p style="margin-top: 0; margin-bottom: 0">           <font style="font-family: Times New Roman, Times, Serif">            <font style="font-size: 10pt">             -            </font>           </font>          </p>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>        </tr>        <tr style="vertical-align: bottom; background-color: White">         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           Interest expense, including $11,329    and $60,135 to related parties for the years ended December 31, 2020 and 2019, respectively          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           (545,675          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           )          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           (404,661          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           )          </font>         </td>        </tr>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td style="text-align: left; padding-bottom: 1.5pt">          <font style="font-family: Times New Roman, Times, Serif">           Foreign currency    transaction (loss) gain          </font>         </td>         <td style="padding-bottom: 1.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           (50,499          </font>         </td>         <td style="padding-bottom: 1.5pt; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           )          </font>         </td>         <td style="padding-bottom: 1.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           26,132          </font>         </td>         <td style="padding-bottom: 1.5pt; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>        </tr>        <tr style="vertical-align: bottom; background-color: White">         <td style="font-size: 11pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="font-size: 11pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="font-size: 11pt; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="font-size: 11pt; text-align: right">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="font-size: 11pt; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="font-size: 11pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="font-size: 11pt; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="font-size: 11pt; text-align: right">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="font-size: 11pt; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>        </tr>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           Net loss          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           $          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           (4,301,211          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           )          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           $          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           (2,115,033          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           )          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">         <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           Deemed    dividends from warrant anti-dilution provisions          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           $          </font>         </td>         <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">          <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            (1,440,214           </font>          </p>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           )          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           $          </font>         </td>         <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">          <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            -           </font>          </p>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">         <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt">          <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            Net                                         loss attributable to common shareholders           </font>          </p>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">          <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            $           </font>          </p>         </td>         <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">          <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            (5,741,425           </font>          </p>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           )          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">          $         </td>         <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">          <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            (2,115,033           </font>          </p>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           )          </font>         </td>        </tr>        <tr style="vertical-align: bottom; background-color: White">         <td style="font-size: 11pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="font-size: 11pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="font-size: 11pt; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="font-size: 11pt; text-align: right">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="font-size: 11pt; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="font-size: 11pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="font-size: 11pt; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="font-size: 11pt; text-align: right">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="font-size: 11pt; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>        </tr>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td style="text-align: left; padding-bottom: 2.5pt">          <font style="font-family: Times New Roman, Times, Serif">           Net loss per    common share - basic and diluted respectively (reflected on a post 10 for 1 reverse stock split basis which occurred on January    5, 2021)          </font>         </td>         <td style="padding-bottom: 2.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="border-bottom: Black 2.5pt double; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           $          </font>         </td>         <td style="border-bottom: Black 2.5pt double; text-align: right">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           (0.22)          </font>         </td>         <td style="padding-bottom: 2.5pt; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="padding-bottom: 2.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="border-bottom: Black 2.5pt double; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           $          </font>         </td>         <td style="border-bottom: Black 2.5pt double; text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           (5.41          </font>         </td>         <td style="padding-bottom: 2.5pt; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           )          </font>         </td>        </tr>        <tr style="vertical-align: bottom; background-color: White">         <td style="font-size: 11pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="font-size: 11pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="font-size: 11pt; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="font-size: 11pt; text-align: right">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="font-size: 11pt; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="font-size: 11pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="font-size: 11pt; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="font-size: 11pt; text-align: right">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="font-size: 11pt; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>        </tr>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td style="text-align: left; padding-bottom: 2.5pt">          <font style="font-family: Times New Roman, Times, Serif">           Weighted average    common shares outstanding - basic and diluted respectively (reflected on a post 10 for 1 reverse stock split basis which occurred    on January 5, 2021)          </font>         </td>         <td style="padding-bottom: 2.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="border-bottom: Black 2.5pt double; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="border-bottom: Black 2.5pt double; text-align: right">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           25,855,664          </font>         </td>         <td style="padding-bottom: 2.5pt; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="padding-bottom: 2.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="border-bottom: Black 2.5pt double; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="border-bottom: Black 2.5pt double; text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           390,848          </font>         </td>         <td style="padding-bottom: 2.5pt; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>        </tr>       </tbody>      </table>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Seeaccompanying notes to consolidated financial statements and       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        reportof independent registered public accounting firm.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <!-- Field: Page; Sequence: 64; Value: 1 -->      <div style="margin-bottom: 6pt; border-bottom: Black 1.5pt solid">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="text-align: center; width: 100%">           F-           <!-- Field: Sequence; Type: Arabic; Name: PageNo -->           6           <!-- Field: /Sequence -->          </td>         </tr>        </tbody>       </table>      </div>      <div style="break-before: page; margin-top: 6pt">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="width: 100%">          </td>         </tr>        </tbody>       </table>      </div>      <!-- Field: /Page -->      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         RESPIRERXPHARMACEUTICALS INC.        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         ANDSUBSIDIARY        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         <a name="f_004">         </a>         CONSOLIDATEDSTATEMENTS OF STOCKHOLDERS’ DEFICIENCY        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         YearsEnded December 31, 2020 and 2019        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">       <font style="font-family: Times New Roman, Times, Serif">       </font>      </p>      <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">       <tbody>        <tr style="vertical-align: bottom">         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="font-weight: bold">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td colspan="6" style="font-weight: bold; text-align: center">          <font style="font-family: Times New Roman, Times, Serif">           Series    B and Series H          </font>         </td>         <td style="font-weight: bold">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td colspan="2">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td colspan="2">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td colspan="2">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td colspan="2">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td colspan="2">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>        </tr>        <tr style="vertical-align: bottom">         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="font-weight: bold">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td colspan="6" style="font-weight: bold; text-align: center">          <font style="font-family: Times New Roman, Times, Serif">           Convertible          </font>         </td>         <td style="font-weight: bold">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td colspan="2">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td colspan="2">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td colspan="2">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td colspan="2">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td colspan="2">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>        </tr>        <tr style="vertical-align: bottom">         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="font-weight: bold; padding-bottom: 1.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">          <font style="font-family: Times New Roman, Times, Serif">           Preferred    Stock          </font>         </td>         <td style="padding-bottom: 1.5pt; font-weight: bold">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="font-weight: bold; padding-bottom: 1.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">          <font style="font-family: Times New Roman, Times, Serif">           Common    Stock          </font>         </td>         <td style="padding-bottom: 1.5pt; font-weight: bold">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="font-weight: bold; padding-bottom: 1.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">          <font style="font-family: Times New Roman, Times, Serif">           Additional          </font>         </td>         <td style="padding-bottom: 1.5pt; font-weight: bold">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="padding-bottom: 1.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td colspan="2">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="padding-bottom: 1.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="font-weight: bold; padding-bottom: 1.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">          <font style="font-family: Times New Roman, Times, Serif">           Total          </font>         </td>         <td style="padding-bottom: 1.5pt; font-weight: bold">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>        </tr>        <tr style="vertical-align: bottom">         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="font-weight: bold; padding-bottom: 1.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">          <font style="font-family: Times New Roman, Times, Serif">           Shares          </font>         </td>         <td style="padding-bottom: 1.5pt; font-weight: bold">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="font-weight: bold; padding-bottom: 1.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">          <font style="font-family: Times New Roman, Times, Serif">           Amount          </font>         </td>         <td style="padding-bottom: 1.5pt; font-weight: bold">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="font-weight: bold; padding-bottom: 1.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">          <font style="font-family: Times New Roman, Times, Serif">           Shares          </font>         </td>         <td style="padding-bottom: 1.5pt; font-weight: bold">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="font-weight: bold; padding-bottom: 1.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">          <font style="font-family: Times New Roman, Times, Serif">           Par    Value          </font>         </td>         <td style="padding-bottom: 1.5pt; font-weight: bold">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="font-weight: bold; padding-bottom: 1.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">          <font style="font-family: Times New Roman, Times, Serif">           Paid-in           <br/>           Capital          </font>         </td>         <td style="padding-bottom: 1.5pt; font-weight: bold">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="font-weight: bold; padding-bottom: 1.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">          <font style="font-family: Times New Roman, Times, Serif">           Accumulated           <br/>           Deficit          </font>         </td>         <td style="padding-bottom: 1.5pt; font-weight: bold">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="font-weight: bold; padding-bottom: 1.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">          <font style="font-family: Times New Roman, Times, Serif">           Stockholders’           <br/>           Deficiency          </font>         </td>         <td style="padding-bottom: 1.5pt; font-weight: bold">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>        </tr>        <tr style="vertical-align: bottom">         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td colspan="2">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td colspan="2">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td colspan="2">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td colspan="2">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td colspan="2">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td colspan="2">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td colspan="2">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>        </tr>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td style="width: 37%">          <font style="font-family: Times New Roman, Times, Serif">           Balance at December 31, 2018          </font>         </td>         <td style="width: 2%">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="width: 1%; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="width: 5%; text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           37,500          </font>         </td>         <td style="width: 1%; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="width: 2%">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="width: 1%; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           $          </font>         </td>         <td style="width: 5%; text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           21,703          </font>         </td>         <td style="width: 1%; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="width: 2%">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="width: 1%; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="width: 5%; text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           387,207          </font>         </td>         <td style="width: 1%; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="width: 2%">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="width: 1%; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           $          </font>         </td>         <td style="width: 5%; text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           387          </font>         </td>         <td style="width: 1%; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="width: 2%">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="width: 1%; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           $          </font>         </td>         <td style="width: 5%; text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           158,638,707          </font>         </td>         <td style="width: 1%; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="width: 2%">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="width: 1%; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           $          </font>         </td>         <td style="width: 5%; text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           (164,394,052          </font>         </td>         <td style="width: 1%; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           )          </font>         </td>         <td style="width: 2%">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="width: 1%; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           $          </font>         </td>         <td style="width: 5%; text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           (5,733,255          </font>         </td>         <td style="width: 1%; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           )          </font>         </td>        </tr>        <tr style="vertical-align: bottom; background-color: White">         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           Warrants issued with respect to convertible    notes issued from January through March 2019          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           45,812          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           45,812          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>        </tr>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           Common stock issued related to convertible    notes          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           1,750          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           2          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           3,331          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           3,333          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>        </tr>        <tr style="vertical-align: bottom; background-color: White">         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           Discounts associated with convertible    note issuances from April through November 2019          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           329,019          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           329,019          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>        </tr>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           Common stock issued as partial settlement    of convertible notes issued from April through May 2019          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           28,550          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           29          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           25,276          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           25,305          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>        </tr>        <tr style="vertical-align: bottom; background-color: White">         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           Net Loss          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           $          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           (2,115,033          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           )          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           $          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           (2,115,033          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           )          </font>         </td>        </tr>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td style="padding-bottom: 1.5pt">          <font style="font-family: Times New Roman, Times, Serif">           Balance at December 31, 2019          </font>         </td>         <td style="padding-bottom: 1.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           37,500          </font>         </td>         <td style="padding-bottom: 1.5pt; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="padding-bottom: 1.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           $          </font>         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           21,703          </font>         </td>         <td style="padding-bottom: 1.5pt; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="padding-bottom: 1.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           417,507          </font>         </td>         <td style="padding-bottom: 1.5pt; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="padding-bottom: 1.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           $          </font>         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           418          </font>         </td>         <td style="padding-bottom: 1.5pt; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="padding-bottom: 1.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           $          </font>         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           159,042,145          </font>         </td>         <td style="padding-bottom: 1.5pt; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="padding-bottom: 1.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           $          </font>         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           (166,509,085          </font>         </td>         <td style="padding-bottom: 1.5pt; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           )          </font>         </td>         <td style="padding-bottom: 1.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           $          </font>         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           (7,444,819          </font>         </td>         <td style="padding-bottom: 1.5pt; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           )          </font>         </td>        </tr>        <tr style="vertical-align: bottom; background-color: White">         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           Issuance of Common Stock for payment    of accrued compensation          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           900,000          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           900          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           305,100          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           306,000          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>        </tr>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           Issuances of  Series H Preferred    Stock payment of accrued compensation          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           1,383          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           $          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           1          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           1,378,217          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           1,378,218          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>        </tr>        <tr style="vertical-align: bottom; background-color: White">         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           Issuance of Series H Preferred Stock    for payment of accounts payable          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           241          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           $          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           0          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           307,015          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           307,015          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>        </tr>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           Conversion of Series H Preferred    Stock to Common Stock          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           (1,624          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           )          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           $          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           (1          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           )          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           (1,685,232          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           )          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           (1,685,233          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           )          </font>         </td>        </tr>        <tr style="vertical-align: bottom; background-color: White">         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           Issuance of Common Stock and Warrants    for Conversion of Series H Preferred Stock          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           25,377,426          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           $          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           25,377          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           1,659,856          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           1,685,233          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>        </tr>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           Sale of Common Stock, net of costs          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           7,900,000          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           $          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           7,900          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           78,237          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           86,137          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>        </tr>        <tr style="vertical-align: bottom; background-color: White">         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           Note payable issued with Common Stock          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           (40,000          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           )          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           (40,000          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           )          </font>         </td>        </tr>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           Note discounts          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           90,000          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           90,000          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>        </tr>        <tr style="vertical-align: bottom; background-color: White">         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           Note payable conversions          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           26,291,373          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           $          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           26,291          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           1,100,347          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           1,126,638          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>        </tr>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           Option grants          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           384,250          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           384,250          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>        </tr>        <tr style="vertical-align: bottom; background-color: White">         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           Cashless Warrant exercises          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           10,384,789          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           $          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           10,385          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           (10,385          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           )          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           -          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>        </tr>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td style="padding-bottom: 1.5pt; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           Warrants issued    with convertible debt          </font>         </td>         <td style="padding-bottom: 1.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: right">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="padding-bottom: 1.5pt; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="padding-bottom: 1.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: right">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="padding-bottom: 1.5pt; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="padding-bottom: 1.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: right">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="padding-bottom: 1.5pt; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="padding-bottom: 1.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: right">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="padding-bottom: 1.5pt; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="padding-bottom: 1.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           44,452          </font>         </td>         <td style="padding-bottom: 1.5pt; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="padding-bottom: 1.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: right">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="padding-bottom: 1.5pt; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="padding-bottom: 1.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           44.452          </font>         </td>         <td style="padding-bottom: 1.5pt; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>        </tr>        <tr style="vertical-align: bottom; background-color: White">         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           Net Loss          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           $          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           (4,301,211          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           )          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           $          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           (4,301,211          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           )          </font>         </td>        </tr>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td style="padding-bottom: 2.5pt">          <font style="font-family: Times New Roman, Times, Serif">           Balance at December 31, 2020          </font>         </td>         <td style="padding-bottom: 2.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="border-bottom: Black 2.5pt double; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="border-bottom: Black 2.5pt double; text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           37,500          </font>         </td>         <td style="padding-bottom: 2.5pt; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="padding-bottom: 2.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="border-bottom: Black 2.5pt double; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           $          </font>         </td>         <td style="border-bottom: Black 2.5pt double; text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           21,703          </font>         </td>         <td style="padding-bottom: 2.5pt; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="padding-bottom: 2.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="border-bottom: Black 2.5pt double; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="border-bottom: Black 2.5pt double; text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           71,271,095          </font>         </td>         <td style="padding-bottom: 2.5pt; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="padding-bottom: 2.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="border-bottom: Black 2.5pt double; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           $          </font>         </td>         <td style="border-bottom: Black 2.5pt double; text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           71,271          </font>         </td>         <td style="padding-bottom: 2.5pt; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="padding-bottom: 2.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="border-bottom: Black 2.5pt double; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           $          </font>         </td>         <td style="border-bottom: Black 2.5pt double; text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           162,654,002          </font>         </td>         <td style="padding-bottom: 2.5pt; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="padding-bottom: 2.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="border-bottom: Black 2.5pt double; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           $          </font>         </td>         <td style="border-bottom: Black 2.5pt double; text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           (170,810,296          </font>         </td>         <td style="padding-bottom: 2.5pt; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           )          </font>         </td>         <td style="padding-bottom: 2.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="border-bottom: Black 2.5pt double; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           $          </font>         </td>         <td style="border-bottom: Black 2.5pt double; text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           (8,063,320          </font>         </td>         <td style="padding-bottom: 2.5pt; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           )          </font>         </td>        </tr>       </tbody>      </table>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Seeaccompanying notes to consolidated financial statements and       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        reportof independent registered public accounting firm.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <!-- Field: Page; Sequence: 65; Value: 1 -->      <div style="margin-bottom: 6pt; border-bottom: Black 1.5pt solid">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="text-align: center; width: 100%">           F-           <!-- Field: Sequence; Type: Arabic; Name: PageNo -->           7           <!-- Field: /Sequence -->          </td>         </tr>        </tbody>       </table>      </div>      <div style="break-before: page; margin-top: 6pt">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="width: 100%">          </td>         </tr>        </tbody>       </table>      </div>      <!-- Field: /Page -->      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         RESPIRERXPHARMACEUTICALS INC.        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         ANDSUBSIDIARY        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         <a name="f_005">         </a>         CONSOLIDATEDSTATEMENTS OF CASH FLOWS        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">       <tbody>        <tr style="vertical-align: bottom">         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="font-weight: bold; padding-bottom: 1.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">          <font style="font-family: Times New Roman, Times, Serif">           Years    Ended December 31,          </font>         </td>         <td style="padding-bottom: 1.5pt; font-weight: bold">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>        </tr>        <tr style="vertical-align: bottom">         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="font-weight: bold; padding-bottom: 1.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">          <font style="font-family: Times New Roman, Times, Serif">           2020          </font>         </td>         <td style="padding-bottom: 1.5pt; font-weight: bold">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="font-weight: bold; padding-bottom: 1.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">          <font style="font-family: Times New Roman, Times, Serif">           2019          </font>         </td>         <td style="padding-bottom: 1.5pt; font-weight: bold">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>        </tr>        <tr style="vertical-align: bottom">         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td colspan="2">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td colspan="2">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>        </tr>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           Cash flows from operating activities:          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>        </tr>        <tr style="vertical-align: bottom; background-color: White">         <td style="padding-left: 10pt; width: 64%; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           Net    loss          </font>         </td>         <td style="width: 2%">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="width: 1%; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           $          </font>         </td>         <td style="width: 14%; text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           (4,301,211          </font>         </td>         <td style="width: 1%; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           )          </font>         </td>         <td style="width: 2%">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="width: 1%; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           $          </font>         </td>         <td style="width: 14%; text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           (2,115,033          </font>         </td>         <td style="width: 1%; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           )          </font>         </td>        </tr>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td style="padding-left: 10pt; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           Adjustments to reconcile    net loss to net cash used in operating activities:          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>        </tr>        <tr style="vertical-align: bottom; background-color: White">         <td style="padding-left: 20pt; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           Amortization of    debt discounts related to convertible notes payable          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           374,080          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           215,575          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>        </tr>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td style="padding-left: 20pt; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           Costs associated    with convertible note conversion paid with common stock          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           49,219          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           750          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>        </tr>        <tr style="vertical-align: bottom; background-color: White">         <td style="padding-left: 20pt; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           Loss on extinguishment    of debt          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           323,996          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           -          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>        </tr>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td style="padding-left: 20pt; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           Loss on extinguishment    of other liabilities          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           65,906          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           -          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>        </tr>        <tr style="vertical-align: bottom; background-color: White">         <td style="padding-left: 20pt; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           Stock-based compensation    and fees included in -          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>        </tr>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td style="padding-left: 30pt; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           General and administrative    expenses          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           345,500          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           -          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>        </tr>        <tr style="vertical-align: bottom; background-color: White">         <td style="padding-left: 30pt; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           Research and development    expenses and vesting options          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           38,750          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           -          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>        </tr>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td style="padding-left: 20pt; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           Foreign currency    transaction loss (gain)          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           50,211          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           (26,132          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           )          </font>         </td>        </tr>        <tr style="vertical-align: bottom; background-color: White">         <td style="padding-left: 20pt; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           Changes in operating    assets and liabilities:          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>        </tr>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td style="padding-left: 30pt; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           (Increase) decrease    in -          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>        </tr>        <tr style="vertical-align: bottom; background-color: White">         <td style="padding-left: 40pt; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           Prepaid expenses    and advanced clinical research payments          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           (3,014          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           )          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           13,355          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>        </tr>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td style="padding-left: 30pt; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           Increase (decrease)    in -          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>        </tr>        <tr style="vertical-align: bottom; background-color: White">         <td style="padding-left: 40pt; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           Accounts payable    and accrued expenses          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           1,260,922          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           524,324          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>        </tr>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td style="padding-left: 40pt; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           Accrued compensation    and related expenses          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           1,141,186          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           779,407          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>        </tr>        <tr style="vertical-align: bottom; background-color: White">         <td style="padding-left: 40pt; text-align: left; padding-bottom: 1.5pt">          <font style="font-family: Times New Roman, Times, Serif">           Accrued    interest payable          </font>         </td>         <td style="padding-bottom: 1.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           141,454          </font>         </td>         <td style="padding-bottom: 1.5pt; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="padding-bottom: 1.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           120,009          </font>         </td>         <td style="padding-bottom: 1.5pt; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>        </tr>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td style="padding-left: 10pt; text-align: left; padding-bottom: 1.5pt">          <font style="font-family: Times New Roman, Times, Serif">           Net    cash used in operating activities          </font>         </td>         <td style="padding-bottom: 1.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           (513,001          </font>         </td>         <td style="padding-bottom: 1.5pt; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           )          </font>         </td>         <td style="padding-bottom: 1.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           (487,745          </font>         </td>         <td style="padding-bottom: 1.5pt; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           )          </font>         </td>        </tr>        <tr style="vertical-align: bottom; background-color: White">         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>        </tr>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           Cash flows from financing activities:          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>        </tr>        <tr style="vertical-align: bottom; background-color: White">         <td style="padding-left: 10pt; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           Proceeds from sale    of common stock          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           162,886          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           -          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>        </tr>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td style="padding-left: 10pt; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           Proceeds from officer    notes          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           59,500          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           22,751          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>        </tr>        <tr style="vertical-align: bottom; background-color: White">         <td style="padding-bottom: 1.5pt; padding-left: 10pt; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           Proceeds    from issuance of notes payable          </font>         </td>         <td style="padding-bottom: 1.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           274,750          </font>         </td>         <td style="padding-bottom: 1.5pt; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="padding-bottom: 1.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           478,150          </font>         </td>         <td style="padding-bottom: 1.5pt; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>        </tr>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td style="padding-left: 10pt; text-align: left; padding-bottom: 1.5pt">          <font style="font-family: Times New Roman, Times, Serif">           Net    cash provided by financing activities          </font>         </td>         <td style="padding-bottom: 1.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           497,136          </font>         </td>         <td style="padding-bottom: 1.5pt; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="padding-bottom: 1.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           471,151          </font>         </td>         <td style="padding-bottom: 1.5pt; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>        </tr>        <tr style="vertical-align: bottom; background-color: White">         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>        </tr>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           Cash and cash equivalents:          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>        </tr>        <tr style="vertical-align: bottom; background-color: White">         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           Net decrease          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           (15,865          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           )          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           (16,594          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           )          </font>         </td>        </tr>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td style="padding-bottom: 1.5pt">          <font style="font-family: Times New Roman, Times, Serif">           Balance at beginning of period          </font>         </td>         <td style="padding-bottom: 1.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           16,690          </font>         </td>         <td style="padding-bottom: 1.5pt; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="padding-bottom: 1.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           33,284          </font>         </td>         <td style="padding-bottom: 1.5pt; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>        </tr>        <tr style="vertical-align: bottom; background-color: White">         <td style="padding-bottom: 2.5pt">          <font style="font-family: Times New Roman, Times, Serif">           Balance at end of period          </font>         </td>         <td style="padding-bottom: 2.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="border-bottom: Black 2.5pt double; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           $          </font>         </td>         <td style="border-bottom: Black 2.5pt double; text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           825          </font>         </td>         <td style="padding-bottom: 2.5pt; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="padding-bottom: 2.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="border-bottom: Black 2.5pt double; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           $          </font>         </td>         <td style="border-bottom: Black 2.5pt double; text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           16,690          </font>         </td>         <td style="padding-bottom: 2.5pt; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>        </tr>       </tbody>      </table>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        (Continued)       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <!-- Field: Page; Sequence: 66; Value: 1 -->      <div style="margin-bottom: 6pt; border-bottom: Black 1.5pt solid">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="text-align: center; width: 100%">           F-           <!-- Field: Sequence; Type: Arabic; Name: PageNo -->           8           <!-- Field: /Sequence -->          </td>         </tr>        </tbody>       </table>      </div>      <div style="break-before: page; margin-top: 6pt">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="width: 100%">          </td>         </tr>        </tbody>       </table>      </div>      <!-- Field: /Page -->      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         RESPIRERXPHARMACEUTICALS INC.        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         ANDSUBSIDIARY        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         CONSOLIDATEDSTATEMENTS OF CASH FLOWS        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         (Continued)        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">       <tbody>        <tr style="vertical-align: bottom">         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="padding-bottom: 1.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td colspan="6" style="text-align: center; border-bottom: Black 1.5pt solid">          <font style="font-family: Times New Roman, Times, Serif">           <b>            Years    Ended December 31,           </b>          </font>         </td>         <td style="padding-bottom: 1.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>        </tr>        <tr style="vertical-align: bottom">         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="padding-bottom: 1.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid">          <font style="font-family: Times New Roman, Times, Serif">           <b>            2020           </b>          </font>         </td>         <td style="padding-bottom: 1.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="padding-bottom: 1.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid">          <font style="font-family: Times New Roman, Times, Serif">           <b>            2019           </b>          </font>         </td>         <td style="padding-bottom: 1.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>        </tr>        <tr style="vertical-align: bottom">         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td colspan="2">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td colspan="2">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>        </tr>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           Supplemental disclosures of cash flow    information:          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>        </tr>        <tr style="vertical-align: bottom; background-color: White">         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           Cash paid for -          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>        </tr>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td style="padding-left: 10pt; width: 64%; padding-bottom: 2.5pt">          <font style="font-family: Times New Roman, Times, Serif">           Interest          </font>         </td>         <td style="width: 2%; padding-bottom: 2.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="width: 1%; border-bottom: Black 2.5pt double; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           $          </font>         </td>         <td style="width: 14%; border-bottom: Black 2.5pt double; text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           6,466          </font>         </td>         <td style="width: 1%; padding-bottom: 2.5pt; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="width: 2%; padding-bottom: 2.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="width: 1%; border-bottom: Black 2.5pt double; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           $          </font>         </td>         <td style="width: 14%; border-bottom: Black 2.5pt double; text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           5,130          </font>         </td>         <td style="width: 1%; padding-bottom: 2.5pt; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>        </tr>        <tr style="vertical-align: bottom; background-color: White">         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>        </tr>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           Non-cash financing activities:          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>        </tr>        <tr style="vertical-align: bottom; background-color: White">         <td style="padding-left: 10pt; text-align: left; padding-bottom: 2.5pt">          <font style="font-family: Times New Roman, Times, Serif">           Issuance    of common stock in exchange for extinguishment of Convertible Notes Payable          </font>         </td>         <td style="padding-bottom: 2.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="border-bottom: Black 2.5pt double; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           $          </font>         </td>         <td style="border-bottom: Black 2.5pt double; text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           694,946          </font>         </td>         <td style="padding-bottom: 2.5pt; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="padding-bottom: 2.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="border-bottom: Black 2.5pt double; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           $          </font>         </td>         <td style="border-bottom: Black 2.5pt double; text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           -          </font>         </td>         <td style="padding-bottom: 2.5pt; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>        </tr>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td style="padding-left: 10pt; text-align: left; padding-bottom: 2.5pt">          <font style="font-family: Times New Roman, Times, Serif">           Conversion    fees paid with common stock upon principal payment on convertible notes payable          </font>         </td>         <td style="padding-bottom: 2.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="border-bottom: Black 2.5pt double; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           $          </font>         </td>         <td style="border-bottom: Black 2.5pt double; text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           30,632          </font>         </td>         <td style="padding-bottom: 2.5pt; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="padding-bottom: 2.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="border-bottom: Black 2.5pt double; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           $          </font>         </td>         <td style="border-bottom: Black 2.5pt double; text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           750          </font>         </td>         <td style="padding-bottom: 2.5pt; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>        </tr>        <tr style="vertical-align: bottom; background-color: White">         <td style="padding-left: 10pt; text-align: left; padding-bottom: 2.5pt">          <font style="font-family: Times New Roman, Times, Serif">           Accounts    payable and accrued expenses extinguished with common stock options          </font>         </td>         <td style="padding-bottom: 2.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="border-bottom: Black 2.5pt double; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           $          </font>         </td>         <td style="border-bottom: Black 2.5pt double; text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           241,109          </font>         </td>         <td style="padding-bottom: 2.5pt; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="padding-bottom: 2.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="border-bottom: Black 2.5pt double; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           $          </font>         </td>         <td style="border-bottom: Black 2.5pt double; text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           -          </font>         </td>         <td style="padding-bottom: 2.5pt; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>        </tr>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td style="padding-left: 10pt; text-align: left; padding-bottom: 2.5pt">          <font style="font-family: Times New Roman, Times, Serif">           Issuance    of common stock in payment of accrued compensation          </font>         </td>         <td style="padding-bottom: 2.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="border-bottom: Black 2.5pt double; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           $          </font>         </td>         <td style="border-bottom: Black 2.5pt double; text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           1,684,218          </font>         </td>         <td style="padding-bottom: 2.5pt; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="padding-bottom: 2.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="border-bottom: Black 2.5pt double; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           $          </font>         </td>         <td style="border-bottom: Black 2.5pt double; text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           -          </font>         </td>         <td style="padding-bottom: 2.5pt; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">         <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left; padding-bottom: 2.5pt">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           Issuance    of commitment note for equity line          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 2.5pt double; text-align: left">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           $          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 2.5pt double; text-align: right">          <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            40,000           </font>          </p>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 2.5pt double; text-align: left">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           $          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 2.5pt double; text-align: right">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           -          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">         <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left; padding-bottom: 2.5pt">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           Issuance    of warrants with convertible notes          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 2.5pt double; text-align: left">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           $          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 2.5pt double; text-align: right">          <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            44,451           </font>          </p>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 2.5pt double; text-align: left">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           $          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 2.5pt double; text-align: right">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           -          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">         <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left; padding-bottom: 2.5pt">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           Beneficial    conversion feature associated with convertible notes          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 2.5pt double; text-align: left">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           $          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 2.5pt double; text-align: right">          <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            90,000           </font>          </p>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 2.5pt double; text-align: left">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           $          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 2.5pt double; text-align: right">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           -          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>        </tr>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td style="padding-left: 10pt; text-align: left; padding-bottom: 2.5pt">          <font style="font-family: Times New Roman, Times, Serif">           Short-term    note payable issued in connection with financing of directors and officers insurance policy          </font>         </td>         <td style="padding-bottom: 2.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="border-bottom: Black 2.5pt double; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           $          </font>         </td>         <td style="border-bottom: Black 2.5pt double; text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           70,762          </font>         </td>         <td style="padding-bottom: 2.5pt; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="padding-bottom: 2.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="border-bottom: Black 2.5pt double; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           $          </font>         </td>         <td style="border-bottom: Black 2.5pt double; text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           61,746          </font>         </td>         <td style="padding-bottom: 2.5pt; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>        </tr>        <tr style="vertical-align: bottom; background-color: White">         <td style="padding-left: 10pt; text-align: left; padding-bottom: 2.5pt">          <font style="font-family: Times New Roman, Times, Serif">           Short-term    note payable issued in connection with financing of clinical trial and other office insurance policies          </font>         </td>         <td style="padding-bottom: 2.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="padding-bottom: 2.5pt; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           $          </font>         </td>         <td style="padding-bottom: 2.5pt; text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           9,215          </font>         </td>         <td style="padding-bottom: 2.5pt; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="padding-bottom: 2.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="padding-bottom: 2.5pt; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           $          </font>         </td>         <td style="padding-bottom: 2.5pt; text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           9,322          </font>         </td>         <td style="padding-bottom: 2.5pt; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">         <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left; padding-bottom: 2.5pt">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           Interest    liability paid with common stock          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 2.5pt double; text-align: left">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 2.5pt double; text-align: right">          <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            11,760           </font>          </p>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 2.5pt double; text-align: left">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 2.5pt double; text-align: right">          <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            -           </font>          </p>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>        </tr>       </tbody>      </table>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Seeaccompanying notes to consolidated financial statements and       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        reportof independent registered public accounting firm.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <!-- Field: Page; Sequence: 67; Value: 1 -->      <div style="margin-bottom: 6pt; border-bottom: Black 1.5pt solid">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="text-align: center; width: 100%">           F-           <!-- Field: Sequence; Type: Arabic; Name: PageNo -->           9           <!-- Field: /Sequence -->          </td>         </tr>        </tbody>       </table>      </div>      <div style="break-before: page; margin-top: 6pt">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="width: 100%">          </td>         </tr>        </tbody>       </table>      </div>      <!-- Field: /Page -->      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         RESPIRERXPHARMACEUTICALS INC.        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         ANDSUBSIDIARY        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         <a name="f_006">         </a>         NOTESTO CONSOLIDATED FINANCIAL STATEMENTS        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         YearsEnded December 31, 2020 and 2019        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         1.Organization and Basis of Presentation        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         Organization        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        RespireRxPharmaceuticals Inc. (“RespireRx”) was formed in 1987 under the name Cortex Pharmaceuticals, Inc. to engage in thediscovery, development and commercialization of innovative pharmaceuticals for the treatment of neurological and psychiatric disorders.On December 16, 2015, RespireRx filed a Certificate of Amendment to its Second Restated Certificate of Incorporation (as amended,the “Certificate of Incorporation”) with the Secretary of State of the State of Delaware to amend its Second RestatedCertificate of Incorporation to change its name from Cortex Pharmaceuticals, Inc. to RespireRx Pharmaceuticals Inc. In August2012, RespireRx acquired Pier Pharmaceuticals, Inc. (“Pier”), which is now a wholly owned subsidiary. Pier was a clinicalstage biopharmaceutical company developing a pharmacologic treatment for obstructive sleep apnea (“OSA”) and had beenengaged in research and clinical development activities which activities are now in RespireRx.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         Basisof Presentation        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Theconsolidated financial statements are of RespireRx and its wholly-owned subsidiary, Pier.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         2.Business        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Themission of the Company is to develop innovative and revolutionary treatments to combat disorders caused by disruption of neuronalsignaling. We are developing treatment options that address conditions that affect millions of people, but for which there arelimited or poor treatment options, including OSA, attention deficit hyperactivity disorder (“ADHD”) epilepsy, chronicpain, including inflammatory and neuropathic pain, recovery from spinal cord injury (“SCI”), as well as other areasof interest based on results of animal studies to date.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        RespireRxis developing a pipeline of new drug products based on our broad patent portfolios across two distinct drug platforms:       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">       <tbody>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           (i)          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           our    pharmaceutical cannabinoids platform (which we refer to as ResolutionRx), including dronabinol (a synthetic form of ∆9-tetrahydrocannabinol    (“Δ9-THC”)), which acts upon the nervous system’s endogenous cannabinoid receptors, and          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           (ii)          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           our    neuromodulators platform (which we refer to as EndeavourRx) is made up of two programs: (a) our ampakines program, including    proprietary compounds that are positive allosteric modulators (“PAMs”) of AMPA-type glutamate receptors to promote    neuronal function and (b) our GABAkines program, including proprietary compounds that are PAMs of GABAA receptors, which was    recently established pursuant to our entry with the University of Wisconsin-Milwaukee Research Foundation, Inc., an affiliate    of the University of Wisconsin-Milwaukee (“UWMRF”), into a patent license agreement (the UWMRF Patent License    Agreement”).          </font>         </td>        </tr>       </tbody>      </table>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <!-- Field: Page; Sequence: 68; Value: 1 -->      <div style="margin-bottom: 6pt; border-bottom: Black 1.5pt solid">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="text-align: center; width: 100%">           F-           <!-- Field: Sequence; Type: Arabic; Name: PageNo -->           10           <!-- Field: /Sequence -->          </td>         </tr>        </tbody>       </table>      </div>      <div style="break-before: page; margin-top: 6pt">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="width: 100%">          </td>         </tr>        </tbody>       </table>      </div>      <!-- Field: /Page -->      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         Financingour Platforms        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Ourmajor challenge has been to raise substantial equity or equity-linked financing to support research and development plans forour cannabinoid and neuromodulator platforms, while minimizing the dilutive effect to pre-existing stockholders. At present, webelieve that we are hindered primarily by our public corporate structure, our OTCQB listing, and low market capitalization asa result of our low stock price.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Forthis reason, the Company has effected an internal restructuring plan through which our two drug platforms havebeen reorganized into separate business units and may in the future, be organized into subsidiaries of RespireRx.       </font>       <font style="font-family: Times New Roman, Times, Serif">        We believe that by creating one or more subsidiaries to furtherthe aims of ResolutionRx and EndeavourRx, it may be possible, through separate finance channels, to optimize the asset valuesof each. We are also planning to commence a securities offering by the Company pursuant to Regulation A by filing a Form1-A.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         GoingConcern        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        TheCompany’s consolidated financial statements have been presented on the basis that it is a going concern, which contemplatesthe realization of assets and satisfaction of liabilities in the normal course of business. The Company has incurred net lossesof $4,301,211 and $2,115,033 for the fiscal years ended December 31, 2020 and 2019, respectively, and negative operating cashflows of $513,001 and $487,745 for the fiscal years ended December 31, 2020 and 2019, respectively. The Company also hada stockholders’ deficiency of $8,063,320 at December 31, 2020 and expects to continue to incur net losses and negative operatingcash flows for at least the next few years. As a result, management has concluded that there is substantial doubt about the Company’sability to continue as a going concern, and the Company’s independent registered public accounting firm, in its report onthe Company’s consolidated financial statements for the year ended December 31, 2020, expressed substantial doubt aboutthe Company’s ability to continue as a going concern.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        TheCompany is currently, and has for some time, been in significant financial distress. It has extremely limited cash resources andcurrent assets and has no ongoing source of sustainable revenue. Management is continuing to address various aspects of the Company’soperations and obligations, including, without limitation, debt obligations, financing requirements, intellectual property, licensingagreements, legal and patent matters and regulatory compliance, and has taken steps to continue to raise new debt and equity capitalto fund the Company’s business activities from both related and unrelated parties.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <!-- Field: Page; Sequence: 69; Value: 1 -->      <div style="margin-bottom: 6pt; border-bottom: Black 1.5pt solid">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="text-align: center; width: 100%">           F-           <!-- Field: Sequence; Type: Arabic; Name: PageNo -->           11           <!-- Field: /Sequence -->          </td>         </tr>        </tbody>       </table>      </div>      <div style="break-before: page; margin-top: 6pt">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="width: 100%">          </td>         </tr>        </tbody>       </table>      </div>      <!-- Field: /Page -->      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        TheCompany is continuing its efforts to raise additional capital in order to be able to pay its liabilities and fund its businessactivities on a going forward basis, including the pursuit of the Company’s planned research and development activities.The Company regularly evaluates various measures to satisfy the Company’s liquidity needs, including development and otheragreements with collaborative partners and, when necessary, seeking to exchange or restructure the Company’s outstandingsecurities. The Company is evaluating certain changes to its operations and structure to facilitate raising capital from sourcesthat may be interested in financing only discrete aspects of the Company’s development programs. Such changes could includea significant reorganization, which may include the formation of one or more subsidiaries into which one or more programs maybe contributed. As a result of the Company’s current financial situation, the Company has limited access to external sourcesof debt and equity financing. Accordingly, there can be no assurances that the Company will be able to secure additional financingin the amounts necessary to fully fund its operating and debt service requirements. If the Company is unable to access sufficientcash resources, the Company may be forced to discontinue its operations entirely and liquidate.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         3.Summary of Significant Accounting Policies        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         Principlesof Consolidation        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Theaccompanying consolidated financial statements are prepared in accordance with United States generally accepted accounting principles(“GAAP”) and include the financial statements of RespireRx and its wholly-owned subsidiary, Pier. Intercompany balancesand transactions have been eliminated in consolidation.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         Useof Estimates        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Thepreparation of financial statements in conformity with GAAP requires management to make estimates and assumptions. These estimatesand assumptions affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at thedate of the financial statements and the reported amounts of revenues and expenses during the reporting period. Significant estimatesinclude, among other things, accounting for potential liabilities, and the assumptions used in valuing stock-based compensationissued for services. Actual amounts may differ from those estimates.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         ReverseStock Split on January 5, 2021        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        OnJanuary 5, 2021, the Company effected a ten to one reverse-stock split of its common stock. Every ten shares of the “old”common stock was exchanged for one “new” share of common stock rounded down to the nearest whole share with any fractionalshares of common stock paid to the stockholder in cash. Option and warrant issuances prior to January 5, 2021 have alsobeen proportionately adjusted by dividing the number of shares into which such options and warrants may exercise by ten and multiplyingthe exercise price by ten. The effect of the reverse-stock split has been reflected retroactively in the Company’sconsolidated financial statements as of December 31, 2020 and 2019 and for the fiscal years ended December 31, 2020 and 2019.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         Concentrationsof Credit Risk        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Financialinstruments that potentially subject the Company to concentrations of credit risk consist primarily of cash and cash equivalents.The Company limits its exposure to credit risk by investing its cash with high quality financial institutions. The Company’scash balances may periodically exceed federally insured limits. The Company has not experienced a loss in such accounts to date.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         Valueof Financial Instruments        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Theauthoritative guidance with respect to fair value of financial instruments established a fair value hierarchy that prioritizesthe inputs to valuation techniques used to measure fair value into three levels and requires that assets and liabilities carriedat fair value be classified and disclosed in one of three categories, as presented below. Disclosure as to transfers into andout of Levels 1 and 2, and activity in Level 3 fair value measurements, is also required.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Level1. Observable inputs such as quoted prices in active markets for an identical asset or liability that the Company has the abilityto access as of the measurement date. Financial assets and liabilities utilizing Level 1 inputs include active-exchange tradedsecurities and exchange-based derivatives.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Level2. Inputs, other than quoted prices included within Level 1, which are directly observable for the asset or liability or indirectlyobservable through corroboration with observable market data. Financial assets and liabilities utilizing Level 2 inputs includefixed income securities, non-exchange-based derivatives, mutual funds, and fair-value hedges.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <!-- Field: Page; Sequence: 70; Value: 1 -->      <div style="margin-bottom: 6pt; border-bottom: Black 1.5pt solid">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="text-align: center; width: 100%">           F-           <!-- Field: Sequence; Type: Arabic; Name: PageNo -->           12           <!-- Field: /Sequence -->          </td>         </tr>        </tbody>       </table>      </div>      <div style="break-before: page; margin-top: 6pt">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="width: 100%">          </td>         </tr>        </tbody>       </table>      </div>      <!-- Field: /Page -->      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Level3. Unobservable inputs in which there is little or no market data for the asset or liability which requires the reporting entityto develop its own assumptions. Financial assets and liabilities utilizing Level 3 inputs include infrequently-traded, non-exchange-basedderivatives and commingled investment funds, and are measured using present value pricing models.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        TheCompany determines the level in the fair value hierarchy within which each fair value measurement falls in its entirety, basedon the lowest level input that is significant to the fair value measurement in its entirety. In determining the appropriate levels,the Company performs an analysis of the assets and liabilities at each reporting period end.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Thecarrying amounts of financial instruments (consisting of cash and accounts payable and accrued expenses) are considered by theCompany to be representative of the respective fair values of these instruments due to the short-term nature of those instruments.With respect to the note payable to SY Corporation and the convertible notes payable, management does not believe that the creditmarkets have materially changed for these types of borrowings since the original borrowing date. The Company considers the carryingamounts of the notes payable to officers, inclusive of accrued interest, to be representative of the respective fair values ofsuch instruments due to the short-term nature of those instruments and their terms.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         DeferredFinancing Costs        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Costsincurred in connection with ongoing debt and equity financings, including legal fees, are deferred until the related financingis either completed or abandoned.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Costsrelated to abandoned debt or equity financings are charged to operations in the period of abandonment. Costs related to completedequity financings are netted against the proceeds.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         CapitalizedFinancing Costs        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        TheCompany presents debt issuance costs related to debt liability in its consolidated balance sheet as a direct deduction from thecarrying amount of that debt liability, consistent with the presentation for debt discounts.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         ConvertibleNotes Payable        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Convertiblenotes are evaluated to determine if they should be recorded at amortized cost. To the extent that there are associated warrants,commitment shares or a beneficial conversion feature, the convertible notes and warrants are evaluated to determine if there areembedded derivatives to be identified, bifurcated and valued at fair value in connection with and at the time of such financing.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         NotesExchanges        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Incases where debt or other liabilities are exchanged for equity, the Company compares the carrying value of debt, inclusive ofaccrued interest, if applicable, being exchanged, to the value of the equity issued and records any loss or gain as a result ofsuch exchange. See Note 4. Notes Payable.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         Extinguishmentof Debt and Settlement of Liabilities        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        TheCompany accounts for the extinguishment of debt and settlement of liabilities by comparing the carrying value of the debt or liabilityto the value of consideration paid or assets given up and recognizing a loss or gain in the consolidated statement of operationsin the amount of the difference in the period in which such transaction occurs.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <!-- Field: Page; Sequence: 71; Value: 1 -->      <div style="margin-bottom: 6pt; border-bottom: Black 1.5pt solid">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="text-align: center; width: 100%">           F-           <!-- Field: Sequence; Type: Arabic; Name: PageNo -->           13           <!-- Field: /Sequence -->          </td>         </tr>        </tbody>       </table>      </div>      <div style="break-before: page; margin-top: 6pt">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="width: 100%">          </td>         </tr>        </tbody>       </table>      </div>      <!-- Field: /Page -->      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         PrepaidInsurance        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Prepaidinsurance represents the premium paid in March 2020 for directors’ and officers’ insurance as well as the amount paidin April 2020 for office-related insurances and clinical trial coverage. Directors’ and Officers’ insurance tail coverage,purchased in March 2013 expired in March 2020 and all prepaid amounts have been fully amortized. The amounts of prepaid insuranceamortizable in the ensuing twelve-month period are recorded as prepaid insurance in the Company’s consolidated balance sheetat each reporting date and amortized to the Company’s consolidated statement of operations for each reporting period.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         Stock-BasedAwards        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        TheCompany periodically issues common stock and stock options to officers, directors, Scientific Advisory Board members, consultantsand other vendors for services rendered. Such issuances vest and expire according to terms established at the issuance date ofeach grant.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        TheCompany accounts for stock-based payments to officers and directors, outside consultants and vendors measuring the cost of servicesreceived in exchange for equity awards based on the grant date fair value of the awards, with the cost recognized as compensationexpense on the straight-line basis in the Company’s consolidated financial statements over the vesting period of the awards.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Stockgrants, which are sometimes subject to time-based vesting, are measured at the grant date fair value of the common stock and chargedto operations ratably over the vesting period.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Stockoptions granted to members of the Company’s outside consultants and other vendors are valued on the grant date. As the stockoptions vest, the Company recognizes this expense over the period in which the services are provided.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Thevalue of stock options granted as stock-based compensation is determined utilizing the Black-Scholes option-pricing model, andis affected by several variables, the most significant of which are the life of the equity award, the exercise price of the stockoption as compared to the fair value of the common stock on the grant date, and the estimated volatility of the common stock overthe estimated life of the equity award. Estimated volatility is based on the historical volatility of the Company’s commonstock. The risk-free interest rate is based on the U.S. Treasury yield curve in effect at the time of grant. The fair value ofcommon stock is determined by reference to the quoted market price of the Company’s common stock.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Stockoptions and warrants issued to non-employees as compensation for services to be provided to the Company or in settlement of debtare accounted for based upon the fair value of the services provided or the estimated fair value of the stock option or warrant,whichever can be more clearly determined. Management uses the Black-Scholes option-pricing model to determine the fair value ofthe stock options and warrants issued by the Company. The Company recognizes this expense over the period in which the servicesare provided.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Asof December 31, 2020, there were stock option grants exercisable into 6,750,000 shares of common stock granted to one officerwho is also a director, one director who is not an officer, consultants and other vendors. Certain stock options granted weresubject to vesting schedules. Stock options exercisable into 5,825,000 shares of common stock vested during the fiscal year endedDecember 31, 2020. The Black Scholes value of vested stock options granted during the fiscal year ended December 31, 2020 was$384,250. During the fiscal year ended December 31, 2019, there were no stock options granted to officers, directors, ScientificAdvisory Board members, consultants or other vendors.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">      </p>      <!-- Field: Page; Sequence: 72; Value: 1 -->      <div style="margin-bottom: 6pt; border-bottom: Black 1.5pt solid">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="text-align: center; width: 100%">           F-           <!-- Field: Sequence; Type: Arabic; Name: PageNo -->           14           <!-- Field: /Sequence -->          </td>         </tr>        </tbody>       </table>      </div>      <div style="break-before: page; margin-top: 6pt">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="width: 100%">          </td>         </tr>        </tbody>       </table>      </div>      <!-- Field: /Page -->      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Forstock options requiring an assessment of fair value during the fiscal years ended December 31, 2020 and 2019 the fair value ofeach stock option award was estimated using the Black-Scholes option-pricing model using the following assumptions:       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">       <tbody>        <tr style="vertical-align: bottom">         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="padding-bottom: 1.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid">          <font style="font-family: Times New Roman, Times, Serif">           <b>            2020           </b>          </font>         </td>         <td style="padding-bottom: 1.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="padding-bottom: 1.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid">          <font style="font-family: Times New Roman, Times, Serif">           <b>            2019           </b>          </font>         </td>         <td style="padding-bottom: 1.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>        </tr>        <tr style="vertical-align: bottom">         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td colspan="2" style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td colspan="2" style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>        </tr>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           Risk-free interest rate          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           0.21-0.28          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           %          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           -          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           %          </font>         </td>        </tr>        <tr style="vertical-align: bottom; background-color: White">         <td style="width: 60%; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           Expected dividend yield          </font>         </td>         <td style="width: 2%">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="width: 1%; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="width: 16%; text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           0          </font>         </td>         <td style="width: 1%; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           %          </font>         </td>         <td style="width: 2%">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="width: 1%; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="width: 16%; text-align: right">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           -          </font>         </td>         <td style="width: 1%; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           %          </font>         </td>        </tr>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           Expected volatility          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           412.81-426.92          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           %          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           -          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           %          </font>         </td>        </tr>        <tr style="vertical-align: bottom; background-color: White">         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           Expected life at date of issuance          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           5          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           -          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>        </tr>       </tbody>      </table>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Theexpected life is estimated to be equal to the term of the common stock options issued in 2020.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        TheCompany recognizes the fair value of stock-based awards in general and administrative costs and in research and development costs,as appropriate, in the Company’s consolidated statements of operations. The Company issues new shares of common stock tosatisfy stock option and warrant exercises. There were no stock options exercised during the fiscal years ended December 31, 2020and 2019.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Therewere no warrants issued as compensation or for services during the fiscal years ended December 31, 2020 and 2019 requiring suchassessment. Warrants, if issued for services, are typically issued to placement agents or brokers for fund raising services andare not issued from any of the Company’s stock and option plans, from which options issued to non-employees for servicesare typically issued.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         IncomeTaxes        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        TheCompany accounts for income taxes under an asset and liability approach for financial accounting and reporting for income taxes.Accordingly, the Company recognizes deferred tax assets and liabilities for the expected impact of differences between the financialstatements and the tax basis of assets and liabilities.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        TheCompany records a valuation allowance to reduce its deferred tax assets to the amount that is more likely than not to be realized.In the event the Company was to determine that it would be able to realize its deferred tax assets in the future in excess ofits recorded amount, an adjustment to the deferred tax assets would be credited to operations in the period such determinationwas made. Likewise, should the Company determine that it would not be able to realize all or part of its deferred tax assets inthe future, an adjustment to the deferred tax assets would be charged to operations in the period such determination was made.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Pursuantto Internal Revenue Code Sections 382 and 383, use of the Company’s net operating loss and credit carryforwards may be limitedif a cumulative change in ownership of more than 50% occurs within any three-year period since the last ownership change. TheCompany may have had a change in control under these Sections. However, the Company does not anticipate performing a completeanalysis of the limitation on the annual use of the net operating loss and tax credit carryforwards until the time that it anticipatesit will be able to utilize these tax attributes.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Asof December 31, 2020, the Company did not have any unrecognized tax benefits related to various federal and state income tax mattersand does not anticipate any material amount of unrecognized tax benefits within the next 12 months.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        TheCompany is subject to U.S. federal income taxes and income taxes of various state tax jurisdictions. As the Company’s netoperating losses have yet to be utilized, all previous tax years remain open to examination by Federal authorities and other jurisdictionsin which the Company currently operates or has operated in the past.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        TheCompany accounts for uncertainties in income tax law under a comprehensive model for the financial statement recognition, measurement,presentation and disclosure of uncertain tax positions taken or expected to be taken in income tax returns as prescribed by GAAP.The tax effects of a position are recognized only if it is “more-likely-than-not” to be sustained by the taxing authorityas of the reporting date. If the tax position is not considered “more-likely-than-not” to be sustained, then no benefitsof the position are recognized. As of December 31, 2020, the Company had not recorded any liability for uncertain tax positions.In subsequent periods, any interest and penalties related to uncertain tax positions will be recognized as a component of incometax expense.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <!-- Field: Page; Sequence: 73; Value: 1 -->      <div style="margin-bottom: 6pt; border-bottom: Black 1.5pt solid">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="text-align: center; width: 100%">           F-           <!-- Field: Sequence; Type: Arabic; Name: PageNo -->           15           <!-- Field: /Sequence -->          </td>         </tr>        </tbody>       </table>      </div>      <div style="break-before: page; margin-top: 6pt">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="width: 100%">          </td>         </tr>        </tbody>       </table>      </div>      <!-- Field: /Page -->      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         ForeignCurrency Transactions        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Thenote payable to SY Corporation, which is denominated in a foreign currency (the South Korean Won), is translated into the Company’sfunctional currency (the United States Dollar) at the exchange rate on the balance sheet date. The foreign currency exchange gainor loss resulting from translation is recognized in the related consolidated statements of operations.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         Researchand Development        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Researchand development costs include compensation paid to management directing the Company’s research and development activities,including but not limited to compensation paid to our Chief Scientific Officer and fees paid to consultants and outside serviceproviders and organizations (including research institutes at universities), and other expenses relating to the acquisition, design,development and clinical testing of the Company’s treatments and product candidates.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         LicenseAgreements        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Obligationsincurred with respect to mandatory payments provided for in license agreements are recognized ratably over the appropriate period,as specified in the underlying license agreement, and are recorded as liabilities in the Company’s consolidated balancesheet, with a corresponding charge to research and development costs in the Company’s consolidated statement of operations.Obligations incurred with respect to milestone payments provided for in license agreements are recognized when it is probablethat such milestone will be reached and are recorded as liabilities in the Company’s consolidated balance sheet, with acorresponding charge to research and development costs in the Company’s consolidated statement of operations.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         PatentCosts        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Dueto the significant uncertainty associated with the successful development of one or more commercially viable products based onthe Company’s research efforts and any related patent applications, all patent costs, including patent-related legal andfiling fees, are expensed as incurred and are charged to general and administrative expenses.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         Earningsper Share        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        TheCompany’s computation of earnings per share (“EPS”) includes basic and diluted EPS. Basic EPS is measured asthe income (loss) attributable to common stockholders divided by the weighted average common shares outstanding for the period.Diluted EPS is similar to basic EPS but presents the dilutive effect on a per share basis of potential common shares (e.g., warrantsand options) as if they had been converted at the beginning of the periods presented, or issuance date, if later. Potential commonshares that have an anti-dilutive effect (i.e., those that increase income per share or decrease loss per share) are excludedfrom the calculation of diluted EPS.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <!-- Field: Page; Sequence: 74; Value: 1 -->      <div style="margin-bottom: 6pt; border-bottom: Black 1.5pt solid">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="text-align: center; width: 100%">           F-           <!-- Field: Sequence; Type: Arabic; Name: PageNo -->           16           <!-- Field: /Sequence -->          </td>         </tr>        </tbody>       </table>      </div>      <div style="break-before: page; margin-top: 6pt">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="width: 100%">          </td>         </tr>        </tbody>       </table>      </div>      <!-- Field: /Page -->      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       Net income (loss) attributable to common stockholdersconsists of net income or loss, as adjusted for actual and deemed preferred stock dividends declared, amortized or accumulated.The Company recorded a deemed dividend for the issuance of warrants during year ended December 31, 2020 of $1,440,214. Thedeemed dividend is added to the net loss in determining the net loss available to common stockholders.      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Lossper common share is computed by dividing net loss by the weighted average number of shares of common stock outstanding duringthe respective periods. Basic and diluted loss per common share is the same for all periods presented because all warrants andstock options outstanding are anti-dilutive.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        AtDecember 31, 2020 and 2019, the Company excluded the outstanding securities summarized below, which entitle the holders thereofto acquire shares of common stock, from its calculation of earnings per share, as their effect would have been anti-dilutive.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">       <tbody>        <tr style="vertical-align: bottom">         <td style="text-align: center">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="font-weight: bold; padding-bottom: 1.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">          <font style="font-family: Times New Roman, Times, Serif">           December    31,          </font>         </td>         <td style="padding-bottom: 1.5pt; font-weight: bold">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>        </tr>        <tr style="vertical-align: bottom">         <td style="text-align: center">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="font-weight: bold; padding-bottom: 1.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">          <font style="font-family: Times New Roman, Times, Serif">           2020          </font>         </td>         <td style="padding-bottom: 1.5pt; font-weight: bold">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="font-weight: bold; padding-bottom: 1.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">          <font style="font-family: Times New Roman, Times, Serif">           2019          </font>         </td>         <td style="padding-bottom: 1.5pt; font-weight: bold">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>        </tr>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td style="width: 64%; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           Series B convertible preferred    stock          </font>         </td>         <td style="width: 2%">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="width: 1%; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="width: 14%; text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           1          </font>         </td>         <td style="width: 1%; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="width: 2%">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="width: 1%; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="width: 14%; text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           11          </font>         </td>         <td style="width: 1%; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>        </tr>        <tr style="vertical-align: bottom; background-color: White">         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           Convertible notes payable          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           13,333,036          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           7,017,896          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>        </tr>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           Common stock warrants          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           28,809,352          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           2,191,043          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>        </tr>        <tr style="vertical-align: bottom; background-color: White">         <td style="text-align: left; padding-bottom: 1.5pt">          <font style="font-family: Times New Roman, Times, Serif">           Common stock    options          </font>         </td>         <td style="padding-bottom: 1.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           7,165,215          </font>         </td>         <td style="padding-bottom: 1.5pt; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="padding-bottom: 1.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           4,344,994          </font>         </td>         <td style="padding-bottom: 1.5pt; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>        </tr>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td style="padding-bottom: 2.5pt">          <font style="font-family: Times New Roman, Times, Serif">           Total          </font>         </td>         <td style="padding-bottom: 2.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="border-bottom: Black 2.5pt double; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="border-bottom: Black 2.5pt double; text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           49,307,604          </font>         </td>         <td style="padding-bottom: 2.5pt; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="padding-bottom: 2.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="border-bottom: Black 2.5pt double; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="border-bottom: Black 2.5pt double; text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           13,553,944          </font>         </td>         <td style="padding-bottom: 2.5pt; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>        </tr>       </tbody>      </table>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         Reclassifications        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Certaincomparative figures in 2019 have been reclassified to conform to the current year’s presentation. These reclassificationswere immaterial, both individually and in the aggregate.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         RecentAccounting Pronouncements        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        InAugust 2020, the FASB issued Accounting Standards Update No. 2020-06, Debt – Debt with Conversion and Other Options (Subtopic470-20) and Derivatives and Hedging—Contracts in Entity’s Own Equity (Subtopic 815-40). The subtitle is Accountingfor Convertible Instruments and Contracts in an Entity’s Own Equity. This Accounting Standard Update (“ASU”)addresses complex financial instruments that have characteristics of both debt and equity. The application of this ASU would reducethe number of accounting models for convertible debt instruments and convertible preferred stock. Limiting the accounting modelswould result in fewer embedded conversion features being separately recognized from the host contract as compared with currentGAAP. Convertible instruments that continue to be subject to separation models are (1) those with embedded conversion featuresthat are not clearly and closely related to the host contract, that meet the definition of a derivative, and that do not qualifyfor a scope exception from derivative accounting and (2) convertible debt instruments issued with substantial premiums for whichthe premiums are recorded as paid-in capital. The Company has historically issued complex financial instruments and has consideredwhether embedded conversion features have existed within those contracts or whether derivatives would appropriately be bifurcated.To date, no such bifurcation has been necessary. However, it is possible that this ASU may have a substantial impact on the Company’sfinancial statements. Management is evaluating the potential impact. This ASU becomes effective for fiscal years beginning afterDecember 15, 2023.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        InJanuary 2020, the FASB issued ASU 2020-01, Clarifying the Interactions between Topic 321, Topic 323, Equity Method and Joint Ventures,and Topic 815, Derivatives and Hedging which represents an amendment clarifying the interaction between accounting standards relatedto equity securities, equity method investments and certain derivatives. The guidance is effective for fiscal years beginningafter December 15, 2020. Management is currently evaluating the impact the guidance will have on our consolidated financial statements.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        InAugust 2018, the FASB issued ASU 2018-13, Disclosure Framework-Changes to the Disclosure Requirements for Fair Value Measurement,an accounting standard update which modifies the disclosure requirements on fair value measurements. This guidance was effectivefor fiscal years beginning after December 15, 2019. The amendments related to the range and weighted average of significant unobservableinputs used to develop Level 3 fair value measurements, and the narrative description of measurement uncertainty was to be appliedprospectively. All other amendments were to be applied retrospectively. An entity was permitted to early adopt any removed ormodified disclosures upon issuance of this guidance and delay adoption of the additional disclosures until their effective date.The adoption of this guidance did not have a material impact on our consolidated financial statements in the year ended December31, 2020.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <!-- Field: Page; Sequence: 75; Value: 1 -->      <div style="margin-bottom: 6pt; border-bottom: Black 1.5pt solid">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="text-align: center; width: 100%">           F-           <!-- Field: Sequence; Type: Arabic; Name: PageNo -->           17           <!-- Field: /Sequence -->          </td>         </tr>        </tbody>       </table>      </div>      <div style="break-before: page; margin-top: 6pt">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="width: 100%">          </td>         </tr>        </tbody>       </table>      </div>      <!-- Field: /Page -->      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         4.Notes Payable        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         ConvertibleNotes Payable        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <u>         ConvertibleNote with EMA Financial, LLC        </u>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        OnJuly 30, 2020, RespireRx  and EMA Financial, LLC (“EMA”) entered into a Securities Purchase Agreement (the “EMASPA”) by which EMA provided a sum of $68,250 (the “EMA Consideration”) to RespireRx, in return for a fixed rateconvertible note (the “EMA Note”) with a face amount of $75,000, and a common stock purchase warrant (the “EMAWarrant”) for 375,000 shares of Common Stock (post-reverse stock split basis). The net proceeds received by RespireRx onAugust 4, 2020 were $63,750 after payment of $3,500 in EMA’s legal fees and the withholding by EMA of $1,000 in diligencefees.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        TheEMA Note obligates RespireRx to pay by October 30, 2021 (the “EMA Maturity Date”) a principal amount of $75,000 togetherwith interest at a rate equal to 10% per annum, which principal exceeds the EMA Consideration by the amount of an original issuediscount of $6,750. Any amount of principal or interest that is not paid by the EMA Maturity Date would bear interest at the rateof 24% from the EMA Maturity Date to the date such amount is paid.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        EMAhas the right, in its discretion, at any time, to convert any outstanding and unpaid amount of the EMA Note into shares of CommonStock, provided that such conversion would not result in EMA beneficially owning more than 4.99% of RespireRx’s then outstandingCommon Stock. In the absence of an event of default, EMA may convert at a per share conversion price equal to $0.02, subject toa retroactive downward adjustment if the lowest traded price on each of the three consecutive trading days following such conversionis lower than $0.02. Upon an event of default, the conversion price is adjusted downward based on a discount to market with respectto subsequent financings or a percentage of the lowest traded price during the twenty one day period prior to the conversion,if lower than $0.02. Upon such conversion, all rights with respect to the portion of the EMA Note being so converted terminate,except for the right to receive Common Stock or other securities, cash or other assets as provided in the EMA Note due upon suchconversion.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        RespireRxmay, with prior written notice to EMA, prepay the outstanding principal amount under the EMA Note during the initial 180 day periodby making a payment to EMA of an amount in cash equal to a certain percentage of the outstanding principal, interest, defaultinterest and other amounts owed. Such percentage varies from 110% to 115% depending on the period in which the prepayment occurs,as set forth in the EMA Note.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        If,prior to the repayment or conversion of the EMA Note, RespireRx consummates a registered, qualified or unregistered primary offeringof its securities for capital raising purposes with aggregate net proceeds in excess of $2,500,000, EMA will have the right, inits discretion, to demand repayment in full of any outstanding principal, interest (including default interest) under the EMANote as of the closing date of such offering.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        TheEMA SPA includes, among other things: (1) an automatic adjustment to the terms of the EMA SPA and related documents to the termsof a future financing if those terms are more beneficial to an investor than the terms of the EMA SPA and related documents areto EMA, subject to limited exceptions; and (2) certain registration rights. In addition, the EMA Note prohibits RespireRx fromselling or otherwise disposing of a significant portion of its assets outside the ordinary course of business or in connectionwith a merger or consolidation or sale of all or substantially all of RespireRx’s assets where the surviving or successorentity does not assume RespireRx’s obligations under the EMA SPA. Further, any subsidiary to which RespireRx transfers amaterial amount of assets must guarantee certain obligations of RespireRx under the EMA Note.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        TheEMA Warrant is a common stock purchase warrant to purchase 375,000 shares of Common, for value received in connection with theissuance of the EMA Note, from the date of issuance of the EMA Warrant until September 30, 2023, at an exercise price of $0.07(subject to adjustment as provided therein) per share of Common Stock.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <!-- Field: Page; Sequence: 76; Value: 1 -->      <div style="margin-bottom: 6pt; border-bottom: Black 1.5pt solid">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="text-align: center; width: 100%">           F-           <!-- Field: Sequence; Type: Arabic; Name: PageNo -->           18           <!-- Field: /Sequence -->          </td>         </tr>        </tbody>       </table>      </div>      <div style="break-before: page; margin-top: 6pt">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="width: 100%">          </td>         </tr>        </tbody>       </table>      </div>      <!-- Field: /Page -->      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 39.65pt">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        TheCompany determined that there were no embedded derivatives to be identified, bifurcated and valued in connection with this financing.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 38.4pt">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Theoutstanding amounts of the EMA Note consists of the following at December 31, 2020 and December 31, 2019:       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">       <tbody>        <tr style="vertical-align: bottom">         <td style="text-align: center">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="padding-bottom: 1.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid">          <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            <b>             December                                         31,            </b>           </font>          </p>          <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            <b>             2020            </b>           </font>          </p>         </td>         <td style="padding-bottom: 1.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="padding-bottom: 1.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid">          <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            <b>             December                                         31,            </b>           </font>          </p>          <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            <b>             2019            </b>           </font>          </p>         </td>         <td style="padding-bottom: 1.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>        </tr>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td style="width: 60%; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           Principal amount of notes    payable          </font>         </td>         <td style="width: 2%">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="width: 1%; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           $          </font>         </td>         <td style="width: 16%; text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           75,000          </font>         </td>         <td style="width: 1%; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="width: 2%">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="width: 1%; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           $          </font>         </td>         <td style="width: 16%; text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           -          </font>         </td>         <td style="width: 1%; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>        </tr>        <tr style="vertical-align: bottom; background-color: White">         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           Unamortized portion of note discounts          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           (18,417          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           )          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           -          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>        </tr>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td style="text-align: left; padding-bottom: 1.5pt">          <font style="font-family: Times New Roman, Times, Serif">           Accrued interest    payable          </font>         </td>         <td style="padding-bottom: 1.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           3,164          </font>         </td>         <td style="padding-bottom: 1.5pt; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="padding-bottom: 1.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           -          </font>         </td>         <td style="padding-bottom: 1.5pt; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>        </tr>        <tr style="vertical-align: bottom; background-color: White">         <td style="padding-bottom: 2.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="padding-bottom: 2.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="border-bottom: Black 2.5pt double; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           $          </font>         </td>         <td style="border-bottom: Black 2.5pt double; text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           59,747          </font>         </td>         <td style="padding-bottom: 2.5pt; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="padding-bottom: 2.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="border-bottom: Black 2.5pt double; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           $          </font>         </td>         <td style="border-bottom: Black 2.5pt double; text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           -          </font>         </td>         <td style="padding-bottom: 2.5pt; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>        </tr>       </tbody>      </table>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <u>         ConvertibleNote and Equity Purchase Agreement with White Lion Capital, LLC        </u>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        OnJuly 28, 2020, RespireRx issued a convertible note, as amended (“Commitment Note”) to White Lion Capital, LLC (“WhiteLion”) pursuant to, and to induce White Lion to enter into an equity purchase agreement dated July 28, 2020 (“WhiteLion EPA”). See Note 9. Commitments and Contingencies - Entry into Equity Purchase Agreement for a description ofthe White Lion EPA and the other agreements entered into pursuant to the White Lion EPA. The Commitment Note had an initial faceamount of $25,000 which was subsequently amended effective July 28, 2020 to $40,000 in consideration for an amendment to the WhiteLion EPA extending the date by which RespireRx was to file a registration statement on Form S-1 listing White Lion as the sellingstockholder on Form S-1. The Commitment Note was accounted for as equity issuance costs in Additional paid-in capital.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        TheCommitment Note obligates RespireRx to pay by July 28, 2021 a principal amount of $40,000, together with a guaranteed interestpayment of $3,200 representing an 8% per annum interest rate applied regardless of any payments or prepayments other than paymentsmade by conversion of the Commitment Note. Upon an event of default, any amount of outstanding principal or interest would bearinterest at the lower of 18% or the highest rate permitted by law.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        WhiteLion has the right, at any time after the first 180 days after execution of the White Lion EPA, to convert any outstanding andunpaid amount (including accrued interest and other fees) into shares of Common Stock, provided that such conversion would notresult in White Lion beneficially owning more than 9.99% of the Company’s then outstanding Common Stock. Unless an eventof default has occurred, White Lion may convert at a per share conversion price equal to $0.02. Upon such conversion, all rightswith respect to the portion of the Commitment Note being so converted terminate, except for the right to receive Common Stock.White Lion also has the right, at any time the Commitment Note is outstanding, to apply any outstanding principal or interestas consideration for any equity, equity-linked and/or debt securities offered by the Company in any public offering or privateplacement, subject to the terms of the Commitment Note.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        RespireRxmay, with prior written notice to White Lion, prepay the entire outstanding principal amount under the Commitment Note at anytime by making a payment to White Lion of an amount in cash equal to 110% of the outstanding principal, guaranteed interest amount,and any default interest or other amounts owed.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 39.65pt">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        RespireRxdetermined that there were no embedded derivatives to be identified, bifurcated and valued in connection with this financing.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 38.4pt">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Theoutstanding amounts of the White Lion Note consist of the following at December 31, 2020 and December 31, 2019:       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">       <tbody>        <tr style="vertical-align: bottom">         <td style="text-align: center">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="padding-bottom: 1.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid">          <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            <b>             December                                         31,            </b>           </font>          </p>          <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            <b>             2020            </b>           </font>          </p>         </td>         <td style="padding-bottom: 1.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="padding-bottom: 1.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid">          <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            <b>             December                                         31,            </b>           </font>          </p>          <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            <b>             2019            </b>           </font>          </p>         </td>         <td style="padding-bottom: 1.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>        </tr>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td style="width: 60%; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           Principal amount of notes    payable          </font>         </td>         <td style="width: 2%">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="width: 1%; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           $          </font>         </td>         <td style="width: 16%; text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           40,000          </font>         </td>         <td style="width: 1%; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="width: 2%">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="width: 1%; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           $          </font>         </td>         <td style="width: 16%; text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           -          </font>         </td>         <td style="width: 1%; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>        </tr>        <tr style="vertical-align: bottom; background-color: White">         <td style="text-align: left; padding-bottom: 1.5pt">          <font style="font-family: Times New Roman, Times, Serif">           Accrued interest    payable          </font>         </td>         <td style="padding-bottom: 1.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           1,368          </font>         </td>         <td style="padding-bottom: 1.5pt; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="padding-bottom: 1.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           -          </font>         </td>         <td style="padding-bottom: 1.5pt; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>        </tr>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td style="padding-bottom: 2.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="padding-bottom: 2.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="border-bottom: Black 2.5pt double; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           $          </font>         </td>         <td style="border-bottom: Black 2.5pt double; text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           41,368          </font>         </td>         <td style="padding-bottom: 2.5pt; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="padding-bottom: 2.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="border-bottom: Black 2.5pt double; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           $          </font>         </td>         <td style="border-bottom: Black 2.5pt double; text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           -          </font>         </td>         <td style="padding-bottom: 2.5pt; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>        </tr>       </tbody>      </table>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <!-- Field: Page; Sequence: 77; Value: 1 -->      <div style="margin-bottom: 6pt; border-bottom: Black 1.5pt solid">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="text-align: center; width: 100%">           F-           <!-- Field: Sequence; Type: Arabic; Name: PageNo -->           19           <!-- Field: /Sequence -->          </td>         </tr>        </tbody>       </table>      </div>      <div style="break-before: page; margin-top: 6pt">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="width: 100%">          </td>         </tr>        </tbody>       </table>      </div>      <!-- Field: /Page -->      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <u>         ConvertibleNote with FirstFire Global Opportunities Fund LLC        </u>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        OnJuly 2, 2020, RespireRx and FirstFire Global Opportunities Fund LLC (“FirstFire”) entered into a Securities PurchaseAgreement (the “FirstFire SPA”) pursuant to which FirstFire provided a sum of $125,000 (the “FirstFire Consideration”)to RespireRx, in return for a convertible promissory note (the “FirstFire Note”) with a face amount of $137,500 (whichdifference in value as compared to the FirstFire Consideration is due to an original issue discount of $12,500), a common stockpurchase warrant for 687,500 shares of the Company’s common stock (post-reverse stock split basis) (the “FirstFireWarrant”), and the Confession of Judgment (as defined below), among other agreements and obligations. The net proceeds ofthe First Fire Consideration, which were received by RespireRx on July 6, 2020, equal $121,000 after payment of $4,000 in FirstFire’slegal fees.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Underthe terms of the FirstFire SPA and the FirstFire Note, FirstFire paid the FirstFire Consideration at closing. The FirstFire Noteobligates RespireRx to pay interest at a rate of 10% per annum on any unpaid principal beginning on July 2, 2020, and to makefive monthly amortization payments in the amount of $30,250 each, with the first such payment due on December 2, 2020, and thefinal such payment, along with any unpaid principal and any accrued and unpaid interest and other fees, due April 2, 2021 (the“FirstFire Note Maturity Date”). Any amount of principal or interest that is not paid when due bears interest at therate of the lesser of 24% and the maximum amount permitted by law, from the due date to the date such amount is paid.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        FirstFirehas the right, at any time, to convert any outstanding and unpaid amount of the FirstFire Note into shares of RespireRx’sCommon Stock or securities convertible into RespireRx’s common stock, provided that such conversion would not result inFirstFire beneficially owning more than 4.99% of RespireRx’s then outstanding shares of Common Stock. Subject to certainlimitations and adjustments as described in the FirstFire Note, FirstFire may convert at a per share conversion price equal to$0.02 (the “FirstFire Fixed Conversion Price”), provided that upon any event of default, the conversion price willequal the lower of (i) the FirstFire Fixed Conversion Price, (ii) discount to market based upon subsequent financings with otherinvestors, or (iii) 60% multiplied by the lowest traded price of Common Stock during the twenty-one consecutive trading day periodimmediately preceding the date of such conversion. Upon such conversion, all rights with respect to the portion of the FirstFireNote being so converted terminate, except for the right to receive Common Stock or other securities, cash or other assets as providedin the FirstFire Note due upon such conversion.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        RespireRxmay, with prior written notice to FirstFire, prepay the outstanding principal amount under the FirstFire Note during the initial180 day period after the execution of the FirstFire SPA by making a payment to FirstFire of an amount in cash equal to a certainpercentage of the outstanding principal, interest, default interest and other amounts owed. Such percentage varies from 105% to115% depending on the period in which the prepayment occurs.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        TheFirstFire SPA provides FirstFire with certain participation rights in any subsequent offering of debt or equity. Under the FirstFireSPA, RespireRx may not enter into an offering of its securities with terms that would benefit an investor more than FirstFireis benefited under the FirstFire SPA and the agreements ancillary thereto, unless RespireRx offers FirstFire those same terms.The FirstFire SPA also grants FirstFire certain registration rights.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        TheFirstFire Warrant is a warrant to purchase 687,500 shares of Common Stock, for value received in connection with the issuanceof the FirstFire Note, from the date of issuance of the FirstFire Warrant until September 30, 2023, at an exercise price of $0.07(subject to adjustment as provided therein) per share of common stock.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Additionally,RespireRx provided a confession of judgment (the “Confession of Judgment”) in favor of FirstFire for the amount ofthe FirstFire Note plus fees and costs, to be filed pursuant to the terms and conditions of the FirstFire SPA and the FirstFireNote.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 39.65pt">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        TheCompany determined that there were no embedded derivatives to be identified, bifurcated and valued in connection with this financing.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <!-- Field: Page; Sequence: 78; Value: 1 -->      <div style="margin-bottom: 6pt; border-bottom: Black 1.5pt solid">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="text-align: center; width: 100%">           F-           <!-- Field: Sequence; Type: Arabic; Name: PageNo -->           20           <!-- Field: /Sequence -->          </td>         </tr>        </tbody>       </table>      </div>      <div style="break-before: page; margin-top: 6pt">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="width: 100%">          </td>         </tr>        </tbody>       </table>      </div>      <!-- Field: /Page -->      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 38.4pt">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Theoutstanding amounts of the FirstFire Note consist of the following at December 31, 2020 and December 31, 2019:       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">       <tbody>        <tr style="vertical-align: bottom">         <td style="text-align: center">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="padding-bottom: 1.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid">          <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            <b>             December                                         31,            </b>           </font>          </p>          <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            <b>             2020            </b>           </font>          </p>         </td>         <td style="padding-bottom: 1.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="padding-bottom: 1.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid">          <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            <b>             December                                         31,            </b>           </font>          </p>          <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            <b>             2019            </b>           </font>          </p>         </td>         <td style="padding-bottom: 1.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>        </tr>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td style="width: 60%; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           Principal amount of notes    payable          </font>         </td>         <td style="width: 2%">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="width: 1%; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           $          </font>         </td>         <td style="width: 16%; text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           137,500          </font>         </td>         <td style="width: 1%; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="width: 2%">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="width: 1%; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           $          </font>         </td>         <td style="width: 16%; text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           -          </font>         </td>         <td style="width: 1%; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>        </tr>        <tr style="vertical-align: bottom; background-color: White">         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           Unamortized portion of note discounts          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           (14,916          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           )          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           -          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>        </tr>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td style="text-align: left; padding-bottom: 1.5pt">          <font style="font-family: Times New Roman, Times, Serif">           Accrued interest    payable          </font>         </td>         <td style="padding-bottom: 1.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           6,856          </font>         </td>         <td style="padding-bottom: 1.5pt; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="padding-bottom: 1.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           -          </font>         </td>         <td style="padding-bottom: 1.5pt; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>        </tr>        <tr style="vertical-align: bottom; background-color: White">         <td style="padding-bottom: 2.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="padding-bottom: 2.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="border-bottom: Black 2.5pt double; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           $          </font>         </td>         <td style="border-bottom: Black 2.5pt double; text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           129,440          </font>         </td>         <td style="padding-bottom: 2.5pt; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="padding-bottom: 2.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="border-bottom: Black 2.5pt double; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           $          </font>         </td>         <td style="border-bottom: Black 2.5pt double; text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           -          </font>         </td>         <td style="padding-bottom: 2.5pt; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>        </tr>       </tbody>      </table>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <u>         ConvertibleNotes with PowerUp Lending Group Ltd.        </u>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        RespireRxand PowerUp Lending Group Ltd. (“PowerUp”) entered into two securities purchase agreements, dated as of April 15,2020 and June 7, 2020 (each, a “PowerUp Agreement”), by which Power Up loaned $53,000 and $43,000, respectively, toRespireRx in return for two convertible promissory notes (the “April 2020 Note” and the “June 2020 Note”respectively), a limited guaranty associated with the April 2020 Note, and the delivery into escrow of a confession of judgmentin favor of Power Up for the amount of the April 2020 Note plus fees and costs to be filed by Power Up upon the occurrence ofan Event of Default (as defined in the April 2020 Note) and other transaction-related documents associated with both the April2020 Note and the June 2020 Note. The proceeds of the loans, which equal $90,000 after payment of $5,000 in legal fees and $1,000in due diligence fees, were used for general corporate purposes.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        TheApril 2020 Note was repaid by conversion in October 2020. The June 2020 Note which would have payable on June 7, 2021, (the “June2020 Note Maturity Date”), and bears interest at a rate equal to 12% per annum, with any amount of principal or interestwhich is not paid when due bearing interest at the rate of 22% per annum was paid in full in December 2020.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 38.4pt">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Therewere no outstanding amounts due with respect to the April 2020 Note and June 2020 Note as of December 31, 2020.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 39.65pt">       <font style="font-family: Times New Roman, Times, Serif">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 39.65pt">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        OnOctober 22, 23 and 26, 2020, Power Up converted the outstanding principal amount and all accrued and unpaid interest related tothe April 2020 Note into 2,080,740 shares of Common Stock and as of October 26, 2020 the April 2020 Note is deemed repaid andterminated. On December 14, 2020 and December 15, 2020, converted the outstanding principal amount and all accrued and unpaidinterest related to the June 2020 Note into 3,506,153 shares of Common Stock (post-reverse stock split basis) and the June 2020Note is deemed repaid and terminated.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 39.65pt">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 39.65pt">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <u>         2019Convertible Notes        </u>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 39.65pt">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        OnApril, 24, 2019, May 17, 2019, August 19, 2019, October 22, 2019 and November 4, 2019, the Company issued a series of convertiblenotes (“2019 Convertible Notes”), all similar in nature, all subject to debt issuance costs (“DIC”) andoriginal issue discount (“OID”) and beneficial conversion (“BCF”) features and some subject to the issuanceof warrants (“NW”) and/or commitment shares (“CS”) and placement agent fees. Two of the notes had maturitydates nine months after issuance and three were for one year. One note was a master note agreement in the amount of $150,000,but with an initial drawdown of $50,000. The Company evaluated all of the terms of the 2019 Convertible Notes and determined that,in accordance with ASC 815, there were no derivatives to be bifurcated or separately valued. Each of the April, 24, 2019, May17, 2019, August 19, 2019, October 22, 2019 and November 4, 2019 Convertible Notes was satisfied in full by the lenders electingto convert the outstanding balances to Common Stock, except for $2,747 of accrued interest that remains outstanding under theMay 17, 2019 Convertible Note.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 39.65pt">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">       <tbody>        <tr style="vertical-align: bottom">         <td style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">          <font style="font-family: Times New Roman, Times, Serif">           Inception    date          </font>         </td>         <td style="font-weight: bold; padding-bottom: 1.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">          <font style="font-family: Times New Roman, Times, Serif">           Maturity    date          </font>         </td>         <td style="font-weight: bold; padding-bottom: 1.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">          <font style="font-family: Times New Roman, Times, Serif">           Original    principal amount          </font>         </td>         <td style="padding-bottom: 1.5pt; font-weight: bold">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="font-weight: bold; padding-bottom: 1.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">          <font style="font-family: Times New Roman, Times, Serif">           Interest    rate          </font>         </td>         <td style="padding-bottom: 1.5pt; font-weight: bold">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="font-weight: bold; padding-bottom: 1.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">          <font style="font-family: Times New Roman, Times, Serif">           Original    aggregate DIC, OID, BCF, NW and CS          </font>         </td>         <td style="padding-bottom: 1.5pt; font-weight: bold">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="font-weight: bold; padding-bottom: 1.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">          <font style="font-family: Times New Roman, Times, Serif">           Cumulative    amortization of DIC, OID, BCF, NW and CS          </font>         </td>         <td style="padding-bottom: 1.5pt; font-weight: bold">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="padding-bottom: 1.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid">          <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            <b>             Principal                                         remaining            </b>           </font>          </p>          <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            <b>             at            </b>           </font>          </p>          <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            <b>             December                                         31, 2020            </b>           </font>          </p>         </td>         <td style="padding-bottom: 1.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="font-weight: bold; padding-bottom: 1.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">          <font style="font-family: Times New Roman, Times, Serif">           Accrued    Interest at December 31, 2020          </font>         </td>         <td style="padding-bottom: 1.5pt; font-weight: bold">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="font-weight: bold; padding-bottom: 1.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">          <font style="font-family: Times New Roman, Times, Serif">           Balance    sheet carrying amount at December 31, 2020 inclusive of accrued interest          </font>         </td>         <td style="padding-bottom: 1.5pt; font-weight: bold">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>        </tr>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td style="width: 13%; padding-bottom: 1.5pt">          <font style="font-family: Times New Roman, Times, Serif">           May 17, 2019          </font>         </td>         <td style="width: 2%; padding-bottom: 1.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="width: 13%; padding-bottom: 1.5pt">          <font style="font-family: Times New Roman, Times, Serif">           May 17, 2020, extended    to November 17, 2020          </font>         </td>         <td style="width: 2%; padding-bottom: 1.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           $          </font>         </td>         <td style="width: 6%; border-bottom: Black 1.5pt solid; text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           50,000          </font>         </td>         <td style="width: 1%; padding-bottom: 1.5pt; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="width: 2%; padding-bottom: 1.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="width: 5%; border-bottom: Black 1.5pt solid; text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           10          </font>         </td>         <td style="width: 1%; padding-bottom: 1.5pt; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           %          </font>         </td>         <td style="width: 2%; padding-bottom: 1.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           $          </font>         </td>         <td style="width: 7%; border-bottom: Black 1.5pt solid; text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           50,000          </font>         </td>         <td style="width: 1%; padding-bottom: 1.5pt; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="width: 2%; padding-bottom: 1.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           $          </font>         </td>         <td style="width: 7%; border-bottom: Black 1.5pt solid; text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           50,000          </font>         </td>         <td style="width: 1%; padding-bottom: 1.5pt; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="width: 2%; padding-bottom: 1.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           $          </font>         </td>         <td style="width: 6%; border-bottom: Black 1.5pt solid; text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           -          </font>         </td>         <td style="width: 1%; padding-bottom: 1.5pt; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="width: 2%; padding-bottom: 1.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           $          </font>         </td>         <td style="width: 6%; border-bottom: Black 1.5pt solid; text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           2,747          </font>         </td>         <td style="width: 1%; padding-bottom: 1.5pt; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="width: 2%; padding-bottom: 1.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           $          </font>         </td>         <td style="width: 7%; border-bottom: Black 1.5pt solid; text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           2,747          </font>         </td>         <td style="width: 1%; padding-bottom: 1.5pt; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>        </tr>        <tr style="vertical-align: bottom; background-color: White">         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>        </tr>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td style="padding-bottom: 2.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="padding-bottom: 2.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="padding-bottom: 2.5pt">          <font style="font-family: Times New Roman, Times, Serif">           Total          </font>         </td>         <td style="padding-bottom: 2.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="border-bottom: Black 2.5pt double; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           $          </font>         </td>         <td style="border-bottom: Black 2.5pt double; text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           50,000          </font>         </td>         <td style="padding-bottom: 2.5pt; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="padding-bottom: 2.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="border-bottom: Black 2.5pt double; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="border-bottom: Black 2.5pt double; text-align: right">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="padding-bottom: 2.5pt; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="padding-bottom: 2.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="border-bottom: Black 2.5pt double; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           $          </font>         </td>         <td style="border-bottom: Black 2.5pt double; text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           50,000          </font>         </td>         <td style="padding-bottom: 2.5pt; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="padding-bottom: 2.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="border-bottom: Black 2.5pt double; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           $          </font>         </td>         <td style="border-bottom: Black 2.5pt double; text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           50,000          </font>         </td>         <td style="padding-bottom: 2.5pt; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="padding-bottom: 2.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="border-bottom: Black 2.5pt double; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           $          </font>         </td>         <td style="border-bottom: Black 2.5pt double; text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           -          </font>         </td>         <td style="padding-bottom: 2.5pt; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="padding-bottom: 2.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="border-bottom: Black 2.5pt double; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           $          </font>         </td>         <td style="border-bottom: Black 2.5pt double; text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           2,747          </font>         </td>         <td style="padding-bottom: 2.5pt; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="padding-bottom: 2.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="border-bottom: Black 2.5pt double; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           $          </font>         </td>         <td style="border-bottom: Black 2.5pt double; text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           2,747          </font>         </td>         <td style="padding-bottom: 2.5pt; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>        </tr>       </tbody>      </table>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <!-- Field: Page; Sequence: 79; Value: 1 -->      <div style="margin-bottom: 6pt; border-bottom: Black 1.5pt solid">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="text-align: center; width: 100%">           F-           <!-- Field: Sequence; Type: Arabic; Name: PageNo -->           21           <!-- Field: /Sequence -->          </td>         </tr>        </tbody>       </table>      </div>      <div style="break-before: page; margin-top: 6pt">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="width: 100%">          </td>         </tr>        </tbody>       </table>      </div>      <!-- Field: /Page -->      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 39.65pt">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        OnDecember 6, 2018, December 7, 2018 and December 31, 2018 the Company issued convertible notes (each a “2018 Q4 Note”)and on January 2, 2019, February 27, 2019, March 6, 2019 and March 14, 2019, the Company issued additional convertible notes (eacha “2019 Q1 Note”, respectively and collectively with the “2018 Q4, the “2018 Q4 and 2019 Q1 Notes”)bearing interest at 10% per year. All of the 2018 Q4 and 2019 Q1 Notes matured on either February 28, 2019 or April 30, 2019.The original aggregate principal amount was $190,000. None of the 2018 Q4 and 2019 Q1 Notes were repaid at maturity. The 2018Q4 and 2019 Q1 Note investors also received an aggregate of 19,000 common stock purchase warrants. The warrants were valued usingthe Black Scholes option pricing model calculated on the date of each grant and had an aggregate value of $146,805. Total valuereceived by the investors was $336,805, the sum of the face value of the convertible note and the value of the warrant. Therefore,the Company recorded a debt discount associated with the warrant issuance of $82,159 and an initial value of the convertible notesof $107,841 using the relative fair value method. All debt discounts were fully amortized by the original maturity dates. On March21, 2020, all except one of the 2018 Q4 and 2019 Q1 Note holders exchanged the outstanding principal amount and accrued interestfor shares of common stock. The exchange price was $0.15 per share of common stock. The closing price on March 20, 2020, the lasttrading day before the closing of the exchange agreements which took place on a Saturday, was $0.34 per share of common stock.An aggregate of $155,000 of principal and $17,911 of accrued interest was exchanged for 1,152,740 shares of common stock.The Company recorded a loss on the extinguishment of the exchanged 2018 Q4 Notes and 2019 Q1 Notes of $219,021. As of December31, 2020, there remains one outstanding 2018 Q4 Note and one outstanding 2019 Q1 Note, both held by the same single investor,with an aggregate principal amount of $35,000 and aggregate accrued interest of $7,201 as of December 31, 2020. The 2019 ConvertibleNotes discussed above, which the Company does not consider to have arisen from one or more offerings, may be interpreted in sucha way that the remaining 2018 Q4 Note and 2019 Q1 Note holders had the right to convert or exchange into such notes. However,no holder of the Q4 2018 and 2019 Notes has requested such a conversion or exchange. The Company does not believe that an offeringoccurred as of December 31, 2020 or as of the date of the issuance of these financial statements. Therefore, the number of sharesof common stock (or preferred stock) into which the remaining 2018 Q4 Note and the remaining 2019 Q1 Note may convert is not determinableand the Company has not accounted for any additional consideration. The warrants to purchase 19,000 shares of common stockissued in connection with the sale of the 2018 Q4 and 2019 Q1 Notes are exercisable at a fixed price of $15.00 per shareof common stock, provide no right to receive a cash payment, and included no reset rights or other protections based on subsequentequity transactions, equity-linked transactions or other events. The warrants issued to the Q4 2018 and Q1 2019 Note holders expireon December 30, 2023. The Company determined that there were no embedded derivatives to be identified, bifurcated and valued inconnection with this financing.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 38.4pt">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 39.65pt">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        The2018 Q4 Notes and 2019 Q1 Notes consist of the following at December 31, 2020 and December 31, 2019:       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">       <tbody>        <tr style="vertical-align: bottom">         <td style="text-align: center">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="padding-bottom: 1.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid">          <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            <b>             December                                         31,            </b>           </font>          </p>          <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            <b>             2020            </b>           </font>          </p>         </td>         <td style="padding-bottom: 1.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="padding-bottom: 1.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid">          <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            <b>             December                                         31,            </b>           </font>          </p>          <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            <b>             2019            </b>           </font>          </p>         </td>         <td style="padding-bottom: 1.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>        </tr>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td style="width: 60%; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           Principal amount of notes    payable          </font>         </td>         <td style="width: 2%">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="width: 1%; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           $          </font>         </td>         <td style="width: 16%; text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           35,000          </font>         </td>         <td style="width: 1%; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="width: 2%">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="width: 1%; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           $          </font>         </td>         <td style="width: 16%; text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           190,000          </font>         </td>         <td style="width: 1%; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>        </tr>        <tr style="vertical-align: bottom; background-color: White">         <td style="text-align: left; padding-bottom: 1.5pt">          <font style="font-family: Times New Roman, Times, Serif">           Accrued interest    payable          </font>         </td>         <td style="padding-bottom: 1.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           7,201          </font>         </td>         <td style="padding-bottom: 1.5pt; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="padding-bottom: 1.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           17,976          </font>         </td>         <td style="padding-bottom: 1.5pt; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>        </tr>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td style="padding-bottom: 2.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="padding-bottom: 2.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="border-bottom: Black 2.5pt double; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           $          </font>         </td>         <td style="border-bottom: Black 2.5pt double; text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           42,201          </font>         </td>         <td style="padding-bottom: 2.5pt; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="padding-bottom: 2.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="border-bottom: Black 2.5pt double; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           $          </font>         </td>         <td style="border-bottom: Black 2.5pt double; text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           207,976          </font>         </td>         <td style="padding-bottom: 2.5pt; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>        </tr>       </tbody>      </table>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <!-- Field: Page; Sequence: 80; Value: 1 -->      <div style="margin-bottom: 6pt; border-bottom: Black 1.5pt solid">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="text-align: center; width: 100%">           F-           <!-- Field: Sequence; Type: Arabic; Name: PageNo -->           22           <!-- Field: /Sequence -->          </td>         </tr>        </tbody>       </table>      </div>      <div style="break-before: page; margin-top: 6pt">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="width: 100%">          </td>         </tr>        </tbody>       </table>      </div>      <!-- Field: /Page -->      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 38.4pt">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Otherconvertible notes were also sold to investors in 2014 and 2015 (the “Original Convertible Notes), which aggregated a totalof $579,500, and had a fixed interest rate of 10% per annum. The Original Convertible Notes have no reset rights or other protectionsbased on subsequent equity transactions, equity-linked transactions or other events. The warrants to purchase shares of commonstock issued in connection with the sale of the Original Convertible Notes have either been exchanged for common stock or expired.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 38.4pt">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 38.4pt">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        OnMarch 21, 2020, the holder of one of the Original Convertible Notes exchanged $50,000 of principal and $32,875 of accrued interestfor 552,501 shares of the Company’s common stock. The exchange price was $0.15 per share of common stock. The closingprice on March 20, 2020, the last trading day before the closing of the exchange agreements, was $0.34 per share of common stock.The Company recorded a loss on the extinguishment of the exchanged Original Convertible Note of $104,975.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 38.4pt">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 38.4pt">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Theremaining outstanding Original Convertible Notes (including that for which a default notice has been received) consist of thefollowing at December 31, 2020 and December 31, 2019:       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">       <tbody>        <tr style="vertical-align: bottom">         <td style="text-align: center">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="padding-bottom: 1.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid">          <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            <b>             December                                         31,            </b>           </font>          </p>          <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            <b>             2020            </b>           </font>          </p>         </td>         <td style="padding-bottom: 1.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="padding-bottom: 1.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid">          <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            <b>             December                                         31,            </b>           </font>          </p>          <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            <b>             2019            </b>           </font>          </p>         </td>         <td style="padding-bottom: 1.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>        </tr>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td style="width: 60%; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           Principal amount of notes    payable          </font>         </td>         <td style="width: 2%">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="width: 1%; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           $          </font>         </td>         <td style="width: 16%; text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           75,000          </font>         </td>         <td style="width: 1%; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="width: 2%">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="width: 1%; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           $          </font>         </td>         <td style="width: 16%; text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           125,000          </font>         </td>         <td style="width: 1%; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>        </tr>        <tr style="vertical-align: bottom; background-color: White">         <td style="text-align: left; padding-bottom: 1.5pt">          <font style="font-family: Times New Roman, Times, Serif">           Accrued interest    payable          </font>         </td>         <td style="padding-bottom: 1.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           64,357          </font>         </td>         <td style="padding-bottom: 1.5pt; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="padding-bottom: 1.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           82,060          </font>         </td>         <td style="padding-bottom: 1.5pt; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>        </tr>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td style="padding-bottom: 2.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="padding-bottom: 2.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="border-bottom: Black 2.5pt double; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           $          </font>         </td>         <td style="border-bottom: Black 2.5pt double; text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           139,357          </font>         </td>         <td style="padding-bottom: 2.5pt; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="padding-bottom: 2.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="border-bottom: Black 2.5pt double; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           $          </font>         </td>         <td style="border-bottom: Black 2.5pt double; text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           207,060          </font>         </td>         <td style="padding-bottom: 2.5pt; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>        </tr>       </tbody>      </table>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 38.4pt">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Asof December 31, 2020, principal and accrued interest on the Original Convertible Note that is subject to a default notice accruesannual interest at 12% instead of 10%, totaled $48,700, of which $23,700 was accrued interest. As of December 31, 2019, principaland accrued interest on Original Convertible Notes subject to default notices totaled $43,666 of which $18,666 was accrued interest.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 38.4pt">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Asof December 31, 2020 all of the outstanding Original Convertible Notes, inclusive of accrued interest, were convertible into anaggregate of 1,225 shares of the Company’s common stock (post-reverse stock split basis). Such Original Convertible Noteswill continue to accrue interest until exchanged, paid or otherwise discharged. There can be no assurance that any of the additionalholders of the remaining Original Convertible Notes will exchange their Original Convertible Notes.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         NotePayable to SY Corporation Co., Ltd.        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        OnJune 25, 2012, the Company borrowed 465,000,000 Won (the currency of South Korea, equivalent to approximately $400,000 UnitedStates Dollars) from and executed a secured note payable to SY Corporation Co., Ltd., formerly known as Samyang Optics Co. Ltd.(“SY Corporation”), an approximately 20% common stockholder of the Company at that time. SY Corporation was a significantstockholder and a related party at the time of the transaction, but has not been a significant stockholder or related party ofthe Company subsequent to December 31, 2014. The note accrues simple interest at the rate of 12% per annum and had a maturitydate of June 25, 2013. The Company has not made any payments on the promissory note. At June 30, 2013 and subsequently, the promissorynote was outstanding and in default, although SY Corporation has not issued a notice of default or a demand for repayment. TheCompany believes that SY Corporation is in default of its obligations under its January 2012 license agreement, as amended, withthe Company, but the Company has not yet issued a notice of default. The Company intends to continue efforts towards a comprehensiveresolution of the aforementioned matters involving SY Corporation.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <!-- Field: Page; Sequence: 81; Value: 1 -->      <div style="margin-bottom: 6pt; border-bottom: Black 1.5pt solid">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="text-align: center; width: 100%">           F-           <!-- Field: Sequence; Type: Arabic; Name: PageNo -->           23           <!-- Field: /Sequence -->          </td>         </tr>        </tbody>       </table>      </div>      <div style="break-before: page; margin-top: 6pt">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="width: 100%">          </td>         </tr>        </tbody>       </table>      </div>      <!-- Field: /Page -->      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Thepromissory note is secured by collateral that represents a lien on certain patents owned by the Company, including compositionof matter patents for certain of the Company’s high impact ampakine compounds and the low impact ampakine compounds CX2007and CX2076, and other related compounds. The security interest does not extend to the Company’s patents for its ampakinecompounds CX1739 and CX1942, or to the patent for the use of ampakine compounds for the treatment of respiratory depression.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Notepayable to SY Corporation consists of the following at December 31, 2020 and 2019:       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">       <tbody>        <tr style="vertical-align: bottom">         <td style="text-align: center">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="font-weight: bold; padding-bottom: 1.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">          <font style="font-family: Times New Roman, Times, Serif">           December    31, 2020          </font>         </td>         <td style="padding-bottom: 1.5pt; font-weight: bold">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="font-weight: bold; padding-bottom: 1.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">          <font style="font-family: Times New Roman, Times, Serif">           December    31, 2019          </font>         </td>         <td style="padding-bottom: 1.5pt; font-weight: bold">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>        </tr>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td style="width: 60%; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           Principal amount of note    payable          </font>         </td>         <td style="width: 2%">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="width: 1%; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           $          </font>         </td>         <td style="width: 16%; text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           399,774          </font>         </td>         <td style="width: 1%; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="width: 2%">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="width: 1%; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           $          </font>         </td>         <td style="width: 16%; text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           399,774          </font>         </td>         <td style="width: 1%; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>        </tr>        <tr style="vertical-align: bottom; background-color: White">         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           Accrued interest payable          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           411,384          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           363,280          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>        </tr>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td style="text-align: left; padding-bottom: 1.5pt">          <font style="font-family: Times New Roman, Times, Serif">           Foreign currency    transaction adjustment          </font>         </td>         <td style="padding-bottom: 1.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           53,393          </font>         </td>         <td style="padding-bottom: 1.5pt; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="padding-bottom: 1.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           3,182          </font>         </td>         <td style="padding-bottom: 1.5pt; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>        </tr>        <tr style="vertical-align: bottom; background-color: White">         <td style="padding-bottom: 2.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="padding-bottom: 2.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="border-bottom: Black 2.5pt double; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           $          </font>         </td>         <td style="border-bottom: Black 2.5pt double; text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           864,551          </font>         </td>         <td style="padding-bottom: 2.5pt; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="padding-bottom: 2.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="border-bottom: Black 2.5pt double; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           $          </font>         </td>         <td style="border-bottom: Black 2.5pt double; text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           766,236          </font>         </td>         <td style="padding-bottom: 2.5pt; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>        </tr>       </tbody>      </table>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Interestexpense with respect to this promissory note was $48,104 and $47,971 for years ended December 31, 2020 and 2019, respectively.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         Advancesfrom and Notes Payable to Officers        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        OnJanuary 29, 2016, Dr. Arnold S. Lippa, the Company’s Interim President, Interim Chief Executive Officer, Chief ScientificOfficer and Chairman of the Board of Directors, advanced $52,600 to the Company for working capital purposes under a demand promissorynote with interest at 10% per annum. On September 23, 2016, Dr. Lippa advanced $25,000 to the Company for working capital purposesunder a second demand promissory note with interest at 10% per annum. The notes are secured by the assets of the Company. Additionally,on April 9, 2018, Dr. Lippa advanced another $50,000 to the Company as discussed in more detail below.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        OnFebruary 2, 2016, Dr. James S. Manuso, the Company’s then Chief Executive Officer and Vice Chairman of the Board of Directors,advanced $52,600 to the Company for working capital purposes under a demand promissory note with interest at 10% per annum. OnSeptember 22, 2016, Dr. Manuso, advanced $25,000 to the Company for working capital purposes under a demand promissory note withinterest at 10% per annum. The notes are secured by the assets of the Company. Additionally, on April 9, 2018, Dr. Manuso advancedanother $50,000 to the Company as discussed in more detail below.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        OnApril 9, 2018, Dr. Arnold S. Lippa, the Company’s Interim President, Interim Chief Executive Officer, Chief Scientific Officerand Chairman of the Board of Directors and Dr. James S. Manuso, the Company’s then Chief Executive Officer and Vice Chairmanof the Board of Directors, advanced $50,000 each, for a total of $100,000, to the Company for working capital purposes. Each noteis payable on demand after June 30, 2018. Each note was subject to a mandatory exchange provision that provided that the principalamount of the note would be mandatorily exchanged into a board approved offering of the Company’s securities, if such offeringheld its first closing on or before June 30, 2018 and the amount of proceeds from such first closing was at least $150,000, notincluding the principal amounts of the notes that would be exchanged, or $250,000 including the principal amounts of such notes.Upon such exchange, the notes would be deemed repaid and terminated. Any accrued but unpaid interest outstanding at the time ofsuch exchange will be (i) repaid to the note holder or (ii) invested in the offering, at the note holder’s election. A firstclosing did not occur on or before June 30, 2018. Dr. Arnold S. Lippa agreed to exchange his note into the board approved offeringthat had its initial closing on September 12, 2018. Accrued interest on Dr. Lippa’s note was not exchanged. As of December31, 2020, Dr. James S. Manuso had not exchanged his note.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <!-- Field: Page; Sequence: 82; Value: 1 -->      <div style="margin-bottom: 6pt; border-bottom: Black 1.5pt solid">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="text-align: center; width: 100%">           F-           <!-- Field: Sequence; Type: Arabic; Name: PageNo -->           24           <!-- Field: /Sequence -->          </td>         </tr>        </tbody>       </table>      </div>      <div style="break-before: page; margin-top: 6pt">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="width: 100%">          </td>         </tr>        </tbody>       </table>      </div>      <!-- Field: /Page -->      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Duringthe year ended December 31, 2020, Dr. Lippa advanced on an interest free basis the Company $65,000 of which $16,036 was repaidto Dr. Lippa. The outstanding balance of the advance is payable on demand.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Duringthe year ended December 31, 2020, Mr. Margolis advanced $10,775 to which when aggregated with the outstanding balance of $5,500as of the beginning of the fiscal year, was $16,275, all of which was repaid by the Company during the fiscal year ended December31, 2020.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Forthe fiscal years ended December 31, 2020 and 2019, $11,329 and $10,272 was charged to interest expense with respect to Dr. Lippa’snotes, respectively.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Forthe fiscal years ended December 31, 2020 and 2019, $16,988 and $15,416 was charged to interest expense with respect to Dr. JamesS. Manuso’s notes, respectively.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Asof September 30, 2018, Dr. James S. Manuso resigned his executive officer positions and as a member of the Board of Directorsof the Company. All of the interest expense noted above for 2020 and 2019 was incurred while Dr. Manuso was no longer an officer.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         OtherShort-Term Notes Payable        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Othershort-term notes payable at December 31, 2020 and December 31, 2019 consisted of premium financing agreements with respect tovarious insurance policies. At December 31, 2020, a premium financing agreement was payable in the initial amount of $70,762,with interest at 11% per annum, in ten monthly installments of $8,256, and another premium financing arrangement was payable inthe initial amount of $9,215 payable in equal quarterly installments. At December 31, 2020 and 2019, the aggregate amount of theshort-term notes payable was $4,608 and $4,635 respectively.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         5.Settlement and Payment Agreements        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif">        OnFebruary 21, 2020, Sharp Clinical Services, Inc. (“Sharp”), a vendor of the Company, filed a complaint against theCompany in the Superior Court of New Jersey Law Division, Bergen County related to a December 16, 2019 demand for payment of pastdue invoices inclusive of late fees totaling $103,890 of which $3,631 related to late fees, seeking $100,259 plus 1.5% interestper month on outstanding unpaid invoices. Amid settlement discussions, the vendor stated on March 13, 2020 its intent to proceedto a default judgment against the Company, and the Company stated on March 14, 2020 its intent to continue settlement discussions.On May 29, 2020, a default was entered against the Company, and on September 4, 2020, a final judgment by default was enteredagainst the Company in the amount of $104,217. The Company has recorded a liability to Sharp of $103,859 as of December 31, 2020.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif">        OnFebruary 23, 2021 our bank received two New Jersey Superior Court Levies totaling $320,911 related to amounts owed to two vendors(Sharp and Salamandra as defined below and herein) which amounts were not in dispute, debited our accounts and restricted accessto those accounts. Our accounts were debited for $1,559 on February 23, 2021 which represented all of the cash in our accountson that date.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        OnMarch 3, 2021, we executed a settlement agreement with one of the two vendors noted below (the “Sharp Settlement Agreement”).The Sharp Settlement Agreement calls for a payment schedule totaling $100,000 in ten bi-monthly installments which beganon April 1, 2021 and are due every other month thereafter and permits early settlement at $75,000 if the Company pays Sharpthat lower total by August 1, 2021. The first $10,000 payment that which was due on April 1, 2021, was paid on March 23,2021. On March 9, 2021, Sharp requested of the Bergen (NJ) County Sheriff, the return of the Writ of Execution which resultedin a release of the lien.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <!-- Field: Page; Sequence: 83; Value: 1 -->      <div style="margin-bottom: 6pt; border-bottom: Black 1.5pt solid">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="text-align: center; width: 100%">           F-           <!-- Field: Sequence; Type: Arabic; Name: PageNo -->           25           <!-- Field: /Sequence -->          </td>         </tr>        </tbody>       </table>      </div>      <div style="break-before: page; margin-top: 6pt">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="width: 100%">          </td>         </tr>        </tbody>       </table>      </div>      <!-- Field: /Page -->      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif">        By       </font>       <font style="font-family: Times New Roman, Times, Serif">        letter dated February 5, 2016, the Company received a demandfrom a law firm representing Salamandra, LLC (“Salamandra”) alleging an amount due and owing for unpaid servicesrendered. On January 18, 2017, following an arbitration proceeding, an arbitrator awarded Salamandra the full amount soughtin arbitration of $146,082. Additionally, the arbitrator granted Salamandra attorneys’ fees and costs of $47,937.All such amounts have been accrued as of December 31, 2020 and December 31, 2019, including accrued interest at 4.5% annuallyfrom February 26, 2018, the date of the judgment, through December 31, 2020, totaling $24,129.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif">        OnAugust 21, 2019, RespireRx and Salamandra entered into a settlement agreement and release, which was amended on December 16, 2019(as amended, the “Salamandra Settlement Agreement”), regarding $202,395 owed by the Company to Salamandra (as reducedby any further payments by the Company to Salamandra, the “Full Amount”) in connection with the above-mentioned arbitrationaward. Under the Salamandra Settlement Agreement, (i) the Company paid to Salamandra $25,000 before December 21, 2019, and uponsuch payment, Salamandra ceased all collection efforts against the Company until March 31, 2020, and (ii) the Company was to payto Salamandra by March 31, 2020 an amount equal to 21% of the working capital amount raised by that date, which would have reducedthe Full Amount owed on a dollar-for-dollar basis. The Company did not make the required payment on March 31, 2020 and has notmade any subsequent payments other than what may have been received by Salamandra pursuant to the levies described above.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif">        <font style="font-size: 10pt">        </font>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        OnSeptember 23, 2019, the Company and a vendor agreed in principle to a proposed settlement agreement, which has not resulted ina formal agreement. In February 2020, the Company and the vendor discussed amendments to this agreement in principal. Thediscussions included, among other things, an extension of time to raise the amount discussed below.  The Company and thevendor are continuing discussions in an attempt to reach a formal settlement agreement.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 39.3pt">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Thedue date of the $100,000 annual amount payable to the University of Illinois that was originally due on December 31, 2020 pursuantto the 2014 License Agreement was extended to April 19, 2021 and was paid in full on April 1, 2021.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 39.3pt">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 38.4pt">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Byemail dated July 21, 2016, the Company received a demand from an investment banking consulting firm that represented the Companyin 2012 in conjunction with the Pier transaction alleging that $225,000 is due and payable for investment banking services rendered.Such amount has been included in accrued expenses at December 31, 2020 and December 31, 2019.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        TheCompany is periodically the subject of various pending and threatened legal actions and claims. In the opinion of management ofthe Company, adequate provision has been made in the Company’s consolidated financial statements as of December 31, 2020and December 31, 2019 with respect to such matters, including, specifically, the matters noted above. The Company intends to vigorouslydefend itself if any of the matters described above results in the filing of a lawsuit or formal claim.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <!-- Field: Page; Sequence: 84; Value: 1 -->      <div style="margin-bottom: 6pt; border-bottom: Black 1.5pt solid">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="text-align: center; width: 100%">           F-           <!-- Field: Sequence; Type: Arabic; Name: PageNo -->           26           <!-- Field: /Sequence -->          </td>         </tr>        </tbody>       </table>      </div>      <div style="break-before: page; margin-top: 6pt">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="width: 100%">          </td>         </tr>        </tbody>       </table>      </div>      <!-- Field: /Page -->      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         6.Stockholders’ Deficiency        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         PreferredStock        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        RespireRxhas authorized a total of 5,000,000 shares of preferred stock, par value $0.001 per share. As of December 31, 2020 and December31, 2019, 1,250,000 shares were designated as 9% Cumulative Convertible Preferred Stock; 37,500 shares were designated as SeriesB Convertible Preferred Stock (non-voting, “Series B Preferred Stock”); 205,000 shares were designated as Series AJunior Participating Preferred Stock; 1,700 shares were designated as Series G 1.5% Convertible Preferred Stock. On July 13, 2020,RespireRx designated 1,200 shares of Series H, Voting, Non-participating, Convertible Preferred Stock (“Series H PreferredStock”) and on September 30, 2020 RespireRx amended the Certificate of Designation of the Series H Preferred Stock to increasethe number of shares of Series H Preferred Stock to 3,000 shares. On July 13, 2020 and September 30, 2020, RespireRx issued anaggregate of 1,624.1552578 shares of Series H Preferred Stock inclusive of 2% accrued dividends, all of which converted on September30, 2020 into 25,377,426 shares of Common Stock and warrants to purchase 25,377,426 shares of Common Stock, and therefore as ofthat time on September 30, 2020, there were no shares of Series H Preferred Stock outstanding. Under the Certificate of Designationof the Series H Preferred Stock, shares of Series H Preferred Stock converted or redeemed by conversion are to be canceled andare not to be reissued. Accordingly, on December 31, 2020 and 2019, 3,504,424.1552578 shares of preferred stock and 3,505,800shares of preferred stock, respectively, were undesignated and were able to be issued with such rights and powers as the Boardof Directors may designate.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        SeriesB Preferred Stock outstanding as of December 31, 2020 and 2019 consisted of 37,500 shares issued in a May 1991 private placement.Each share of Series B Preferred Stock is convertible into approximately 0.000030 shares of common stock at an effective conversionprice of $22,083.75 per share of common stock, which is subject to adjustment under certain circumstances. As of December 31,2020 and December 31, 2019, the shares of Series B Preferred Stock outstanding are convertible into 1 share of common stock. RespireRxmay redeem the Series B Preferred Stock for $25,001, equivalent to $0.6667 per share, an amount equal to its liquidation preference,at any time upon 30 days prior notice.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         CommonStock        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Thereare 71,271,095 shares of the Company’s Common Stock outstanding as of December 31, 2020. After reserving for conversionsof convertible debt as well as common stock purchase options and warrants exercises before accounting for incremental contractexcess reserves, there were 1,870,650,077 shares of the Company’s Common Stock available for future issuances asof December 31, 2020. After accounting for incremental excess reserves required by the FirstFire Note, the EMA Note, the CrownBridge unpaid accrued interest, and the White Lion Note as well the FirstFire Warrant, the EMA warrant, aggregating 68,777,142and other outstanding convertible notes and all outstanding options and warrants, there were 1,801,872,935, shares of commonstock available for future issuances as of December 31, 2020. Each conversion or exercise on a convertible note, or option orwarrant, as appropriate reduces the excess reserve requirements. The FirstFire Note and EMA Note were converted in full in 2021and the White Lion Note was converted in part in 2021. No warrants or options were exercised after December 31, 2020. See Note10. Subsequent Events in the notes to our consolidated financial statements as of December 31, 2020.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <!-- Field: Page; Sequence: 85; Value: 1 -->      <div style="margin-bottom: 6pt; border-bottom: Black 1.5pt solid">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="text-align: center; width: 100%">           F-           <!-- Field: Sequence; Type: Arabic; Name: PageNo -->           27           <!-- Field: /Sequence -->          </td>         </tr>        </tbody>       </table>      </div>      <div style="break-before: page; margin-top: 6pt">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="width: 100%">          </td>         </tr>        </tbody>       </table>      </div>      <!-- Field: /Page -->      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         CommonStock Warrants        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">       As part of our priordebt financings with FirstFire, EMA and Crown Bridge, the Company issued warrants that contained anti-dilution provisions thatrequired a reduction to the exercise price and an increase to the number of warrant shares in the event that we issued equityinstruments with a lower price than the exercise price. During the year ended December 31, 2020, we adjusted downward the warrantexercise price for these warrants. The resulting fair value of the warrants with the new exercise price was $1,440,214, recordedas a deemed dividend in our consolidated statements of stockholders’ deficiency. As the Company has an accumulated deficit,the deemed dividend was recorded within additional paid-in capital.      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        OnSeptember 30, 2020, the Company issued warrants exercisable into 25,377,426 of commons stock at $0.07 per share and expiring onSeptember 30, 2023 which issuance occurred upon the conversion of all Series H Preferred Stock into common stock and warrantson September 30, 2020.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        OnJuly 30, 2020, the Company issued warrants exercisable into 375,000 shares of common stock at an exercise price of $0.07 per shareand expiring on September 30, 2023.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        OnJuly 2, 2020, the Company issued warrants exercisable into 687,500 shares of common stock at an exercise price of $0.07 per shareand expiring on September 30, 2023.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Duringthe fiscal year ended December 31, 2020, inclusive of anti-dilution provisions, the Company issued warrants exercisable into 13,145,114shares of common stock at exercise prices ranging from $0.01485 to $0.03416 of which 10,969,352 were exercised.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Asummary of warrant activity for the year ended December 31, 2020 is presented below.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">       <tbody>        <tr style="vertical-align: bottom">         <td style="text-align: center">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="padding-bottom: 1.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid">          <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            <b>             Number                                         of            </b>           </font>          </p>          <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            <b>             Shares            </b>           </font>          </p>         </td>         <td style="padding-bottom: 1.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="padding-bottom: 1.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid">          <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            <b>             Weighted            </b>           </font>          </p>          <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            <b>             Average            </b>           </font>          </p>          <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            <b>             Exercise                                         Price            </b>           </font>          </p>         </td>         <td style="padding-bottom: 1.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="padding-bottom: 1.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid">          <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            <b>             Weighted            </b>           </font>          </p>          <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            <b>             Average            </b>           </font>          </p>          <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            <b>             Remaining            </b>           </font>          </p>          <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            <b>             Contractual            </b>           </font>          </p>          <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            <b>             Life                                         (in Years)            </b>           </font>          </p>         </td>         <td style="padding-bottom: 1.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>        </tr>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td style="width: 46%">          <font style="font-family: Times New Roman, Times, Serif">           Warrants outstanding at December 31, 2019          </font>         </td>         <td style="width: 2%">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="width: 1%; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="width: 14%; text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           219,104          </font>         </td>         <td style="width: 1%; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="width: 2%">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="width: 1%; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           $          </font>         </td>         <td style="width: 14%; text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           18.7109          </font>         </td>         <td style="width: 1%; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="width: 2%">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="width: 1%; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="width: 14%; text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           3.44          </font>         </td>         <td style="width: 1%; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>        </tr>        <tr style="vertical-align: bottom; background-color: White">         <td>          <font style="font-family: Times New Roman, Times, Serif">           Issued          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           39,585,040          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           0.0521          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          2.89          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>        </tr>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td>          <font style="font-family: Times New Roman, Times, Serif">           Expired          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           (25,434          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           )          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           2.9899          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>        </tr>        <tr style="vertical-align: bottom; background-color: White">         <td style="padding-bottom: 2.5pt">          <font style="font-family: Times New Roman, Times, Serif">           Exercised          </font>         </td>         <td style="padding-bottom: 2.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="border-bottom: Black 2.5pt double; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="border-bottom: Black 2.5pt double; text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           (10,969,352          </font>         </td>         <td style="padding-bottom: 2.5pt; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           )          </font>         </td>         <td style="padding-bottom: 2.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="border-bottom: Black 2.5pt double; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="border-bottom: Black 2.5pt double; text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           0.0161          </font>         </td>         <td style="padding-bottom: 2.5pt; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="padding-bottom: 2.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="border-bottom: Black 2.5pt double; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="border-bottom: Black 2.5pt double; text-align: right">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="padding-bottom: 2.5pt; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>        </tr>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td style="padding-bottom: 2.5pt">          <font style="font-family: Times New Roman, Times, Serif">           Warrants outstanding at December    31, 2020          </font>         </td>         <td style="padding-bottom: 2.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="border-bottom: Black 2.5pt double; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="border-bottom: Black 2.5pt double; text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           28,809,352          </font>         </td>         <td style="padding-bottom: 2.5pt; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="padding-bottom: 2.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="border-bottom: Black 2.5pt double; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           $          </font>         </td>         <td style="border-bottom: Black 2.5pt double; text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           0.1528          </font>         </td>         <td style="padding-bottom: 2.5pt; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="padding-bottom: 2.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="border-bottom: Black 2.5pt double; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="border-bottom: Black 2.5pt double; text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           2.64          </font>         </td>         <td style="padding-bottom: 2.5pt; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>        </tr>        <tr style="vertical-align: bottom; background-color: White">         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>        </tr>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td style="padding-bottom: 2.5pt">          <font style="font-family: Times New Roman, Times, Serif">           Warrants exercisable at December    31, 2019          </font>         </td>         <td style="padding-bottom: 2.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="border-bottom: Black 2.5pt double; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="border-bottom: Black 2.5pt double; text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           219,104          </font>         </td>         <td style="padding-bottom: 2.5pt; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="padding-bottom: 2.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="border-bottom: Black 2.5pt double; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           $          </font>         </td>         <td style="border-bottom: Black 2.5pt double; text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           18.7109          </font>         </td>         <td style="padding-bottom: 2.5pt; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="padding-bottom: 2.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="border-bottom: Black 2.5pt double; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="border-bottom: Black 2.5pt double; text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           3.44          </font>         </td>         <td style="padding-bottom: 2.5pt; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>        </tr>        <tr style="vertical-align: bottom; background-color: White">         <td style="padding-bottom: 2.5pt">          <font style="font-family: Times New Roman, Times, Serif">           Warrants exercisable at December    31, 2020          </font>         </td>         <td style="padding-bottom: 2.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="border-bottom: Black 2.5pt double; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="border-bottom: Black 2.5pt double; text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           28,809,352          </font>         </td>         <td style="padding-bottom: 2.5pt; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="padding-bottom: 2.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="border-bottom: Black 2.5pt double; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           $          </font>         </td>         <td style="border-bottom: Black 2.5pt double; text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           0.1528          </font>         </td>         <td style="padding-bottom: 2.5pt; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="padding-bottom: 2.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="border-bottom: Black 2.5pt double; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="border-bottom: Black 2.5pt double; text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           2.64          </font>         </td>         <td style="padding-bottom: 2.5pt; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>        </tr>       </tbody>      </table>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">      </p>      <!-- Field: Page; Sequence: 86; Value: 1 -->      <div style="margin-bottom: 6pt; border-bottom: Black 1.5pt solid">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="text-align: center; width: 100%">           F-           <!-- Field: Sequence; Type: Arabic; Name: PageNo -->           28           <!-- Field: /Sequence -->          </td>         </tr>        </tbody>       </table>      </div>      <div style="break-before: page; margin-top: 6pt">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="width: 100%">          </td>         </tr>        </tbody>       </table>      </div>      <!-- Field: /Page -->      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Theexercise prices of common stock warrants outstanding and exercisable are as follows at December 31, 2020:       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">       <tbody>        <tr style="vertical-align: bottom">         <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">          <font style="font-family: Times New Roman, Times, Serif">           Exercise    Price          </font>         </td>         <td style="padding-bottom: 1.5pt; font-weight: bold">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="font-weight: bold; padding-bottom: 1.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">          <font style="font-family: Times New Roman, Times, Serif">           Warrants    Outstanding           <br/>           (Shares)          </font>         </td>         <td style="padding-bottom: 1.5pt; font-weight: bold">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="font-weight: bold; padding-bottom: 1.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">          <font style="font-family: Times New Roman, Times, Serif">           Warrants    Exercisable           <br/>           (Shares)          </font>         </td>         <td style="padding-bottom: 1.5pt; font-weight: bold">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="font-weight: bold; padding-bottom: 1.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">          <font style="font-family: Times New Roman, Times, Serif">           Expiration    Date          </font>         </td>        </tr>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td style="width: 1%; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           $          </font>         </td>         <td style="width: 14%; text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           0.0160          </font>         </td>         <td style="width: 1%; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="width: 2%">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="width: 1%; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="width: 14%; text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           2,212,500          </font>         </td>         <td style="width: 1%; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="width: 2%">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="width: 1%; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="width: 14%; text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           2,212,500          </font>         </td>         <td style="width: 1%; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="width: 2%">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="width: 46%; text-align: center">          <font style="font-family: Times New Roman, Times, Serif">           May 17, 2022          </font>         </td>        </tr>        <tr style="vertical-align: bottom; background-color: White">         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           $          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           0.0700          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           26,439,926          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           26,439,926          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: center">          <font style="font-family: Times New Roman, Times, Serif">           September 30, 2023          </font>         </td>        </tr>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           $          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           15.000          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           19,000          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           19,000          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: center">          <font style="font-family: Times New Roman, Times, Serif">           December 30, 2023          </font>         </td>        </tr>        <tr style="vertical-align: bottom; background-color: White">         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           $          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           15.750          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           23,881          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           23,881          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: center">          <font style="font-family: Times New Roman, Times, Serif">           April 30, 2023          </font>         </td>        </tr>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           $          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           27.500          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           800          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           800          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: center">          <font style="font-family: Times New Roman, Times, Serif">           December 31, 2021          </font>         </td>        </tr>        <tr style="vertical-align: bottom; background-color: White">         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           $          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           11.000          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           104,650          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           104,650          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: center">          <font style="font-family: Times New Roman, Times, Serif">           September 29, 2022          </font>         </td>        </tr>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td style="padding-bottom: 1.5pt; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           $          </font>         </td>         <td style="padding-bottom: 1.5pt; text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           79.300          </font>         </td>         <td style="padding-bottom: 1.5pt; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="padding-bottom: 1.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           8,595          </font>         </td>         <td style="padding-bottom: 1.5pt; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="padding-bottom: 1.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           8,595          </font>         </td>         <td style="padding-bottom: 1.5pt; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="padding-bottom: 1.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: center; padding-bottom: 1.5pt">          <font style="font-family: Times New Roman, Times, Serif">           February 28,    2021          </font>         </td>        </tr>        <tr style="vertical-align: bottom; background-color: White">         <td style="padding-bottom: 2.5pt; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="padding-bottom: 2.5pt; text-align: right">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="padding-bottom: 2.5pt; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="padding-bottom: 2.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="border-bottom: Black 2.5pt double; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="border-bottom: Black 2.5pt double; text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           28,809,352          </font>         </td>         <td style="padding-bottom: 2.5pt; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="padding-bottom: 2.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="border-bottom: Black 2.5pt double; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="border-bottom: Black 2.5pt double; text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           29,809,352          </font>         </td>         <td style="padding-bottom: 2.5pt; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="padding-bottom: 2.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: center; padding-bottom: 2.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>        </tr>       </tbody>      </table>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Basedon a fair value of $0.029 per share on December 31, 2020, there were 2,212,500 exercisable in-the money common stock warrantswith an intrinsic value of $28,763 as of December 31, 2020.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Asummary of warrant activity for the year ended December 31, 2019 is presented below.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">       <tbody>        <tr style="vertical-align: bottom">         <td style="text-align: center">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="padding-bottom: 1.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid">          <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            <b>             Number                                         of            </b>           </font>          </p>          <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            <b>             Shares            </b>           </font>          </p>         </td>         <td style="padding-bottom: 1.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="padding-bottom: 1.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid">          <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            <b>             Weighted            </b>           </font>          </p>          <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            <b>             Average            </b>           </font>          </p>          <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            <b>             Exercise                                         Price            </b>           </font>          </p>         </td>         <td style="padding-bottom: 1.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="padding-bottom: 1.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid">          <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            <b>             Weighted            </b>           </font>          </p>          <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            <b>             Average            </b>           </font>          </p>          <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            <b>             Remaining            </b>           </font>          </p>          <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            <b>             Contractual            </b>           </font>          </p>          <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            <b>             Life                                         (in Years)            </b>           </font>          </p>         </td>         <td style="padding-bottom: 1.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>        </tr>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td style="width: 46%">          <font style="font-family: Times New Roman, Times, Serif">           Warrants outstanding at December 31, 2018          </font>         </td>         <td style="width: 2%">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="width: 1%; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="width: 14%; text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           178,322          </font>         </td>         <td style="width: 1%; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="width: 2%">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="width: 1%; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           $          </font>         </td>         <td style="width: 14%; text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           22.0393          </font>         </td>         <td style="width: 1%; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="width: 2%">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="width: 1%; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="width: 14%; text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           3.06          </font>         </td>         <td style="width: 1%; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>        </tr>        <tr style="vertical-align: bottom; background-color: White">         <td>          <font style="font-family: Times New Roman, Times, Serif">           Issued          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           47,737          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           7.9079          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           4.36          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>        </tr>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td style="padding-bottom: 2.5pt">          <font style="font-family: Times New Roman, Times, Serif">           Expired          </font>         </td>         <td style="padding-bottom: 2.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="border-bottom: Black 2.5pt double; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="border-bottom: Black 2.5pt double; text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           (6,955          </font>         </td>         <td style="padding-bottom: 2.5pt; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           )          </font>         </td>         <td style="padding-bottom: 2.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="border-bottom: Black 2.5pt double; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="border-bottom: Black 2.5pt double; text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           29.8989          </font>         </td>         <td style="padding-bottom: 2.5pt; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="padding-bottom: 2.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="border-bottom: Black 2.5pt double; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="border-bottom: Black 2.5pt double; text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           -          </font>         </td>         <td style="padding-bottom: 2.5pt; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>        </tr>        <tr style="vertical-align: bottom; background-color: White">         <td style="padding-bottom: 2.5pt">          <font style="font-family: Times New Roman, Times, Serif">           Warrants outstanding at December    31, 2019          </font>         </td>         <td style="padding-bottom: 2.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="border-bottom: Black 2.5pt double; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="border-bottom: Black 2.5pt double; text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           219,104          </font>         </td>         <td style="padding-bottom: 2.5pt; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="padding-bottom: 2.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="border-bottom: Black 2.5pt double; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           $          </font>         </td>         <td style="border-bottom: Black 2.5pt double; text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           18.7109          </font>         </td>         <td style="padding-bottom: 2.5pt; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="padding-bottom: 2.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="border-bottom: Black 2.5pt double; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="border-bottom: Black 2.5pt double; text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           3.44          </font>         </td>         <td style="padding-bottom: 2.5pt; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>        </tr>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>        </tr>        <tr style="vertical-align: bottom; background-color: White">         <td style="padding-bottom: 2.5pt">          <font style="font-family: Times New Roman, Times, Serif">           Warrants exercisable at December    31, 2018          </font>         </td>         <td style="padding-bottom: 2.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="border-bottom: Black 2.5pt double; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="border-bottom: Black 2.5pt double; text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           178,322          </font>         </td>         <td style="padding-bottom: 2.5pt; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="padding-bottom: 2.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="border-bottom: Black 2.5pt double; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           $          </font>         </td>         <td style="border-bottom: Black 2.5pt double; text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           22.0393          </font>         </td>         <td style="padding-bottom: 2.5pt; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="padding-bottom: 2.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="border-bottom: Black 2.5pt double; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="border-bottom: Black 2.5pt double; text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           3.06          </font>         </td>         <td style="padding-bottom: 2.5pt; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>        </tr>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td style="padding-bottom: 2.5pt">          <font style="font-family: Times New Roman, Times, Serif">           Warrants exercisable at December    31, 2019          </font>         </td>         <td style="padding-bottom: 2.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="border-bottom: Black 2.5pt double; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="border-bottom: Black 2.5pt double; text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           219,104          </font>         </td>         <td style="padding-bottom: 2.5pt; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="padding-bottom: 2.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="border-bottom: Black 2.5pt double; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           $          </font>         </td>         <td style="border-bottom: Black 2.5pt double; text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           18.7109          </font>         </td>         <td style="padding-bottom: 2.5pt; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="padding-bottom: 2.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="border-bottom: Black 2.5pt double; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="border-bottom: Black 2.5pt double; text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           3.44          </font>         </td>         <td style="padding-bottom: 2.5pt; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>        </tr>       </tbody>      </table>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         StockOptions        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        OnMarch 18, 2014, RespireRx adopted its 2014 Equity, Equity-Linked and Equity Derivative Incentive Plan (the “2014 Plan”).The Plan permits the grant of options and restricted stock with respect to up to 325,025 shares of common stock, in addition tostock appreciation rights and phantom stock, to directors, officers, employees, consultants and other service providers of theCompany.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        OnJune 30, 2015, the Board of Directors adopted the 2015 Stock and Stock Option Plan (as amended, the “2015 Plan”).As of March 31, 2020, there were 8,985,260 shares that may be issued under the 2015 Plan. On May 5, 2020 the Board of Directorsincreased the number of shares that may be issued under the 2015 Plan to 58,985,260. On July 31, 2020 the Board of Directors increasedthe number of shares that may be issued under the 2015 Plan to 158,985,260. The Company has not and does not intend to presentthe 2015 Plan to stockholders for approval.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Otherthan the change in the number of shares available under the 2015 Plan, no other changes were made to the 2015 Plan by these amendmentsnoted above.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <!-- Field: Page; Sequence: 87; Value: 1 -->      <div style="margin-bottom: 6pt; border-bottom: Black 1.5pt solid">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="text-align: center; width: 100%">           F-           <!-- Field: Sequence; Type: Arabic; Name: PageNo -->           29           <!-- Field: /Sequence -->          </td>         </tr>        </tbody>       </table>      </div>      <div style="break-before: page; margin-top: 6pt">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="width: 100%">          </td>         </tr>        </tbody>       </table>      </div>      <!-- Field: /Page -->      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Therewere no stock grants and there were stock option grants for 6,750,000 shares of RespireRx’s Common Stock during thefiscal year ended December 31, 2020 and there were no stock grants or stock option grants in the during the fiscal year endedDecember 31, 2019.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Informationwith respect to the Black-Scholes variables used in connection with the evaluation of the fair value of stock-based compensationcosts and fees is provided at Note 3 Summary of Significant Accounting Policies.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Asummary of stock option activity for the fiscal year ended December 31, 2020 is presented below.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">       <tbody>        <tr style="vertical-align: bottom">         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="padding-bottom: 1.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid">          <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            <b>             Number                                         of            </b>           </font>          </p>          <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            <b>             Shares            </b>           </font>          </p>         </td>         <td style="padding-bottom: 1.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="padding-bottom: 1.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid">          <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            <b>             Weighted            </b>           </font>          </p>          <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            <b>             Average            </b>           </font>          </p>          <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            <b>             Exercise            </b>           </font>          </p>          <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            <b>             Price            </b>           </font>          </p>         </td>         <td style="padding-bottom: 1.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="padding-bottom: 1.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid">          <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            <b>             Weighted            </b>           </font>          </p>          <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            <b>             Average            </b>           </font>          </p>          <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            <b>             Remaining            </b>           </font>          </p>          <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            <b>             Contractual            </b>           </font>          </p>          <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            <b>             Life                                         (in Years)            </b>           </font>          </p>         </td>         <td style="padding-bottom: 1.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>        </tr>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td style="width: 46%">          <font style="font-family: Times New Roman, Times, Serif">           Options outstanding at December 31, 2019          </font>         </td>         <td style="width: 2%">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="width: 1%; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="width: 14%; text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           428,761          </font>         </td>         <td style="width: 1%; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="width: 2%">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="width: 1%; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           $          </font>         </td>         <td style="width: 14%; text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           33.798          </font>         </td>         <td style="width: 1%; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="width: 2%">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="width: 1%; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="width: 14%; text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           4.98          </font>         </td>         <td style="width: 1%; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>        </tr>        <tr style="vertical-align: bottom; background-color: White">         <td>          <font style="font-family: Times New Roman, Times, Serif">           Granted          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           6,750,000          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           0.0660          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          4.63         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>        </tr>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td style="padding-bottom: 1.5pt">          <font style="font-family: Times New Roman, Times, Serif">           Expired          </font>         </td>         <td style="padding-bottom: 1.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           (13,546          </font>         </td>         <td style="padding-bottom: 1.5pt; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           )          </font>         </td>         <td style="padding-bottom: 1.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           (65.9190          </font>         </td>         <td style="padding-bottom: 1.5pt; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           )          </font>         </td>         <td style="padding-bottom: 1.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           -          </font>         </td>         <td style="padding-bottom: 1.5pt; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>        </tr>        <tr style="vertical-align: bottom; background-color: White">         <td style="padding-bottom: 2.5pt">          <font style="font-family: Times New Roman, Times, Serif">           Options outstanding at December    31, 2020          </font>         </td>         <td style="padding-bottom: 2.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="border-bottom: Black 2.5pt double; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="border-bottom: Black 2.5pt double; text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           7,165,215          </font>         </td>         <td style="padding-bottom: 2.5pt; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="padding-bottom: 2.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="border-bottom: Black 2.5pt double; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           $          </font>         </td>         <td style="border-bottom: Black 2.5pt double; text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           1.961          </font>         </td>         <td style="padding-bottom: 2.5pt; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="padding-bottom: 2.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="border-bottom: Black 2.5pt double; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="border-bottom: Black 2.5pt double; text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           4.60          </font>         </td>         <td style="padding-bottom: 2.5pt; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>        </tr>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>        </tr>        <tr style="vertical-align: bottom; background-color: White">         <td style="padding-bottom: 2.5pt">          <font style="font-family: Times New Roman, Times, Serif">           Options exercisable at December    31, 2020          </font>         </td>         <td style="padding-bottom: 2.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="border-bottom: Black 2.5pt double; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="border-bottom: Black 2.5pt double; text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           6,290,215          </font>         </td>         <td style="padding-bottom: 2.5pt; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="padding-bottom: 2.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="border-bottom: Black 2.5pt double; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           $          </font>         </td>         <td style="border-bottom: Black 2.5pt double; text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           2.225          </font>         </td>         <td style="padding-bottom: 2.5pt; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="padding-bottom: 2.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="border-bottom: Black 2.5pt double; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="border-bottom: Black 2.5pt double; text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           4.59          </font>         </td>         <td style="padding-bottom: 2.5pt; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>        </tr>       </tbody>      </table>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Theexercise prices of common stock options outstanding and exercisable were as follows at December 31, 2020:       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">       <tbody>        <tr style="vertical-align: bottom">         <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">          <font style="font-family: Times New Roman, Times, Serif">           Exercise    Price          </font>         </td>         <td style="padding-bottom: 1.5pt; font-weight: bold">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="font-weight: bold; padding-bottom: 1.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">          <font style="font-family: Times New Roman, Times, Serif">           Options    Outstanding (Shares)          </font>         </td>         <td style="padding-bottom: 1.5pt; font-weight: bold">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="padding-bottom: 1.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid">          <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            <b>             Options            </b>           </font>          </p>          <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            <b>             Exercisable            </b>           </font>          </p>          <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            <b>             (Shares)            </b>           </font>          </p>         </td>         <td style="padding-bottom: 1.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="font-weight: bold; padding-bottom: 1.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">          <font style="font-family: Times New Roman, Times, Serif">           Expiration    Date          </font>         </td>        </tr>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td style="width: 1%; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           $          </font>         </td>         <td style="width: 14%; text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           0.072          </font>         </td>         <td style="width: 1%; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="width: 2%">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="width: 1%; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="width: 14%; text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           5,050,000          </font>         </td>         <td style="width: 1%; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="width: 2%">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="width: 1%; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="width: 14%; text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           4,525,000          </font>         </td>         <td style="width: 1%; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="width: 2%">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="width: 46%; text-align: center">          <font style="font-family: Times New Roman, Times, Serif">           September 30, 2025          </font>         </td>        </tr>        <tr style="vertical-align: bottom; background-color: White">         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           $          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           0.054          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           1,700,000          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           1,350,000          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: center">          <font style="font-family: Times New Roman, Times, Serif">           July 31, 2025          </font>         </td>        </tr>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           $          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           7.000          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           2,168          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           2,168          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: center">          <font style="font-family: Times New Roman, Times, Serif">           November 21, 2023          </font>         </td>        </tr>        <tr style="vertical-align: bottom; background-color: White">         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           $          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           11.200          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           31,038          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           31,038          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: center">          <font style="font-family: Times New Roman, Times, Serif">           April 5, 2023          </font>         </td>        </tr>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           $          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           12.500          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           1,676          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           1,676          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: center">          <font style="font-family: Times New Roman, Times, Serif">           December 7, 2022          </font>         </td>        </tr>        <tr style="vertical-align: bottom; background-color: White">         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           $          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           13.500          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           3,400          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           3,400          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: center">          <font style="font-family: Times New Roman, Times, Serif">           July 28, 2022          </font>         </td>        </tr>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           $          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           14.500          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           184,942          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           184,942          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: center">          <font style="font-family: Times New Roman, Times, Serif">           December 9, 2027          </font>         </td>        </tr>        <tr style="vertical-align: bottom; background-color: White">         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           $          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           14.500          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           10,000          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           10,000          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: center">          <font style="font-family: Times New Roman, Times, Serif">           December 9, 2027          </font>         </td>        </tr>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           $          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           20.000          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           28,500          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           28,500          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: center">          <font style="font-family: Times New Roman, Times, Serif">           June 30, 2022          </font>         </td>        </tr>        <tr style="vertical-align: bottom; background-color: White">         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           $          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           20.000          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           2,500          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           2,500          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: center">          <font style="font-family: Times New Roman, Times, Serif">           July 26, 2022          </font>         </td>        </tr>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           $          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           39.000          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           39,500          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           39,500          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: center">          <font style="font-family: Times New Roman, Times, Serif">           January 17, 2022          </font>         </td>        </tr>        <tr style="vertical-align: bottom; background-color: White">         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           $          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           45.000          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           722          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           722          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: center">          <font style="font-family: Times New Roman, Times, Serif">           September 2, 2021          </font>         </td>        </tr>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           $          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           57.500          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           261          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           261          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: center">          <font style="font-family: Times New Roman, Times, Serif">           September 12, 2021          </font>         </td>        </tr>        <tr style="vertical-align: bottom; background-color: White">         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           $          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           64.025          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           12,923          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           12,923          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: center">          <font style="font-family: Times New Roman, Times, Serif">           August 18, 2022          </font>         </td>        </tr>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           $          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           64.025          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           26,179          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           26,179          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: center">          <font style="font-family: Times New Roman, Times, Serif">           August 18, 2025          </font>         </td>        </tr>        <tr style="vertical-align: bottom; background-color: White">         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           $          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           73.775          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           52,308          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           52,308          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: center">          <font style="font-family: Times New Roman, Times, Serif">           March 31, 2021          </font>         </td>        </tr>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           $          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           81.250          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           16,923          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           16,923          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: center">          <font style="font-family: Times New Roman, Times, Serif">           June 30, 2022          </font>         </td>        </tr>        <tr style="vertical-align: bottom; background-color: White">         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           $          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           139.750          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           339          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           339          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: center">          <font style="font-family: Times New Roman, Times, Serif">           March 14, 2024          </font>         </td>        </tr>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           $          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           159.250          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           246          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           246          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: center">          <font style="font-family: Times New Roman, Times, Serif">           February 28, 2024          </font>         </td>        </tr>        <tr style="vertical-align: bottom; background-color: White">         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           $          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           195.000          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           949          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           949          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: center">          <font style="font-family: Times New Roman, Times, Serif">           July 17, 2022          </font>         </td>        </tr>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td style="padding-bottom: 1.5pt; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           $          </font>         </td>         <td style="padding-bottom: 1.5pt; text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           195.000          </font>         </td>         <td style="padding-bottom: 1.5pt; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="padding-bottom: 1.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           641          </font>         </td>         <td style="padding-bottom: 1.5pt; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="padding-bottom: 1.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           641          </font>         </td>         <td style="padding-bottom: 1.5pt; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="padding-bottom: 1.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: center; padding-bottom: 1.5pt">          <font style="font-family: Times New Roman, Times, Serif">           August 10,    2022          </font>         </td>        </tr>        <tr style="vertical-align: bottom; background-color: White">         <td style="padding-bottom: 2.5pt; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="padding-bottom: 2.5pt; text-align: right">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="padding-bottom: 2.5pt; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="padding-bottom: 2.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="border-bottom: Black 2.5pt double; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="border-bottom: Black 2.5pt double; text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           7,165,215          </font>         </td>         <td style="padding-bottom: 2.5pt; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="padding-bottom: 2.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="border-bottom: Black 2.5pt double; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="border-bottom: Black 2.5pt double; text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           6,290,215          </font>         </td>         <td style="padding-bottom: 2.5pt; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="padding-bottom: 2.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: center; padding-bottom: 2.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>        </tr>       </tbody>      </table>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Basedon a fair value of $0.029 per share on December 31, 2020, there were no exercisable in-the-money common stock options as of December31, 2020.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <!-- Field: Page; Sequence: 88; Value: 1 -->      <div style="margin-bottom: 6pt; border-bottom: Black 1.5pt solid">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="text-align: center; width: 100%">           F-           <!-- Field: Sequence; Type: Arabic; Name: PageNo -->           30           <!-- Field: /Sequence -->          </td>         </tr>        </tbody>       </table>      </div>      <div style="break-before: page; margin-top: 6pt">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="width: 100%">          </td>         </tr>        </tbody>       </table>      </div>      <!-- Field: /Page -->      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Asummary of stock option activity for the year ended December 31, 2019 is presented below.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">       <tbody>        <tr style="vertical-align: bottom">         <td style="font-weight: bold; text-align: center">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="padding-bottom: 1.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid">          <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            <b>             Number                                         of            </b>           </font>          </p>          <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            <b>             Shares            </b>           </font>          </p>         </td>         <td style="padding-bottom: 1.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="padding-bottom: 1.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid">          <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            <b>             Weighted            </b>           </font>          </p>          <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            <b>             Average            </b>           </font>          </p>          <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            <b>             Exercise            </b>           </font>          </p>          <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            <b>             Price            </b>           </font>          </p>         </td>         <td style="padding-bottom: 1.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="padding-bottom: 1.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid">          <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            <b>             Weighted            </b>           </font>          </p>          <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            <b>             Average            </b>           </font>          </p>          <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            <b>             Remaining            </b>           </font>          </p>          <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            <b>             Contractual            </b>           </font>          </p>          <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            <b>             Life                                         (in Years)            </b>           </font>          </p>         </td>         <td style="padding-bottom: 1.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>        </tr>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td style="width: 46%">          <font style="font-family: Times New Roman, Times, Serif">           Options outstanding at December 31, 2018          </font>         </td>         <td style="width: 2%">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="width: 1%; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="width: 14%; text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           434,499          </font>         </td>         <td style="width: 1%; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="width: 2%">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="width: 1%; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           $          </font>         </td>         <td style="width: 14%; text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           35.414          </font>         </td>         <td style="width: 1%; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="width: 2%">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="width: 1%; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="width: 14%; text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           5.90          </font>         </td>         <td style="width: 1%; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>        </tr>        <tr style="vertical-align: bottom; background-color: White">         <td style="padding-bottom: 1.5pt">          <font style="font-family: Times New Roman, Times, Serif">           Expired          </font>         </td>         <td style="padding-bottom: 1.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           (5,738          </font>         </td>         <td style="padding-bottom: 1.5pt; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           )          </font>         </td>         <td style="padding-bottom: 1.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           156.139          </font>         </td>         <td style="padding-bottom: 1.5pt; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="padding-bottom: 1.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           -          </font>         </td>         <td style="padding-bottom: 1.5pt; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>        </tr>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td style="padding-bottom: 2.5pt">          <font style="font-family: Times New Roman, Times, Serif">           Options outstanding at December    31, 2019          </font>         </td>         <td style="padding-bottom: 2.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="border-bottom: Black 2.5pt double; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="border-bottom: Black 2.5pt double; text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           428,761          </font>         </td>         <td style="padding-bottom: 2.5pt; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="padding-bottom: 2.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="border-bottom: Black 2.5pt double; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           $          </font>         </td>         <td style="border-bottom: Black 2.5pt double; text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           33.798          </font>         </td>         <td style="padding-bottom: 2.5pt; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="padding-bottom: 2.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="border-bottom: Black 2.5pt double; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="border-bottom: Black 2.5pt double; text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           4.98          </font>         </td>         <td style="padding-bottom: 2.5pt; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>        </tr>        <tr style="vertical-align: bottom; background-color: White">         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>        </tr>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td style="padding-bottom: 2.5pt">          <font style="font-family: Times New Roman, Times, Serif">           Options exercisable at December    31, 2018          </font>         </td>         <td style="padding-bottom: 2.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="border-bottom: Black 2.5pt double; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="border-bottom: Black 2.5pt double; text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           434,499          </font>         </td>         <td style="padding-bottom: 2.5pt; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="padding-bottom: 2.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="border-bottom: Black 2.5pt double; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           $          </font>         </td>         <td style="border-bottom: Black 2.5pt double; text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           35.414          </font>         </td>         <td style="padding-bottom: 2.5pt; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="padding-bottom: 2.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="border-bottom: Black 2.5pt double; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="border-bottom: Black 2.5pt double; text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           5.90          </font>         </td>         <td style="padding-bottom: 2.5pt; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>        </tr>        <tr style="vertical-align: bottom; background-color: White">         <td style="padding-bottom: 2.5pt">          <font style="font-family: Times New Roman, Times, Serif">           Options exercisable at December    31, 2019          </font>         </td>         <td style="padding-bottom: 2.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="border-bottom: Black 2.5pt double; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="border-bottom: Black 2.5pt double; text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           428,761          </font>         </td>         <td style="padding-bottom: 2.5pt; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="padding-bottom: 2.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="border-bottom: Black 2.5pt double; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           $          </font>         </td>         <td style="border-bottom: Black 2.5pt double; text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           33.789          </font>         </td>         <td style="padding-bottom: 2.5pt; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="padding-bottom: 2.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="border-bottom: Black 2.5pt double; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="border-bottom: Black 2.5pt double; text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           4.98          </font>         </td>         <td style="padding-bottom: 2.5pt; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>        </tr>       </tbody>      </table>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Theexercise prices of common stock options outstanding and exercisable were as follows at December 31, 2019:       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">       <tbody>        <tr style="vertical-align: bottom">         <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">          <font style="font-family: Times New Roman, Times, Serif">           Exercise    Price          </font>         </td>         <td style="padding-bottom: 1.5pt; font-weight: bold">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="font-weight: bold; padding-bottom: 1.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">          <font style="font-family: Times New Roman, Times, Serif">           Options    Outstanding (Shares)          </font>         </td>         <td style="padding-bottom: 1.5pt; font-weight: bold">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="font-weight: bold; padding-bottom: 1.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">          <font style="font-family: Times New Roman, Times, Serif">           Options    Exercisable (Shares)          </font>         </td>         <td style="padding-bottom: 1.5pt; font-weight: bold">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="font-weight: bold; padding-bottom: 1.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">          <font style="font-family: Times New Roman, Times, Serif">           Expiration    Date          </font>         </td>        </tr>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td style="width: 1%; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           $          </font>         </td>         <td style="width: 14%; text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           7.000          </font>         </td>         <td style="width: 1%; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="width: 2%">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="width: 1%; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="width: 14%; text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           2,168          </font>         </td>         <td style="width: 1%; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="width: 2%">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="width: 1%; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="width: 14%; text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           2,168          </font>         </td>         <td style="width: 1%; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="width: 2%">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="width: 46%; text-align: center">          <font style="font-family: Times New Roman, Times, Serif">           November 21, 2023          </font>         </td>        </tr>        <tr style="vertical-align: bottom; background-color: White">         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           $          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           11.200          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           31,038          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           31,038          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: center">          <font style="font-family: Times New Roman, Times, Serif">           April 5, 2023          </font>         </td>        </tr>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           $          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           12.500          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           1,676          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           1,676          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: center">          <font style="font-family: Times New Roman, Times, Serif">           December 7, 2022          </font>         </td>        </tr>        <tr style="vertical-align: bottom; background-color: White">         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           $          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           13.500          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           3,400          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           3,400          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: center">          <font style="font-family: Times New Roman, Times, Serif">           July 28, 2022          </font>         </td>        </tr>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           $          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           14.500          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           184,942          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           184,942          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: center">          <font style="font-family: Times New Roman, Times, Serif">           December 9, 2027          </font>         </td>        </tr>        <tr style="vertical-align: bottom; background-color: White">         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           $          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           14.500          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           10,000          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           10,000          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: center">          <font style="font-family: Times New Roman, Times, Serif">           December 9, 2027          </font>         </td>        </tr>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           $          </font>         </td>         <td style="text-align: right">          <p style="margin: 0">           <font style="font-family: Times New Roman, Times, Serif">            20.000           </font>          </p>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           28,500          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           28,500          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: center">          <font style="font-family: Times New Roman, Times, Serif">           June 30, 2022          </font>         </td>        </tr>        <tr style="vertical-align: bottom; background-color: White">         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           $          </font>         </td>         <td style="text-align: right">          <p style="margin: 0">           <font style="font-family: Times New Roman, Times, Serif">            20.000           </font>          </p>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           2,500          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           2,500          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: center">          <font style="font-family: Times New Roman, Times, Serif">           July 26, 2022          </font>         </td>        </tr>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           $          </font>         </td>         <td style="text-align: right">          <p style="margin: 0">           <font style="font-family: Times New Roman, Times, Serif">            39.500           </font>          </p>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           39,500          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           39,500          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: center">          <font style="font-family: Times New Roman, Times, Serif">           January 17, 2022          </font>         </td>        </tr>        <tr style="vertical-align: bottom; background-color: White">         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           $          </font>         </td>         <td style="text-align: right">          <p style="margin: 0">           <font style="font-family: Times New Roman, Times, Serif">            45.000           </font>          </p>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           722          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           722          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: center">          <font style="font-family: Times New Roman, Times, Serif">           September 2, 2021          </font>         </td>        </tr>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           $          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           56.875          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           8,969          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           8,969          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: center">          <font style="font-family: Times New Roman, Times, Serif">           June 30, 2020          </font>         </td>        </tr>        <tr style="vertical-align: bottom; background-color: White">         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           $          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           57.500          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           261          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           261          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: center">          <font style="font-family: Times New Roman, Times, Serif">           September 12, 2021          </font>         </td>        </tr>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           $          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           64.025          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           2,769          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           2,769          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: center">          <font style="font-family: Times New Roman, Times, Serif">           August 18, 2020          </font>         </td>        </tr>        <tr style="vertical-align: bottom; background-color: White">         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           $          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           64.025          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           12,923          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           12,923          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: center">          <font style="font-family: Times New Roman, Times, Serif">           August 18, 2022          </font>         </td>        </tr>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           $          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           64.025          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           26,179          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           26,179          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: center">          <font style="font-family: Times New Roman, Times, Serif">           August 18, 2025          </font>         </td>        </tr>        <tr style="vertical-align: bottom; background-color: White">         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           $          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           68.250          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           879          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           879          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: center">          <font style="font-family: Times New Roman, Times, Serif">           December 11, 2020          </font>         </td>        </tr>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           $          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           73.775          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           52,308          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           52,308          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: center">          <font style="font-family: Times New Roman, Times, Serif">           March 31, 2021          </font>         </td>        </tr>        <tr style="vertical-align: bottom; background-color: White">         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           $          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           81.250          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           16,923          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           16,923          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: center">          <font style="font-family: Times New Roman, Times, Serif">           June 30, 2022          </font>         </td>        </tr>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           $          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           139.750          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           339          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           339          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: center">          <font style="font-family: Times New Roman, Times, Serif">           March 14, 2024          </font>         </td>        </tr>        <tr style="vertical-align: bottom; background-color: White">         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           $          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           154.700          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           775          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           755          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: center">          <font style="font-family: Times New Roman, Times, Serif">           April 8, 2020          </font>         </td>        </tr>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           $          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           159.250          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           246          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           246          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: center">          <font style="font-family: Times New Roman, Times, Serif">           February 28, 2024          </font>         </td>        </tr>        <tr style="vertical-align: bottom; background-color: White">         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           $          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           166.400          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           154          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           154          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: center">          <font style="font-family: Times New Roman, Times, Serif">           January 29, 2020          </font>         </td>        </tr>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           $          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           195.000          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           949          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           949          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: center">          <font style="font-family: Times New Roman, Times, Serif">           July 17, 2022          </font>         </td>        </tr>        <tr style="vertical-align: bottom; background-color: White">         <td style="padding-bottom: 1.5pt; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           $          </font>         </td>         <td style="padding-bottom: 1.5pt; text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           195.000          </font>         </td>         <td style="padding-bottom: 1.5pt; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="padding-bottom: 1.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           641          </font>         </td>         <td style="padding-bottom: 1.5pt; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="padding-bottom: 1.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           641          </font>         </td>         <td style="padding-bottom: 1.5pt; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="padding-bottom: 1.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: center; padding-bottom: 1.5pt">          <font style="font-family: Times New Roman, Times, Serif">           August 10,    2022          </font>         </td>        </tr>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td style="padding-bottom: 2.5pt; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="padding-bottom: 2.5pt; text-align: right">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="padding-bottom: 2.5pt; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="padding-bottom: 2.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="border-bottom: Black 2.5pt double; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="border-bottom: Black 2.5pt double; text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           428,761          </font>         </td>         <td style="padding-bottom: 2.5pt; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="padding-bottom: 2.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="border-bottom: Black 2.5pt double; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="border-bottom: Black 2.5pt double; text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           428,761          </font>         </td>         <td style="padding-bottom: 2.5pt; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="padding-bottom: 2.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: center; padding-bottom: 2.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>        </tr>       </tbody>      </table>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <!-- Field: Page; Sequence: 89; Value: 1 -->      <div style="margin-bottom: 6pt; border-bottom: Black 1.5pt solid">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="text-align: center; width: 100%">           F-           <!-- Field: Sequence; Type: Arabic; Name: PageNo -->           31           <!-- Field: /Sequence -->          </td>         </tr>        </tbody>       </table>      </div>      <div style="break-before: page; margin-top: 6pt">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="width: 100%">          </td>         </tr>        </tbody>       </table>      </div>      <!-- Field: /Page -->      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Basedon a fair value of $1.00 per share on December 31, 2019, there were 0 exercisable in-the-money common stock options asof December 31, 2019.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Forthe years ended December 31, 2020 and 2019, stock-based compensation costs and fees included in the consolidated statements ofoperations consisted of general and administrative expenses of $345,500 and $0 respectively, and research and development expensesof $38,750 and $0, respectively.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         PierContingent Stock Consideration        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Inconnection with the merger transaction with Pier effective August 10, 2012, RespireRx issued 17,975 newly issued shares of itscommon stock with an aggregate fair value of $3,271,402 ($182.00 per share), based upon the closing price of RespireRx’scommon stock on August 10, 2012. The shares of common stock were distributed to stockholders, convertible note holders, warrantholders, option holders, and certain employees and vendors of Pier in satisfaction of their interests and claims. The common stockissued by RespireRx represented approximately 41% of the 44,321 common shares outstanding immediately following the closing ofthe transaction.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        TheCompany concluded that the issuance of any of the contingent shares to the Pier Stock Recipients was remote, as a result of thelarge spread between the exercise prices of these stock options and warrants as compared to the common stock trading range, thesubsequent expiration or forfeiture of most of the options and warrants, the Company’s distressed financial condition andcapital requirements, and that these stock options and warrants have remained significantly out-of-the-money through December31, 2020. Accordingly, the Company considered the fair value of the contingent consideration to be immaterial and therefore didnot ascribe any value to such contingent consideration. If any such shares are ultimately issued to the former Pier stockholders,the Company will recognize the fair value of such shares as a charge to operations at that time.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         Reservedand Unreserved Shares of Common Stock        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 38.4pt">       <font style="font-family: Times New Roman, Times, Serif">        OnJanuary 17, 2017, the Board of Directors of the Company approved the adoption of an amendment of the Amended and Restated RespireRxPharmaceuticals, Inc. 2015 Stock and Stock Option Plan (as amended, the “2015 Plan”). That amendment increased theshares issuable under the plan by 150,000, from 153,846 to 303,846. On December 9, and December 28, 2018, the Board of Directorsfurther amended the 2015 Plan to increase the number of shares that may be issued under the 2015 Plan to 698,526 and 898,526 sharesof the Company’s common stock. On May 5, 2020 and July 31, 2020, the Board of Directors further amended the 2015 Plan toincrease the number of shares that may be issued under the 2015 Plan by 5,000,000 and 10,000,000 shares respectively. As of December31, 2020, there are 8,704,251 shares of common stock available for issuance under the 2015 Plan.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 38.4pt">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <!-- Field: Page; Sequence: 90; Value: 1 -->      <div style="margin-bottom: 6pt; border-bottom: Black 1.5pt solid">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="text-align: center; width: 100%">           F-           <!-- Field: Sequence; Type: Arabic; Name: PageNo -->           32           <!-- Field: /Sequence -->          </td>         </tr>        </tbody>       </table>      </div>      <div style="break-before: page; margin-top: 6pt">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="width: 100%">          </td>         </tr>        </tbody>       </table>      </div>      <!-- Field: /Page -->      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 38.4pt">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Otherthan the change in the number of shares available under the 2015 Plan, no other changes were made to the 2015 Plan by these amendmentsnoted above.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 38.4pt">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        AtDecember 31, 2020, the Company had 2,000,000,000 shares of common stock authorized and 71,271,095 shares of common stock issuedand outstanding. The Company has reserved 1 shares of common stock for the conversion of the Series B Preferred Stock. The Companyhas reserved an aggregate of 13,333,036 for the calculated amount of shares of common stock into which convertible notes may convertand an additional 53,464,642 shares of common stock for contractual reserves with respect to such notes. In addition, The Companyhas reserved 7,165,215 and 28,809,352 shares of the Company’s common stock for exercises of common stock purchase optionsgranted and warrants issued respectively and an additional 15,312,500 shares of common stock for contractual reserves associatedwith certain of the warrants. The Company has reserved 649 shares of common stock with respect to the Pier contingent shares.There are 8,770,576 shares reserved for future issuances under the Company’s 2014 Plan and 2015 Plan. Accordingly, aftertaking into consideration the shares of common stock reserved for all conversions, exercises, contingent share issuances and contractualreserves, there were 1,801,872,935 shares of the Company’s common stock available for future issuances as of December31, 2020.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         7.Income Taxes        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Deferredincome taxes reflect the net tax effects of temporary differences between the carrying amounts of assets and liabilities for financialreporting purposes and the amounts used for income tax purposes. Significant components of the Company’s deferred tax assetsas of December 31, 2020 and 2019 are summarized below.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">      </p>      <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">       <tbody>        <tr style="vertical-align: bottom">         <td style="text-align: center">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="padding-bottom: 1.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           <b>            December    31,           </b>          </font>         </td>         <td style="padding-bottom: 1.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>        </tr>        <tr style="vertical-align: bottom">         <td style="text-align: center">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="padding-bottom: 1.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           <b>            2020           </b>          </font>         </td>         <td style="padding-bottom: 1.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="padding-bottom: 1.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           <b>            2019           </b>          </font>         </td>         <td style="padding-bottom: 1.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>        </tr>        <tr style="vertical-align: bottom; background-color: #CCEEFF">         <td>          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           Capitalized research and development costs          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           $          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           -          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           $          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           -          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>        </tr>        <tr style="vertical-align: bottom; background-color: white">         <td style="width: 64%">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           Research and development    credits          </font>         </td>         <td style="width: 2%">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="width: 1%">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="width: 14%; text-align: right">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           3,017,000          </font>         </td>         <td style="width: 1%">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="width: 2%">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="width: 1%">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="width: 14%; text-align: right">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           3,017,000          </font>         </td>         <td style="width: 1%">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>        </tr>        <tr style="vertical-align: bottom; background-color: #CCEEFF">         <td>          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           Stock-based compensation          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           3,975,000          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           3,787,000          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>        </tr>        <tr style="vertical-align: bottom; background-color: white">         <td>          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           Stock options issued in connection with the    payment of debt          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           202,000          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           202,000          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>        </tr>        <tr style="vertical-align: bottom; background-color: #CCEEFF">         <td>          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           Net operating loss carryforwards          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           20,536,000          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           19,982,000          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>        </tr>        <tr style="vertical-align: bottom; background-color: white">         <td>          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           Accrued compensation          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           155,000          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           586,000          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>        </tr>        <tr style="vertical-align: bottom; background-color: #CCEEFF">         <td>          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           Accrued interest due to related party          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           146,000          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           217,000          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>        </tr>        <tr style="vertical-align: bottom; background-color: white">         <td style="padding-bottom: 1.5pt">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           Other, net          </font>         </td>         <td style="padding-bottom: 1.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="border-bottom: black 1.5pt solid">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="border-bottom: black 1.5pt solid; text-align: right">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           8,000          </font>         </td>         <td style="padding-bottom: 1.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="padding-bottom: 1.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="border-bottom: black 1.5pt solid">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="border-bottom: black 1.5pt solid; text-align: right">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           8,000          </font>         </td>         <td style="padding-bottom: 1.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>        </tr>        <tr style="vertical-align: bottom; background-color: #CCEEFF">         <td>          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           Total deferred tax assets          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           28,039,000          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           27,799,000          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>        </tr>        <tr style="vertical-align: bottom; background-color: white">         <td style="padding-bottom: 1.5pt">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           Valuation allowance          </font>         </td>         <td style="padding-bottom: 1.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="border-bottom: black 1.5pt solid">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="border-bottom: black 1.5pt solid; text-align: right">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           (28,039,000          </font>         </td>         <td style="padding-bottom: 1.5pt">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           )          </font>         </td>         <td style="padding-bottom: 1.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="border-bottom: black 1.5pt solid">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="border-bottom: black 1.5pt solid; text-align: right">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           (27,799,000          </font>         </td>         <td style="padding-bottom: 1.5pt">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           )          </font>         </td>        </tr>        <tr style="vertical-align: bottom; background-color: #CCEEFF">         <td style="padding-bottom: 2.5pt">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           Net deferred tax    assets          </font>         </td>         <td style="padding-bottom: 2.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="border-bottom: black 2.25pt double">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           $          </font>         </td>         <td style="border-bottom: black 2.25pt double; text-align: right">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           -          </font>         </td>         <td style="padding-bottom: 2.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="padding-bottom: 2.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="border-bottom: black 2.25pt double">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           $          </font>         </td>         <td style="border-bottom: black 2.25pt double; text-align: right">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           -          </font>         </td>         <td style="padding-bottom: 2.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>        </tr>       </tbody>      </table>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Inassessing the potential realization of deferred tax assets, management considers whether it is more likely than not that someportion or all of the deferred tax assets will be realized. The ultimate realization of deferred tax assets is dependent uponthe Company attaining future taxable income during the periods in which those temporary differences become deductible. As of December31, 2020 and 2019, management was unable to determine that it was more likely than not that the Company’sdeferred tax assets will be realized, and has therefore recorded an appropriate valuation allowance against deferred tax assetsat such dates.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Nofederal tax provision has been provided for the years ended December 31, 2020 and 2019 due to the losses incurredduring such periods. Reconciled below is the difference between the income tax rate computed by applying the U.S. federal statutoryrate and the effective tax rate for the years ended December 31, 2020 and 2019.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <!-- Field: Page; Sequence: 91; Value: 1 -->      <div style="margin-bottom: 6pt; border-bottom: Black 1.5pt solid">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="text-align: center; width: 100%">           F-           <!-- Field: Sequence; Type: Arabic; Name: PageNo -->           33           <!-- Field: /Sequence -->          </td>         </tr>        </tbody>       </table>      </div>      <div style="break-before: page; margin-top: 6pt">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="width: 100%">          </td>         </tr>        </tbody>       </table>      </div>      <!-- Field: /Page -->      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">       <tbody>        <tr style="vertical-align: bottom">         <td style="text-align: center">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="font-weight: bold; padding-bottom: 1.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">          <font style="font-family: Times New Roman, Times, Serif">           Years    Ended December 31,          </font>         </td>         <td style="padding-bottom: 1.5pt; font-weight: bold">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>        </tr>        <tr style="vertical-align: bottom">         <td style="font-weight: bold; text-align: center">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="font-weight: bold; padding-bottom: 1.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">          <font style="font-family: Times New Roman, Times, Serif">           2020          </font>         </td>         <td style="padding-bottom: 1.5pt; font-weight: bold">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="font-weight: bold; padding-bottom: 1.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">          <font style="font-family: Times New Roman, Times, Serif">           2019          </font>         </td>         <td style="padding-bottom: 1.5pt; font-weight: bold">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>        </tr>        <tr style="vertical-align: bottom">         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td colspan="2">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td colspan="2">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>        </tr>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td style="width: 64%; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           U. S. federal statutory    tax rate          </font>         </td>         <td style="width: 2%">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="width: 1%; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="width: 14%; text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           (21.0          </font>         </td>         <td style="width: 1%; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           )%          </font>         </td>         <td style="width: 2%">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="width: 1%; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="width: 14%; text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           (21.0          </font>         </td>         <td style="width: 1%; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           )%          </font>         </td>        </tr>        <tr style="vertical-align: bottom; background-color: White">         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           Change in valuation allowance          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           (1.0          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           )%          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           (1.0          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           )%          </font>         </td>        </tr>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           Adjustment to deferred tax asset          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           22.0          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           %          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           22.0          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           %          </font>         </td>        </tr>        <tr style="vertical-align: bottom; background-color: White">         <td style="padding-bottom: 1.5pt">          <font style="font-family: Times New Roman, Times, Serif">           Other          </font>         </td>         <td style="padding-bottom: 1.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           -          </font>         </td>         <td style="padding-bottom: 1.5pt; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           %          </font>         </td>         <td style="padding-bottom: 1.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           -          </font>         </td>         <td style="padding-bottom: 1.5pt; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           %          </font>         </td>        </tr>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td style="text-align: left; padding-bottom: 2.5pt">          <font style="font-family: Times New Roman, Times, Serif">           Effective tax    rate          </font>         </td>         <td style="padding-bottom: 2.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="border-bottom: Black 2.5pt double; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="border-bottom: Black 2.5pt double; text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           0.0          </font>         </td>         <td style="padding-bottom: 2.5pt; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           %          </font>         </td>         <td style="padding-bottom: 2.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="border-bottom: Black 2.5pt double; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="border-bottom: Black 2.5pt double; text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           0.0          </font>         </td>         <td style="padding-bottom: 2.5pt; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           %          </font>         </td>        </tr>       </tbody>      </table>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif">        Asof December 31, 2020, the Company had federal and state tax net operating loss carryforwards of approximately $104,166,000and $44,252,000, respectively. The state tax net operating loss carryforward consists of $19,673,000 for Californiapurposes and $24,579,000 for New Jersey purposes. The difference between the federal and state tax loss carryforwards wasprimarily attributable to the capitalization of research and development expenses for California franchise tax purposes. The federalnet operating loss carryforwards will expire at various dates from 2021 through 2040. State net operating losses expire at variousdates from 2021 through 2029 for California and through 2040 for New Jersey. The Company also had federaland California research and development tax credit carryforwards that totaled approximately $1,871,000 and $1,146,000, respectivelyat December 31, 2020. The federal research and development tax credit carryforwards will expire at various dates from 2021through 2032. The California research and development tax credit carryforward does not expire and will carryforwardindefinitely until utilized.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Whilethe Company has not performed a formal analysis of the availability of its net operating loss carryforwards under Internal RevenueCode Sections 382 and 383, management expects that the Company’s ability to use its net operating loss carryforwards willbe limited in future periods.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif">        TheCompany has not filed its federal and state tax returns for the year ended December 31, 2020, for which the Company has fileda request for extension of time to file such returns. The Company does not expect there to be any material non-filing penalties.The Company intends to file such returns as soon as practical.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         8.Related Party Transactions        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 38.4pt">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Dr.Arnold S. Lippa and Jeff E. Margolis, officers and directors of the Company since March 22, 2013, have indirect ownership interestsand managing memberships in Aurora Capital LLC (“Aurora”) through interests held in its members, and Jeff. E. Margolisis also an officer of Aurora. Aurora is a boutique investment banking firm specializing in the life sciences sector that limitsits securities related activities primarily to investment banking services.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 38.4pt">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Adescription of advances and notes payable to officers is provided at Note 4. Notes Payable – Advances from and Notes Payableto Officer.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         9.Commitments and Contingencies        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         Pendingor Threatened Legal Action and Claims        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        TheCompany is periodically the subject of various pending and threatened legal actions and claims. In the opinion of management ofthe Company, adequate provision has been made in the Company’s consolidated financial statements as of December 31, 2020and 2019 with respect to such matters. See Note 5. Settlement and Payment Agreements to the consolidated financial statementsas of December 31, 2020 for additional items and details.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <!-- Field: Page; Sequence: 92; Value: 1 -->      <div style="margin-bottom: 6pt; border-bottom: Black 1.5pt solid">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="text-align: center; width: 100%">           F-           <!-- Field: Sequence; Type: Arabic; Name: PageNo -->           34           <!-- Field: /Sequence -->          </td>         </tr>        </tbody>       </table>      </div>      <div style="break-before: page; margin-top: 6pt">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="width: 100%">          </td>         </tr>        </tbody>       </table>      </div>      <!-- Field: /Page -->      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         SignificantAgreements and Contracts        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         ConsultingAgreements        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        RichardPurcell, the Company’s Senior Vice President of Research and Development since October 15, 2014, provides his services tothe Company on a month-to-month basis through his consulting firm, DNA Healthlink, Inc., through which the Company has contractedfor his services, for a monthly cash fee of $12,500. Cash compensation expense pursuant to this agreement totaled $112,500 and$150,000 for the fiscal years ended December 31, 2020 and 2019, respectively, which is included in research and development expensesin the Company’s consolidated statements of operations for such periods.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif">        TheCompany entered into a consulting contract with David Dickason effective September 15, 2020 pursuant to which Mr. Dickason wasappointed to and serves as the Company’s Senior Vice President of Pre-Clinical Product Development on an at-will basis atthe rate of $250 per hour.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         EmploymentAgreements        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Effectiveon May 6, 2020, Timothy Jones was appointed as RespireRx’s President and Chief Executive Officer and entered into an employmentagreement as of that date. In addition, Mr. Jones has continued to serve as a member of the Company’s Board of Directors,a position he has held since January 28, 2020. On November 19, 2019, Mr. Jones became an advisor to the Company’s Boardof Directors, a position he held until January 27, 2020. Under the employment agreement, a provisional period of “at will”employment expired on July 31, 2020. Neither party terminated the employment agreement prior to July 31, 2020, and on that dateall rights and obligations under the agreement were deemed effective, including with respect to the certain economic obligationsof the Company upon termination of Mr. Jones’ employment. The Board of Directors and Mr. Jones agreed to continue the employmentagreement after the initial provisional period. The employment agreement has a termination date of September 30, 2023 and willautomatically extend annually, upon the same terms and conditions, for successive periods of one year, unless either party provideswritten notice of its intention not to extend the term of the agreement at least 90 days prior to the applicable renewal date.On July 31, 2020, the employment agreement was amended. The terms of the amended agreement call for a base salary through September30, 2020 of $300,000 per year which may remain accrued but unpaid at the discretion of the Board of Directors until such timeas at least $2,500,000 has been raised. As of December 31, 2020, Mr. Jones base salary remained $300,000 per year. If $10,000,000or more has been raised by September 30, 2021, Mr. Jones’ base salary would be increased to $375,000 per year. Otherwise,it would remain at $300,000 annually unless increased pursuant to the employment agreement or by the Board of Directors. Mr. Jones’base salary is subject to cost of living increases. Mr. Jones was eligible for a guaranteed bonus of $200,000 on October 31,2020.Mr. Jones is also entitled to bonuses of $200,000 on March 31, 2021 and $150,000 each six months thereafter on each March 31stand September 30        <sup>         th        </sup>        thereafter, unless the agreement is earlier terminated. The guaranteed bonus of $200,000 that wasdue on October 31, 2020 was not paid and is accrued and payable as of that date. At the end of the provisional period, pursuantto the employment agreement, Mr. Jones was granted an option grant for the purchase of 1,000,000 shares of the Company’scommon stock upon the expiration of the provisional period which has since been adjusted to 100,000 shares after the reverse stock-splitand is presented in the options tables in our consolidated financial statements as of December 31, 2020 on a post reverse stock-splitbasis. In addition, until such time as the Company establishes comparable benefits, Mr. Jones is entitled to $1,200 per monthon a tax equalized basis for health insurance and $1,000 per month on a tax equalized basis for term life insurance plus a disabilitypolicy. Mr. Jones is entitled to be reimbursed for business expenses. Mr. Jones would be entitled to a $12,000 tax equalized annualautomobile allowance after the Company has raised $10,000,000. In addition, on July 31, 2020, the Board of Directors granted Mr.Jones a discretionary bonus that was a grant of an option to purchase 16,000,000 shares of common stock expiring on July 31, 2025at an exercise price equal to the closing price of the Company’s common stock on July 31, 2020 of $0.0072 which has beenadjusted to 1,600,000 shares and an exercise price of $0.072 after the reverse stock-split, and which is presented in the optionstables in our consolidated financial statements as of December 31, 2020 on a post reverse stock-split basis, 25% of which vestedimmediately, 25% of which vested on September 30, 2020, December 31, 2020 and March 31, 2021. Upon commencement of Mr. Jones’employment agreement on May 6, 2020, Mr. Jones was no longer eligible to receive fees for his participation as a member of theBoard of Directors. For the fiscal year ended December 31, 2020, the Company accrued $436,059 of compensation and related benefitsfor Mr. Jones in the form of Board of Directors advisory fees, salary and benefits and bonus, of which Mr. was paid $16,073 incash and exchanged $28,218 of the accrued obligation for Series H Preferred Stock as discussed below. These amounts are includedin accounts payable and accrued expenses and in accrued compensation in the Company’s consolidated balance sheet as of December31, 2020. On September 30, 2020, Mr. Jones, pursuant to an exchange agreement, forgave $28,218 of accrued Board of Directors andother fees owed to him in exchange for 28.218 shares of Series H Preferred Stock which, on the same day, was converted into 4,409,063shares of Common Stock and a warrant to purchase 4,409,063 shares of Common Stock, both of which were adjusted to 440,906 sharesof Common Stock and warrants respectively after the reverse stock-split and which are presented on a reverse stock-split basisin our consolidated financial statements as of December 31, 2020.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        EffectiveMay 6, 2020, with the appointment of Timothy Jones as RespireRx’s President and Chief Executive Officer, Dr. Lippa resignedthe interim officer positions of Interim Chief Executive Officer and Interim President, positions that Dr. Lippa had assumed onOctober 12, 2018 after the resignation of Dr. James Manuso on September 30, 2018. Dr. Lippa continues to serve as RespireRx’sExecutive Chairman and as a member of the Board of Directors as well as the Company’s Chief Scientific Officer.       </font>       <font style="font: 10pt Times New Roman, Times, Serif">        Dr. Lippa has continued to serve as the Company’s Executive Chairman and as a member of the Board of Directors. On August18, 2015, Dr. Lippa was named Chief Scientific Officer of the Company, and the Company entered into an employment agreement withDr. Lippa in that capacity. Pursuant to the agreement, which was for an initial term through September 30, 2018 (and which automaticallyextended on September 30, 2018, 2019 and 2020 and will automatically extend annually, upon the same terms and conditions,for successive periods of one year, unless either party provides written notice of its intention not to extend the term of theagreement at least 90 days prior to the applicable renewal date), Dr. Lippa earned an annual base salary of $300,000. Dr. Lippais also eligible to earn a performance-based annual bonus award of up to 50% of his base salary, based upon the achievement ofannual performance goals established by the Board of Directors in consultation with the executive prior to the start of such fiscalyear, or any amount at the discretion of the Board of Directors. Additionally, Dr. Lippa has been granted stock options on severaloccasions and is eligible to receive additional awards under the Company’s Plans at the discretion of the Board of Directors.Dr. Lippa did not receive any option to purchase shares of common stock during fiscal year ended December 31, 2020. Dr.Lippa is also entitled to receive, until such time as the Company establishes a group health plan for its employees, $1,200 permonth, on a tax-equalized basis, as additional compensation to cover the cost of health coverage and up to $1,000 per month, ona tax-equalized basis, as reimbursement for a term life insurance policy and disability insurance policy. Dr. Lippa is also entitledto be reimbursed for business expenses. Additional information with respect to the stock options granted to Dr. Lippa is providedat Note 6  to the Company’s consolidated financial statements for the fiscal years ended December 31, 2020 and2019. Cash compensation inclusive of employee benefits accrued pursuant to this agreement totaled $339,600 for each ofthe fiscal years ended December 31, 2020 and 2019, respectively, which amounts are included in accrued compensation and relatedexpenses in the Company’s consolidated balance sheet at December 31, 2020 and 2019, and in research and developmentexpenses in the Company’s consolidated statement of operations for the fiscal years ended December 31, 2020 and 2020.Dr. Lippa does not receive any additional compensation for serving as Executive Chairman and on the Board of Directors.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">      </p>      <p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">      </p>      <!-- Field: Page; Sequence: 93; Value: 1 -->      <div style="margin-bottom: 6pt; border-bottom: Black 1.5pt solid">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="text-align: center; width: 100%">           F-           <!-- Field: Sequence; Type: Arabic; Name: PageNo -->           35           <!-- Field: /Sequence -->          </td>         </tr>        </tbody>       </table>      </div>      <div style="break-before: page; margin-top: 6pt">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="width: 100%">          </td>         </tr>        </tbody>       </table>      </div>      <!-- Field: /Page -->      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif">        OnMarch 22, 2020, July 13, 2020 and September 30, 2020, Dr. Lippa, forgave an aggregate of $853,000 of accrued compensation andbenefits. On March 22, 2020, Dr, Lippa received 4,500,000 shares Common Stock for $153,000 of forgiven compensation, which sharesof Common Stock were adjusted to 450,000 shares of Common Stock on a post reverse stock-split basis. On July 13, 2020, pursuantto an exchange agreement, Dr. Lippa forgave $600,000 of accrued compensation and benefits and in exchange received 600 sharesof Series H Preferred Stock. On September 30, 2020, pursuant to an additional exchange agreement, Dr. Lippa forgave $100,000 ofaccrued compensation and benefits and in exchange received 100 shares of Series H Preferred Stock. Between July 13, 2020 and September30, 2020, Dr. Lippa earned 2.6333333 shares of Series H Preferred Stock as dividends in-kind. On July 13, 2020 and September 30,2020, Dr. Lippa contributed all of his Series H Preferred Stock to a family trust. On September 30, 2020, the family trust convertedall of its Series H Preferred Stock into 109,786,458 shares of RespireRx Common Stock and a warrant to purchase 109,786,458 sharesof Common Stock which were subsequently adjusted to 10,978,645 shares of Common Stock and warrants to purchase 10,978,645 sharesof Common Stock.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        OnAugust 18, 2015, the Company also entered into an employment agreement with Jeff E. Margolis, in his role at that time as VicePresident, Secretary and Treasurer. Pursuant to the agreement, which was for an initial term through September 30, 2016 and lateramended (and which automatically extended on September 30, 2016, 2017, 2018 and 2019 and will automatically extend annually, uponthe same terms and conditions for successive periods of one year, unless either party provides written notice of its intentionnot to extend the term of the agreement at least 90 days prior to the applicable renewal date), Mr. Margolis currently receivesan annual base salary of $300,000, and is eligible to receive performance-based annual bonus awards based upon the achievementof annual performance goals established by the Board of Directors in consultation with the executive prior to the start of suchfiscal year. Additionally, Mr. Margolis has granted stock options on several occasions and is eligible to receive additional awardsunder the Company’s Plans at the discretion of the Board of Directors. Mr. Margolis is also entitled to receive, until suchtime as the Company establishes a group health plan for its employees, $1,200 per month, on a tax-equalized basis, as additionalcompensation to cover the cost of health coverage and up to $1,000 per month, on a tax-equalized basis, as reimbursement for aterm life insurance policy and disability insurance policy. Mr. Margolis is also entitled to be reimbursed for business expenses.Additional information with respect to the stock options granted to Mr. Margolis is provided at Note 6       </font>       <font style="font-family: Times New Roman, Times, Serif; font-size: 8pt">       </font>       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        to the Company’s consolidated financialstatements for fiscal years ended December 31, 2020 and 2019. Recurring cash compensation accrued pursuant to this amendedagreement totaled $321,600 for the fiscal year ended December 31, 2020 and 2019 which amounts are included in accrued compensationand related expenses in the Company’s consolidated balance sheet December 31, 2020 and 2019, and in general and administrativeexpenses in the Company’s consolidated statement of operations.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        OnMarch 22, 2020, July 13, 2020 and September 30, 2020, Mr. Margolis, forgave an aggregate of $803,000 of accrued compensation andbenefits. On March 22, 2020, Mr. Margolis received 4,500,000 shares Common Stock for $153,000 of forgiven compensation, whichshares of Common Stock were adjusted to 450,000 shares of Common Stock on a post reverse stock-split basis. On July 13, 2020,pursuant to an exchange agreement, Mr. Margolis forgave $500,000 of accrued compensation and benefits and in exchange received500 shares of Series H Preferred Stock. On September 30, 2020, pursuant to an additional exchange agreement, Mr. Margolis forgave$150,000 of accrued compensation and benefits and in exchange received 150 shares of Series H Preferred Stock. Between July 13,2020 and September 30, 2020, Mr. Margolis earned 2.194444 shares of Series H Preferred Stock as dividends in-kind. On July 13,2020 and September 30, 2020, Mr. Margolis contributed all of his Series H Preferred Stock to three family trusts. On September30, 2020, the family trusts converted all of their Series H Preferred Stock into 101,905,382 shares of RespireRx Common Stockand a warrant to purchase 101,905,382 shares of Common Stock which were subsequently adjusted to 10,190,538 shares of Common Stockand warrants to purchase 10,190,538 shares of Common Stock.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Theemployment agreements between the Company and Dr. Lippa, and Mr. Margolis (prior to the 2017 amendment), respectively, providedthat the payment obligations associated with the first year base salary were to accrue, but no payments were to be made, untilat least $2,000,000 of net proceeds from any offering or financing of debt or equity, or a combination thereof, was received bythe Company, at which time scheduled payments were to commence. Dr. Lippa, and Mr. Margolis (who are each also directors of theCompany) have each agreed, effective as of August 11, 2016, to continue to defer the payment of such amounts indefinitely, untilsuch time as the Board of Directors of the Company determines that sufficient capital has been raised by the Company or is otherwiseavailable to fund the Company’s operations on an ongoing basis.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         UWMRFPatent License Agreement        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        OnAugust 1, 2020, RespireRx exercised its option pursuant to its option agreement dated March 2, 2020, between RespireRx and UWMResearch Foundation, an affiliate of the University of Wisconsin-Milwaukee (“UWMRF”). Upon exercise RespireRx andUWMRF executed the UWMRF Patent License Agreement effective August 1, 2020 pursuant to which RespireRx licensed the identifiedintellectual property.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Underthe UWMRF Patent License Agreement, the Company has an exclusive license to commercialize GABAkine products based on UWMRF’srights in certain patents and patent applications, and a non-exclusive license to commercialize products based on UWMRF’srights in certain technology that is not the subject of the patents or patent applications. UWMRF maintains the right to use,and, upon the approval of the Company, to license, these patent and technology rights for any non-commercial purpose, includingresearch and education. The UWMRF Patent License Agreement expires upon the later of the expiration of the Company’s paymentobligations to UWMRF or the expiration of the last remaining licensed patent granted thereunder, subject to early terminationupon the occurrence of certain events. The License Agreement also contains a standard indemnification provision in favor of UWMRFand confidentiality provisions obligating both parties.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">      </p>      <!-- Field: Page; Sequence: 94; Value: 1 -->      <div style="margin-bottom: 6pt; border-bottom: Black 1.5pt solid">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="text-align: center; width: 100%">           F-           <!-- Field: Sequence; Type: Arabic; Name: PageNo -->           36           <!-- Field: /Sequence -->          </td>         </tr>        </tbody>       </table>      </div>      <div style="break-before: page; margin-top: 6pt">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="width: 100%">          </td>         </tr>        </tbody>       </table>      </div>      <!-- Field: /Page -->      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Underthe UWMRF Patent License Agreement, in consideration for the licenses granted, the Company will pay to UWMRF the following: (i)patent filing and prosecution costs incurred by UWMRF prior to the effective date, paid in yearly installments over three yearsfrom the Effective Date; (ii) annual maintenance fees, beginning on the second anniversary of the Effective Date, which annualmaintenance fees terminate upon the Company’s payment of royalties pursuant to clause (iv) below; (iii) milestone payments,paid upon the occurrence of certain dosing events of patients during clinical trials and certain approvals by the FDA; and (iv)royalties on net sales of products developed with the licenses, subject to minimum annual payments and to royalty rate adjustmentsbased on whether separate royalty payments by the Company yield an aggregate rate beyond a stated threshold. The Company has alsogranted UWMRF certain stock appreciation rights with respect to the Company’s neuromodulator programs, subject to certainlimitations, and will pay to UWMRF certain percentages of revenues generated from sublicenses of the licenses provided under theUWMRF Patent License Agreement by the Company to third parties.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         Universityof Illinois 2014 Exclusive License Agreement        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        OnJune 27, 2014, the Company entered into an Exclusive License Agreement (the “2014 License Agreement”) with the Universityof Illinois, the material terms of which were similar to a License Agreement between the parties that had been previously terminatedon March 21, 2013. The 2014 License Agreement became effective on September 18, 2014, upon the completion of certain conditionsset forth in the 2014 License Agreement, including: (i) the payment by the Company of a $25,000 licensing fee, (ii) the paymentby the Company of outstanding patent costs aggregating $15,840, and (iii) the assignment to the University of Illinois of rightsthe Company held in certain patent applications, all of which conditions were fulfilled.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        The2014 License Agreement granted the Company (i) exclusive rights to several issued and pending patents in numerous jurisdictionsand (ii) the non-exclusive right to certain technical information that is generated by the University of Illinois in connectionwith certain clinical trials as specified in the 2014 License Agreement, all of which relate to the use of cannabinoids for thetreatment of sleep related breathing disorders. The Company is developing dronabinol (Δ9-tetrahydrocannabinol), a cannabinoid,for the treatment of OSA, the most common form of sleep apnea.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        The2014 License Agreement provides for various commercialization and reporting requirements commencing on June 30, 2015. In addition,the 2014 License Agreement provides for various royalty payments, including a royalty on net sales of 4%, payment on sub-licenseerevenues of 12.5%, and a minimum annual royalty beginning in 2015 of $100,000, which is due and payable on December 31 of eachyear beginning on December 31, 2015. The minimum annual royalty obligation of $100,000 due on December 31, 2020, was extendedto April 19, 2021 and was paid in full on April 1, 2021. One-time milestone payments may become due based upon the achievementof certain development milestones. $350,000 will be due within five days after the dosing of the first patient is a Phase IIIhuman clinical trial anywhere in the world. $500,000 will be due within five days after the first NDA filing with FDA or a foreignequivalent. $1,000,000 will be due within twelve months of the first commercial sale. One-time royalty payments may also becomedue and payable. Annual royalty payments may also become due. In the year after the first application for market approval is submittedto the FDA or a foreign equivalent and until approval is obtained, the minimum annual royalty will increase to $150,000. In theyear after the first market approval is obtained from the FDA or a foreign equivalent and until the first sale of a product, theminimum annual royalty will increase to $200,000. In the year after the first commercial sale of a product, the minimum annualroyalty will increase to $250,000.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Duringthe fiscal years ended December 31, 2020 and 2019, the Company recorded charges to operations of $100,000, respectively, withrespect to its 2020 and 2019 minimum annual royalty obligation, which is included in research and development expenses in theCompany’s consolidated statement of operations for the fiscal years ended December 31, 2020 and 2019. The Company did notpay the amount due on December 31, 2020 for which the Company was granted an extension until April 19, 2021 and which was paidin full on April 1, 2021.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <!-- Field: Page; Sequence: 95; Value: 1 -->      <div style="margin-bottom: 6pt; border-bottom: Black 1.5pt solid">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="text-align: center; width: 100%">           F-           <!-- Field: Sequence; Type: Arabic; Name: PageNo -->           37           <!-- Field: /Sequence -->          </td>         </tr>        </tbody>       </table>      </div>      <div style="break-before: page; margin-top: 6pt">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="width: 100%">          </td>         </tr>        </tbody>       </table>      </div>      <!-- Field: /Page -->      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         Universityof Alberta License Agreement        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 38.4pt">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        OnMay 18, 2018, the Company received a letter from counsel claiming to represent TEC Edmonton and The Governors of the Universityof Alberta, which purported to terminate, effective December 12, 2017, the license agreement dated May 9, 2007 (as subsequentlyamended) between the Company and The Governors of the University of Alberta. The Company, through its counsel, disputed any groundsfor termination and notified the representative that it invoked Section 13 of that license agreement, which mandates a meetingto be attended by individuals with decision-making authority to attempt in good faith to negotiate a resolution to the dispute.In February 2019, the Company and TEC Edmonton tentatively agreed to terms acceptable to all parties to establish a new licenseagreement and the form of a new license agreement. However, after reaching that tentative agreement, the Company has re-evaluatedthat portion of its ampakine program and has decided not to enter into a new agreement at this time. The lack of entry into anew agreement at this time does not affect the Company’s other ampakine programs and permits the Company to reallocate resourcesto those programs, including, but not limited to ADHD, FXS, SCI and CNS-driven Disorders.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 38.4pt">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         NoramcoInc. - Dronabinol Development and Supply Agreement        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        OnSeptember 4, 2018, RespireRx entered into a dronabinol Development and Supply Agreement with Noramco Inc., one of the world’smajor dronabinol manufacturers. Under the terms of the Agreement, Noramco agreed to (i) provide all of the active pharmaceuticalingredient (“API”) estimated to be needed for the clinical development process for both the first- and second-generationproducts (each a “Product” and collectively, the “Products”), three validation batches for New Drug Application(“NDA”) filing(s) and adequate supply for the initial inventory stocking for the wholesale and retail channels, subjectto certain limitations, (ii) maintain or file valid drug master files (“DMFs”) with the FDA or any other regulatoryauthority and provide the Company with access or a right of reference letter entitling the Company to make continuing referenceto the DMFs during the term of the agreement in connection with any regulatory filings made with the FDA by the Company, (iii)participate on a development committee, and (iv) make available its regulatory consultants, collaborate with any regulatory consultingfirms engaged by the Company and participate in all FDA or Drug Enforcement Agency (“DEA”) meetings as appropriateand as related to the API.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Inconsideration for these supplies and services, the Company has agreed to purchase exclusively from Noramco during the commercializationphase all API for its Products as defined in the Development and Supply Agreement at a pre-determined price subject to certainproducer price adjustments and agreed to Noramco’s participation in the economic success of the commercialized Product orProducts up to the earlier of the achievement of a maximum dollar amount or the expiration of a period of time.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         Transactionswith Biovail Laboratories International SRL        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Beginningin March 2010, the Company entered into a series of asset purchase and license agreements with Biovail Laboratories InternationalSRL later merged with Valeant Pharmaceuticals International, Inc. which was later renamed Bausch Health Companies Inc. (“Biovail”).       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        InMarch 2011, the Company entered into a new agreement with Biovail to reacquire the ampakine compounds, patents and rights thatBiovail had acquired from the Company in March 2010. The new agreement provided for potential future payments of up to $15,150,000by the Company based upon the achievement of certain developments, including new drug application submissions and approval milestonespertaining to an intravenous dosage form of the ampakine compounds for respiratory depression, a therapeutic area not currentlypursued by the Company. Biovail is also eligible to receive additional payments of up to $15,000,000 from the Company based uponthe Company’s net sales of an intravenous dosage form of the compounds for respiratory depression.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <!-- Field: Page; Sequence: 96; Value: 1 -->      <div style="margin-bottom: 6pt; border-bottom: Black 1.5pt solid">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="text-align: center; width: 100%">           F-           <!-- Field: Sequence; Type: Arabic; Name: PageNo -->           38           <!-- Field: /Sequence -->          </td>         </tr>        </tbody>       </table>      </div>      <div style="break-before: page; margin-top: 6pt">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="width: 100%">          </td>         </tr>        </tbody>       </table>      </div>      <!-- Field: /Page -->      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Atany time following the completion of Phase 1 clinical studies and prior to the end of Phase 2A clinical studies, Biovail retainsan option to co-develop and co-market intravenous dosage forms of an ampakine compound as a treatment for respiratory depressionand vaso-occlusive crises associated with sickle cell disease. In such an event, the Company would be reimbursed for certain developmentexpenses to date and Biovail would share in all such future development costs with the Company. If Biovail makes the co-marketingelection, the Company would owe no further milestone payments to Biovail and the Company would be eligible to receive a royaltyon net sales of the compound by Biovail or its affiliates and licensees.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         Summaryof Principal Cash Obligations and Commitments        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Thefollowing table sets forth the Company’s principal cash obligations and commitments for the next five fiscal years as ofDecember 31, 2020, aggregating $2,885,270. Employment agreement amounts included in the 2021 column represent amounts contractuallydue from January 1, 2021 through September 30, 2021 or in one case, September 30, 2023 when such contracts expire unless extendedpursuant to the terms of the contracts.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">       <tbody>        <tr style="vertical-align: bottom">         <td style="font-weight: bold; text-align: center">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="font-weight: bold; padding-bottom: 1.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td colspan="2" style="font-weight: bold; text-align: center">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="padding-bottom: 1.5pt; font-weight: bold">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="font-weight: bold; padding-bottom: 1.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td colspan="18" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">          <font style="font-family: Times New Roman, Times, Serif">           Payments    Due By Year          </font>         </td>         <td style="padding-bottom: 1.5pt; font-weight: bold">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>        </tr>        <tr style="vertical-align: bottom">         <td style="font-weight: bold; text-align: center">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="font-weight: bold; padding-bottom: 1.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">          <font style="font-family: Times New Roman, Times, Serif">           Total          </font>         </td>         <td style="padding-bottom: 1.5pt; font-weight: bold">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="font-weight: bold; padding-bottom: 1.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">          <font style="font-family: Times New Roman, Times, Serif">           2021          </font>         </td>         <td style="padding-bottom: 1.5pt; font-weight: bold">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="font-weight: bold; padding-bottom: 1.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">          <font style="font-family: Times New Roman, Times, Serif">           2022          </font>         </td>         <td style="padding-bottom: 1.5pt; font-weight: bold">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="font-weight: bold; padding-bottom: 1.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">          <font style="font-family: Times New Roman, Times, Serif">           2023          </font>         </td>         <td style="padding-bottom: 1.5pt; font-weight: bold">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="font-weight: bold; padding-bottom: 1.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">          <font style="font-family: Times New Roman, Times, Serif">           2024          </font>         </td>         <td style="padding-bottom: 1.5pt; font-weight: bold">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="font-weight: bold; padding-bottom: 1.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">          <font style="font-family: Times New Roman, Times, Serif">           2025          </font>         </td>         <td style="padding-bottom: 1.5pt; font-weight: bold">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>        </tr>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td style="width: 40%; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           License agreements          </font>         </td>         <td style="width: 2%">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="width: 1%; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           $          </font>         </td>         <td style="width: 6%; text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           560,370          </font>         </td>         <td style="width: 1%; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="width: 2%">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="width: 1%; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           $          </font>         </td>         <td style="width: 6%; text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           100,000          </font>         </td>         <td style="width: 1%; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="width: 2%">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="width: 1%; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           $          </font>         </td>         <td style="width: 6%; text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           115,092          </font>         </td>         <td style="width: 1%; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="width: 2%">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="width: 1%; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           $          </font>         </td>         <td style="width: 6%; text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           115,093          </font>         </td>         <td style="width: 1%; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="width: 2%">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="width: 1%; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           $          </font>         </td>         <td style="width: 6%; text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           130,185          </font>         </td>         <td style="width: 1%; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="width: 2%">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="width: 1%; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           $          </font>         </td>         <td style="width: 6%; text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           100,000          </font>         </td>         <td style="width: 1%; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>        </tr>        <tr style="vertical-align: bottom; background-color: White">         <td style="text-align: left; padding-bottom: 1.5pt">          <font style="font-family: Times New Roman, Times, Serif">           Employment agreements    (1)          </font>         </td>         <td style="padding-bottom: 1.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           2,294,900          </font>         </td>         <td style="padding-bottom: 1.5pt; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="padding-bottom: 1.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           1,100,600          </font>         </td>         <td style="padding-bottom: 1.5pt; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="padding-bottom: 1.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           639,600          </font>         </td>         <td style="padding-bottom: 1.5pt; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="padding-bottom: 1.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           554,700          </font>         </td>         <td style="padding-bottom: 1.5pt; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="padding-bottom: 1.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           -          </font>         </td>         <td style="padding-bottom: 1.5pt; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="padding-bottom: 1.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           -          </font>         </td>         <td style="padding-bottom: 1.5pt; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>        </tr>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td style="padding-bottom: 2.5pt">          <font style="font-family: Times New Roman, Times, Serif">           Total          </font>         </td>         <td style="padding-bottom: 2.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="border-bottom: Black 2.5pt double; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           $          </font>         </td>         <td style="border-bottom: Black 2.5pt double; text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           2,855,270          </font>         </td>         <td style="padding-bottom: 2.5pt; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="padding-bottom: 2.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="border-bottom: Black 2.5pt double; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           $          </font>         </td>         <td style="border-bottom: Black 2.5pt double; text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           1,200,600          </font>         </td>         <td style="padding-bottom: 2.5pt; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="padding-bottom: 2.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="border-bottom: Black 2.5pt double; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           $          </font>         </td>         <td style="border-bottom: Black 2.5pt double; text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           754,692          </font>         </td>         <td style="padding-bottom: 2.5pt; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="padding-bottom: 2.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="border-bottom: Black 2.5pt double; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           $          </font>         </td>         <td style="border-bottom: Black 2.5pt double; text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           669,793          </font>         </td>         <td style="padding-bottom: 2.5pt; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="padding-bottom: 2.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="border-bottom: Black 2.5pt double; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           $          </font>         </td>         <td style="border-bottom: Black 2.5pt double; text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           130,185          </font>         </td>         <td style="padding-bottom: 2.5pt; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="padding-bottom: 2.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="border-bottom: Black 2.5pt double; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           $          </font>         </td>         <td style="border-bottom: Black 2.5pt double; text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           100,000          </font>         </td>         <td style="padding-bottom: 2.5pt; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>        </tr>       </tbody>      </table>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        (1)The payment of certain of such amounts has been deferred indefinitely, as described above in “Employment Agreements”.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         10.Subsequent Events        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Asof 5pm eastern time on January 5, 2021, the Company effected a ten to one (10:1) reverse stock split of its Common Stockby filing the Sixth Amendment of Second Restated Certificate of Incorporation of RespireRx Pharmaceuticals Inc. with the Secretaryof State of the State of Delaware on January 4, 2021. The financial statements have been prepared as of December 31, 2020 andfor the fiscal year then ended on a post-reverse stock split basis.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Aftera downgrade of the trading of our Common Stock to the OTC Pink Market on December 10, 2020, the reverse stock split describedabove occurred on January 5, 2021 and the Common Stock began trading on a post-reverse stock split basis on the OTC Markets OTCPink Market from January 6, 2021 through Friday, February 5, 2021 while measuring for thirty calendar days, compliance with theuplisting requirements for listing on the OTC Markets OTCQB Venture Market. The stock was upgraded to the OTCQB Venture Marketon Monday, February 8, 2021.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Apurchase notice was sent to White Lion on February 19, 2021 was for 3,600,000 shares of Common Stock resulting in net proceedsafter closing costs of $2,070 aggregating $115,229. The total of all shares sold pursuant to purchase notices (including threepurchase notices in the fiscal year ended December 31, 2020 and the one February 19, 2021 purchase notice is 11,500,000 whichis all of the shares registered and offered for sale is the registration statement on Form S-1 that became effective on October29, 2020. There are no shares available for sale under that registration statement. In order for the Company to issue additionalpurchase notices to White Lion, the Company would either have to file a new registration statement or amend the current registrationstatement covering shares representing any remaining amounts available under the White Lion EPA, or up to $1,711,581.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <!-- Field: Page; Sequence: 97; Value: 1 -->      <div style="margin-bottom: 6pt; border-bottom: Black 1.5pt solid">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="text-align: center; width: 100%">           F-           <!-- Field: Sequence; Type: Arabic; Name: PageNo -->           39           <!-- Field: /Sequence -->          </td>         </tr>        </tbody>       </table>      </div>      <div style="break-before: page; margin-top: 6pt">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="width: 100%">          </td>         </tr>        </tbody>       </table>      </div>      <!-- Field: /Page -->      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        TheFirstFire Note dated July 2, 2020 was paid in full by conversion as follows:       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">       <tbody>        <tr style="vertical-align: bottom">         <td style="text-align: center; border-bottom: Black 1.5pt solid">          <font style="font-family: Times New Roman, Times, Serif">           <b>            Conversion    Date           </b>          </font>         </td>         <td style="padding-bottom: 1.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">          <font style="font-family: Times New Roman, Times, Serif">           <b>            Principal    Converted           </b>          </font>         </td>         <td style="padding-bottom: 1.5pt; text-align: center">          <font style="font-family: Times New Roman, Times, Serif">           <b>           </b>          </font>         </td>         <td style="padding-bottom: 1.5pt; text-align: center">          <font style="font-family: Times New Roman, Times, Serif">           <b>           </b>          </font>         </td>         <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">          <font style="font-family: Times New Roman, Times, Serif">           <b>            Interest    Converted           </b>          </font>         </td>         <td style="padding-bottom: 1.5pt; text-align: center">          <font style="font-family: Times New Roman, Times, Serif">           <b>           </b>          </font>         </td>         <td style="padding-bottom: 1.5pt; text-align: center">          <font style="font-family: Times New Roman, Times, Serif">           <b>           </b>          </font>         </td>         <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">          <font style="font-family: Times New Roman, Times, Serif">           <b>            Costs    paid by the Company by conversion           </b>          </font>         </td>         <td style="padding-bottom: 1.5pt; text-align: center">          <font style="font-family: Times New Roman, Times, Serif">           <b>           </b>          </font>         </td>         <td style="padding-bottom: 1.5pt; text-align: center">          <font style="font-family: Times New Roman, Times, Serif">           <b>           </b>          </font>         </td>         <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">          <font style="font-family: Times New Roman, Times, Serif">           <b>            Conversion    Price per Share           </b>          </font>         </td>         <td style="padding-bottom: 1.5pt; text-align: center">          <font style="font-family: Times New Roman, Times, Serif">           <b>           </b>          </font>         </td>         <td style="padding-bottom: 1.5pt; text-align: center">          <font style="font-family: Times New Roman, Times, Serif">           <b>           </b>          </font>         </td>         <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">          <font style="font-family: Times New Roman, Times, Serif">           <b>            Shares    of Common Stock Issued           </b>          </font>         </td>         <td style="padding-bottom: 1.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>        </tr>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td style="width: 31%">          <font style="font-family: Times New Roman, Times, Serif">           January 19, 2021          </font>         </td>         <td style="width: 2%">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="width: 1%; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           $          </font>         </td>         <td style="width: 9%; text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           30,000          </font>         </td>         <td style="width: 1%; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="width: 2%">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="width: 1%; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           $          </font>         </td>         <td style="width: 9%; text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           0          </font>         </td>         <td style="width: 1%; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="width: 2%">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="width: 1%; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           $          </font>         </td>         <td style="width: 9%; text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           0          </font>         </td>         <td style="width: 1%; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="width: 2%">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="width: 1%; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           $          </font>         </td>         <td style="width: 9%; text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           0.02          </font>         </td>         <td style="width: 1%; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="width: 2%">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="width: 1%; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="width: 13%; text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           1,500,000          </font>         </td>         <td style="width: 1%; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>        </tr>        <tr style="vertical-align: bottom; background-color: White">         <td>          <font style="font-family: Times New Roman, Times, Serif">           February 4, 2021          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           $          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           37,500          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           $          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           0          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           $          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           0          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           $          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           0.02          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           1,875,000          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>        </tr>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td>          <font style="font-family: Times New Roman, Times, Serif">           February 16, 2021          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           $          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           50,000          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           $          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           0          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           $          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           0          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           $          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           0.02          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           2,500,000          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>        </tr>        <tr style="vertical-align: bottom; background-color: White">         <td style="padding-bottom: 1.5pt">          <font style="font-family: Times New Roman, Times, Serif">           March 3, 2021          </font>         </td>         <td style="padding-bottom: 1.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           $          </font>         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           20,000          </font>         </td>         <td style="padding-bottom: 1.5pt; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="padding-bottom: 1.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           $          </font>         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           6,875          </font>         </td>         <td style="padding-bottom: 1.5pt; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="padding-bottom: 1.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           $          </font>         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           0          </font>         </td>         <td style="padding-bottom: 1.5pt; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="padding-bottom: 1.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           $          </font>         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           0.02          </font>         </td>         <td style="padding-bottom: 1.5pt; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="padding-bottom: 1.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="padding-bottom: 1.5pt; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           1,343,750          </font>         </td>         <td style="padding-bottom: 1.5pt; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>        </tr>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td style="padding-bottom: 2.5pt">          <font style="font-family: Times New Roman, Times, Serif">           Total          </font>         </td>         <td style="padding-bottom: 2.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="border-bottom: Black 2.5pt double; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           $          </font>         </td>         <td style="border-bottom: Black 2.5pt double; text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           137,500          </font>         </td>         <td style="padding-bottom: 2.5pt; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="padding-bottom: 2.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="border-bottom: Black 2.5pt double; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           $          </font>         </td>         <td style="border-bottom: Black 2.5pt double; text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           6,875          </font>         </td>         <td style="padding-bottom: 2.5pt; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="padding-bottom: 2.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="border-bottom: Black 2.5pt double; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           $          </font>         </td>         <td style="border-bottom: Black 2.5pt double; text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           0          </font>         </td>         <td style="padding-bottom: 2.5pt; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="padding-bottom: 2.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="border-bottom: Black 2.5pt double; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="border-bottom: Black 2.5pt double; text-align: right">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="padding-bottom: 2.5pt; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="padding-bottom: 2.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="padding-bottom: 2.5pt; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="border-bottom: Black 2.5pt double; text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           7,218,750          </font>         </td>         <td style="padding-bottom: 2.5pt; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>        </tr>       </tbody>      </table>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        TheEMA Note dated July 30, 2020 was paid in full by conversion as follows:       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">       <tbody>        <tr style="vertical-align: bottom">         <td style="border-bottom: Black 1.5pt solid; text-align: center">          <font style="font-family: Times New Roman, Times, Serif">           <b>            Conversion    Date           </b>          </font>         </td>         <td style="padding-bottom: 1.5pt; text-align: center">          <font style="font-family: Times New Roman, Times, Serif">           <b>           </b>          </font>         </td>         <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">          <font style="font-family: Times New Roman, Times, Serif">           <b>            Principal    Converted           </b>          </font>         </td>         <td style="padding-bottom: 1.5pt; text-align: center">          <font style="font-family: Times New Roman, Times, Serif">           <b>           </b>          </font>         </td>         <td style="padding-bottom: 1.5pt; text-align: center">          <font style="font-family: Times New Roman, Times, Serif">           <b>           </b>          </font>         </td>         <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">          <font style="font-family: Times New Roman, Times, Serif">           <b>            Interest    Converted           </b>          </font>         </td>         <td style="padding-bottom: 1.5pt; text-align: center">          <font style="font-family: Times New Roman, Times, Serif">           <b>           </b>          </font>         </td>         <td style="padding-bottom: 1.5pt; text-align: center">          <font style="font-family: Times New Roman, Times, Serif">           <b>           </b>          </font>         </td>         <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">          <font style="font-family: Times New Roman, Times, Serif">           <b>            Costs    paid by the Company by conversion           </b>          </font>         </td>         <td style="padding-bottom: 1.5pt; text-align: center">          <font style="font-family: Times New Roman, Times, Serif">           <b>           </b>          </font>         </td>         <td style="padding-bottom: 1.5pt; text-align: center">          <font style="font-family: Times New Roman, Times, Serif">           <b>           </b>          </font>         </td>         <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">          <font style="font-family: Times New Roman, Times, Serif">           <b>            Conversion    Price per Share           </b>          </font>         </td>         <td style="padding-bottom: 1.5pt; text-align: center">          <font style="font-family: Times New Roman, Times, Serif">           <b>           </b>          </font>         </td>         <td style="padding-bottom: 1.5pt; text-align: center">          <font style="font-family: Times New Roman, Times, Serif">           <b>           </b>          </font>         </td>         <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">          <font style="font-family: Times New Roman, Times, Serif">           <b>            Shares    of Common Stock Issued           </b>          </font>         </td>         <td style="padding-bottom: 1.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>        </tr>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td style="width: 31%">          <font style="font-family: Times New Roman, Times, Serif">           February 4, 2021          </font>         </td>         <td style="width: 2%">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="width: 1%; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           $          </font>         </td>         <td style="width: 9%; text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           19,000          </font>         </td>         <td style="width: 1%; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="width: 2%">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="width: 1%; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           $          </font>         </td>         <td style="width: 9%; text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           0          </font>         </td>         <td style="width: 1%; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="width: 2%">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="width: 1%; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           $          </font>         </td>         <td style="width: 9%; text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           1,000          </font>         </td>         <td style="width: 1%; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="width: 2%">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="width: 1%; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           $          </font>         </td>         <td style="width: 9%; text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           0.02          </font>         </td>         <td style="width: 1%; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="width: 2%">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="width: 1%; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="width: 13%; text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           1,000,000          </font>         </td>         <td style="width: 1%; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>        </tr>        <tr style="vertical-align: bottom; background-color: White">         <td>          <font style="font-family: Times New Roman, Times, Serif">           February 10, 2021          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           $          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           19,000          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           $          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           0          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           $          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           1,000          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           $          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           0.02          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           1,000,000          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>        </tr>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td>          <font style="font-family: Times New Roman, Times, Serif">           February 12, 2021          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           $          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           19,000          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           $          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           0          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           $          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           1,000          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           $          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           0.02          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           1,000,000          </font>         </td>         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>        </tr>        <tr style="vertical-align: bottom; background-color: White">         <td style="padding-bottom: 1.5pt">          <font style="font-family: Times New Roman, Times, Serif">           March 3, 2021          </font>         </td>         <td style="padding-bottom: 1.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           $          </font>         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           18,000          </font>         </td>         <td style="padding-bottom: 1.5pt; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="padding-bottom: 1.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           $          </font>         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           4,136          </font>         </td>         <td style="padding-bottom: 1.5pt; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="padding-bottom: 1.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           $          </font>         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           1,000          </font>         </td>         <td style="padding-bottom: 1.5pt; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="padding-bottom: 1.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           $          </font>         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           0.02          </font>         </td>         <td style="padding-bottom: 1.5pt; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="padding-bottom: 1.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="padding-bottom: 1.5pt; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           1,156,807          </font>         </td>         <td style="padding-bottom: 1.5pt; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>        </tr>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td style="padding-bottom: 2.5pt">          <font style="font-family: Times New Roman, Times, Serif">           Total          </font>         </td>         <td style="padding-bottom: 2.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="border-bottom: Black 2.5pt double; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           $          </font>         </td>         <td style="border-bottom: Black 2.5pt double; text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           75,000          </font>         </td>         <td style="padding-bottom: 2.5pt; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="padding-bottom: 2.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="border-bottom: Black 2.5pt double; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           $          </font>         </td>         <td style="border-bottom: Black 2.5pt double; text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           4,136          </font>         </td>         <td style="padding-bottom: 2.5pt; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="padding-bottom: 2.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="border-bottom: Black 2.5pt double; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           $          </font>         </td>         <td style="border-bottom: Black 2.5pt double; text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           4,000          </font>         </td>         <td style="padding-bottom: 2.5pt; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="padding-bottom: 2.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="border-bottom: Black 2.5pt double; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="border-bottom: Black 2.5pt double; text-align: right">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="padding-bottom: 2.5pt; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="padding-bottom: 2.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="padding-bottom: 2.5pt; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="border-bottom: Black 2.5pt double; text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           4,156,807          </font>         </td>         <td style="padding-bottom: 2.5pt; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>        </tr>       </tbody>      </table>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        OnMarch 15, 2021, the White Lion Commitment Note was repaid in part by conversion as follows:       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">       <tbody>        <tr style="vertical-align: bottom">         <td style="border-bottom: Black 1.5pt solid; text-align: center">          <font style="font-family: Times New Roman, Times, Serif">           <b>            Conversion    Date           </b>          </font>         </td>         <td style="padding-bottom: 1.5pt; text-align: center">          <font style="font-family: Times New Roman, Times, Serif">           <b>           </b>          </font>         </td>         <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">          <font style="font-family: Times New Roman, Times, Serif">           <b>            Principal    Converted           </b>          </font>         </td>         <td style="padding-bottom: 1.5pt; text-align: center">          <font style="font-family: Times New Roman, Times, Serif">           <b>           </b>          </font>         </td>         <td style="padding-bottom: 1.5pt; text-align: center">          <font style="font-family: Times New Roman, Times, Serif">           <b>           </b>          </font>         </td>         <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">          <font style="font-family: Times New Roman, Times, Serif">           <b>            Interest    Converted           </b>          </font>         </td>         <td style="padding-bottom: 1.5pt; text-align: center">          <font style="font-family: Times New Roman, Times, Serif">           <b>           </b>          </font>         </td>         <td style="padding-bottom: 1.5pt; text-align: center">          <font style="font-family: Times New Roman, Times, Serif">           <b>           </b>          </font>         </td>         <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">          <font style="font-family: Times New Roman, Times, Serif">           <b>            Costs    paid by the Company by conversion           </b>          </font>         </td>         <td style="padding-bottom: 1.5pt; text-align: center">          <font style="font-family: Times New Roman, Times, Serif">           <b>           </b>          </font>         </td>         <td style="padding-bottom: 1.5pt; text-align: center">          <font style="font-family: Times New Roman, Times, Serif">           <b>           </b>          </font>         </td>         <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">          <font style="font-family: Times New Roman, Times, Serif">           <b>            Conversion    Price per Share           </b>          </font>         </td>         <td style="padding-bottom: 1.5pt; text-align: center">          <font style="font-family: Times New Roman, Times, Serif">           <b>           </b>          </font>         </td>         <td style="padding-bottom: 1.5pt; text-align: center">          <font style="font-family: Times New Roman, Times, Serif">           <b>           </b>          </font>         </td>         <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">          <font style="font-family: Times New Roman, Times, Serif">           <b>            Shares    of Common Stock Issued           </b>          </font>         </td>         <td style="padding-bottom: 1.5pt">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>        </tr>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td style="padding-bottom: 2.5pt; width: 31%">          <font style="font-family: Times New Roman, Times, Serif">           March 15, 2021          </font>         </td>         <td style="padding-bottom: 2.5pt; width: 2%">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           $          </font>         </td>         <td style="border-bottom: Black 2.5pt double; width: 9%; text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           25,000          </font>         </td>         <td style="padding-bottom: 2.5pt; width: 1%; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="padding-bottom: 2.5pt; width: 2%">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           $          </font>         </td>         <td style="border-bottom: Black 2.5pt double; width: 9%; text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           0          </font>         </td>         <td style="padding-bottom: 2.5pt; width: 1%; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="padding-bottom: 2.5pt; width: 2%">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           $          </font>         </td>         <td style="border-bottom: Black 2.5pt double; width: 9%; text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           0          </font>         </td>         <td style="padding-bottom: 2.5pt; width: 1%; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="padding-bottom: 2.5pt; width: 2%">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">           $          </font>         </td>         <td style="border-bottom: Black 2.5pt double; width: 9%; text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           0.02          </font>         </td>         <td style="padding-bottom: 2.5pt; width: 1%; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="padding-bottom: 2.5pt; width: 2%">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="padding-bottom: 2.5pt; width: 1%; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="border-bottom: Black 2.5pt double; width: 13%; text-align: right">          <font style="font-family: Times New Roman, Times, Serif">           1,250,000          </font>         </td>         <td style="padding-bottom: 2.5pt; width: 1%; text-align: left">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>        </tr>       </tbody>      </table>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        OnFebruary 17, 2021, the Company and FirstFire entered into a Securities Purchase Agreement (the “FirstFire Feb 2021 SPA”)pursuant to which FirstFire provided a sum of $100,000 (the “FirstFire Feb 2021 Consideration”) to the Company, inreturn for a convertible promissory note (the “FirstFire Feb 2021 Note”) with a face amount of $112,000 (which differencein value as compared to the FirstFire Feb 2021 Consideration is due to an original issue discount of $12,000) and 2,000,000 commitmentshares of Common Stock, a piggy-back registration rights agreement and other agreements and obligations. The net proceeds of theFirst Fire Feb 2021 Consideration, which were received by the Company on February 19, 2021, equal $97,500 after payment of $2,500in FirstFire’s legal fees. The FirstFire Feb 2021 Note bears interest at 10% per annum. The terms of the FirstFire Feb 2021Note require that the Company reserve 18,060,000 shares of Common Stock or three times the number of shares into which the FirstFireFeb 2021 Note may convert, but no less than the initial number of shares of Common Stock that must be reserved.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        OnMarch 31, 2021, the Company and EMA entered into a Securities Purchase Agreement (the “EMA March 2021 SPA”) pursuantto which EMA provided a sum of $100,000 (the “EMA March 2021 Consideration”) to the Company, in return for a convertiblepromissory note (the “EMA March 2021 Note”) with a face amount of $112,500 (which difference in value as comparedto the EMA March 2021 Consideration is due to an original issue discount of $12,500) and a warrant exercisable for five yearsat $0.02 per share on a cash or cashless basis, into 2,400,000 shares of Common Stock, a piggy-back registration rights agreementand other agreements and obligations. The net proceeds of the EMA March 2021 Consideration, which were received by the Companyon April 1, 2021, equal $96,750 after payment of $2,750 in EMA’s legal fees. And $500 of EMA’s due diligence fees.The EMA March 2021 Note bears interest at 10% per annum and matures on March 31, 2022. The EMA March 2021 Note is convertibleat a fixed conversion price of $0.02 per share of Common Stock. The terms of the EMA March 2021 Note require that the Companyreserve the greater of (i) 26,602,500 shares of Common Stock or (ii) three times the number of shares into which the EMAMarch 2021 Note may convert and into which the warrant may exercise.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <!-- Field: Page; Sequence: 98; Value: 1 -->      <div style="margin-bottom: 6pt; border-bottom: Black 1.5pt solid">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="text-align: center; width: 100%">           F-           <!-- Field: Sequence; Type: Arabic; Name: PageNo -->           40           <!-- Field: /Sequence -->          </td>         </tr>        </tbody>       </table>      </div>      <div style="break-before: page; margin-top: 6pt">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="width: 100%">          </td>         </tr>        </tbody>       </table>      </div>      <!-- Field: /Page -->      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         RespireRxPharmaceuticals Inc.        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         AnnualReport on Form 10-K        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         YearEnded December 31, 2019        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         ExhibitIndex        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">       <tbody>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">         <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 0.75in">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           <b>            Exhibit    Number           </b>          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; width: 0.1in">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           <b>           </b>          </font>         </td>         <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           <b>            Description           </b>          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           2.1          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif">           <a href="https://www.sec.gov/Archives/edgar/data/849636/000119312512359056/d396191dex21.htm" style="-sec-extract: exhibit">            <font style="font-size: 10pt">             Agreement    and Plan of Merger, dated as of August 10, 2012, by and among Cortex Pharmaceuticals, Inc., Pier Acquisition Corp. and Pier    Pharmaceuticals, Inc., incorporated by reference to Exhibit 2.1 to the Company’s Current Report on Form 8-K filed on    August 16, 2012 (File no. 001-16467).            </font>           </a>          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           3.1          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif">           <a href="https://www.sec.gov/Archives/edgar/data/849636/000119312510127442/dex31.htm" style="-sec-extract: exhibit">            <font style="font-size: 10pt">             Second    Restated Certificate of Incorporation dated May 19, 2010, incorporated by reference to the same numbered Exhibit to the Company’s    Current Report on Form 8-K filed May 24, 2010 (File no. 001-16467).            </font>           </a>          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           3.2          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif">           <a href="https://www.sec.gov/Archives/edgar/data/849636/000114420414023573/v375191_ex3-2.htm" style="-sec-extract: exhibit">            <font style="font-size: 10pt">             Certificate    of Amendment of the (Second Restated) Certificate of Incorporation of Cortex Pharmaceuticals, Inc., incorporated by reference    to Exhibit 3.2 to the Company’s Current Report on Form 8-K filed on April 18, 2014 (File no. 001-16467).            </font>           </a>          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           3.3          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif">           <a href="https://www.sec.gov/Archives/edgar/data/849636/000149315215006294/ex3-1.htm" style="-sec-extract: exhibit">            <font style="font-size: 10pt">             Second    Certificate of Amendment of the (Second Restated) Certificate of Incorporation of Cortex Pharmaceuticals, Inc., incorporated    by reference to Exhibit 3.1 to the Company’s Current Report on Form 8-K filed December 17, 2015 (File no. 001-16467).            </font>           </a>          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           3.4          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif">           <a href="https://www.sec.gov/Archives/edgar/data/849636/000149315216013045/ex3-1.htm" style="-sec-extract: exhibit">            <font style="font-size: 10pt">             Third    Certificate of Amendment of the Second Restated Certificate of Incorporation of RespireRx Pharmaceuticals Inc., incorporated    by reference to Exhibit 3.1 to the Company’s Current Report on Form 8-K filed September 1, 2016 (File no. 001-16467).            </font>           </a>          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           3.5          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif">           <a href="https://www.sec.gov/Archives/edgar/data/849636/0000912057-96-022884.txt" style="-sec-extract: exhibit">            <font style="font-size: 10pt">             By-Laws    of the Company, as adopted March 4, 1987, and amended on October 8, 1996, incorporated by reference to Exhibit 3.2 to the    Company’s Annual Report on Form 10-KSB filed October 15, 1996 (File no. 001-17951).            </font>           </a>          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           3.6          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif">           <a href="https://www.sec.gov/Archives/edgar/data/849636/000119312507248296/dex35.htm" style="-sec-extract: exhibit">            <font style="font-size: 10pt">             Certificate    of Amendment of By-Laws of the Company, incorporated by reference to Exhibit 3.5 to the Company’s Report on Form 8-K    filed November 15, 2007. (File no. 001-16467)            </font>           </a>          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           3.7          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif">           <a href="https://www.sec.gov/Archives/edgar/data/849636/000114420414017395/v372457_ex3-1.htm" style="-sec-extract: exhibit">            <font style="font-size: 10pt">             Certificate    of Designation, Preferences, Rights and Limitations of Series G 1.5% Convertible Preferred Stock, incorporated by reference    to Exhibit 3.1 to the Company’s Current Report on Form 8-K filed on March 24, 2014 (File no. 001-16467).            </font>           </a>          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif">           3.8          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <a href="https://www.sec.gov/Archives/edgar/data/849636/000149315220007848/ex3-1.htm" style="-sec-extract: exhibit">           <font style="font-family: Times New Roman, Times, Serif">            Fourth Certificate of Amendment of Second Restated Certificate of Incorporation of RespireRx Pharmaceuticals Inc. (incorporated by reference to Exhibit 3.1 of the Company’s Current Report on Form 8-K (file no. 001-16467) filed on May 6, 2020).           </font>          </a>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif">           3.9          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <a href="https://www.sec.gov/Archives/edgar/data/849636/000149315220013182/ex3-1.htm" style="-sec-extract: exhibit">           <font style="font-family: Times New Roman, Times, Serif">            Certificate of Designation, Preferences, Rights and Limitations of Series H 2% Voting, Non-Participating, Convertible Preferred Stock (incorporated by reference to Exhibit 3.1 of the Company’s Current Report on Form 8-K (file no. 001-16467) filed on July 13, 2020).           </font>          </a>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif">           3.10          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <a href="https://www.sec.gov/Archives/edgar/data/849636/000149315220018916/ex3-1.htm" style="-sec-extract: exhibit">           <font style="font-family: Times New Roman, Times, Serif">            Amendment to Certificate of Designation, Preferences, Rights and Limitations of Series H 2% Voting, Non-Participating, Convertible Preferred Stock (incorporated by reference to Exhibit 3.1 of the Company’s Current Report on Form 8-K (file no. 001-16467) filed on October 5, 2020).           </font>          </a>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif">           3.11          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <a href="https://www.sec.gov/Archives/edgar/data/849636/000149315220022502/ex3-1.htm" style="-sec-extract: exhibit">           <font style="font-family: Times New Roman, Times, Serif">            Fifth Certificate of Amendment of the Second Restated Certificate of Incorporation of RespireRx Pharmaceuticals Inc. (incorporated by reference to Exhibit 3.1 of the Company’s Current Report on Form 8-K (file no. 001-16467) filed on November 25, 2020).           </font>          </a>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           4.1          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif">           <a href="https://www.sec.gov/Archives/edgar/data/849636/000119312507189172/dex11.htm" style="-sec-extract: exhibit">            <font style="font-size: 10pt">             Placement    Agency Agreement, dated August 24, 2007, by and between Cortex Pharmaceuticals, Inc. and JMP Securities LLC and Rodman and    Renshaw, LLC, Form of Subscription Agreement and Form of Common Stock Purchase Warrant issued by Cortex Pharmaceuticals, Inc.,    incorporated by reference to Exhibits 1.1, 1.2 and 4.1, respectively, to the Company’s Report on Form 8-K filed August    27, 2007 (File no. 001-16467).            </font>           </a>          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           4.2          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif">           <a href="https://www.sec.gov/Archives/edgar/data/849636/000119312509081574/dex12.htm" style="-sec-extract: exhibit">            <font style="font-size: 10pt">             Placement    Agency Agreement, dated April 13, 2009, by and between the Company and Rodman &amp; Renshaw, LLC, Form of Securities Purchase    Agreement and Form of Common Stock Purchase Warrant issued by the Company, incorporated by reference to Exhibits 1.1, 1.2    and 4.1, respectively, to the Company’s Current Report on Form 8-K filed April 17, 2009 (File no. 001-16467).            </font>           </a>          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           4.3          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           <a href="ex4-3.htm">            Description    of Registrant’s Securities           </a>          </font>         </td>        </tr>       </tbody>      </table>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <!-- Field: Page; Sequence: 99; Options: NewSection; Value: 59 -->      <div style="margin-bottom: 6pt; border-bottom: Black 1.5pt solid">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="text-align: center; width: 100%">           <!-- Field: Sequence; Type: Arabic; Name: PageNo -->           59           <!-- Field: /Sequence -->          </td>         </tr>        </tbody>       </table>      </div>      <div style="break-before: page; margin-top: 6pt">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="width: 100%">          </td>         </tr>        </tbody>       </table>      </div>      <!-- Field: /Page -->      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">       <tbody>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           10.1†          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; width: 0.1in; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif">           <a href="https://www.sec.gov/Archives/edgar/data/849636/000119312506107964/dex1094.htm" style="-sec-extract: exhibit">            <font style="font-size: 10pt">             Cortex    Pharmaceuticals, Inc. 2006 Stock Incentive Plan, incorporated by reference to Exhibit 10.94 to the Company’s Report    on Form 8-K filed May 11, 2006 (File no. 001-16467).            </font>           </a>          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           10.2†          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif">           <a href="https://www.sec.gov/Archives/edgar/data/849636/000119312506165678/dex1096.htm" style="-sec-extract: exhibit">            <font style="font-size: 10pt">             Form    of Notice of Grant of Stock Options and Option Agreement under the Company’s 2006 Stock Incentive Plan, incorporated    by reference to Exhibit 10.96 to the Company’s Quarterly Report on Form 10-Q filed August 8, 2006 (File no. 001-16467).            </font>           </a>          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           10.3†          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif">           <a href="https://www.sec.gov/Archives/edgar/data/849636/000119312506165678/dex1097.htm" style="-sec-extract: exhibit">            <font style="font-size: 10pt">             Form    of Incentive/Non-qualified Stock Option Agreement under the Company’s 2006 Stock Incentive Plan, incorporated by reference    to Exhibit 10.97 to the Company’s Quarterly Report on Form 10-Q filed August 8, 2006 (File no. 001-16467).            </font>           </a>          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           10.4†          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif">           <a href="https://www.sec.gov/Archives/edgar/data/849636/000119312507115609/dex10101.htm" style="-sec-extract: exhibit">            <font style="font-size: 10pt">             Amendment    No. 1 to the Company’s 2006 Stock Incentive Plan, dated May 9, 2007, incorporated by reference to Exhibit 10.101 to    the Company’s Current Report on Form 8-K filed May 15, 2007 (File no. 001-16467).            </font>           </a>          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           10.5†          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif">           <a href="https://www.sec.gov/Archives/edgar/data/849636/000119312509174702/dex10115.htm" style="-sec-extract: exhibit">            <font style="font-size: 10pt">             Amendment    No. 2 to the Company’s 2006 Stock Incentive Plan, effective as of June 5, 2009, incorporated by reference Exhibit 10.115    to the Company’s Quarterly Report on Form 10-Q filed August 14, 2009 (File no. 001-16467).            </font>           </a>          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           10.6†          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif">           <a href="https://www.sec.gov/Archives/edgar/data/849636/000119312510127442/dex10118.htm" style="-sec-extract: exhibit">            <font style="font-size: 10pt">             Amendment    No. 3 to the Company’s 2006 Stock Incentive Plan, effective May 19, 2010, incorporated by reference to Exhibit 10.118    to the Company’s Current Report on Form 8-K filed May 24, 2010 (File no. 001-16467).            </font>           </a>          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           10.7          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif">           <a href="https://www.sec.gov/Archives/edgar/data/849636/000119312508058922/dex10105.htm" style="-sec-extract: exhibit">            <font style="font-size: 10pt">             Patent    License Agreement between the Company and the University of Alberta, dated as of May 9, 2007, incorporated by reference to    Exhibit 10.105 to the Company’s Annual Report on Form 10-K filed March 17, 2008 (File no. 001-16467). (Portions of this    Exhibit are omitted and were filed separately with the Secretary of the Commission pursuant to the Company’s application    requesting confidential treatment under Rule 24b-2 under the Securities Exchange Act of 1934).            </font>           </a>          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           10.8          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif">           <a href="https://www.sec.gov/Archives/edgar/data/849636/000119312509158883/dex10114.htm" style="-sec-extract: exhibit">            <font style="font-size: 10pt">             Securities    Purchase Agreement, dated July 29, 2009, by and between the Company and the Investors, including a form of Registration Rights    Agreement attached as Exhibit B thereto and a form of Common Stock Purchase Warrant attached as Exhibit C thereto, incorporated    by reference to Exhibit 10.114 to the Company’s Current Report on Form 8-K filed July 30, 2009 (File no. 001-16467).            </font>           </a>          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           10.9          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif">           <a href="https://www.sec.gov/Archives/edgar/data/849636/000119312511147812/dex10122.htm" style="-sec-extract: exhibit">            <font style="font-size: 10pt">             Asset    Purchase Agreement, dated March 15, 2011, by and between the Company and Biovail Laboratories International SRL, incorporated    by reference to Exhibit 10.122 to the Company’s Quarterly Report on Form 10-Q filed May 23, 2011 (File no. 001-16467).    (Portions of this exhibit are omitted and were filed separately with the Secretary of the Commission pursuant to the Company’s    application requesting confidential treatment under Rule 24b-2 of the Securities Exchange Act of 1934).            </font>           </a>          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           10.10          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif">           <a href="https://www.sec.gov/Archives/edgar/data/849636/000119312511226494/dex10125.htm" style="-sec-extract: exhibit">            <font style="font-size: 10pt">             Patent    Assignment and Option and Amended and Restated Agreement, dated June 10, 2011, between the Company and Les Laboratoires Servier,    incorporated by reference to Exhibit 10.125 to the Company’s Quarterly Report on Form 10-Q filed August 18, 2011 (File    no. 001-16467). (Portions of this exhibit are omitted and were filed separately with the Secretary of the Commission pursuant    to the Company’s application requesting confidential treatment under Rule 24b-2 of the Securities Exchange Act of 1934.            </font>           </a>          </font>         </td>        </tr>       </tbody>      </table>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <!-- Field: Page; Sequence: 100; Value: 59 -->      <div style="margin-bottom: 6pt; border-bottom: Black 1.5pt solid">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="text-align: center; width: 100%">           <!-- Field: Sequence; Type: Arabic; Name: PageNo -->           60           <!-- Field: /Sequence -->          </td>         </tr>        </tbody>       </table>      </div>      <div style="break-before: page; margin-top: 6pt">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="width: 100%">          </td>         </tr>        </tbody>       </table>      </div>      <!-- Field: /Page -->      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">       <tbody>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           10.11          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; width: 0.1in; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif">           <a href="https://www.sec.gov/Archives/edgar/data/849636/000119312510009794/dex10116.htm" style="-sec-extract: exhibit">            <font style="font-size: 10pt">             Securities    Purchase Agreement, dated January 15, 2010, by and between the Company and Samyang Optics Co., Ltd., including a form of Convertible    Promissory Note attached as Exhibit A thereto and a form of Common Stock Purchase Warrant attached as Exhibit B thereto, incorporated    by reference to Exhibit 10.116 to the Company’s Current Report on Form 8-K filed January 21, 2010 (File no. 001-16467).            </font>           </a>          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           10.12          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif">           <a href="https://www.sec.gov/Archives/edgar/data/849636/000119312512143643/d275401dex10127.htm" style="-sec-extract: exhibit">            <font style="font-size: 10pt">             Securities    Purchase Agreement, dated October 20, 2011, by and between the Company and Samyang Value Partners Co., Ltd., including the    Common Stock Purchase Warrant attached as Exhibit A thereto, incorporated by reference to Exhibit 10.127 to the Company’s    Annual Report on Form 10-K filed March 30, 2012 (File no. 001-16467).            </font>           </a>          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           10.13          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif">           <a href="https://www.sec.gov/Archives/edgar/data/849636/000119312512359062/d347756dex10129.htm" style="-sec-extract: exhibit">            <font style="font-size: 10pt">             Securities    Purchase Agreement, dated June 25, 2012, by and between the Company and Samyang Optics Co., Ltd., including a form of Secured    Promissory Note attached as Exhibit A thereto, a form of Common Stock Purchase Warrant attached as Exhibit B thereto, and    a form of Patent Security Agreement attached as Exhibit C thereto, incorporated by reference to Exhibit 10.129 to the Company’s    Quarterly Report on Form 10-Q filed on August 16, 2012 (File no. 001-16467).            </font>           </a>          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           10.14          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif">           <a href="https://www.sec.gov/Archives/edgar/data/849636/000114420414017395/v372457_ex10-1.htm" style="-sec-extract: exhibit">            <font style="font-size: 10pt">             Form    of Securities Purchase Agreement, incorporated by reference to Exhibit 10.1 to the Company’s Current Report on Form    8-K filed on March 24, 2014 (File no. 001-16467).            </font>           </a>          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           10.15†          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif">           <a href="https://www.sec.gov/Archives/edgar/data/849636/000114420414017395/v372457_ex10-2.htm" style="-sec-extract: exhibit">            <font style="font-size: 10pt">             Cortex    Pharmaceuticals, Inc. 2014 Equity, Equity-Linked and Equity Derivative Incentive Plan, established March 14, 2014, incorporated    by reference to Exhibit 10.2 to the Company’s Current Report on Form 8-K filed on March 24, 2014 (File no. 001-16467).            </font>           </a>          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           10.16          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif">           <a href="https://www.sec.gov/Archives/edgar/data/849636/000149315214002061/ex10-1.htm" style="-sec-extract: exhibit">            <font style="font-size: 10pt">             Exclusive    License Agreement, dated as of June 27, 2014, by and between the Board of Trustees of the University of Illinois, a body corporate    and politic of the State of Illinois, and Cortex Pharmaceuticals, Inc., incorporated by reference to Exhibit 10.1 to the Company’s    Current Report on Form 8-K filed on July 1, 2014 (File no. 001-16467).            </font>           </a>          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           10.17          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif">           <a href="https://www.sec.gov/Archives/edgar/data/849636/000149315216006821/ex99-1.htm" style="-sec-extract: exhibit">            <font style="font-size: 10pt">             Standard    Agreement for Submitting Compounds for Preclinical Pharmacological, Pharmacokinetic and Toxicological Evaluation, dated October    19, 2015, by and between the National Institute on Drug Abuse (hereinafter referred to as “NIDA”), a component    of the National Institutes of Health (NIH); and Cortex Pharmaceuticals, incorporated by reference to Exhibit 99.1 of the Company’s    Current Report on Form 8-K filed on January 19, 2016 (File no. 001-16467).            </font>           </a>          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           10.18†          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif">           <a href="https://www.sec.gov/Archives/edgar/data/849636/000149315214002250/ex10-1.htm" style="-sec-extract: exhibit">            <font style="font-size: 10pt">             Form    of Non-Statutory Stock Option Award Agreement, incorporated by reference to Exhibit 10.1 to the Company’s Current Report    on Form 8-K filed on July 23, 2014 (File no. 001-16467).            </font>           </a>          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           10.19†          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif">           <a href="https://www.sec.gov/Archives/edgar/data/849636/000149315214002250/ex10-2.htm" style="-sec-extract: exhibit">            <font style="font-size: 10pt">             Form    of Incentive Stock Option Award Agreement, incorporated by reference to Exhibit 10.2 to the Company’s Current Report    on Form 8-K filed on July 23, 2014 (File no. 001-16467).            </font>           </a>          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           10.20†          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif">           <a href="https://www.sec.gov/Archives/edgar/data/849636/000149315214002250/ex10-3.htm" style="-sec-extract: exhibit">            <font style="font-size: 10pt">             Form    of Restricted Stock Award Agreement, incorporated by reference to Exhibit 10.3 to the Company’s Current Report on Form    8-K filed on July 23, 2014 (File no. 001-16467).            </font>           </a>          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           10.21          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif">           <a href="https://www.sec.gov/Archives/edgar/data/849636/000149315214002850/ex10-1.htm" style="-sec-extract: exhibit">            <font style="font-size: 10pt">             Release    Agreement, dated September 2, 2014, between the Company and the Institute for the Study of Aging Inc., incorporated by reference    to Exhibit 10.1 to the Company’s Current Report on Form 8-K filed on September 5, 2014 (File no. 001-16467).            </font>           </a>          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           10.22          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif">           <a href="https://www.sec.gov/Archives/edgar/data/849636/000149315214003632/ex10-1.htm" style="-sec-extract: exhibit">            <font style="font-size: 10pt">             Form    of Convertible Note and Warrant Agreement, including a form of 10% Convertible Note due September 15, 2012 attached as Exhibit    A thereto and a Form of Warrant to Purchase Common Stock attached as Exhibit B thereto, incorporated by reference to Exhibit    10.1 to the Company’s Current Report on Form 8-K filed on November 12, 2014 (File no. 001-16467).            </font>           </a>          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           10.23          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif">           <a href="https://www.sec.gov/Archives/edgar/data/849636/000149315215002571/ex10-1.htm" style="-sec-extract: exhibit">            <font style="font-size: 10pt">             Demand    Promissory Note, dated June 16, 2015, held by Arnold S. Lippa on behalf of the Company, incorporated by reference to Exhibit    10.1 to the Company’s Current Report on Form 8-K filed on June 19, 2015 (File no. 001-16467).            </font>           </a>          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           10.24          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif">           <a href="https://www.sec.gov/Archives/edgar/data/849636/000149315216007128/ex10-1.htm" style="-sec-extract: exhibit">            <font style="font-size: 10pt">             Form    of Demand Promissory Note, incorporated by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K filed    on February 3, 2016 (File no. 001-16467).            </font>           </a>          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           10.25          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif">           <a href="https://www.sec.gov/Archives/edgar/data/849636/000149315216007128/ex10-2.htm" style="-sec-extract: exhibit">            <font style="font-size: 10pt">             Form    of Warrant to Purchase Common Stock, incorporated by reference to Exhibit 10.2 to the Company’s Current Report on Form    8-K filed on February 3, 2016 (File no. 001-16467).            </font>           </a>          </font>         </td>        </tr>       </tbody>      </table>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <!-- Field: Page; Sequence: 101; Value: 59 -->      <div style="margin-bottom: 6pt; border-bottom: Black 1.5pt solid">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="text-align: center; width: 100%">           <!-- Field: Sequence; Type: Arabic; Name: PageNo -->           61           <!-- Field: /Sequence -->          </td>         </tr>        </tbody>       </table>      </div>      <div style="break-before: page; margin-top: 6pt">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="width: 100%">          </td>         </tr>        </tbody>       </table>      </div>      <!-- Field: /Page -->      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">       <tbody>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           10.26†          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; width: 0.1in; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif">           <a href="https://www.sec.gov/Archives/edgar/data/849636/000149315215002868/ex10-1.htm" style="-sec-extract: exhibit">            <font style="font-size: 10pt">             2015    Stock and Stock Option Plan, dated June 30, 2015, incorporated by reference to Exhibit 10.1 to the Company’s Current    Report on Form 8-K filed on July 8, 2015 (File no. 001-16467).            </font>           </a>          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           10.27†          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif">           <a href="https://www.sec.gov/Archives/edgar/data/849636/000149315216008690/ex10-1.htm" style="-sec-extract: exhibit">            <font style="font-size: 10pt">             Amended    and Restated RespireRx Pharmaceuticals Inc. 2015 Stock and Stock Option Plan, incorporated by reference to Exhibit 10.1 to    the Company’s Current Report on Form 8-K filed on April 6, 2016 (File no. 001-16467).            </font>           </a>          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           10.28†          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif">           <a href="https://www.sec.gov/Archives/edgar/data/849636/000149315217000725/ex10-1.htm" style="-sec-extract: exhibit">            <font style="font-size: 10pt">             First    Amendment of Amended and Restated RespireRx Pharmaceuticals Inc. 2015 Stock and Stock Option Plan, incorporated by reference    to Exhibit 10.1 to the Company’s Current Report on Form 8-K filed on January 23, 2017 (File no. 001-16467).            </font>           </a>          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           10.29†          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif">           <a href="https://www.sec.gov/Archives/edgar/data/849636/000149315215002868/ex10-2.htm" style="-sec-extract: exhibit">            <font style="font-size: 10pt">             Form    of Non-Statutory Stock Option Award Agreement, incorporated by reference to Exhibit 10.2 to the Company’s Current Report    on Form 8-K filed on July 8, 2015 (File no. 001-16467).            </font>           </a>          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           10.30†          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif">           <a href="https://www.sec.gov/Archives/edgar/data/849636/000149315215003890/ex10-2.htm" style="-sec-extract: exhibit">            <font style="font-size: 10pt">             Employment    Agreement, dated August 18, 2015, between the Company and James S. J. Manuso, incorporated by reference to Exhibit 10.2 to    Form 8-K filed on August 19, 2015 (File no. 001-16467).            </font>           </a>          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           10.31†          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif">           <a href="https://www.sec.gov/Archives/edgar/data/849636/000149315215003890/ex10-3.htm" style="-sec-extract: exhibit">            <font style="font-size: 10pt">             Employment    Agreement, dated August 18, 2015, between the Company and Arnold S. Lippa, incorporated by reference to Exhibit 10.3 to Form    8-K filed on August 19, 2015 (File no. 001-16467).            </font>           </a>          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           10.32†          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif">           <a href="https://www.sec.gov/Archives/edgar/data/849636/000149315215003890/ex10-4.htm" style="-sec-extract: exhibit">            <font style="font-size: 10pt">             Employment    Agreement, dated August 18, 2015, between the Company and Robert N. Weingarten, incorporated by reference to Exhibit 10.4    to Form 8-K filed on August 19, 2015 (File no. 001-16467).            </font>           </a>          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           10.33†          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif">           <a href="https://www.sec.gov/Archives/edgar/data/849636/000149315215003890/ex10-5.htm" style="-sec-extract: exhibit">            <font style="font-size: 10pt">             Employment    Agreement, dated August 18, 2015, between the Company and Jeff E. Margolis, incorporated by reference to Exhibit 10.5 to Form    8-K filed on August 19, 2015 (File no. 001-16467).            </font>           </a>          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           10.34          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif">           <a href="https://www.sec.gov/Archives/edgar/data/849636/000149315215004076/ex10-1.htm" style="-sec-extract: exhibit">            <font style="font-size: 10pt">             Form    of Second Amended and Restated Common Stock and Warrant Purchase Agreement, including a Form of Warrant to Purchase Common    Stock attached as Exhibit A thereto, incorporated by reference to Exhibit 10.1 to Form 8-K filed on August 31, 2015 (File    no. 001-16467).            </font>           </a>          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           10.35          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif">           <a href="https://www.sec.gov/Archives/edgar/data/849636/000149315216006725/ex10-1.htm" style="-sec-extract: exhibit">            <font style="font-size: 10pt">             Form    of Common Stock and Warrant Purchase Agreement, including a Form of Warrant to Purchase Common Stock attached as Exhibit A    thereto, incorporated by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K filed on January 11,    2016 (File no. 001-16467).            </font>           </a>          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           10.36          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif">           <a href="https://www.sec.gov/Archives/edgar/data/849636/000149315217000196/ex10-1.htm" style="-sec-extract: exhibit">            <font style="font-size: 10pt">             Form    of Common Stock and Warrant Purchase Agreement, including a Form of Warrant to Purchase Common Stock attached as Exhibit A    thereto, incorporated by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K filed on January 5, 2017    (File no. 001-16467).            </font>           </a>          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           10.37          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif">           <a href="https://www.sec.gov/Archives/edgar/data/849636/000149315217002509/ex10-1.htm" style="-sec-extract: exhibit">            <font style="font-size: 10pt">             Form    of Common Stock and Warrant Purchase Agreement, including a Form of Warrant to Purchase Common Stock attached as Exhibit A    thereto, incorporated by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K filed on March 16, 2017    (File no. 001-16467).            </font>           </a>          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           10.38          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif">           <a href="https://www.sec.gov/Archives/edgar/data/849636/000149315216008803/ex10-1.htm" style="-sec-extract: exhibit">            <font style="font-size: 10pt">             Form    of Exchange Agreement, including a Form of New Warrant attached as Exhibit A thereto, incorporated by reference to Exhibit    10.1 to the Company’s Current Report on Form 8-K filed on April 11, 2016 (File no. 001-16467).            </font>           </a>          </font>         </td>        </tr>       </tbody>      </table>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <!-- Field: Page; Sequence: 102; Value: 59 -->      <div style="margin-bottom: 6pt; border-bottom: Black 1.5pt solid">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="text-align: center; width: 100%">           <!-- Field: Sequence; Type: Arabic; Name: PageNo -->           62           <!-- Field: /Sequence -->          </td>         </tr>        </tbody>       </table>      </div>      <div style="break-before: page; margin-top: 6pt">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="width: 100%">          </td>         </tr>        </tbody>       </table>      </div>      <!-- Field: /Page -->      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">       <tbody>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           10.39          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; width: 0.1in; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif">           <a href="https://www.sec.gov/Archives/edgar/data/849636/000149315216008803/ex10-2.htm" style="-sec-extract: exhibit">            <font style="font-size: 10pt">             Form    of Exchange Agreement incorporated by reference to Exhibit 10.2 to the Company’s Current Report on Form 8-K filed on    April 11, 2016 (File no. 001-16467).            </font>           </a>          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           10.40          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif">           <a href="https://www.sec.gov/Archives/edgar/data/849636/000149315217000196/ex10-1.htm" style="-sec-extract: exhibit">            <font style="font-size: 10pt">             Form    of Purchase Agreement (including a Form of Warrant) incorporated by reference to Exhibit 10.1 of the Company’s Current    Report on Form 8-K filed on January 5, 2017 (File no. 001-16467)            </font>           </a>          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           10.41          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif">           <a href="https://www.sec.gov/Archives/edgar/data/849636/000149315217002509/ex10-1.htm" style="-sec-extract: exhibit">            <font style="font-size: 10pt">             Form    of Purchase Agreement (including a Form of Warrant) incorporated by reference to Exhibit 10.1 of the Company’s Current    Report on Form 8-K filed on April 3, 2017 (File no. 001-16467)            </font>           </a>          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           10.42†          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif">           <a href="https://www.sec.gov/Archives/edgar/data/849636/000149315217013568/ex10-1.htm" style="-sec-extract: exhibit">            <font style="font-size: 10pt">             Amendment    No. One of the Employment Agreement of Jeff E. Margolis, effective July 1, 2017, incorporated by reference to Exhibit 10.1    of the Company’s Quarterly Report on Form 10-Q filed on November 20, 2017 (File no. 001-16467)            </font>           </a>          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           10.43          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif">           <a href="https://www.sec.gov/Archives/edgar/data/849636/000149315217010064/ex10-1.htm" style="-sec-extract: exhibit">            <font style="font-size: 10pt">             Form    of Purchase Agreement (including a Form of Warrant) incorporated by reference to Exhibit 10.1 of the Company’s Current    Report on Form 8-K filed on August 30, 2017 (File no. 001-16467)            </font>           </a>          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           10.44          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif">           <a href="https://www.sec.gov/Archives/edgar/data/849636/000149315217010064/ex10-1.htm" style="-sec-extract: exhibit">            <font style="font-size: 10pt">             Form    of Purchase Agreement (including a Form of Warrant) incorporated by reference to Exhibit 10.1 of the Company’s Current    Report on Form 8-K filed on October 3, 2017 (File no. 001-16467)            </font>           </a>          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           10.45†          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif">           <a href="https://www.sec.gov/Archives/edgar/data/849636/000149315217014606/ex10-3.htm" style="-sec-extract: exhibit">            <font style="font-size: 10pt">             Second    Amendment of the Amended and Restated RespireRx Pharmaceuticals Inc. 2015 Stock and Stock Option Plan incorporated by reference    to Exhibit 10.3 of the Company’s Current Report on Form 8-K filed on December 14, 2017 (File no. 001-16467)            </font>           </a>          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           10.46          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif">           <a href="https://www.sec.gov/Archives/edgar/data/849636/000149315218005052/ex99-1.htm" style="-sec-extract: exhibit">            <font style="font-size: 10pt">             Form    of Demand Promissory Note incorporated by reference to Exhibit 99.1 to the Company’s Current Report on Form 8-K filed    on April 11, 2018.            </font>           </a>          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           10.47          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="padding-left: -10pt; font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif">           <a href="https://www.sec.gov/Archives/edgar/data/849636/000149315218008285/ex99-1.htm" style="-sec-extract: exhibit">            <font style="font-size: 10pt">             Form    of Note Exchange Agreement, incorporated by reference to Exhibit 99.1 to the Company’s Current Report on Form 8-K filed    on June 6, 2018.            </font>           </a>          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           10.48          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif">           <a href="https://www.sec.gov/Archives/edgar/data/849636/000149315218013161/ex10-1.htm" style="-sec-extract: exhibit">            <font style="font-size: 10pt">             Form    of Purchase Agreement (including a Form of Warrant), incorporated by reference to the Company’s Current Report on Form    8-K filed on September 12, 2018 (File no. 1-16467).            </font>           </a>          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           10.49          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif">           <a href="https://www.sec.gov/Archives/edgar/data/849636/000149315218016366/ex10-1.htm" style="-sec-extract: exhibit">            <font style="font-size: 10pt">             Development    and Supply Agreement, dated September 4, 2018, between the Company and Noramco, Inc., incorporated by reference to Exhibit    10.1 of the Company’s Quarterly Report on Form 10-Q filed on November 16, 2018.            </font>           </a>          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           10.50          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif">           <a href="https://www.sec.gov/Archives/edgar/data/849636/000149315218017611/ex99-1.htm" style="-sec-extract: exhibit">            <font style="font-size: 10pt">             Form    of Convertible Promissory Note (including a Form of Warrant), incorporated by reference to the Company’s Current Report    on Form 8-K filed on December 17, 2018 (File no. 1-16467).            </font>           </a>          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           10.51          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif">           <a href="https://www.sec.gov/Archives/edgar/data/849636/000149315218017611/ex99-1.htm" style="-sec-extract: exhibit">            <font style="font-size: 10pt">             Form    of Convertible Promissory Note (including the Form of Warrant), incorporated by reference to the Company’s Current Report    on Form 8-K (file no. 1-16467) filed March 5, 2019.            </font>           </a>          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           10.52          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif">           <a href="https://www.sec.gov/Archives/edgar/data/849636/000149315219006161/ex99-1.htm" style="-sec-extract: exhibit">            <font style="font-size: 10pt">             Securities    Purchase Agreement, dated April 24, 2019, between RespireRx Pharmaceuticals Inc. and Power Up Lending Group Ltd., incorporated    by reference to the Company’s Current Report on Form 8-K (file no. 1-16467) filed April 30, 2019.            </font>           </a>          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           10.53          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif">           <a href="https://www.sec.gov/Archives/edgar/data/849636/000149315219006161/ex99-2.htm" style="-sec-extract: exhibit">            <font style="font-size: 10pt">             Convertible    Promissory Note, dated April 24, 2019, incorporated by reference to the Company’s Current Report on Form 8-K (file no.    1-16467) filed April 30, 2019.            </font>           </a>          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           10.54          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif">           <a href="https://www.sec.gov/Archives/edgar/data/849636/000149315219008173/ex99-1.htm" style="-sec-extract: exhibit">            <font style="font-size: 10pt">             Securities    Purchase Agreement, dated May 17, 2019, between RespireRx Pharmaceuticals Inc. and Crown Bridge Partners, LLC, incorporated    by reference to the Company’s Current Report on Form 8-K (file no. 1-16467) filed May 23, 2019.            </font>           </a>          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           10.55          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif">           <a href="https://www.sec.gov/Archives/edgar/data/849636/000149315219008173/ex99-2.htm" style="-sec-extract: exhibit">            <font style="font-size: 10pt">             Convertible    Promissory Note, dated May 17, 2019, incorporated by reference to the Company’s Current Report on Form 8-K (file no.    1-16467) filed May 23, 2019.            </font>           </a>          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           10.56          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif">           <a href="https://www.sec.gov/Archives/edgar/data/849636/000149315219008173/ex99-3.htm" style="-sec-extract: exhibit">            <font style="font-size: 10pt">             Common    Stock Purchase Warrant, dated May 17, 2019, incorporated by reference to the Company’s Current Report on Form 8-K (file    no. 1-16467) filed May 23, 2019.            </font>           </a>          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           10.57          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif">           <a href="https://www.sec.gov/Archives/edgar/data/849636/000149315219013422/ex99-1.htm" style="-sec-extract: exhibit">            <font style="font-size: 10pt">             Securities    Purchase Agreement, dated August 19, 2019, between RespireRx Pharmaceuticals Inc. and FirstFire Global Opportunities Fund,    LLC, incorporated by reference to the Company’s Current Report on Form 8-K (file no. 1-16467) filed August 27, 2019.            </font>           </a>          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           10.58          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif">           <a href="https://www.sec.gov/Archives/edgar/data/849636/000149315219013422/ex99-2.htm" style="-sec-extract: exhibit">            <font style="font-size: 10pt">             Convertible    Promissory Note, dated August 19, 2019, incorporated by reference to the Company’s Current Report on Form 8-K (file    no. 1-16467) filed August 27, 2019.            </font>           </a>          </font>         </td>        </tr>       </tbody>      </table>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <!-- Field: Page; Sequence: 103; Value: 59 -->      <div style="margin-bottom: 6pt; border-bottom: Black 1.5pt solid">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="text-align: center; width: 100%">           <!-- Field: Sequence; Type: Arabic; Name: PageNo -->           63           <!-- Field: /Sequence -->          </td>         </tr>        </tbody>       </table>      </div>      <div style="break-before: page; margin-top: 6pt">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="width: 100%">          </td>         </tr>        </tbody>       </table>      </div>      <!-- Field: /Page -->      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">       <tbody>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.75in">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           10.59          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; width: 0.1in">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif">           <a href="https://www.sec.gov/Archives/edgar/data/849636/000149315219013422/ex99-2.htm" style="-sec-extract: exhibit">            <font style="font-size: 10pt">             Common    Stock Purchase Warrant, dated August 19, 2019, incorporated by reference to the Company’s Current Report on Form 8-K    (file no. 1-16467) filed August 27, 2019.            </font>           </a>          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           10.60          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif">           <a href="https://www.sec.gov/Archives/edgar/data/849636/000149315219013422/ex99-4.htm" style="-sec-extract: exhibit">            <font style="font-size: 10pt">             Settlement    Agreement and Release, dated August 21, 2019, between RespireRx Pharmaceuticals Inc. and Salamandra, LLC, incorporated by    reference to the Company’s Current Report on Form 8-K (file no. 1-16467) filed August 27, 2019.            </font>           </a>          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           10.61          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif">           <a href="https://www.sec.gov/Archives/edgar/data/849636/000149315219016059/ex99-1.htm" style="-sec-extract: exhibit">            <font style="font-size: 10pt">             Securities    Purchase Agreement, dated October 22, 2019, between RespireRx Pharmaceuticals Inc. and EMA Financial, LLC, incorporated by    reference to the Company’s Current Report on Form 8-K (file no. 1-16467) filed October 28, 2019.            </font>           </a>          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           10.62          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif">           <a href="https://www.sec.gov/Archives/edgar/data/849636/000149315219016059/ex99-2.htm" style="-sec-extract: exhibit">            <font style="font-size: 10pt">             10%    Convertible Note, dated October 22, 2019, incorporated by reference to the Company’s Current Report on Form 8-K (file    no. 1-16467) filed October 28, 2019.            </font>           </a>          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           10.63          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif">           <a href="https://www.sec.gov/Archives/edgar/data/849636/000149315219016059/ex99-3.htm" style="-sec-extract: exhibit">            <font style="font-size: 10pt">             Common    Stock Purchase Warrant, dated October 22, 2019, incorporated by reference to the Company’s Current Report on Form 8-K    (file no. 1-16467) filed October 28, 2019.            </font>           </a>          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           10.64          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif">           <a href="https://www.sec.gov/Archives/edgar/data/849636/000149315219016445/ex99-1.htm" style="-sec-extract: exhibit">            <font style="font-size: 10pt">             Securities    Purchase Agreement, dated November 4, 2019, between RespireRx Pharmaceuticals Inc. and Odyssey Funding, LLC, incorporated    by reference to the Company’s Current Report on Form 8-K (file no. 1-16467) filed November 5, 2019.            </font>           </a>          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           10.65          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif">           <a href="https://www.sec.gov/Archives/edgar/data/849636/000149315219016445/ex99-2.htm" style="-sec-extract: exhibit">            <font style="font-size: 10pt">             RespireRx    Pharmaceuticals Inc. 10% Convertible Redeemable Note due November 4, 2020, dated November 4, 2019, incorporated by reference    to the Company’s Current Report on Form 8-K (file no. 1-16467) filed November 5, 2019.            </font>           </a>          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           10.66          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif">           <a href="https://www.sec.gov/Archives/edgar/data/849636/000149315219019406/ex99-1.htm" style="-sec-extract: exhibit">            <font style="font-size: 10pt">             First    Amendment to Settlement Agreement and Release, dated as of December 16, 2019, between RespireRx Pharmaceuticals Inc. and Salamandra,    LLC, incorporated by reference to the Company’s Current Report on Form 8-K (file no. 1-16467) filed December 18, 2019.            </font>           </a>          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif">           10.67          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <a href="https://www.sec.gov/Archives/edgar/data/849636/000149315220003320/ex99-1.htm" style="-sec-extract: exhibit">           <font style="font-family: Times New Roman, Times, Serif">            Company Option Agreement, dated as of March 2, 2020, by and between the UWM Research Foundation, Inc. and RespireRx Pharmaceuticals Inc. (incorporated by reference to the Company’s Current Report on Form 8-K (file no. 1-16467) filed March 4, 2020).           </font>          </a>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif">           10.68          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <a href="https://www.sec.gov/Archives/edgar/data/849636/000149315220004825/ex99-1.htm" style="-sec-extract: exhibit">           <font style="font-family: Times New Roman, Times, Serif">            Form of Exchange Agreement (incorporated by reference to the Company’s Current Report on Form 8-K (file no. 1-16467) filed March 26, 2020).           </font>          </a>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif">           10.69          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <a href="https://www.sec.gov/Archives/edgar/data/849636/000149315220006852/ex99-1.htm" style="-sec-extract: exhibit">           <font style="font-family: Times New Roman, Times, Serif">            Securities Purchase Agreement, dated April 15, 2020, between RespireRx Pharmaceuticals Inc. and Power Up Lending Group Ltd. (incorporated by reference to Exhibit 99.1 of the Company’s Current Report on Form 8-K (file no. 001-16467) filed on April 21, 2020).           </font>          </a>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif">           10.70          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <a href="https://www.sec.gov/Archives/edgar/data/849636/000149315220006852/ex99-2.htm" style="-sec-extract: exhibit">           <font style="font-family: Times New Roman, Times, Serif">            Convertible Promissory Note, dated April 15, 2020, in favor of Power Up Lending Group Ltd. (incorporated by reference to Exhibit 99.2 of the Company’s Current Report on Form 8-K (file no. 001-16467) filed on April 21, 2020).           </font>          </a>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif">           10.71          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <a href="https://www.sec.gov/Archives/edgar/data/849636/000149315220011015/ex99-1.htm" style="-sec-extract: exhibit">           <font style="font-family: Times New Roman, Times, Serif">            Securities Purchase Agreement, dated June 7, 2020, between RespireRx Pharmaceuticals Inc. and Power Up Lending Group Ltd. (incorporated by reference to Exhibit 99.1 of the Company’s Current Report on Form 8-K (file no. 001-16467) filed on June 11, 2020).           </font>          </a>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif">           10.72          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <a href="https://www.sec.gov/Archives/edgar/data/849636/000149315220011015/ex99-2.htm" style="-sec-extract: exhibit">           <font style="font-family: Times New Roman, Times, Serif">            Convertible Promissory Note, dated June 7, 2020, in favor of Power Up Lending Group Ltd. (incorporated by reference to Exhibit 99.2 of the Company’s Current Report on Form 8-K (file no. 001-16467) filed on June 11, 2020).           </font>          </a>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif">           10.73†          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <a href="https://www.sec.gov/Archives/edgar/data/849636/000149315220007848/ex99-1.htm" style="-sec-extract: exhibit">           <font style="font-family: Times New Roman, Times, Serif">            Employment Agreement, dated May 6, 2020, between RespireRx Pharmaceuticals Inc. and Timothy Jones (incorporated by reference to Exhibit 99.1 of the Company’s Current Report on Form 8-K (file no. 001-16467) filed on May 6, 2020).           </font>          </a>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif">           10.74†          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <a href="https://www.sec.gov/Archives/edgar/data/849636/000149315220014502/ex99-5.htm" style="-sec-extract: exhibit">           <font style="font-family: Times New Roman, Times, Serif">            Amendment No. 1 to Employment Agreement of Timothy Jones, effective July 31, 2020 (incorporated by reference to Exhibit 99.1 of the Company’s Current Report on Form 8-K (file no. 001-16467) filed on August 3, 2020).           </font>          </a>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif">           10.75†          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <a href="https://www.sec.gov/Archives/edgar/data/849636/000149315220007848/ex99-7.htm" style="-sec-extract: exhibit">           <font style="font-family: Times New Roman, Times, Serif">            Fourth Amendment of Amended and Restated RespireRx Pharmaceuticals Inc. 2015 Stock and Stock Option Plan (incorporated by reference to Exhibit 99.7 of the Company’s Current Report on Form 8-K (file no. 001-16467) filed on May 6, 2020).           </font>          </a>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif">           10.76†          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <a href="https://www.sec.gov/Archives/edgar/data/849636/000149315220014502/ex99-14.htm" style="-sec-extract: exhibit">           <font style="font-family: Times New Roman, Times, Serif">            Fifth Amendment of Amended and Restated RespireRx Pharmaceuticals Inc. 2015 Stock and Stock Option Plan (incorporated by reference to Exhibit 99.14 of the Company’s Current Report on Form 8-K (file no. 001-16467) filed on August 3, 2020).           </font>          </a>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif">           10.77          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <a href="https://www.sec.gov/Archives/edgar/data/849636/000149315220012745/ex99-1.htm" style="-sec-extract: exhibit">           <font style="font-family: Times New Roman, Times, Serif">            Securities Purchase Agreement, dated July 2, 2020, between RespireRx Pharmaceuticals Inc. and FirstFire Global Opportunities Fund, LLC (incorporated by reference to Exhibit 99.1 of the Company’s Current Report on Form 8-K (file no. 001-16467) filed on July 7, 2020).           </font>          </a>         </td>        </tr>       </tbody>      </table>      <p style="margin: 0">       <font style="font-family: Times New Roman, Times, Serif">       </font>      </p>      <p style="margin: 0">      </p>      <!-- Field: Page; Sequence: 104; Value: 59 -->      <div style="margin-bottom: 6pt; border-bottom: Black 1.5pt solid">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="text-align: center; width: 100%">           <!-- Field: Sequence; Type: Arabic; Name: PageNo -->           64           <!-- Field: /Sequence -->          </td>         </tr>        </tbody>       </table>      </div>      <div style="break-before: page; margin-top: 6pt">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="width: 100%">          </td>         </tr>        </tbody>       </table>      </div>      <!-- Field: /Page -->      <p style="margin: 0">       <font style="font-family: Times New Roman, Times, Serif">       </font>      </p>      <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">       <tbody>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.75in">          <font style="font-family: Times New Roman, Times, Serif">           10.78          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.1in">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <a href="https://www.sec.gov/Archives/edgar/data/849636/000149315220012745/ex99-2.htm" style="-sec-extract: exhibit">           <font style="font-family: Times New Roman, Times, Serif">            Convertible Promissory Note, dated July 2, 2020, in favor of FirstFire Global Opportunities Fund, LLC (incorporated by reference to Exhibit 99.2 of the Company’s Current Report on Form 8-K (file no. 001-16467) filed on July 7, 2020).           </font>          </a>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif">           10.79          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <a href="https://www.sec.gov/Archives/edgar/data/849636/000149315220012745/ex99-3.htm" style="-sec-extract: exhibit">           <font style="font-family: Times New Roman, Times, Serif">            Common Stock Purchase Warrant, dated July 2, 2020, in favor of FirstFire Global Opportunities Fund, LLC (incorporated by reference to Exhibit 99.3 of the Company’s Current Report on Form 8-K (file no. 001-16467) filed on July 7, 2020).           </font>          </a>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif">           10.80†          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <a href="https://www.sec.gov/Archives/edgar/data/849636/000149315220013182/ex99-1.htm" style="-sec-extract: exhibit">           <font style="font-family: Times New Roman, Times, Serif">            Exchange Agreement, dated July 13, 2020, between RespireRx Pharmaceuticals Inc. and Jeff Eliot Margolis (incorporated by reference to Exhibit 99.1 of the Company’s Current Report on Form 8-K (file no. 001-16467) filed on July 13, 2020).           </font>          </a>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif">           10.81†          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <a href="https://www.sec.gov/Archives/edgar/data/849636/000149315220013182/ex99-2.htm" style="-sec-extract: exhibit">           <font style="font-family: Times New Roman, Times, Serif">            Exchange Agreement, dated July 13, 2020, between RespireRx Pharmaceuticals Inc. and Arnold S. Lippa (incorporated by reference to Exhibit 99.1 of the Company’s Current Report on Form 8-K (file no. 001-16467) filed on July 13, 2020).           </font>          </a>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif">           10.82          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <a href="https://www.sec.gov/Archives/edgar/data/849636/000149315220014502/ex99-1.htm" style="-sec-extract: exhibit">           <font style="font-family: Times New Roman, Times, Serif">            Equity Purchase Agreement, dated July 28, 2020, between RespireRx Pharmaceuticals Inc. and White Lion Capital, LLC (incorporated by reference to Exhibit 99.1 of the Company’s Current Report on Form 8-K (file no. 001-16467) filed on August 3, 2020).           </font>          </a>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif">           10.83          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <a href="https://www.sec.gov/Archives/edgar/data/849636/000149315220014502/ex99-2.htm" style="-sec-extract: exhibit">           <font style="font-family: Times New Roman, Times, Serif">            Registration Rights Agreement, dated July 28, 2020, between RespireRx Pharmaceuticals Inc. and White Lion Capital, LLC (incorporated by reference to Exhibit 99.2 of the Company’s Current Report on Form 8-K (file no. 001-16467) filed on August 3, 2020).           </font>          </a>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif">           10.84          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <a href="https://www.sec.gov/Archives/edgar/data/849636/000149315220014502/ex99-3.htm" style="-sec-extract: exhibit">           <font style="font-family: Times New Roman, Times, Serif">            8% Fixed Promissory Note, dated July 28, 2020 in favor of White Lion Capital, LLC (incorporated by reference to Exhibit 99.3 of the Company’s Current Report on Form 8-K (file no. 001-16467) filed on August 3, 2020).           </font>          </a>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif">           10.85          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <a href="https://www.sec.gov/Archives/edgar/data/849636/000149315220018916/ex99-6.htm" style="-sec-extract: exhibit">           <font style="font-family: Times New Roman, Times, Serif">            Amendment No. 1 to 8% Fixed Promissory Note in favor of White Lion Capital, LLC, dated September 30, 2020 (incorporated by reference to Exhibit 99.6 of the Company’s Current Report on Form 8-K (file no. 001-16467) filed on October 5, 2020).           </font>          </a>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif">           10.86†          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <a href="https://www.sec.gov/Archives/edgar/data/849636/000149315220014502/ex99-5.htm" style="-sec-extract: exhibit">           <font style="font-family: Times New Roman, Times, Serif">            Amendment No. 1 to Employment Agreement of Timothy Jones, effective July 31, 2020 (incorporated by reference to Exhibit 99.5 of the Company’s Current Report on Form 8-K (file no. 001-16467) filed on August 3, 2020).           </font>          </a>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif">           10.87†          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <a href="https://www.sec.gov/Archives/edgar/data/849636/000149315220014502/ex99-14.htm" style="-sec-extract: exhibit">           <font style="font-family: Times New Roman, Times, Serif">            Fifth Amendment of Amended and Restated RespireRx Pharmaceuticals Inc. 2015 Stock and Stock Option Plan (incorporated by reference to Exhibit 99.14 of the Company’s Current Report on Form 8-K (file no. 001-16467) filed on August 3, 2020).           </font>          </a>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif">           10.88          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <a href="https://www.sec.gov/Archives/edgar/data/849636/000149315220014604/ex99-1.htm" style="-sec-extract: exhibit">           <font style="font-family: Times New Roman, Times, Serif">            Patent License Agreement, dated as of August 1, 2020, between RespireRx Pharmaceuticals Inc. and the University of Wisconsin-Milwaukee Research Foundation, Inc. (incorporated by reference to Exhibit 99.1 of the Company’s Current Report on Form 8-K (file no. 001-16467) filed on August 4, 2020).           </font>          </a>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif">           10.89          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <a href="https://www.sec.gov/Archives/edgar/data/849636/000149315220014604/ex99-4.htm" style="-sec-extract: exhibit">           <font style="font-family: Times New Roman, Times, Serif">            Securities Purchase Agreement, dated July 30, 2020, between RespireRx Pharmaceuticals Inc. and EMA Financial, LLC (incorporated by reference to Exhibit 99.4 of the Company’s Current Report on Form 8-K (file no. 001-16467) filed on August 4, 2020).           </font>          </a>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif">           10.90          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <a href="https://www.sec.gov/Archives/edgar/data/849636/000149315220014604/ex99-5.htm" style="-sec-extract: exhibit">           <font style="font-family: Times New Roman, Times, Serif">            10% Convertible Note, dated July 30, 2020, in favor of EMA Financial, LLC (incorporated by reference to Exhibit 99.5 of the Company’s Current Report on Form 8-K (file no. 001-16467) filed on August 4, 2020).           </font>          </a>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif">           10.91          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <a href="https://www.sec.gov/Archives/edgar/data/849636/000149315220014604/ex99-6.htm" style="-sec-extract: exhibit">           <font style="font-family: Times New Roman, Times, Serif">            Common Stock Purchase Warrant, dated July 30, 2020, in favor of EMA Financial, LLC (incorporated by reference to Exhibit 99.6 of the Company’s Current Report on Form 8-K (file no. 001-16467) filed on August 4, 2020).           </font>          </a>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif">           10.92†          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <a href="https://www.sec.gov/Archives/edgar/data/849636/000149315220018916/ex99-1.htm" style="-sec-extract: exhibit">           <font style="font-family: Times New Roman, Times, Serif">            Exchange Agreement, dated September 30, 2020, between RespireRx Pharmaceuticals Inc. and Timothy Jones (incorporated by reference to Exhibit 99.1 of the Company’s Current Report on Form 8-K (file no. 001-16467) filed on October 5, 2020).           </font>          </a>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif">           10.93†          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <a href="https://www.sec.gov/Archives/edgar/data/849636/000149315220018916/ex99-2.htm" style="-sec-extract: exhibit">           <font style="font-family: Times New Roman, Times, Serif">            Exchange Agreement, dated September 30, 2020, between RespireRx Pharmaceuticals Inc. and Jeff Eliot Margolis (incorporated by reference to Exhibit 99.2 of the Company’s Current Report on Form 8-K (file no. 001-16467) filed on October 5, 2020).           </font>          </a>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif">           10.94†          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <a href="https://www.sec.gov/Archives/edgar/data/849636/000149315220018916/ex99-3.htm" style="-sec-extract: exhibit">           <font style="font-family: Times New Roman, Times, Serif">            Exchange Agreement, dated September 30, 2020, between RespireRx Pharmaceuticals Inc. and Arnold S. Lippa (incorporated by reference to Exhibit 99.3 of the Company’s Current Report on Form 8-K (file no. 001-16467) filed on October 5, 2020).           </font>          </a>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif">           10.95†          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <a href="https://www.sec.gov/Archives/edgar/data/849636/000149315220018916/ex99-4.htm" style="-sec-extract: exhibit">           <font style="font-family: Times New Roman, Times, Serif">            Exchange Agreement, dated September 30, 2020, between RespireRx Pharmaceuticals Inc. and Marc Radin PC (incorporated by reference to Exhibit 99.4 of the Company’s Current Report on Form 8-K (file no. 001-16467) filed on October 5, 2020).           </font>          </a>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif">           10.96†          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <a href="https://www.sec.gov/Archives/edgar/data/849636/000149315220018916/ex99-5.htm" style="-sec-extract: exhibit">           <font style="font-family: Times New Roman, Times, Serif">            Exchange Agreement, dated September 30, 2020, between RespireRx Pharmaceuticals Inc. and Patent Network Law Group (incorporated by reference to Exhibit 99.5 of the Company’s Current Report on Form 8-K (file no. 001-16467) filed on October 5, 2020).           </font>          </a>         </td>        </tr>       </tbody>      </table>      <p style="margin: 0">       <font style="font-family: Times New Roman, Times, Serif">       </font>      </p>      <p style="margin: 0">      </p>      <!-- Field: Page; Sequence: 105; Value: 59 -->      <div style="margin-bottom: 6pt; border-bottom: Black 1.5pt solid">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="text-align: center; width: 100%">           <!-- Field: Sequence; Type: Arabic; Name: PageNo -->           65           <!-- Field: /Sequence -->          </td>         </tr>        </tbody>       </table>      </div>      <div style="break-before: page; margin-top: 6pt">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="width: 100%">          </td>         </tr>        </tbody>       </table>      </div>      <!-- Field: /Page -->      <p style="margin: 0">       <font style="font-family: Times New Roman, Times, Serif">       </font>      </p>      <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">       <tbody>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           21**          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; width: 0.1in; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           <a href="ex21.htm">            Subsidiaries    of the Registrant.           </a>          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           23.1**          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           <a href="ex23-1.htm">            Consent    of Haskell &amp; White LLP, Independent Registered Public Accounting Firm.           </a>          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           24**          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif">           <a href="#b_007">            <font style="font-size: 10pt">             Power    of Attorney (included as part of the signature page of this Annual Report on Form 10-K).            </font>           </a>          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           31.1**          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           <a href="ex31-1.htm">            Certification    of Chief Executive Officer Pursuant to Rule 13a-14(a)/15d-14(a) of the Securities Exchange Act of 1934.           </a>          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           31.2**          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           <a href="ex31-2.htm">            Certification    of Chief Financial Officer Pursuant to Rule 13a-14(a)/15d-14(a) of the Securities Exchange Act of 1934.           </a>          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           32**          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           <a href="ex32.htm">            Certification    of Chief Executive Officer and Chief Financial Officer Pursuant to Rule 13a-14(b)/15d-14(b) of the Securities Exchange Act    of 1934 and 18 U.S.C. Section 1350.           </a>          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           101.INS**          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           XBRL    Instance Document.          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           101.SCH**          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           XBRL    Taxonomy Extension Schema Document.          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           101.CAL**          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           XBRL    Taxonomy Extension Calculation Linkbase Document†          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           101.DEF**          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           XBRL    Taxonomy Extension Definition Linkbase Document.          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           101.LAB**          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           XBRL    Taxonomy Extension Label Linkbase Document.          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           101.PRE**          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           XBRL    Taxonomy Extension Presentation Linkbase Document.          </font>         </td>        </tr>       </tbody>      </table>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">       <tbody>        <tr style="font: 10pt Times New Roman, Times, Serif">         <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           †          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; width: 99%; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           Each    of these Exhibits constitutes a management contract, compensatory plan or arrangement.          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif">         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           **          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           Filed    herewith.          </font>         </td>        </tr>       </tbody>      </table>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <!-- Field: Page; Sequence: 106; Value: 59 -->      <div style="margin-bottom: 6pt; border-bottom: Black 1.5pt solid">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="text-align: center; width: 100%">           <!-- Field: Sequence; Type: Arabic; Name: PageNo -->           66           <!-- Field: /Sequence -->          </td>         </tr>        </tbody>       </table>      </div>      <div style="break-before: page; margin-top: 6pt">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="width: 100%">          </td>         </tr>        </tbody>       </table>      </div>      <!-- Field: /Page -->      <p style="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         <a name="b_007">         </a>         Signatures        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Pursuantto the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this reportto be signed on its behalf by the undersigned, thereunto duly authorized.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">       <tbody>        <tr style="font: 10pt Times New Roman, Times, Serif">         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td colspan="2" style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           <b>            RESPIRERX    PHARMACEUTICALS INC.           </b>          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif">         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td colspan="2" style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif">         <td style="font: 10pt Times New Roman, Times, Serif; width: 50%">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           Date:    April 15, 2021          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; width: 3%">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           By:          </font>         </td>         <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 47%">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           <i>            /s/    Timothy L. Jones           </i>          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif">         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           Timothy    L. Jones          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif">         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           President,    Chief Executive Officer, and Director          </font>         </td>        </tr>       </tbody>      </table>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        We,the undersigned directors and officers of RespireRx Pharmaceuticals Inc., do hereby constitute and appoint each of TimothyL. Jones., and Jeff E. Margolis as our true and lawful attorneys-in-fact and agents with power of substitution, to do anyand all acts and things in our name and behalf in our capacities as directors and officers and to execute any and all instrumentsfor us and in our names in the capacities indicated below, which said attorneys-in-fact and agents, or either of them, may deemnecessary or advisable to enable said corporation to comply with the Securities and Exchange Act of 1934, as amended, and anyrules, regulations and requirements of the Securities and Exchange Commission, in connection with this Annual Report on Form 10-K,including specifically but without limitation, power and authority to sign for us or any of us in our names in the capacitiesindicated below, any and all amendments hereto; and we do hereby ratify and confirm all that said attorney-in-fact and agent,shall do or cause to be done by virtue hereof.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Inaccordance with the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of theregistrant and in the capacities and on the dates indicated.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">       <tbody>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">         <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; width: 26%; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           <b>            Signature           </b>          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; width: 2%">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           <b>           </b>          </font>         </td>         <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 57%; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           <b>            Title           </b>          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; width: 2%">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           <b>           </b>          </font>         </td>         <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 13%; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           <b>            Date           </b>          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td colspan="2" style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td colspan="2" style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif">         <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           <i>            /s/    Timothy Jones           </i>          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           President,    Chief Executive Officer and Director          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: top; text-align: center">          <font style="font-family: Times New Roman, Times, Serif">           April    15, 2021          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           Timothy    Jones          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif">         </td>         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           <i>            /s/    Jeff E. Margolis           </i>          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           Senior    Vice President, Chief Financial Officer, Treasurer, Secretary,          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: center">          <font style="font-family: Times New Roman, Times, Serif">           April    15, 2021          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           Jeff    E. Margolis          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           and    Director          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td colspan="2" style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td colspan="2" style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           <i>            /s/    Arnold S. Lippa, Ph.D.           </i>          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           Chief    Scientific Officer and Executive Chairman of the Board          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: center">          <font style="font-family: Times New Roman, Times, Serif">           April    15, 2021          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           Arnold    S. Lippa, Ph.D.          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td colspan="2" style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td colspan="2" style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           <i>            /s/    Kathryn MacFarlane           </i>          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           Director          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: center">          <font style="font-family: Times New Roman, Times, Serif">           April    15, 2021          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           Kathryn    MacFarlane          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>        </tr>       </tbody>      </table>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <!-- Field: Page; Sequence: 107; Options: Last -->      <div style="margin-bottom: 6pt; border-bottom: Black 1.5pt solid">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="text-align: center; width: 100%">           <!-- Field: Sequence; Type: Arabic; Name: PageNo -->           67           <!-- Field: /Sequence -->          </td>         </tr>        </tbody>       </table>      </div>      <!-- Field: /Page -->     </text>    </filename>   </sequence>  </type> </document></body>